Analysis of Pax6 expression in the developing vertebrate head by Lin, Pei-Cheng David
Analysis of Pax6 expression in the developing vertebrate head
Pei-Cheng David Lin, MSc
Submitted in satisfaction of the requirement for
the degree of Ph.D. in the University of Edinburgh 1997
ABSTRACT
Pax6 is a member of the Pax gene family — a family that encodes highly conserved and
developmentally important transcription factors. Mutation of Pax6 leads to Small eye (Sey) in the
mouse and aniridia in the human. Sey/Sey mice are characterized by craniofacial abnormalities,
including absence of eye and nasal derivatives, formation of supernumerary upper incisor teeth and a
rod-like cartilaginous structure in the premaxilla, as well as defects in the developing brain. This thesis
aims to investigate Pax6 expression in the head region of normal and mutant vertebrate embryos in
order to elucidate its role during development and understand the mutant phenotypes.
Pax6 expression in the mouse is investigated by in situ hybridization, with particular emphasis on the
higher centres of the visual and olfactory nervous system — areas that have not been previously
investigated in detail. Pax6 expression is detected along the visual pathway, in the neural retina, optic
nerve, pretectum, superior colliculus, pulvinar, dorsal and ventral lateral geniculate nucleus and other
neural nuclei that are implicated in visual connections. Within the olfactory nervous system, Pax6 is
expressed in the olfactory and vomeronasal epithelium, main and accessory olfactory bulb, anterior
olfactory nucleus, precommisural hippocampus, piriform and endopiriform cortex, as well as olfactory
and vomeronasal amygdaloid areas. The results demonstrate that Pax6 is extensively expressed
throughout the visual and olfactory pathways and strongly indicate that Pax6 is involved in their
development. It is also shown that Pax6 expression is developmentally restricted during mouse
embryogenesis. The restriction is implicated in neuroblast proliferation, migration, connection and
axonogenesis.
Expression of Pax6 in the chick has not been previously reported for stages later than Hamburger-
Hamilton stage 14. This study confirms formerly reported data before stage 14 and establishes that
Pax6 is expressed in the olfactory epithelium, lens, corneal epithelium, and neural retina after stage 14.
Furthermore, temporary Pax6 expression is found in Hensen's node before stage 9. In the hindbrain, in
addition to the formerly reported expression in all the rhombomeres, Pax6 transcripts are also detected
in cells flanking rhombomeres 3 and 5.
The distribution of Pax6 transcripts in the head surface ectoderm appears to correspond to the
previously reported areas that are capable of forming lens in culture. This suggests a crucial role for
Pax6 in lens differentiation, which is supported by absence of lens in the Sey/Sey mice. The correlation
between Pax6 expression and lens differentiation is investigated by culturing fragments of head surface
ectoderm on millipore membranes. The fragments are then assessed for lens differentiation using an
antibody against aB crystallin and the presence of Pax6 transcripts is checked by in situ hybridization.
The results indicate that lens can differentiate from non-Pax6-expressing fragments of head surface
ectoderm, whilst Pax6-expressing fragments do not always give lens. Whenever lens differentiates in
culture, however, Pax6 is always expressed, suggesting that it is necessary for the process of lens
differentiation.
The phenotype of Sey/Sey mice suggests that Pax6 may play a role in tooth development and this
possibility is preliminarily investigated in this study. The results demonstrate that Pax6 is not expressed
in the premaxilla, suggesting that the supernumerary teeth are not directly caused by Pax6 mutation. To
investigate whether the supernumerary teeth show normal development, the presence of two genes
involved in tooth development, Msx-1 and Msx-2, are examined. The results show that the patterns of
Msx-1 and Msx-2 expression in the Sey/Sey premaxilla are normal, although the area exhibits formerly
reported abnormalities and is developmentally retarded. This suggests that Msx-1 and Msx-2 are not
directly regulated by Pax6. Possible mechanisms that may cause the abnormalities with presumptive
involvement of Pax6 regulation are discussed.
One possible regulator of Pax6 is all-frans-retinoic acid (RA; a derivative of vitamin A). Maternal
vitamin A deficiency causes a variety of abnormalities, including micropthalmia that is also seen in the
Sey/Sey mice. In vitamin A-deficient quail embryos, the segmentation of rhombomeres 4-8, where
Pax6 is expressed, is disturbed. Furthermore, expression of some Pax genes, for example, AmphiPaxl
and Pax2, is affected by RA. This thesis investigates the effect of RA on Pax6 expression during
gastrulation. Six groups of chick embryos at stage 4 are treated in vitro with RA at concentrations from
1 x 10"8 M to 5 x 10° M. Pax6 expression after culture for 30 hours is investigated by wholemount in
situ hybridization. The results show dosage-dependent abnormalities in the head, heart, neural tube,
and somites. Pax6 remains expressed in all the abnormal embryos investigated after RA treatment,
indicating that Pax6 is not switched off by RA. In the head that is severely affected by RA treatment,
most structures are condensed or distorted. In either cases, Pax6 expression patterns are altered. The
alteration appears to be resulted from the gross malformations following RA treatment, although direct
effect of RA on Pax6 expression can not be excluded.
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This thesis deals with the role of Pax6 during vertebrate craniofacial development. Areas of
investigation include the central nervous system (particularly the visual nervous system and the
olfactory nervous system), the eye, and the teeth. The effect of retinoic acid on Pax6 expression during
early embryogenesis is also investigated. To investigate any topic with "gene" and "development"
involved, one has to put these two terms both in conjunction and in contrast. In conjunction means that
one can learn the role of genes during development by looking at their genotypes: normal expression
(both at the RNA and the protein level), up-regulation, down-regulation, loss of function, ectopic
function, function at the wrong time; but one also needs to look at the phenotypes: normal
embryogenesis, hyperplasia, hypoplasia, aplasia, ectopic growth or teratogenesis, early maturation,
growth retardation, and other non-morphological phenomena. In contrast means to compare normal
development with the aftermaths of genetic deviations. Modern developmental biologists (or
geneticists) like to refer to a study started with phenotypes as "genetics" and those started with
genotypes as "reverse genetics", though the latter is becoming the more normal approach.
In the sense mentioned above, I put this introductory chapter in two parts. Part A is the "gene" side and
part B is the "development" side. Part A (from section 1.1 to 1.6) introduces the background and
current knowledge of Pax6, starting with the homeotic mutations and the homeobox genes, then going
on to the Pax gene family — their genomic organization, structures, and expression, and then to the
mutations found in the Pax gene family, with concentrations on Pax6 per se. The common aspects of
the Pax genes are summarized in section 1.6. In part B (from section 1.7 to 1.12), the development of
vertebrate craniofacial areas to be investigated in this thesis, i.e. the central nervous system (particularly
the visual nervous system and the olfactory nervous system), the lens, and the teeth, will be briefly
described. This will provide the necessary background information for further discussions to be
developed in the following chapters. After part A and part B, I will address the questions to be
investigated in this thesis in section 1.13.
1
Part A: the "gene" side
1.1 Homeosis and homeobox genes
This thesis deals with Pax6 which contains a paired-like homeodomain (a specific type of homeobox)
and a paired domain. Section 1.1 will start with the definition of "homeosis", the identification of the
homeotic mutants, the isolation of the homeobox genes, current understanding about these genes and
the importance of homeobox genes in developmental biology. I will then introduce the paired box and
the Pax genes.
1.1.1 Identification of the homeotic mutants and isolation of the homeobox genes
"Homeosis" was a term coined by William Bateson in order to describe "something has been changed
into the likeness of something else" (Bateson, 1894). Twenty-one years later after Bateson introduced
the term "homeosis", the first homeotic mutant -- bithorax, was established in the fruit fly (Bridges and
Morgan, 1923). The second homeotic mutant, the spineless-aristapedia, was found in 1926
(Balkaschina,1929) and the third, proboscipedia, in 1931 (Bridges and Dobzhansky, 1933). After the
development of recombinant DNA techniques in early 1980s, bithorax was found to belong to a
complex gene cluster called BX-C and proboscipedia to another complex — ANT-C. However, before
that, E.B. Lewis had started some insightful genetic analyses and found that mutations in single genes
can result in homeotic transformations. He therefore assumed that the mutations affected master
regulating genes, which might then control consecutive gene activations and specify the plan of body
formation (Lewis, 1978).
In early 1980s, W. Bender and colleagues became the first to isolate the genes in BX-C complex
(Bender, et al, 1983). They were followed by M.P. Scott and collaborators, .who isolated first genes of
the ANT-C complex (Scott, et al., 1983; Gehring, 1987). Although quite a few genes that were
responsible for the homeotic mutations had been isolated at that time, no one had a precise knowledge
on how those genes worked to produce homeotic information during embryonic development. A crucial
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finding came when W.J. Gehring and W.J. McGinnis found a DNA sequence that was conserved
between one homeotic gene and another (McGinnis et al, 1984). The same conserved sequence was
also independently found by M.P. Scott and A.J. Weiner in another laboratory (Scott and Weiner,
1984). The conserved sequence was named the "homeobox" which contained a 180-bp stretch coding
for a homeodomain. Genes that contained the conserved sequence were hence called the homeobox-
containing genes.
The finding of homeobox genes has been a huge impact in the field of developmental biology. In a very
short period of time, dozens of homeobox-containing genes were identified, not only in fruit fly but also
in a wild range of metazoans including vertebrates such as mammals and humans.
1.1.2 Current status of the homeobox genes
To date, the analyses of mouse and human homeobox genes are the most detailed in the vertebrates.
Those genes most closely related to the Drosophila HOM-C (ANT-C and BX-C) complex are denoted
the HOX complex in the vertebrate (reviewed by Krumlauf, 1994). By 1994, the vertebrate HOX
complex had already been found to consist 38 genes that are organized into four different intra-
chromosomal complexes (Hox-a, -b, -c, and -d); each intra-chromosomal complex is approximately 120
kb in length (Krumlauf , 1994). Even to date, the number of Hox genes being found is still increasing.
The HOX genes, however, are only a subset of all the vertebrate homeobox-containing genes. For
example, the homeobox-containing genes in the mouse has been divided into four families according to
their sequence characteristics (Hill et al., 1989). They are Antp-like (Antennapedia), en-like
(engrailed), paired-\\kt, and Msh-Yike (muscle-segment) (Hill et al., 1989). All these families have
homeoboxes similar to those in the Drosophila, but only the Antp-like genes are grouped into the HOX
complex.
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1.1.3 The importance of homeobox genes in developmental biology
The importance of homeobox genes in developmental biology is not revealed just by their large
numbers. Extensive analyses have led to some striking findings in vertebrate embryos: (1) The
expression patterns of Hox genes are spatially restricted according to their physical order along the
chromosomes. This restriction can be found in most developing tissues, including the paraxial
mesoderm, the neural tube, the neural crest, the limbs, the hindbrain segments, the surface ectoderm, the
gut, the branchial arches, and the gonadal tissues (Dolle et al., 1989; Dolle and Duboule, 1989; Graham
et al., 1989; Wilkinson et al., 1989; Gaunt, 1991; Hunt and Krumlauf, 1991; Kessel and Gruss, 1991).
This correlation between the physical order along chromosomes and patterns of expression is termed
"spatial colinearity" (reviewed by Krumlauf, 1994). Typically, "spatial colinearity" is found in a way
that the genes more at 3' end of each gene cluster are expressed more anteriorly in developing tissues,
while those at more 5' end are activated more posteriorly. (2) There is also a "temporal colinearity" of
Hox gene expression during embryogenesis (Krumlauf, 1994). The more 3' a gene is located in each
cluster of Hox genes along the chromosome, the earlier the gene is activated (Munke et al., 1986;
Izpisua-Belmonte et al., 1991). (3) The responding sensitivity to retinoic acid treatment in cell lines or
embryos is also colinear with the organization of Hox genes, i.e. the extreme 3' end gene displays the
highest sensitivity to retinoic acid and the extreme 5' end gene displays the lowest sensitivity (Simeone
et al., 1990, 1991; Papalopulu et al., 1991; Dekker et al., 1993; reviewed by Krumlauf, 1994). These
colinear characteristics of Hox gene expression, along with information from gene knockouts (reviewed
by Krumlauf, 1994) suggest that they are involved in establishing regional identities during vertebrate
embryogenesis.
1.1.4 From the homeobox to the paired box
While the surprising structural-functional correlation of the Hox complexes were being discovered, the
other homeobox-containing gene families, such as paired, msh, engrailed, and Pit-Oct-Unc (POU),
were also under extensive investigation. For example, the msh is an ancient gene family, represented in
animals ranging from coelenterates to mammals (reviewed by Davidson, 1995).
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The paired-box, like the homeobox, was identified as a conserved motif in several Drosophila
developmental genes. These genes in the Drosophila include paired (Frigerio et al., 1986),
gooseberry-proximal, gooseberry-distal (Baumgartner, et al., 1987), Pox meso, and Pox neuro (Bopp
et al., 1991). These first Drosophila paired-box containg genes were used to isolate orthologous genes
in other organisms such as nematodes, zebrafish, urodele, chicken, quail, mouse, rat, and man (Dressier
et al., 1988; Burri et al., 1989; Quiring et al., 1994; Ton et al., 1991; Walther and Gruss, 1991; Li et
al., 1994; Turque et al., 1994; Chisholm and Horvitz, 1995; Krauss et al., 1991; Rio-Tsonis et al.,
1995). Thus, the vertebrate homologues were termed the Pax gene family.
1.2 Paired-box (Pax) gene family
1.2.1 Current members of the Pax gene family
In 1996, eight members of the Pax gene family have been isolated in the mouse (Paxl to Pax8) and
nine members have been isolated in the human (PAX-J to PAX-9), along with other Pax genes found in
other vertebrates. Among them, Paxl, Pax2, Pax3, and Pax6 have been found to be involved in
developmental abnormalities in the mouse, rat, and human (Balling et al., 1988; Hill et al., 1991; Ton et
al., 1991; Epstein et al., 1991; Matsuo et al., 1993; Keller et al., 1994; Sanyanusin et al., 1995).
Since the Pax gene family is best characterised in the mouse, I will introduce most of the information in
the mouse. Information on Pax genes in other species will only be referred to if it is relevant to this
thesis.
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1.2.2 Genomic organization and structure of the Pax gene family
1.2.2.1 Genomic organization
Unlike the Hox genes, Pax genes are not arranged in physical clusters along chromosomes (Stapelton et
al., 1993; Pilz et al., 1993; Walther et al., 1991). The eight mouse Pax genes are located on five
different chromosomes (chromosomes 1, 2, 4, 6 and 19) and the nine human PAX genes are located on
eight different chromosomes (chromosomes 1, 2, 7, 9, 10, 11, 14, 20) (Stuart et al., 1994; Chalepakis et
al., 1992; Hill and Hanson, 1992).
1.2.2.2 Structure
1.2.2.2.1 Gene structure
Vertebrate Pax genes contain three elements: a paired domain, a paired-specific homeodomain and a
sequence encoding for an octapeptide (see figure 1.1 on the following page). They are arranged in a
physical order as 5' — paired box — octapeptide — paired-like homeodomain — 3' (Hill and Hanson,
1992). The three elements (paired box, octapeptide, and paired-like homeodomain) vary from one
member of the gene family to another so that, according to structure, the murine and human Pax genes
can be grouped into four classes. The first class consists of Paxl and Pax9. They encode a paired
domain and a conserved octapeptide sequence but lack a homeodomain. The second class consists of
Pax3 and Pax7. They have in addition to a paired domain, an octapeptide sequence and a full
homeodomain. The third class is represented by Pax2, Pax5 and Pax8. Each encodes a paired domain
and an octapeptide, but only a partial homeodomain. Pax4 and Pax6 represent the fourth class. They
encode a paired domain and a homeodomain but lack an octapeptide. This structure-based
classification of the mouse and the human Pax genes has, to some extent, some implications of their
expression patterns, particularly in the developing central nervous system (to be detailed in section
1.6.5) (Chalepakis et al., 1993).
6
1.2.2.2.2 Messenger RNA
Pax genes encode mRNAs ranging from 3.0 to 5.0 kb in length, with the exception of Pax5 whose
mRNA is 9.5 - 10 kb long (Adams et al., 1992; Chalepakis et al., 1993; Chalepakis et al., 1992). Each
Pax gene probably has its alternative splice products, though so far only some Pax genes have been
identified as having mRNA isoforms. For example, Pax2 (Dressier and Douglass, 1992) and Pax6
(Walther and Gruss, 1991) each have two isoforms of mRNA; Pax8 has six splice products termed
Pax8a to Pax&f (Kozmik et al., 1993). These alternative splice products do not differ in DNA-binding
ability but each isoform has its distinct transactivation ability (Stuart et al., 1993).
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1.2.2.2.3 Pax protein
Pax proteins vary from 361 to 479 amino acids in length (Chalepakis et al., 1992). The paired domain
consists of a stretch of 128 amino acids and shows no obvious resemblance to other known DNA-
binding motifs (Gruss and Walther, 1992). Pax proteins are assumed to act as nuclear transcription
factors because they are present in the nucleus and they are able to bind DNA in vitro (Dressier and
Douglas, 1992; Adama et al., 1992; Chalepakis et al., 1991; Chalepakis et al., 1994; Zannini et al.,
1992).
Although only a few of the physiological targets of the Pax proteins have been identified, optimal
binding sites have been selected from randomized DNA for the paired domains of Drosophila Prd
protein and Pax2, Pax5, Pax6, and Pax8 proteins of mouse (Czerny et al., 1993; Epstein et al., 1994;
Xu et al., 1995). The Prd protein (encoded by paired gene) of the Drosophila is the most studied so far
and thus provides an example of how Pax proteins interact with their target DNA sequences. Prd is
shown to bind to the sequence in the even-skipped promotor fraction e5 (Triesman et al , 1989;
Triesman et al, 1991). The target sequences bound by Prd protein include an ATTA motif which is
recognized by the homeodomain, and further downstream sequences of the ATTA motif are presumably
targeted by the paired domain (Triesman et al., 1991). Furthermore, a pentanucleotide GTTCC has
been identified as the DNA binding core motif recognized by the paired domain (Chalepakis et al.,
1991). A further analysis using Pax5 protein leads to the proposal of a DNA-paired domain interaction
model in which the paired domain is composed of two subdomains (bipartite structure) that bind to the
two sites in adjacent major grooves on the same side of the target DNA helix (Czerny et al., 1993).
This "bipartite structure" of the paired domain is clearly demonstrated by the crystal structure of
Drosophila Prd protein in a paired domain-15 bp DNA complex (Xu et al., 1995). The N-terminal
domain of the bipartite structure consists of a turn which makes critical contacts in the minor groove,
while a HTH (Helix-Turn-Helix) unit makes critical contacts in the major groove (Xu et al., 1995).
Analyses of crystal structures will provide a firm interpretation of the known Pax developmental
mutations.
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For Pax6, at least four variants (p46, p48, p43, and p33/32) have been detected in cellular extracts using
specific antisera (reviewed by Cvekl and Joram, 1996). The presence of four Pax6 variants raises
questions such as whether they possess equal transcriptional activity, whether all the four variants are
present in developing cells in vivo, as well as whether they maintain relatively constant amounts during
cellular differentiation. These questions are to be answered by further investigations in the future.
1.3 Pax gene expression and mutation - a general picture
Section 1.3 will briefly describe the areas of Pax gene expression and their mutations, except for Pax4
which is not yet published, and Pax6 which will be described in detail in section 1.4. Since Pax genes
have been more commonly investigated in the mouse (except for Pax9 that is only described in the
chick), I will concentrate on information in the mouse, with data in human mutations if available. My
intention here is to give a general picture of Pax gene expression and mutation in the vertebrate so that
common aspects of the Pax genes may become explicit. For Pax6 per se, detailed expression profiles
and mutations in all published reports available so far will be described in section 1.4 and section 1.5.
1.3.1 PaxI
Paxl mutation leads to undulated in the mouse. Mouse undulated mutation is characterized by
distortions to the vertebral column and sternum, fusion of the sternebrae, absence of intervertebral
disks, reduction in the posterior part of the vertebrae, as well as fusions of the dorsal root ganglia,
abnormalities of the pectoral girdle and reductions in the thymus and facial skeleton (Gruneberg, 1954;
Deutsch et al., 1988; Dietrich et ai, 1993; Koseki et al., 1993; Timmons et al., 1994; Wallin et al.,
1994; Dietrich and Gruss, 1995). It was originally identified by Wright (Wright, 1947) and described
and designated "un" by Carter (Carter, 1947). Three alleles of the mouse Paxl mutants have been
established so far: un, un", and un (Balling et al., 1988; 1992; Dietrich and Gruss, 1995). All three
alleles display axial skeletal defects. Ectopic expression of Paxl transforms cells and lead them to
oncogenesis (Maulbecker and Gruss, 1993).
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Paxl is expressed mainly in mesodermal tissues, notably during the formation of axial structures, the
vertebral bodies, and the intervertebral disks (Deutsch et al., 1988; Dietrich et al., 1993; Wallin et al.,
1994; Dietrich and Gruss, 1995). Paxl is also expressed in extra-vertebral tissues such as in the
connective tissues surrounding dorsal root ganglia, in the anterior forelimb, in the endoderm of the
pharangeal pouches, and in the mandibular/maxillary processes (Deutsch et al., 1988; Dietrich et al.,
1993; Timmons et al., 1994; Wallin et al., 1994; Dietrich and Gruss, 1995). Paxl is not expressed in
the developing central nervous system, which is unusual among Pax genes (Deutsch et al., 1988). The
chPaxl (chick Paxl) expression is similar to that of the mouse. It is expressed in the developing
pectoral girdle, in cells of the ventral part of sclerotomes, in sclerotome cells of the perichordal tube,
and later in sclerotome-derived cells in the intervertebral disks (Peters et al., 1995).
The spectrum of mutant phenotypes, the expression data, and the transforming ability induced by
ectopic expression suggest that Paxl could be important for regulating the proliferation of specific
precursor cell populations. It may also play a role in regulating the early differentiation of affected
structures, for example, by controlling the condensation of cells (Maulbecker and Gruss, 1993;
Timmons et al., 1994; Dietrich and Gruss, 1995).
1.3.2 Pax2
Pax2 is involved in kidney and eye development. This is from evidence of gene expression patterns
(Dressier et al., 1990; Nornes et al., 1990), gene regulation studies (Rothenpieler and Dressier, 1993;
Dressier et al., 1993; Phelps and Dressier, 1993; Ryan et al., 1995), together with analyses of
phenotypes from mutations in the mouse (Keller et al., 1994) and in the human (Sanyanusin et al.,
1995).
Pax2 is expressed during the differentiation of renal epithelium, being first in the induced mesenchyme
and then in the same population of cells through transition and condensation stages (Dressier et al.,
1990; Dressier and Douglass, 1990). In more mature renal epithelium, Pax2 is downregulated (Dressier
and Douglass, 1990). In the developing eye, Pax2 transcripts are first present in the distal part of the
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optic vesicle before optic cup is formed. After optic cup formation, Pax2 expression is restricted to the
optic stalk and the ventral half to two-thirds of both inner and outer layers of the optic cup (Nornes et
al., 1990). Pax2 is then expressed during optic nerve formation, in the region that forms the optic
fissure, at the exit of the optic nerves from the eye, in the optic disk, optic stalk, and in cells along the
vitreal border of the neuroblast layer of the central retina (Nornes et al., 1990).
Phenotypes correlate well with expression data and with the roles of Pax2 in kidney and eye
development. In the mouse, dominant kidney and retina defects (Krd) have been described with a
deletion including the entire Pax2 sequences (Keller et al., 1994). In the human, a frame-shift mutation
is found in a family manifested with eye and kidney defects (Sanyanusin et al., 1995).
1.3.3 Pax3
Pax3 seems to involve in the regulation of proliferation during neural tube development, as well as in
neural crest migration and in the development of limb musculature. This is based on expression pattern
(Goulding et al., 1991; Bober et al., 1994; Tsukamato et al., 1994), mutant defects from mouse Splotch
mutation (Epstein et al., 1991, 1993; Goulding et al., 1993; Vogan et al., 1993), and human
Waardenburgh syndrome (Tassabehji et al., 1992; Baldwin et al., 1992; Hoth et al., 1993; reviewed by
Farrar et al., 1994).
Pax3 is expressed in the dorsal neural tube and in neural crest derivatives such as the dorsal root
ganglia, as well as in some lateral parts of somites from which limb musculature is derived (Goulding et
al., 1991). In the mouse, homozygous Splotch animals exhibit neural tube defects, deficiencies in
neural crest derivatives, and severely impaired development of limb musculature (Auerbach, 1954;
Moase and Trasler, 1989, 1990; Franz, 1989, 1990, 1993; Franz et al., 1993). In the human, PAX3
mutation causes Waardenburg symdrome (WS). Waardenburg syndrome is a dominantly-inherited
syndrome that displays variable phenotypes of deafness, pigmentary abnormalities such as a white
forelock or heterochromic irises, and characteristic facial features (reviewed by Pantke and Cohen,
1971). According to the spectrum of defects, WS is clinically subdived into subtypes. WS type I and
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type III are most likely to have resulted from mutations in PAX3 (reviewed by Farrar et al., 1994). WS
type I patients typically have dystopia canthorum, in which the inner corner of the eye is displaced
outwards and the bridge of the nose is unusually broad. WS type I patients also usually display
pigmentation abnormalities and hearing defects, but rarely have neural tube defects similar to those
found in the homozygous Splotch mutant mice (Pantke and Cohen, 1971; Narod et al., 1988; Begleiter
and Harris, 1992; Moline and Sandlin, 1993). WS type III patients have defects found in type I with
additional limb abnormalities that are comparable to those found in the mouse Splotch mutants. Thus,
patients of WS syndromes display phenotypes similar to those found in the mouse Splotch. This is
consistent with the role of Pax3 in the neural crest migration and in the development of limb
musculature.
Pax3 is also involved in alveolar rhabdosarcoma, a tumour that is characteristically found in regions of
striated muscle differentiation, suggesting a role for Pax3 in controlling cellular proliferation (Barr et
al., 1993; Fredricks et al., 1995).
1.3.4 PaxS
Pax5 has been demonstrated to involve in B cell differentiation and in the development of midbrain-
hindbrain boundary by analyses of its expression patterns, loss-of-function phenotypes and gene
regulation.
During hematopoiesis, Pax5 encodes a B-cell specific transcription factor, BSAP (Adams et al., 1992).
BSAP is expressed in early B cell differentiation (Barberis et al., 1990) and exhibits a role in the
regulation of B cell proliferation (Wakatsuki et al., 1994; reviewed by Dorshkind, 1994). The role of
Pax5 in B cell development is further demonstrated by Pax5 deficient mice in which early B cell
differentiation is completely blocked (Urbanek et al., 1995). Pax5 is also expressed in the midbrain-
hindbrain boundary, suggesting a role in the development of this region (Asano and Gruss, 1992).
Further evidence from the homozygous Pax5 mutant mice shows reduction in the posterior midbrain,
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but without increased cell death or an imbalance in cell types, indicating that Pax5 is important for
proliferation of this region (Urbanek et al., 1994).
1.3.5 Pax7
Pax7 is closely related to Pax3 in structure, both at the DNA and at the amino acid sequence level
(Jostes et al., 1991; Goulding et al., 1991). Their expression patterns and induction of expression are
also similar. Both Pax3 and Pax7 are expressed in the dorsal nervous system and in the dermomyotome
(Jostes et al., 1991; Goulding et al., 1991; Bober et al., 1994). In the dermomyotome, both genes can
be induced by contact with surface ectoderm and a diffusible signal from the dorsal neural tube (Fan et
al., 1994). Pax7 is also involved in alveolar rhabdosarcoma, suggesting a role in controlling cellular
proliferation (Davies et al., 1994).
1.3.6 Pax8
Pax8 shares similarities in both structure and expression with Pax2, although some differences exist.
Both genes are expressed in the developing kidney and in Wilms' tumours, although the dynamics of
expression suggests that Pax8 may be expressed slightly later than Pax2 (Plachov et al., 1990; Poleev et
al., 1992; Zannini et al., 1992). Unlike Pax2, Pax8 is not reported to be expressed in the developing
eye (Plachov et al., 1990). Pax8 is also expressed in the thyroid where it appears to involve in the
regulation of two target genes, thyroglobulin and thyroperoxidase (Zannini et al., 1992).
1.3.7 Pax9
Pax9 expression has not been reported in the mouse; only chick Pax9 (chPax9) expression is described
(Peters et al., 1995). Expression of chPax9 is found in the epithelial cells of the embryonic and adult
thymus and in cells of the developing intervertebral disks where it overlaps with the expression of
15
chPaxl (Peters et al., 1995). Unlike chPaxl, chPax9 is not expressed in the perichordal sclerotome
cells that will give rise to vertebral bodies. Transcripts of chPax9 are also distributed in circumscribed
areas of mesenchyme in the metatarsus as well as in endodermal derivatives, i.e. in the lining epithelium
of the developing pharynx and of embryonic and adult esophagus (Peters et al., 1995). No Pax9
mutation has been described.
1.4 Pax6 expression profiles
When this study was initiated, little was known about Pax6 and its expression. The only publications
concerning Pax6 were only brief descriptions of patterns of expression in the mouse (Walther and
Grass, 1991), the human (Ton et al., 1991), and the zebrafish (Krauss et al., 1991; Puschel et al., 1992).
However, during the course of this study, much more information about Pax6 has been published. For
example, orthologous genes of Pax6 have been isolated in other species and their expression profiles
have been established. These orthologous genes were named either the same as their murine
counterpart, for example, "Pax6" in the chick (Li et al., 1994; Turque et al., 1994), the urodele (Rio-
Tsonis et al., 1995), and in the nematode (Chisholm and Horvitz, 1995; Zhang and Emmons, 1995); or
in other names such as Pax-QNR in the quail (Martin et al., 1992; Carriere et al., 1993; Turque et al.,
1994), Pax[zf-a] in the zebrafish (Krauss et al., 1991; Puschel et al., 1992) and ey in the Drosophila
(Quirring et al., 1994; Haider et al., 1995). Section 1.4 will describe the expression profiles that have
been published.
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1.4.1 Pax6 expression in the mouse/rat
In the mouse, Pax6 is expressed in discrete regions of the brain, in the neural tube, in the developing
eye, the pituitary, the pancreas, and the nasal epithelium (Walther and Gruss, 1991; Turque et al., 1992;
Goulding et al., 1993; Matsuo et al., 1993; Grindley et al., 1995; Stoykova et al., 1996). Details of
Pax6 expression in those areas are described in the following sub-sections (1.4.1.1 - 1.4.1.4).
1.4.1.1 In the developing brain
Pax6 expression is first detected in the presumptive telencephalon and rhombencephalon at day 8.0 p.c.
(or alternatively denoted as E 8.0 p.c.) (Walther and Gruss, 1991; Grindley et al., 1995); however, Pax6
transcripts are not detectable in the presumptive met- and mesencephalon (Walther and Gruss, 1991).
This overall distribution of Pax6 expression in the developing brain is maintained, with the exception of
the metencephalon where expression is detected from day 15.5 p.c. onwards (Walther and Gruss, 1991).
In the primitive telencephalon, high levels of expression are detected mainly at the ventricular zone in
the lateral and dorsal neuroepithelium but not in the basal neuroepithelium. Some areas of expression
have been specifically localized, including the ventricular zone, the epithalamus, the pineal gland, and
the piriform cortex (Walther and Gruss, 1991; Grindley, 1996; Stoykova and Gruss, 1996). The
olfactory bulbs also exhibit high levels of Pax6 transcripts (Walther and Gruss, 1991).
From the telencephalon to the diencephalon, Pax6 expression domain extends to a sharp caudal border
at the posterior commissure (the boundary between diencephalon and mesencephalon). Expression in
the ventral thalamus, the preoptic recess, and the supraoptic/paraventricular areas of the diencephalon
can be specifically localized at day 10.5 p.c. to day 12.5 p.c. (Walther and Gruss, 1991; Grindley, 1996;
Stoykova and Gruss, 1996). Pax6 transcripts are not detected in the metencephalon until day 15.5 p.c.
when expression can be detected in the external granular layer and in the cells distributed in the dorsal
cerebellum. Transcripts of Pax6 are also found in the pontine nuclei and the inferior olivary nuclei
(Walther and Gruss, 1991).
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Pax6 expression in the myelencephalon is basically the same as that in the spinal cord. Transcripts are
most abundant in the ventricular zone at earlier stages and the expression is decreased later, as the
ventricular zone becomes regressed (Walther and Grass, 1991).
1.4.1.2 In the developing spinal cord
Pax6 transcripts are initially present in the developing spinal cord in a broad band of cells at day 8.5
p.c., being absent only from the most dorsal and ventral cells. As the spinal cord develops, Pax6
expression is gradually restricted. At the beginning of day 9.0 p.c., Pax6 expression in the dorsal part
of the neural tube appears to be downregulated and Pax6 transcripts are confined only in the ventral
part, i.e. in the basal plate, although weaker signals can be detected in the alar plate (Walther and Grass,
1991). Between day 11.5 p.c. to day 12.5 p.c., Pax6 transcripts are only detectable in the ventricular
zone and the ventral intermediate zone in the basal plate (Walther and Grass, 1991). By day 13.5 p.c.,
Pax6 transcripts are found further regressed, concordant with reduction of the ventricular zone. By day
15.5 p.c., further restriction has made Pax6 transcripts only detectable within a subset of ependymal
cells and in a subset of postmitotic cells (Walther and Grass, 1991).
1.4.1.3 In the developing eye
The first transcripts of Pax6 in the developing eye are detected in the optic pit at day 8.5 p.c. (Grindley
et al., 1995). Later, Pax6 expression is found in the lens, the optic cup, and the optic stalk (Walther and
Grass, 1991; Matsuo et al., 1993; Grindley et al., 1995).
Pax6 expression is developmentally restricted in the developing eye. By day 9.5 p.c., Pax6 transcripts
are found in the optic vesicle, the optic stalk, and in a broad area of surface ectoderm, including the area
where the furare lens will develop. Between day 10.0 p.c. and day 12.0 p.c., i.e. during the period when
the optic cup and the lens are formed, Pax6 is expressed in both the inner and the outer layers of optic
cup, as well as in the lens and the overlying future cornea (Grindley et al., 1995). By day 15.5 p.c.,
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Pax6 transcripts are restricted to the rim of optic cup (Grindley et al.,, 1995). The broad area of Pax6
expression in the surface ectoderm also becomes confined to the future corneal epithelium bordering at
the conjunctiva (Grindley et al., 1995).
1.4.1.4 In the developing pituitary, pancreas, and nasal epithelium
Pax6 expression is detected in the developing adenohypophysis (anterior pituitary) from day 11.5 p.c.
(Walther and Gruss, 1991). Transcripts are detected within Rathke's pouch and its derivatives, the pars
intermedia and distalis, but not in the infundibulum or the differentiating pars neuralis (Walther and
Gruss, 1991). By day 15.5 p.c., Pax6 expression is still detectable in the epithelium lining the lumen of
Rathke's pouch and in the anterior lobe; the expression is reduced to just about background level by day
18.5 p.c.
In the nasal region, the earliest Pax6 expression is found in the nasal placode by day 9.5 p.c. (Grindley
et al., 1995). Pax6 transcripts remain in the placodal epithelium during the course of nasal pit
formation and subsequently in the nasal epithelium (Walther and Gruss, 1991; Matsuo et al., 1993;
Grindley et al., 1995).
Pax6 is also expressed in the developing pancreas in the mouse (Turque et al., 1992).
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1.4.2 PAX6 expression in the human
PAX6 transcripts are expressed in the eyes, the brain, and the pancreas (Ton et al., 1991). In the brain,
the cerebellum and the pons have the highest level of expression, whilst the temporal lobe, midregions,
medulla oblongata and choroid plexus have less expression (Ton et al., 1991). PAX6 transcripts are
also detected in the olfactory bulb and in the intermediate brain layers (Ton et al., 1991). In the human
eye at 49 days of gestation, PAX6 expression is found in the rim of the optic cup, the neural retina, the
lens and the surface ectoderm that will give rise to cornea and conjunctiva, but no PAX6 expression is
found in the pigmented retinal epithelium (Ton et al., 1991).
1.4.3 Pax6 expression in the chick and Pax-QNR expression in the quail
1.4.3.1 Pax6 expression in the chick
The first evident Pax6 expression is detected at Hamburger-Hamilton stage 6 (Hamburger and
Hamilton, 1951) during chick embryogenesis in a crescent-shaped band of prospective ectodermal cells
near the anterior margin of the neural plate, but not in the neural plate itself (Li et al., 1994). At stage
7+, Pax6 transcripts are concentrated in the cells lateral to the neural plate, i.e. the cells that will give
rise to the facial, lens, and corneal ectoderm. The neural plate itself exhibits only trace amount of
signals in contrast with those in the lateral cells. Thus, Pax6 expression in the chick is initiated not in
the neural tissues, but in the anterior ectodermal cells.
In the developing brain, a significant amount of Pax6 transcripts appear at stage 8+ over the presumptive
dorsal forebrain region. This distribution of Pax6 expression in the presumptive forebrain is so quickly
restricted that at stage 9 only the areas of optic outgrowths and the dorsal midline of diencephalon
remain Pax<5-expressing (Li et al., 1994). By stage 11, Pax6 expression is further restricted and found
only in the roof of diencephalon and in the optic vesicle. Pax6 is also expressed in the neuroepithelium
of rhombomere 3 in the developing hindbrain, but not in the midbrain as shown in the published
photographs by Li et al. (1994).
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In the surface ectoderm of the head, the distribution of Pax6 transcripts is restricted in accordance with
that of the developing brain. At stage 8+, a large area of surface ectoderm is Pax6-expressing. By stage
9, however, the Paxd-expressing territory in the head surface ectoderm is diminished and covers only
the outgrowths of optic vesicles and the dorsal midline of diencephalon (Li et al., 1994).
In the developing eye, Pax6 is highly expressed in the optic placode and at later stages in the
developing lens and its surrounding surface ectoderm where a part will give rise to the corneal
epithelium. In the developing optic cup and optic stalk, Pax6 transcripts are found in the neural retina
and the optic nerve. In the nasal epithelium, however, whether Pax6 expression is present is not yet
determined (Li et al., 1994).
In the trunk region, Pax6 is expressed in the neural plate overlying each newly formed somite and in a
cluster of endodermal cells of the stage 13 gut (Li et al., 1994). Li et al. (1994) did not specify the
cluster of endodermal cells in the midbody region as pancreatic cells.
1.4.3.2 Pax-QNR expression in the quail
The distribution of Pax-QNR transcripts during quail embryogenesis has been investigated using both
Northern blot analysis and in situ hybridization and was reported to be comparable to that during chick
embryogenesis (Martin et al., 1992). In the developing quail brain, Pax-QNR is expressed in the
forebrain area (particularly in components of the developing eyes) and the hindbrain area (particularly
in the cerebellum), but not in the midbrain. In the developing eye, the lens and the neural retina are
reported as highly expressing areas, whereas transcripts of Pax-QNR are not detected in the pigmented
retinal epithelium (Martin et al., 1992; Carriere et al., 1993). In the neural retina, Pax-QNR transcripts
are clearly shown in the ganglionic cell layer and in the ventral portion of the inner nuclear layer
(Martin et al., 1992). Pax-QNR-encoded proteins that contain only the homeodomain are also detected
in the neural retina (Carriere et al., 1993). Pax-QNR is also expressed in the developing pancreas
(Turque et al., 1994).
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1.4.4 Pax6 expression in the urodele
Pax6 expression during normal newt and axolotol eye development as well as during lens regeneration
following lentectomy have been investigated (Del Rio-Tsonis et al., 1995). Pax6 transcripts are
localized in the neural retina, the lens, and the corneal epithelium. Following lentectomy in the newt,
Pax6 transcripts are detected in all stages of lens regeneration in the growing lens, the retina, and the
corneal epithelium (Del Rio-Tsonis et al., 1995), whereas, in the axolotol which is not capable of
regenerating lens, Pax6 expression is decreased in the larval eye as the animal grows older (Del Rio-
Tsonis et al., 1995).
1.4.5 Pax[zf-a] expression in the zebrafish
Pax[zf-a], the Pax6 homologue in the zebrafish, is expressed in the developing central nervous system,
the eye, the olfactory bulb, and the pituitary (Krauss et al., 1991; Puschel et al., 1992). The expression
is developmentally restricted in a way comparable to that in other vertebrates (Krauss et al., 1991;
Puschel et al., 1992).
In the developing central nervous system, Pax[zf-a] expression begins in a strip of cells in the
neuroectoderm, including the prospective diencephalon and a part of the telencephalon as well as the
hindbrain and the ventral spinal cord extending from the level of the first rhombomere to the posterior
end of the CNS (Puschel et al., 1992). The anterior boundary of expression in the hindbrain lies
between the met- and myelencephalon. The posterior boundary of expression in the diencephalon is
detected at the border between the di- and mesencephalon. At later stages, expression in the brain
becomes restricted to smaller groups of cells in the di- and telencephalon. Pax[zf-a] is also expressed
in the olfactory bulb and in the pituitary (Puschel et al., 1992).
In the eye, during the course of optic cup formation, Pax[zf-a] is expressed in the developing lens and
the neural retina, but not in the optic stalk or the pigmented retinal epithelium. The expression in the
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retina is first found in both the ganglion cell layer and the inner nuclear layer (Krauss et al., 1991), but
it becomes restricted to the ganglion cell layer at later stages (Puschel et al., 1992).
1.4.6 Pax6 expression in the nematode
The nematode Caenorhabditis elegans Pax6 encodes at least two types of transcripts with two
independent genetic functions. The first one is called vab-3. Transcripts of vab-3, like the other Pax6
genes found in other species, contain a paired domain and a homeodomain (Chisholm and Horvitz,
1995). The second one is called mab-18. Transcripts of mab-18 contain only the homeodomain and is
expressed under the control from an internal promotor (between the paired domain and the
homeodomain) (Zhang and Emmons, 1995. Transcripts of vab-3 are found initially in precursors of the
head hypodermal (epidermal-like) cells and neurons, and subsequently in the progeny of these cells
(Chisholm and Horvitz, 1995). Transcripts of mab-18 are located in the similar areas as those of vab-3,
i.e. in the anterior hypodermal nuclei and head neurons (Zhang and Emmons, 1995; Chisholm and
Horvitz, 1995).
1.4.7 Expression of ey in the Drosophila
The orthologous Pax6 gene in the Drosophila is ey, which is established by homology of amino acid
sequence and mutant phenotypes (Quiring et al., 1994). The transcripts of ey are distributed in a
bilaterally symmetrical pattern in the brain and in every segment of the ventral nervous system at the
germ-band stage, ey is also expressed in the imaginal discs (primordia of eye) and in the salivary
glands anterior to the brain (Quiring et al., 1994). Later in embryogenesis, ey transcripts become
confined to the brain and the primordia of the eye, while in the segmental ventral ganglions ey
transcripts disappear (Quiring et al., 1994).
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1.5 Pax6 mutations
1.5.1 Pax6 mutations in the mouse and in the rat
Mutations in the Pax6 gene result in Small eye (Sey) in the mouse (Hill et ai, 1991) and rat Small eye
(rSey) in the rat (Matsuo et ai, 1993). These two species are very closely related and their mutations in
the Pax6 display very similar characteristics. They are therefore described together.
Small eye is an autosomal, semi-dominant, homozygous lethal mutation first found as a spontaneous
mutation in Edinburgh in 1967 (Roberts, 1967), but without being described in detail until 1986 (Hogan
et ai, 1986). To date, five murine Small eye alleles have been described: Sey, Seynm, Seyneu2, SeyH, and
SeyDey (reviewed by Chalepakis et al., 1993). Except for Seyneu2, all Small eye alleles have been
described in detail. Sequence analyses reveal that Sey is caused by a point mutation which introduces a
stop codon between the paired and the homeodomain (Hill et al., 1991). Seyneu also displays a point
mutation, leaving an unspliced intron and a premature translation termination signal at the downstream
of the homeodomain. Both SeyH and Sey0" contain a deletion in the Pax6 locus (Chalepakis et al.,
1993).
In general, more severe phenotypes are found in the homozygous state, suggesting a gene-dosage effect.
Small eye mutants in the homozygous state are generally 10 % smaller than their unaffected littermates
(M.H. Kaufman, personal communication). Homozygous mutants do not survive and die either during
early neonatal stage (for Sey) or at implantation (for Sey11). The homozygous Sey mice die shortly after
birth, probably because they do not develop nasal cavities and thus can not breathe (Hogan et al.,
1986). The homozygous SeyH embryos die at implantation, presumably because the deletion also
contains genes essential for early embryo survival (Glaser et al., 1990).
The effect of Sey mutation was previously believed to be limited only to the growth and differentiation
of the presumptive lens and nasal placodes (Hogan et al., 1986). Homozygous Sey/Sey embryos can be
distinguished as early as 10.5 days p.c. (Grindley, 1996). The optic cup grows, but the surface
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ectoderm does not give rise to the lens and the nasal placode (Hogan et al., 1986; Grindley et al., 1995).
As a result, the optic cup degenerates and all the other derivatives of the eye, including the cornea, do
not develop (Grindley et al., 1995).
More detailed analyses, however, led to discoveries of other affected areas. In the developing cerebral
cortex in the forebrain at days 12.5 to 14.5 p.c., homozygous Seyneu and Sey mice exhibit defects of
neuronal migration and cortical plate reduction with heterotopic groups of cells found in the
intermediate zone in the posterior and dorso-lateral telencephalon (Schmahl et al., 1993; Grindley,
1996). The archicortex anlage fails to invaginate along the medial wall of the telencephalic vesicle
(Stoykova et al., 1996). In the developing diencephalon of the mutant brain (for Sey/Sey), the
primordia of prosomere 3 (the very rostrodorsal part of the ventral thalamus) and prosomere 4
(eminentia thalami) grow in the wrong direction and the compartmentalization within the hypothalamus
is distorted (Stoykova et al., 1996). Further analyses at day 18.5 p.c. show underdevelopment of the
internal capsule, corpus callosum, posterior commissure and the basal ganglia. The third and the lateral
forebrain ventricles are connected through wide openings (instead of through the normally thin
foramina Monro) (Stoykova et al., 1996). The left and right sides of the diencephalon are not fused
(Grindley, 1996; Stoykova et al., 1996), probably as a result of dysgenesis in the diencephalon. The
forebrain abnormalities are coincident with domains of Pax6 expression and the boundaries between
/>ax6-expressing domains and those of other genes, for example Dlxl, are disturbed (Stoykova et al.,
1996).
In the developing maxilla, Sey/Sey embryos exhibit a shorter snout at day 14.5 p.c. as compared to that
of their wildtype litermates (Hill et al., 1991). The homozygous embryos also display a cartilaginous
rod-like structure which protrudes forwards from the rostral part of the cranial base and extends to the
tip of the shortened snout (Kaufman et al., 1995). In addition to that rod-like structure, a high
percentage (82 %) of the Sey/Sey embryos have one or two additional upper incisor teeth (Kaufman et
al., 1995). The rat Small eye (rSey) shows that Pax6 mutation also impairs the migration of the
midbrain neural crest cells in the homozygous state (Matsuo et al., 1993).
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In the heterozygous state, mice affected by Sey and Seyneu can survive but display smaller eyes with
defects in the lens and the cornea, although without obvious abnormalities within the nose and the teeth.
In addition to the presence of smaller eyes, mice affected by SeyH and Sey0" mutations also show
growth retardation, small ears, white belly pots and eye coloboma in the heterozygous state (Chalepakis
etal., 1993).
The combination of these findings suggests extensive roles of Pax6 during development, particularly in
the craniofacial area.
1.5.2 PAX6 mutations in the human
In the human, PAX6 mutation leads to a variety of abnormalities associated with aniridia (AN) and
Peter's anomaly (Ton et al., 1991; Jordan et ai, 1992; Hanson and van Heyningen, 1995).
Aniridia is a panocular disorder with an incidence between 1 in 64.000 and 1 in 96,000 (Shaw, 1960).
In the homozygous state, PAX6 mutation may lead to death after birth (Hodgson and Saunders, 1980;
Jordan et al., 1992). In the heterozygous state, AN phenotypes are variable with anomalies of cataracts,
lens dislocation, foveal dysplasia, optic nerve hypoplasia, and nystagmus. In particular, corneal
vascularization and glaucoma are commonly found (Jordan et al., 1992; Hanson and van Heyningen,
1995). The effects on vision are variable, in accordance with the anomalies. Peter's anomaly
represents one of the wide spectrum of anterior segment malformations found in the patients affected by
aniridia (Hanson and van Heyningen, 1995). PAX6 mutations are therefore proposed to be associated
with anterior segmentation in the human (Hanson and van Heyningen, 1995). The combination of these
findings, like the findings in the mouse, also suggests extensive roles of PAX6 during craniofacial
development.
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1.5.3 Pax6 mutations in the nematode
Several nematode C. elegans Pax6 mutants have been identified, including vab-3 and mab-18 mutants
(Chisholm and Horvis, 1995; Zhang and Emmons, 1995). The abnormal phenotypes caused by loss-of-
function defects in vab-3 and mab-18 include aberrant morphogenesis in the head region,
transformation of hypodermal (epidermal-like) cell fates to those of posterior homologues, and
abnormal specification of neurons (Chisholm and Horvis, 1995). In the tail region of the male animals,
defects in gonadogenesis (for vab-3) and transformation of sense-organ identity (for mab-18) are found,
i.e. the sense ray 6 is transformed into ray 4 (Chisholm and Horvitz, 1995; Zhang and Emmons, 1995).
These mutant phenotypes are generally located in regions showing Pax6 (both vab-3 and mab-18
transcripts) expression and support a general role of Pax6 in defining cell fate during nematode
embryogenesis.
1.5.4 The eyeless (ey) mutation in the Drosophila
The eyeless (ey) mutation of Drosophila was first reported in 1915 and since then was introduced as an
artificially produced mutation characterized by partial or complete absence of compound eyes (Haider
et al., 1995). In addition to ey mutation, two spontaneous mutations, ey2 and eyR, were established
afterwards among many others with mutated eye defects (Quiring et al., 1994). However, the ey gene
was not isolated until 1994 (Quiring et al, 1994), after Pax6 in the mouse (Walther and Gruss, 1991)
and PAX6 in the human (Ton et al., 1991) were isolated.
In addition to the obvious absence of eye formation, it is shown that ey expression is also disturbed in
the mutants. In contrast to the normal embryos (see section 1.4.7), the ey2 and eyR mutant embryos
show no ey expression in the anterior edge of the eye disk (Quiring et al., 1995), supporting a role of ey
in eye formation. More surprisingly, ectopic expression of the ey gene leads to ectopic eye formations
on the wings, the legs, and the antennae (Haider et al., 1995), indicating that ey may be a master gene in
eye formation.
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The finding of ey gene and its expression pattern in the normal and wildtype eye disks indicate a role of
ey gene in the formation of the Drosophila eye.
1.6 Common aspects of the Pax genes
This section summarizes common aspects of the Pax genes. To support the common characteristics
raised here, as many examples as possible are given. This will inevitably repeat many points that are
already described in previous sections.
1.6.1 Pax genes are developmentally restricted
Pax genes are expressed at early stages of development, usually before the onset of an activity
(differentiation, migration, or formation) in a cell population and become restricted as the embryo
develops. Paxl, for example, is expressed during the formation of the vertebral bodies and
intervertebral disks (Deutsch et al., 1988; Dietrich et al., 1993; Wallin et al., 1994; Dietrich and Gruss,
1995). The expression is later downregulated as vertebral bodies begin to chondrify (Wallin et al.,
1994; Dietrich and Gruss, 1995). Pax2 is first expressed in the mesenchyme and later is downregulated
in more mature renal epithelium (Dressier et al., 1990; Dressier and Douglas, 1990). Pax3 is first
expressed in the dorsal neural tube and in the neural crest derivatives. The expression of Pax3 in the
dorsal neural tube is later restricted to mitotic stem cell populations (Goulding et al., 1991). Pax6
expression is also developmentally restricted. Pax6 expression in the head surface ectoderm is first
detected in a broad domain, but later it is restricted to the areas of future cornea (Grindley et al., 1995).
Restriction of Pax6 expression is also seen in the optic cup where Pax6 transcripts can be detected only
in the rim at later stages (Grindley et al., 1995). In the developing central nervous system, Pax6-
expressing domains are reduced in older embryos (Walther and Gruss, 1991; Stoykova and Gruss,
1994; Stoykova et al., 1996).
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1.6.2 Pax genes are expressed in highly mitotic or immature cells
Pax genes are expressed in cells of highly mitotic activity and are often downregulated as cells
differentiate, implicating involvement in cellular proliferation and oncogenesis (Read, 1995). Paxl is
expressed in the mitotic scleratome and anterior limb mesenchyme and is later downregulated during
chondrogenesis (Deutsch et al., 1988; Timmons et al., 1994). Pax2 is expressed during the maturation
of renal epithelium and is downregulated as the renal epithelium matures (Dressier et al., 1990; Dressier
and Douglas, 1990). In the developing CNS, Pax2 expression correlates with the transition from
predominantly mitotic to migratory behaviour of neuroblasts (Nornes et al., 1990). Pax3 is expressed
in the myoblast stem cells in the developing limb (Bober et al., 1994), as well as in the highly mitotic
cells in the ventricular zone in the developing CNS where it is downregulated before neuroblast
migration (Goulding et al., 1991; Jostes, et al., 1991). Pax5 is expressed in early B cell proliferation
(Barberis et al., 1990) and is involved in the regulation of B cell proliferation (Wakatsuki et al., 1994).
Pax6 expression in the telencephalon is seen within the mitotic ventricular zone (Walther and Gruss,
1991). Pax7 expression in the CNS is also limited to mitotic stem cells in the ventricular zone and is
downregulated before neuroblast migration (Jostes et al., 1991).
Oncogenic potential has been reported for some Pax genes under in vitro (Maulbecker and Gruss,
1993) and in vivo conditions (Dressier and Douglas, 1992; Barr et al., 1993; Poleev et al., 1992 a, b).
Overexpression of intact or truncated Pax genes {Paxl, Pax2, Pax6 and Pax8) in fibroblasts leads to
uncontrolled growth (Maulbecker and Gruss, 1993; reviewed by Stuart et al., 1993). Pax2 and Pax8
proteins have been detected in the Wilms' tumour (reviewed by Hastie, 1993), suggesting their
involvements. Pax3 and Pax7 have also been implicated in the formation of alveolar rhabdosarcoma
(Barr et al., 1993; Davis et al., 1994). Pax5 may be involved in the progression of astrocytomas to
glioblastoma (Stuart et al., 1993).
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1.6.3 Areas of Pax gene expression coincide well with sites of loss-of-function defects
Areas of Pax gene expressions are generally coincident with areas where loss-of-function defects are
found during embryogenesis, which suggests functional necessity for Pax genes in their expression
areas. For example, Paxl is expressed in mesodermal tissues during the formation of axial structures.
Thus, Paxl mutation (undulated), leads to axial skeletal defects (Deutsch et al., 1988; Balling et al.,
1988). Pax2 is expressed during kidney and eye development. Defects in these two organs are found in
the Krd mouse (Keller et al., 1994) and in the family with PAX2 mutation (Sanyanusin et al., 1995).
Pax3 is expressed in the dorsal neural tube, neural crest derivatives, as well as in the tissues designated
to form the limb musculature (Goulding et al., 1991). Thus, homozygous Splotch mice show neural
tube defects, deficiencies in neural crest derivatives, and severely impaired limb musculature (Moase
and Trasler, 1989; 1990; Franz, 1989, 1990, 1993; Franz et al., 1993). The coincidence is also seen in
the human WS (Waardenburg syndrome) mutations. Neuralcristopathies such as pigmentary
abnormalities, characteristic facial features, and deafness, as well as limb abnormalities are commonly
seen in WS patients (Pantke and Cohen, 1971; Farrar et al., 1994). Pax6 is expressed in the eye, the
nose, and the developing CNS. Thus, defects of Sey and rSey mutations are found in areas where Pax6
is expressed (Hogan et al., 1986, 1988; Matsuo et al., 1993; Fujiwara et al., 1994; Kaufman et al.,
1994; Grindley et al., 1995; Stoykova et al., 1996). Comparable coincidence is also seen in the
Aniridia mutation in the human (Ton et al., 1991; Jordan et al., 1992; Hanson et al., 1994a). Areas of
functional necessity, as compared to loss-of-function phenotypes, are also seen in Pax5-expressing
tissues (Adams et al., 1990; Asano and Gruss, 1992; Urbanek et al., 1994).
1.6.4 Regulatory signals of Pax genes from notochord and floor plate
Signals from notochord or floor plate appear to regulate Pax gene expression in various systems. Paxl
expression in the scleratome depends on the presence of notochord, either for activation or maintenance
(Koseki et al., 1993; Brand-Saberi et al., 1993). Pax2 expression is also suggested to be regulated by
notochord or floor plate, based on the presence of Pox2-expressing domains in the ectopic ventral basal
plate found in the Danforth's short tail mice (Phelps and Dressier, 1993). In the developing spinal
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chord, Pax3 and Pax6 expressing domains are altered in response to notochord grafts (Goulding et al.,
1993). Documented candidate signals that regulate Pax gene expression include Sonic hedgehog (Shh)
(Echelard el al., 1993; Roelink et al., 1994; Johnson et al., 1994; Macdonald et al., 1995), NGF
(Kioussi and Gruss, 1994), BDNF (Kioussi and Gruss, 1994), activin A (Yamada et al., 1994; Pituello
et al., 1995) and bFGF (Yamada et al., 1994). Most of them are signals that can be found in the
notochord or the floor plate. The floor plate is also a site of retinoid synthesis (Wagner et al., 1990;
Chen et al., 1992; Flogan et al., 1992) and may have a regulatory role in Pax gene expression in a way
similar to the regulation of many Hox genes (reviewed by Mavilio, 1993).
1.6.5 Pax genes in the developing CNS and in the adult brain
1.6.5.1 Pax genes in the developing central nervous system
All Pax genes (except for Paxl) are spatially and temporally expressed during the development of
central nervous system (CNS) (Chalepakis et al., 1992). Current data suggest that Pax genes are
involved in the specification of cells along the anterior-posterior (A-P) and the dorsal-ventral (D-V)
axis, in the developing brain and spinal cord (Chalepakis et al., 1992; Stuart et al., 1993; Puelles and
Rubenstein, 1993).
The structure-based classification (introduced in section 1.2.2.2.1) of Pax genes have, to a certain
extent, some implications on their expression patterns during CNS development as illustrated in figure
1.2 (Chalepakis et al., 1992; Stuart et al., 1993; Stoykova and Gruss, 1994).
Murine Pax genes (Pax3, Pax6, PaxT) that contain a paired-specific homeobox in addition to the paired
box begin to express at day 8.0 - 8.5 p.c., i.e. before the onset of cellular differentiation in the
developing central nervous system. The expression domains of these genes along the anterior-posterior
axis are initially confined to the mitotically active cells of the ventricular neuroepithelium throughout
the entire length of the prechordal (anterior) and the epichordal (posterior) subdivisions of the neural
tube. By day 10.0 p.c., Pax3 and Pax7 expression domains retract to a rostral limit that appears to be at
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the level of posterior commissure in the diencephalon (Goulding et al., 1991; Jostes et al., 1991). This
area represents an anatomical landmark of an axon tract, which develops at the furrow between the
diencephalon and the telencephalon. Pax6 expression, comparable to that of Pax3 and Pax7, also
exhibits a caudal limit in the forebrain at day 10.5 p.c. (Walther and Gruss, 1991; Grindley, 1996).
Pax genes without a homeobox domain, i.e. Pax2, Pax5 and Pax8, are first expressed in the neural tube
between day 9.5 - 10.0 p.c. when CNS differentiation initiates (Chalepakis et al., 1992; Stuart et al.,
1993; Stoykova and Gruss, 1994). Pax2 and Pax8 transcripts are confined within the epichordal part of
the neural tube throughout the spinal cord, myelencephalon and pons, with a rostral limit of expression
at the hindbrain-midbrain boundary (Stuart et al., 1993). Areas of Pax5 expression overlap with those
of Pax2 and Pax8 throughout the spinal cord. Pax5 exhibits an early (around day 9.5 p.c.) strong and
specific expression at the hindbrain-midbrain boundary, extending into the posterior part of the
mesencephalic tegmentum (Asano and Gruss, 1992).
Murine Pax4 and Pax9 expression in the developing CNS has not been reported.
1.6.5.2 Pax genes in the adult brain
Most murine Pax genes are expressed in discrete areas in the posterior regions of the adult brain (see
figure 1.2 on the following page) (Stuart et al., 1993). The expression patterns in the adult brain are
similar to those of the midgestation brain, with the exception of Pax6 which is expressed in the
olfactory bulb that is formed during late gestation period (Walther and Gruss, 1991). In the adult brain,
Pax6 transcripts are also detected in the septum, in the lateral and septal nucleus, as well as in the nuclei
of the diagonal band of Broca (Walther and Gruss, 1991). Pax6 is also expressed in the zona inserta,
endopeduncular nucleus, and reticular nucleus as well as the amygdala (Walther and Gruss, 1991).
In the adult midbrain, neurons in distinct nuclei express Pax3, Pax5, Pax6, and Pax7 in accordance
with that of midgestation stages (Stoykova and Gruss, 1994). Pax6 transcripts are detected in a subset
of neuronal cells in the dorsolateral part of the reticular substantia nigra and in the central gray matter
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(Walther and Gruss, 1991). Pax7 is expressed in the optic tectum, especially in the superficial,
intermediate and deep layers of superior colliculus and in discrete nuclei of the tegmentum (Jostes et
al., 1991). Pax5 is localized in the more caudolateral and the ventral parts of the central gray matter as
well as in parts of the tegmentum. In the fovea isthmii, Pax3, Pax7, and Pax6 are expressed in different
nuclei. Pax2 and Pax8 are expressed in different nuclei of myelencephalon (Stuart et al., 1993;
Stoykova and Gruss, 1994).
Within the adult cerebellum, only three Pax genes are expressed. Pax2 is expressed in two neuronal
populations of the granular layer, i.e. the Golgi type II neurons and the granular neurons, but only in
one type of the glial cells, the astrocyte. Pax3 is expressed in Purkinje neurons, in the granule neurons,
as well as in two types of the cerebellar glia -- the Bergmann glia and astrocytes. Pax6 is expressed in
granule neurons and astrocytes (Stuart et al., 1993; Kioussi and Gruss, 1994).
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Part B: the "development" side
Part B will first give a general background on vertebrate craniofacial development with emphasis on the
contribution of three primary germ layers to different parts of the head (section 1.7). It is then followed
by common aspects of vertebrate CNS development (section 1.8) and the development of specific
regions — the visual nervous system (section 1.9), the olfactory nervous system (section 1.10), the eye
(section 1.11) and the teeth (section 1.12). These regions are affected by Pax6 mutation and are to be
investigated in this study. The introduction here in part B aims to give a general background
information for describing and discussing results in the present work. Therefore, it has to be brief on
the general background and at the same time highly selective, concentrating on the craniofacial areas
related to Pax6 mutation and expression. Most of the background information is described regardless
of temporal sequences.
1.7 Vertebrate craniofacial development — general background
All vertebrate embryos develop following the same processes: fertilization, blastulation, gastrulation,
neurulation, and then organogenesis. After fertilization, the fertlized egg becomes an early embryo and
begins to divide until it becomes a mass of cells called a blastula. Following the formation of a blastula,
the next stage of development concentrates on rearranging the embryonic cells into a body plan by
polarizing them along three axes: the anteroposterior axis, the dorsoventral axis, and the left-right axis.
This process of polarization is highlighted during gastrulation, when cells of the blastoderm are
translocated to new positions in the embryo, producing three primary germ layers: ectoderm, mesoderm,
and endoderm; all of them contribute to the genesis of craniofacial structures. During neurulation, the
ectoderm will differentiate into three populations of cells: surface ectoderm, neural ectoderm and neural
crest cells. The surface ectoderm contributes to the epidermis, hair, anterior pituitary gland, enamel of
teeth, inner ear, and lens (Balinsky, 1981). The neural ectoderm will form the central nervous system,
retina, pineal body, posterior pituitary (Purves and Lichman, 1985). The neural crest cells will
contribute to cranial and sensory ganglia, pigment cells, branchial arch cartilages, a substantial part of
the head mesenchyme (Le Douarin, 1981), most of the face (Hunt et al., 1991), and some skeletal
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elements within the head, including the nasal, lacrimal, zygomatic, maxillary, incisive, mandibular and
squamous temporal elements (Noden, 1986).
A special feature of the ectodermal contribution to craniofacial development is the formation of
placodes. Placodes are thickenings of the surface ectoderm and consist of the nasal placode, lens
placode, otic placode, and smaller epibranchial and intermediate placode formations during vertebrate
embryogenesis (Browder et al., 1991). Some placodal cells, i.e. lens and otic cells, will detach from the
surface ectoderm during development. Others, for example the nasal placodal cells, just invaginate and
differentiate without detachment from the surface ectoderm.
The mesodermal derivatives contribute to most of the muscles and their innervating nerves in the head
(Noden and Lahunta, 1985; Noden, 1983), as well as the frontal, parietal, petrous temporal, occipital,
and most of the sphenoidal elements of the skull (Noden, 1986).
The endodermal derivatives contribute to the anterior pharyngeal pouches (Browder et al., 1991). In
the lower vertebrates, contact sites between the ectoderm and the endoderm in the pharyngeal pouches
perforate to form gill slits. In the higher vertebrates, respiratory function of the gill is undertaken by the
lungs. In the human, pharyngeal pouches will develop to contribute to the paired eustachian tubes and
tympanic cavities of the ears and the tonsils (Moore, 1988).
1.8 Common aspects of the vertebrate CNS development
1.8.1 Macroscopic morphogenesis of the CNS
During gastrulation, embryonic cells are arranged into three primary germ layers through ingression of
cells from the epiblast into the blastocoel. This displacement of cells leads to the formation of a long
midline cleft, the primitive streak, while a thickening called the primitive knot (known as Hensen's node
in the chick) develops at the anterior end of the primitive streak. Presumptive notochordal cells
accumulate within the region of primitive knot.
37
When the primitive streak reaches its maximal length, the primitive knot appears to recede toward the
posterior end and the presumptive notochordal cells, which are located in front of the retreating node,
extend anteriorly to form the notochordal process. The majority of the length of the embryo takes shape
as the notochordal process extends. During neurulation, the dorsal ectoderm covering the notochordal
process becomes flattened and thickened to form the neural plate. Parts of the neural plate from each
side of the embryo rise to form the neural folds that flank a central depression called the neural groove.
The neural groove extends along the entire dorsal midline of the embryo. As the neural groove
becomes deeper, the neural folds from each side of the embryo eventually meet and fuse, resulting in
the formation of the neural tube -- the rudiment of CNS. The anterior portion of neural tube will
become the brain and will be developed into distinct brain vesicles, while the posterior portion of the
neural tube develops into a tube-like structure, the spinal cord.
The brain vesicles in the anterior portion of the neural tube will develop into, from the anterior to the
posterior, the prosencephalon (forebrain), the mesencephalon (midbrain), and the rhombencephalon
(hindbrain). These brain vesicles become more distinguishable as the cranial flexures between them
form. The prosencephalon will rapidly subdivide into the anterior telencephalon (which gives rise to
the cerebral cortex, basal ganglia and some other structures) and the posterior diencephalon (which
gives rise to the thalamus and hypothalamus). The rhombencephalon is further partitioned into
metencephalon (which gives rise to the cerebellum and the pons) and myelencephalon (which gives rise
to the primordium of the medulla).
1.8.2 Microscopic histogenesis of the CNS
1.8.2.1 Three-zone pattern formation and its modifications
Histologically, the cells along the primitive neural tube (which includes both the brain and the spinal
cord) are initially arranged in a layer of neuroectoderm. The neuroectodermal layer is also called the
germinal epithelium (or the ventricular zone), since the neuroectodermal cells divide rapidly. Nuclei of
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the dividing cells are predominantly located at the inner surface of the germinal epithelium and only
when mitosis is completed, the nuclei migrate back toward the outer surface.
The highly mitotic activities in the germinal epithelium results in the formation of the second layer, the
mantle layer (the intermediate zone). Cells within the mantle layer differentiate into both neurons and
glia. The neurons in the mantle layer make connections among themselves and project axons away
from the lumen. Thus, a third cell-poor layer — the marginal zone is formed. Glial cells from the
mantle layer eventually cover many of the axons in myelin sheaths, giving them a whitish appearance.
The mantle zone where the neuronal cell bodies are located, is often called the "gray matter", while the
axonal, marginal layer is often called the "white matter". Thus, at early stage of CNS development,
three layers (or zones) are derived from a primary germinal layer. These layers are maintained
throughout spinal cord development, but in many parts of the brain very complicated modifications
occur. The modifications result from cell migration, differential growth, and selective cell death during
axonogenesis. Modifications are particularly common in the cerebellum and the telencephalon
(cerebrum) where the greatest structural deviation from the primitive neural tube occurs. Some neurons
enter the white matter and differentiate into clusters of neurons known as nuclei. Many dividing
neuronal precursor cells, the neuroblasts, migrate to the outer surface of the developing cerebellum and
cerebrum to form a new germinal zone, the secondary germinative layer (or called the secondary
germinative epithelium). Those secondary germinative layers that are close to the ventricle are known
as "subventricular zones" and those farther away from the ventricle, usually in a submarginal position,
are known as the "external germinal layers" or the "external granular layers" (Altman and Bayer, 1995).
Typically, secondary germinal epithelia begin to expand in a given brain region after the primary
neuroepithelium has started to shrink. Cell proliferation in the secondary germinal epithelia typically
give rise to late-developed neurons with short axons, or microneurons known in many brain regions as
granule cells (Altman and Bayer, 1995).
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1.8.2.2 The alar plate and the basal plate formation
The division of developing CNS into a dorsal part (the alar plate) and a ventral part (the basal plate)
along the dorsal-ventral axis is as important as the division of brain vesicles along the antero-posterior
axis. In the spinal cord and the medulla, the basic three-zone pattern of ventricular (also called
ependymal or primary germinal layer), mantle (intermediate), and marginal (pial) layers is maintained
throughout development. The gray matter in the mantle zone gradually becomes a butterfly-shaped
structure surrounded by white matter; both will be encased in connective tissues. As the neural tube
develops, a longitudinal groove, the sulcus limitans, appears to divide the neural tube into dorsal and
ventral halves (Arey, 1974). The dorsal half receives input from sensory neurons, whereas the ventral
portion is involved in effecting various motor functions (Placzek et ai, 1991). This arrangement of
sensory and motor neurons can be easily traced to the mesencephalon and the diencephalon (Altman
and Bayer, 1995). In the mesencephalon, the alar plate is the source of neurons in the superior and
inferior colliculus (which receive optic and auditory afferents, respectively), whereas the basal plate is
the primordium of tegmentum (which is a major motor outflow region) (Altman and Bayer, 1981a, b,
c). In the diencephalon, the alar plate is the source of neurons of the thalamic nuclei (which are relay
stations in the somesthetic, auditory and visual pathways), while the basal plate is the primordium of the
hypothalamus (which contains many of the efferent centers of the autonomic, endocrine, and other
motor systems) (Altman and Bayer, 1979). However, the alar plate and basal plate are not tracible in
the telencephalon. For example, the course of sulcus limitans is not tracible in the telencephalon.
1.8.2.3 Cerebral organization
The cerebral organization is established (see figure 1.3 on the following page) as a result of
modifications on the three-layered primitive cerebrum through migration, differential growth, and
selective cell death of neuroblasts. Neuroblasts may migrate from the mantle zone toward the outer
surface to form a new zone of neurons — the neocortex. The neortex will eventually stratify into six
layers of cell bodies. These layers of the neocortex differ in their functional properties, the types of
neurons found therein, and the set of connections that emerge. For example, neurons from layer 6 send
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their major output to the thalamus, while neurons from layer 4 receive their major input from
thethalamus (Rakic, 1974). Horizontally, the cerebral cortex is organized into more than 40 functional
regions (Walsh and Cepko, 1988; 1992).
41













Figure1.3Diagrammaticrepresent tionofthform tionm lt plelay sinc r bel umdc r bralco t x.
1.8.2.4 Cerebellar organization
The three-layered pattern is also modified in the cerebellum (see figure 1.3 on the preceding page).
Neuroblasts proliferate at the secondary (external) germinal layer and form an inner and an outer
compartment. The inner compartment contains postmitotic neuroblasts that constitute the precursors of
the major neurons, the granular cells, in the cerebellar cortex (reviewed by Zilles and Wree, 1985).
Some of the precursor cells migrate back into the cerebellar white matter to form a region of granular
cell neurons, the internal granular layer. Meanwhile, the primary ventricular layer of the cerebellum
generates a wide variety of neurons and glial cells, including the large Purkinje neurons. Purkinje
neurons have an enormous dendritic apparatus and a slender axon that connects to the other cells in the
deep cerebellar nuclei. Functionally, Purkinje neurons are the only output neurons of the cerebellar
cortex.
1.8.3 Primary induction and regionalization
1.8.3.1 Primary induction
Experiments using amphibian embryos by Spemann and his colleagues (particularly Hilde Mangold) led
to the discovery that the dorsal blastopore has an organiser activity that recruits surrounding ceils to
form the antero-posterior axis (reviewed by Spemann, 1938). Spemann referred to the dorsal
blastopore lip cells as the "organiser" where dorsal mesoderm can provide directly or indirectly signals
for the specification of neural tissues during gastrulation. In birds, Hensen's node acts as the dorsal
blastopore lip. When a Hensen's node from young gastrula is transplanted into epiblasts of another
young gastrula, it will induce the formation of a complete secondary axis (Waddington, 1933). Similar
organizer activity is also found in the primitive node in the mouse (Storey et al., 1992; Beddington,
1994).
Spemann's organiser used to be called the "primary organiser" because it is not sufficient to organise
the entire embryo; instead, it initiates a series of sequential inductive events. But the concept of
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primary organiser is gradually fading because of two main reasons: (1) there is evidence of multiple
neural inductions (reviewed by Harland, 1994; Shawlot and Behringer, 1995). (2) regionalization of the
nervous system occurs well before neurulation, at about the time when neural fates are being acquired
(Quinian et al., 1995).
1.8.3.2 Forebrain and hindbrain regionalization
Regionalization is a necessary process following or during neural induction. Regionalization appears to
occur well before the presence of obvious brain vesicles or even before the presence of neural plate
(Quinian et al., 1995). Fate mapping studies in the mouse show that almost the entire precursor
population of the neural tube is contained within the distal cap region of the epiblast, and there is
already some regionalization within this population (Quinian et al., 1995). Mouse embryos start
showing primary cranial flexures along the longitudinal axis well before the closure of neural tube
(Jacobson and Tam, 1982). Early regionalization of the CNS is likely to involve in a mechanism
similar to that in the process of neurulation. Concurrent changes in cell shape, such as the formation of
wedged shaped cells and cell elongation, as well as influences from other tissues and extracellular
matrix, are important for the shaping and bending of the neural plate during neurulation (Jacobson,
1981; Schoenwolf and Smith, 1990). Similar mechanisms may be involved in early regionalization of
the CNS and in the formation of the cranial flexures and the brain vesicles.
Further regionalization of the developing brain vesicles leads to the formation of proneuromeres and
neuromeres (reviewed by Berquist and Kallen, 1954; Vaage, 1969; Keyser, 1972). Based on
neuromeric segmentation and expression patterns of the homeobox genes and other regulatory genes,
seven rhombomeres (eight in the chick) in the hindbrain (rhombencephalon) and six prosomeres in the
forebrain (telencephalon and diencephalon) are defined in the mouse (see figure 1.4 on the following
page) (Lumsden and Keynes, 1989; Puelles and Rubenstein, 1993).
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Figure 1.4 Forebrain and hindbrain regionalization based on neuromeric segmentation and patterns of
expression of homeobox-containing genes and other regulatory genes. Six (PI - P6) prosomeres are
defined in the forebrain region, starting from the pretectum (pi) toward dorsal thalamus (P2), ventral
thalamus (P3), mammillary area (P4), tuberal hypothalamus (P5), and terminating in retrochiasmatic
area (p6). Seven rhombomeres (rl - r7) are defined in the hindbrain region, starting with rl in the
boundary of the cerebellum and isthmus of mesencephalon and terminating with r7 that connects by its
caudal end with the spinal cord (Based on the illustrations in Puelle and Rubenstein, 1993 and Stoykova
et al., 1996). Abbreviations: ACX: archicortex; AEP: anterior entopeduncular area; AH; anterior
hypothalamus; Cb: cerebellum; CGE: caudal ganglionic eminence; DB: diagonal band (Broca); DT:
dorsal thalamus; EMT: eminentia thalami; ET: epithalamus; HCC: hypothalamic cell cord: Is: isthmus
of mesencephalon; LGE: lateral ganglionic eminence; M: mesencephalon; MA: mammillary area;
MGE: medial ganglionic eminence; NCX: neocortex; OB: olfactory bulb: PEP: posterior
entopeduncular area; POA; anterior preoptic area; POP: posterior preoptic area; PT: pretectum; RCH:
retrochiasmatic area; SCH: suprachiasmatic area; SE; septum; SPV: supraoptic/paraventricular area;
TU: tuberal hypothalamus; VT; ventral thalamus.
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Neuromeres are centres for proliferation, migration, compartmentation, and differentiation of the
neuroblasts (Kallen, 1965; Layer and Alber, 1990; Fraser et al., 1990; Fidger and Stern, 1993;
Brigbauer and Fraser, 1994). Activities of proliferation and migration of neuroblasts are higher within
the neuromeric domains than in their boundaries (reviewed by Bergquist and Kallen, 1954). Cells in
the boundary regions are packed differently from those in the body of rhombomeres (Lumsden and
Keynes, 1989; Figdor and Stern, 1993; Heyman et al., 1993). Cells from neighbouring neuromeres mix
little (Fraser et al., 1990; Figdor and Stern, 1993), but those from two odd-numbered or two even-
numbered neuromeres generally mix (Guthrie and Lumsden, 1991; Guthrie et al., 1993). Furthermore,
from the time the first neurons differentiate, the boundaries between rhombomeres become delineated
by transversely oriented axons (Lumsden and Keynes, 1989; Keynes and Lumsden, 1990).
Neurogenesis of the somatic motor system, reticular system and branchial neurons conforms to the
rhombomeric pattern (Keynes and Lumsden, 1990). The neuromeric patterning of cell proliferation,
migration, compartmentation, and differentiation can be correlated with segmental gene expression data
therein (for example, see Kuratani, 1991), providing clues for the role of specific genes in those events.
1.8.4 Proliferation
Proliferation of neuroblasts occurs intially in the primary germinal epithelium and at later stages in the
secondary germinal epithelium, which is governed by a strict timetable (Altman and Bayer, 1995).
Most mammals cease producing neuroblasts in the CNS at some time after birth, as a result of gradually
dissolution of the neuroepithelium and the rapid growth of the brain parenchyma. Neuronal cells are
also reduced by cell death as they enter the phase of differentiation and pathfinding (reviewed by
Cunningham, 1982; Cowan et al., 1984; Oppenheim, 1991).
Based on the structural features of the developing rat brain, Altman and Bayer (1995) divide prenatal
brain development into three stages: The initial stage spans from Ell to E14 and is characterised by
rapid expansion of the primary germinal neuroepithelim. The differentiating brain regions with
postmitotic neurons only become obvious in the caudal and ventral portion of the developing CNS by
the end of the initial stage (E14). The intermediate stage covers period between E15 to E18. During
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the intermediate stage, the germinal neuroepithelium remains prominent and expansion of the secondary
germinal neuroepithelium adds to the increasing number of neuroblasts. Neuroblast proliferation is
coupled with progressive enlargement of the brain parenchyma. As a result, by the end of the
intermediate stage (El8), all major brain systems are identifiable. The third is the final stage that
covers the period from E20 to E22. The final stage is characterised by gradual dissolution of the
germinal neuroepithelium and rapid expansion of the brain parenchyma. Although neuroblast
proliferation still continues in the secondary germinal neuroepithelium after birth, the major event in
postnatal brain development is the accelerated differentiation of neurons and myelin fibers.
1.8.5 Migration and glial guidance
The three-layered structure of the developing CNS is formed as a result of the migration of neuroblasts
produced in the primary and secondary germinal epithelia (Arey, 1974). Cells leaving the germinal
layer generally lose their potential to divide and, during the same process, become differentiated into
neurons and glial cells, depending on the environment they enter (Cajal, 1960; Miale and Sidman,
1961; Rakic and Goldman, 1982; Turner and Cepko, 1987). Upon leaving the germinal
neuroepithelium, the young neurons either settle near the sites of proliferation or migrate to distant sites.
Those settle near the germinal layer can permanently rest and differentiate into cranial nerve nuclei.
Alternatively, young neurons may be displaced by new waves of later produced neurons leaving the
germinal layer (Altman and Bayer, 1995). Those young neurons that migrate to distant sites take part in
more drastic transformations. They can not only migrate in a relatively simple radially-directed process
such as during the formation of the cerebral cortex, but also involve in long distance migration in
various directions through dense brain tissue, over the surface of the brain, or in rare cases across the
midline from one side to the other (O'Rouke et al., 1992; Walsh and Cepko, 1993; Tan and Breen,
1993; Lois and Alvarez-Buylla, 1994; Altman and Bayer, 1995).
Since migration is crucial for the spatial organization and thus obtaining proper functions of the
developing CNS, it has to follow a strict timetable. The process of migration is not achieved merely by
passive movement. Rather active positioning of young neurons through glial guidance constitues the
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primary mechanism (Rakic, 1972; Hatten, 1990). A sunstantial amount of evidences suggest that
throughout the cortex formation, neurons ride "the glial monorail" to their destinations (Rakic and
Sidman, 1973; Rakic, 1975; Komuro and Rakic, 1992). Failure of glial guidance can lead to
abnormalities in cortex organization, such as the absence of the granular neuron layer in the mouse
weaver mutation (Goldowitz and Mullen, 1982; Hatten, 1990; Gao and Hatten, 1993).
1.8.6 Connection and pathfinding
Once the young neurons are following the tracts of migration and differentiation, neuronal connection
and pathfinding take place to construct a functional and intergrated central nervous system. Axon
growth cones navigate to their targets to make initial connections by two mechanisms: extratracellular
matrix guidance and diffusible molecule guidance (reviewed by Hynes and Lander, 1992; Goodman and
Shatz, 1993; Travis, 1994).
Extracelluar matrix may regulate axon growth by activities of specific adhesion and specific repulsion
(Hynes and Lander, 1992). Laminin, for example, has axon-promoting activities. Axons of certain
spinal neurons travel through the neuroepithelium over a transient laminin-coated surface that precisely
marks the path of these axons (Letourneau et al., 1988). There is also a good correlation between the
elongation of retinal axons and the presence of laminin on the neuroepithelial cells and astrocytes in
embryonic mouse brain (Cohen et al., 1986, 1987; Liesi and Silver, 1988). Tenescin, for example,
appears to have a repulsive function. It is only expressed at boundaries through which axons do not
cross (Stenideler et al., 1989).
An example for diffusible molecule guidance is the involvement of F-spondin in the growth of spinal
commissural neurons toward the neural plate (Tessier-Lavigne et al., 1988; Plazek et al., 1990; Klar et
al., 1992). Another example is the expression of netrin-1 and netrin-2 in the developing floor plate and
the spinal cord. Both act to promote initial ventral growth of commissural axons and to direct the
growth cones ventral to the floor plate (Kennedy et al., 1994; Serafini et al., 1994). Molecule repulsion
activity is also found for netrin-l (Colamario and Tesssier-Lavigne, 1995).
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1.8.7 Cell death during axongenesis
In many parts of the vertebrate central nervous system, over half of neurons die during the normal
course of development (reviewed by Cunningham, 1982; Cowan et al., 1984; Oppenheim, 1991). The
death of neurons seems to be due to inadequate supply of some critical survival factors such as NGF
(nerve growth factor) (Levi-Montalcini and Booker, 1960), BDNF (brain-derived neurotrophic factor)
(Oppenheim et al., 1992), NT-3 (neurotrophin-3), NT-4/5 (neurotrophin-4/5), FGF-5 (fibroblast growth
factor-5) (Hohn et al., 1990; Maisonpiere et al., 1990; Henderson et al., 1993; Hughes et al., 1993),
GDNF (glial cell line-derived neurotrophic factor) (Lin et al., 1993) and CNTF (ciliary neurotrophic
factor) (Sendtner et al., 1992). Some reports proposed that the neurotrophic factors, depolarilization
and interactions with substrates all contribute to the determination of neuronal survival (Schmidt and
Kater, 1993; Raff et al., 1994).
1.9 Integration of the visual nervous system
The visual nervous system, particularly the mammalian visual nervous system, is generally regarded as
a set of pathways working largely in parallel, i.e. separate classes of retinal ganglion cells send specific
information through separate classes of relay cells within one particular visual nucleus (Stone, 1984).
Thus, visual fields can be traced from the retina via optic nerve, chiasma, tract through dorsal and
ventral lateral geniculate nuclei and superior colliculus, all the way to specific areas of the visual cortex
(see figure 1.5 on page 49) (reviewed by Sefton and Drefer, 1985). This forms the
retinogeniculocortical pathway that integrates the main parts of the visual nervous system. In addition
to the nuclei of the retinogeniculocortical pathway, there have been suggestions of small retinal
projections to the hypothalamus, including the inferior collicus, the anterodorsal and anteroventral
thalamic nuclei, as well as the subthalamus (reviewed by Sefton and Drefer, 1985). But little is known
about these additional pathways. From sections 1.9.1 to 1.9.9, I will therefore concentrate only on the
nuclei and their afferent and efferent connections within the main parts of the visual pathways. In
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section 1.9.9, a highly schematic diagram summarizing the major connections between the visual nuclei
will be added to give a clear picture of the integration of the visual nervous system.
1.9.1 Retinal output through optic nerve, chiasma, and tract
Along the retinogeniculocortical pathway, the retina is the only site that provides efferent axons of
ganglionic cells. The axons cross at the optic chiasma and thereafter are called the optic tracts.
Although some axons branch at the chiasma to project into both optic tracts (Cunningham and Freeman,
1977), most axons project into the optic tract to the opposite side (Jeffery et al., 1981). Within optic
nerves and optic tracts, the relative positions of axons arising in different retinal quadrants are
maintained (Yamadori, 1981), but the number of fibers in the optic tract exceeds that in the nerve
(Sefton and Drefer, 1985). This excess presumably includes any branches of optic axons arising at the
chiasma, as well as fibers that pass from one parabigeminal nucleus through the optic chiasma to
contralateral visual nuclei (Stevenson and Lund, 1982; Watanabe and Kawana, 1979). Ganglion cells
project to the superior colliculus (SC) (Linden and Perry, 1983), as well as the dorsal lateral geniculate
nucleus (DLG) (Sefton, 1968). It is suggested that axons also branch to supply the ventral lateral
geniculate nucleus (VLG) and pretectum (Giolli and Towns, 1980).
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1.9.2 Dorsal lateral geniculate nucleus
The dorsal lateral geniculate (DLG) is a visual relay nucleus that occupies the dorsolateral part of the
thalamus and relays information to the visual cortex. Apart from the retinal input (Hayhow et al.,
1962), afferents to the DLG arise in many sources: various layers of the occipital cortex (Montero and
Guillery, 1968; Jacobson and Trojanowski, 1975), the visual Rt (visual thalamic reticular nucleus)
(Ohara and Lieberman, 1981; Hale et al., 1982), the superficial gray layer of the superior colliculus
(Mason and Groos, 1981; Sefton and Martin, 1984), the optic tract nucleus and the olivary pretectal
nucleus in the pretectal area (Mackey-Sim et al., 1983), the parabigeminal nucleus (Sefton and Martin,
1984), the dorsal terminal nucleus (Mackey-Sim et al., 1983) and some other nuclei of the brain stem.
Efferent projections from the DLG are restricted to the occipital cortex (Oc) and the visual thalamic
reticular nucleus (visual Rt) (Matthews, 1973; Scheibel and Scheibel, 1966; Hale et al., 1982).
1.9.3 Superior colliculus
In the rat, the superior colliculus (SC) or the optic tectum is the major target of the retinal ganglion cells
(Linden and Perry, 1983). SC is organized in seven laminated layers: zonal, superficial gray, optic,
intermediate gray and intermediate white, deep gray and deep white (Huber and Crosby, 1943). The
superficial gray layer and upper optic layer are innervated by retinal axons. Cells in the innervated
layers in turn project to deeper layers where neurons of other sensory systems are located (Harting et
al., 1973; Stein, 1981).
Connections of SC can be divided into those with the upper layers (zonal, superficial gray, and optic)
and those with the deeper layers (below intermediate gray). Afferent axons to the upper layers include
those from the retina (Cajal, 1911), different layers of occipital cortex (Huber and Crosby, 1943),
parabigeminal nucleus (Sefton and Martin, 1984), pretectum (Huber and Crosby, 1943), and the
magnocellular part of the ventral lateral geniculate nucleus (Brauer and Schober, 1982). Efferents from
upper layers lead to deep layers of SC (Cajal, 1911), dorsal lateral geniculate nucleus (Perry, 1980;
Rhoades and Fish, 1982), lateral posterior nucleus (Takahashi, 1985), ventral lateral geniculate nucleus
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(Takahashi, 1985), parabigeminal nucleus (Sefton and Martin, 1984), and pretectum (Takahashi, 1985).
Afferent axons to the deep layers include those from superficial gray and optic layers of SC (Cajal,
1911), retina (Beckstead and Frankfurter, 1983), occipital cortex (Takahashi, 1985), locus coerulus and
substantia nigra (Pasquier and Tremazzini, 1979), spinal cord (Antonetty and Webster, 1952),
magnocellular part of the ventral lateral nucleus (Brauer and Schober, 1982), and nucleus of posterior
commisure (Pasquier and Tremazzini, 1979). Efferent axons from the deep layers lead to pontine
nuclei (via tectopontine tract) (Petrovicky, 1975), lateral reticular regions in midbrain and pons
(tectoreticular tract) (Petrovicky, 1975), medial reticular formation in brain stem (cruciate tectoreticular
tract)(Petrovicky, 1975), medulla (Waldron and Gwyn, 1969), cervical spinal cord (Murray and
Coulter, 1982), and hypothalamus (Fallon and Moore, 1979).
1.9.4 Lateral posterior nucleus (pulvinar)
The lateral posterior nucleus (LP) lies medial and caudal to the dorsal lateral geniculate (DLG) in the
lateral thalamus (Paxinos and Watson, 1982). It receives projections from the SC and the occipital
cortex and is considered to be the homologue of the pulvinar in the primates (Harting et al„ 1972) as
well as the LP-pulvinar complex in cats (Berson and Graybiel, 1983; Updyke, 1983). Demonstrated
afferent axons to the lateral posterior nucleus are from superior colliculus (Takahashi, 1985), pretectum
(Schober, 1981), some layers of the occipital cortex (Takahashi, 1985), temporal cortex area 36 (Mason
and Gross, 1981), and retina (Perry and Cowley, 1982). Efferent axons from the lateral posterior
nucleus project to occipital layers and temporal cortical areas (Schober, 1981; Mason ans Groos, 1981).
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1.9.5 Ventral lateral geniculate nucleus
The ventral lateral geniculate nucleus (VLG) extends deep to the DLG (dorsal lateral geniculate
nucleus) and borders medially to the optic tract. Between DLG and VLG lies a small lamina, the
intergeniculate leaflet (IGL) (Hickey and Spear, 1976). In many mammals, including the rat, two
divisions can be recognized clearly within VLG (Niimi et al., 1963). Only the external, lateral and
magnocellular (VLGMC) divisions contain cells that respond to visual stimuli (Sumitomo et al., 1979),
receive a significant retinal input from both eyes (Hickney and Spear, 1976), and contain cells
projecting to the superior colliculus (Brauer and Schober, 1982).
Afferent connections to VLG include those from retina, occipital cortex, superior colliculus, pretectum.
dorsal raphe nucleus, perirubral reticular formation (Mackay-Sim, 1983), and locus coeruleus (Pasquier
and Villar, 1982; Mackay-Sim et al., 1983; Takahashi, 1985). Efferent connections from VLG lead to
pretectum (including anterior pretectal nucleus, nucleus of the optic tract and olivary pretectal nucleus),
superior colliculus (Perry, 1980; Brauer and Schober, 1982), pontine nuclei (Legg, 1979), and
perirubral formation (Graybiel, 1975).
1.9.6 Pretectum
The pretectum is derived from the epithalamus and lies at the most rostral pole of the midbrain
bordering the thalamus (Paxinos and Watson, 1985). Although often referred to as a single entity, the
pretectum contains a number of distinct nuclear groups (Sefton and Dreher, 1985). The nuclei in the
pretectum include nucleus of the optic tract (OT), olivary pretectal nucleus (OPT), anterior pretectal
nucleus (APT), and posterior pretectal nucleus (PPT) (see figure 1.5 on the following page).
Afferent axons to the pretectum include those from the retina (Hayhow et al., 1962; Hickey and Spear,
1976; Perry and Cowley, 1979), superior colliculus (Perry, 1980; Pasquier and Villar, 1982; Takahashi,
1985), ventral lateral geniculate (Mackay-Sim et al., 1983) and the occipital cortex (Nauta and Bucher,
1954; Leong, 1980). Efferent axons from the pretectum lead to superior colliculus (Watanabe and
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Kawana, 1979), dorsal and ventral lateral geniculate nuclei (Blanks et al., 1982; Mackay-Sim et al.,
1983), lateral posterior thalamic nucleus (Schober, 1981), visual reticular thalamic nucleus (Hale et al.,
1982), laterodorsal thalamic nucleus (Robertson, 1983), optic tract nucleus (Terasawa et al., 1979),
lateral pons (Scalia and Arango, 1979), reticulotegmental nucleus of the pons (Terasawa et al., 1979),
and inferior olive (Robertson, 1983).
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Figure 1.5 Diagrammatic representation of the visual pathways originating in the retina and
terminating in the visual cortex. Each nucleus is depicted by a typical coronal section through it. On
the left hand side of the diagram, visual nuclei are labelled. The shaded nuclei on the right hand side
indicate those which have been reported to receive an input from visual cortical areas. Each projection
is shown as a branch of a single fiber for simplicity, but this si not meant to imply that all nuclei are
necessarily innervated by branches of retinocollicular axons. Note that the reticular thalamic nucleus
(Rt) and the parabigeminal nucleus (PBg) do not receive a direct retinal input, but are reciprocally
connected to the dorsal lateral geniculate nucleus (DLG) and the superior colliculus (SC) respectively.
The dotted lines connecting the dorsal, lateral, and medial accessory nuclei (DT, LT, MT) indicate that
they are not determined (Based on an illustration in Sefton and Dreher, 1985). Abbreviations: 17: area
17 of the visual cortex; 18: area 18 of the visual coetex; 18a, area 18a of the visual cortex; APT:
anterior pretectal nucleus; DLG: dorsal lateral geniculate nucleus; DT: dorsal terminal nucleus of the
accessory optic tract; iao: internal accessory optic tract; IGL: intergeniculate leaflet; InG: intermediate
gray layer of the superior colliculus; LT: lateral terminal nucleus of the accessory optic tract; MT:
medial terminal nucleus of the accessory optic tract; OPT: olivary pretectal nucleus; OS: optic nerve
layer of the superior colliculus; OT: nucleus of the optic tract; ox: optic chiasma; PBg: parabigeminal
nucleus; PPT: posterior pretectal nucleus; Rt: reticular thalamic nucleus; sao: superficial accessory
optic tract; SC: superior colliculus; SGS: superficial gray layer of the superior colliculus; SCh:
suprachiasmatic nucleus; VLGMC: ventral lateral geniculate nucleus, magnocellular part; VLGPC:
ventral lateral geniculate nucleus, parvocellular part.
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1.9.7 Accessory optic system
The accessory optic system include the dorsal terminal nuclei (DT), the lateral terminal nuclei (LT), and
the medial terminal nuclei (MT) (Hayhow et al., 1960). Two (superior and inferior) crossed accessory
fasciculi leave the main optic tract behind the chiasm. The inferior fasciculus can be identified initially
as a small separate bundle which lies medial to the main optic tract. Subsequently, its fibers intermingle
with the median forebrain bundle as they run close to the base of the peduncle to innervate the medial
terminal nucleus, the principle nucleus of the accessory optic system. The superior fasciculus
terminates in two branches: one in the medial terminal nucleus; the other in the lateral terminal nucleus
(Hayhow et al., 1960).
Connections to the accessory optic system include those of retinal origin (Hayhow et al., 1960) and of
the ventral lateral geniculate nucleus (Mackay-Sim, 1983; Ribak and Peters, 1975) as well as the
occipital cortex (Leong, 1980).
1.9.8 Visual cortex
The visual cortex in the rat is located in the occipital (Oc) region of the rat isocortex. The occipital
region can be divided into three areas (Ocl, Oc2M, and Oc2L) on the basis of cytoarchitectural and
myeloarchitectural methods (reviewed by Zilles and Wree, 1985). The Ocl is the primary visual cortex
and is partially surrounded at its rostromedial border by visual area Oc2M and at its rostrolateral border
by visual area Oc2L. The visual cortex receives inputs from the retina via the dorsal lateral geniculate
nucleus of the thalamus, as well as many extrageniculate thalamic nuclei including the pulvinar and
lateral posterior complex (Price, 1991), the laterodorsal thalamic nucleus (Schober et al., 1979), locus
coeruleus (Morrison et al., 1981), raphe nuclei (Lidov et al., 1980), and temporal cortex 1 (Schober et
al., 1979). Between the right and the left hemispheres, the visual cortical areas are reciprocally
interconnected by axons that run through the corpus callosum (Price, 1991).
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Efferent axons from the occipital areas target to dorsal and ventral lateral geniculate nucleus (Nauta and
Bucher, 1954; Sefton et al., 1980), lateral posterior complex (Ribak, 1977; Schober et al., 1976),
superior colliculus (Sefton et al., 1980), pontine nuclei (Ribak, 1977), reticular thalamic nucleus
(Sefton et al., 1980), and pretectal area (Nauta and Bucher, 1954; Ribak, 1977).
1.9.9 Summary of the visual pathways
Sections 1.9.1 to 1.9.8 describe the highly complicated pathways that connect and integrate
components of the visual system. Garey et al. (1991) reviewed the organization of the visual thalamus
in the laboratory rat, the domestic cat, and the macaque monkey and summarised their major visual
nerve connections in a highly schematic diagram (see figure 1.6 on the following page). The diagram
shows that the reticulogeniculostriate pathway and the pathway from the retina to extrastriate cortex via
the superior colliculus and pretectum are the major (indicated by thick arrows) visual pathways. Other
complicated minor pathways are also indicated. Thus, the diagram serves as a comprehensive map of
the visual system at a glance.
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Figure 1.6 A highly schematic diagram summarizing some of the connections between the visual
nuclei as reviewed in the laboratory rat, domestic cat, and macaque monkey (After Garey et al., 1991).
The retinogeniculostriate pathway, and the pathway from the retina to extrastriate cortex via the
superior colliculus and pretectum are indicated with thick arrows to highlight the main visual
pathways. Abbreviations: CH: brainstem cholinergic nuclei; EX STR: extrastriate cortex; LGD: dorsal
lateral geniculate nucleus; LGV PRE: ventral lateral geniculate nucleus/pregeniculate nucleus; PGB:
parabigeminal nucleus; PG/RN: perigeniculate/reticular nucleus; PT: pretectum; PUL LP:
pulvinar/lateral posterior complex; R LC: raphe nucleus and locus coeruleus; RET: retina; SC: superior
colliculus; 17: area 17 of striate cortex (see following page for figure).
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PBG
Figure- 1.6 A. highly schematic diagram summarizing visual connections in three- species (see the
preceding page for legend).
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1.10 Integration of the olfactory nervous system
The olfactory nervous system, like the visual nervous system, covers a good variety of nuclei and
pathways that can be traced from the external olfactory epithelium to the higher olfactory centers. The
lateral olfactory tract and the lateral olfactory nucleus function in a comparable way as compared to the
optic tract and the lateral geniculate nucleus in the visual nervous system. Components of the olfactory
nervous system include the olfactory epithelium, the main olfactory bulb, the accessory olfactory bulb,
the anterior olfactory nucleus, the precommissural hippocampus, the olfactory periallocortex, the
endopiriform nucleus, the piriform cortex, the amygdalopiriform transition area, as well as the olfactory
and vomeronasal amygdala (reviewed by Switzer et al., 1985; Farman, 1992; Halasz, 1990). I will
briefly describe, concentrating on afferent and efferent connections, each of these components from
sections 1.10.1 to 1.10.9 (see figure 1.7 on the following page).
1.10.1 Main olfactory bulb
Most mammals have two chemosensory organs in the nasal cavity, the olfactory epithelium and the
vomeronasal organ. The olfactory epithelium projects axons to the main olfactory bulb, while the
vomeronasal organ projects axons to the accessory olfactory bulb (Farman, 1992). The olfactory
epithelium covers the superior and the posterior regions of the nasal cavities and contains three cellular
types: the olfactory receptor cells, the secretory or supporting cells, and the basal cells (Graziadei,
1971). The olfactory receptors are bipolar neurons. Each olfactory receptor emits a thin axon that joins
others into small bundles. Bundles join together into fascicles that pass through the foramina of the
sieve-like cribriform plate to form a fibrous outer layer of the main olfactory bulb and terminate in the
glomeruli layer of the main olfactory bulb. The main olfactory bulb contains six well-defined layers,
from the surface to the ependymal zone (the oblitered ventricular zone in the center of the bulb) (see
figure 1.7 on the following page).
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Afferent axons to the main olfactory bulb include those from accessory olfactory bulb, piriform
olfactory cortex, lateral, dorsal, and medial transition zone, nucleus of the vertical and horizontal limb
of the diagonal band (Broca), nucleus of the lateral olfactory tract, taenia tecta, ventral pallidum,
posterolateral cortical amygdaloid nucleus, anterior amygdaloid area, anterior pituitary, lateral
hypothalamic area, zona incerta, locus coeruleus, dorsal raphe nucleus, median raphe nucleus and
median septal nucleus (de Olmos et al., 1978; Haberly and Price, 1978a, b; Luskin and Price, 1983;
Macrides and Davis, 1983; Shipley and Adamek, 1984; Uemura-Sumi et al., 1985). Efferent axons
from the main olfactory bulb target to accessory olfactory lobe, piriform cortex, olfactory tubercle,
anterior amygdaloid area, posterolateral cortical amygdaloid nucleus, rostral part of medial amygdaloid
nucleus and entorhinal cortex (Heimer, 1968; Kosel et al., 1981; Price, 1973; Scalia and Winans, 1975;
White, 1965).
1.10.2 Accessory olfactory bulb
The receptors for the accessory olfactory bulb are distributed in the vomeronasal organ which is located
in the rostral floor of nasal cavity (Estes, 1972). The vomeronasal nerve fibers penetrate the cribriform
plate along with the olfactory nerve fibers and traverse, as a bundle, the medial surface of the main
olfactory bulb in order to reach the accessory olfactory bulb. Input axons to the accessory olfactory
bulb include the bed nucleus of the accessory nucleus tract, medial amygdaloid nucleus, posteromedial
cortical amygdaloid nucleus, and ventral bed nucleus of the stria terminalis (medial part) (de Olmos et
al., 1978). Efferent axons lead to the bed nucleus of the accessory nucleus tract, medial amygdaloid
nucleus, posteromedial cortical amygdaloid nucleus, and the posterodorsal bed nucleus of the stria
terminalis (medial part) (Scalia and Winas, 1975).
1.10.3 Anterior olfactory nucleus
The anterior olfactory nucleus, which is first visible at the caudolateral border of the olfactory bulb,
surrounds the anterior limb of anterior commissure and forms the main part of the olfactory peduncle.
The caudal border of anterior olfactory nucleus is characterized by transitional areas (de Olmos et al.,
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1978). The transitional areas separate it from anterior or frontal portions of the piriform cortex, frontal
orbital cortex, and ventral precommissural hippocampus.
The anterior olfactory nucleus (AO) is closely related to the olfactory bulb. In particular, the
centrifugal pathways from the anterior olfactory nucleus to the olfactory bulb are especially impressive
(Switzer et ai, 1985). Apart from contributing to the centrifugal innervation of the main olfactory bulb,
the AO participates in the formation of association systems of the primary olfactory (piriform) cortex,
through which the AO is directly connected to the ventral precommissural hippocampus, the
endopiriform nucleus, and particularly to the anterior part of the primary olfactory cortex. Anterior
olfactory axons in the association system also branch to form a commissural projection to the anterior
piriform cortex, the endopiriform nucleus and the AO on the opposite side (Haberly and Price, 1978b;
Luskin and Price, 1983a). The AO also projects to the olfactory tubercle and the nucleus of the
horizontal limb of the diagonal band (Broca), with the continum of projections contributing to the
lateral preoptic and lateral hypothalamic areas (de Olmos et al., 1978; Luskin and Price, 1983a). In
addition, efferent projections to the bed nucleus of the stria terminalis, and to the nuclei gemini in the
posterolateral part of hypothalamus have been reported in the rabbits (Broadwell, 1975).
Afferent connections of the AO include the main olfactory bulb, piriform cortex, transitional olfactory
areas, lateral entorhinal area, as well as the complex composed of the ventral subiculum and CA1
division of the hippocampus, the horizontal and vertical nuclei of the diagonal band (Broca), the bed
nucleus of stria terminalis, the nuclei comprising the olfactory amygdala, and the tuberomammillary
hypothalamus (Conrad and Pfaff, 1976; de Olmos, 1972; de Olmos, 1978; Haberly and Price, 1978a;
Kevetter and Winans, 1981b; Luskin and Price, 1983a).
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1.10.4 Precommissural hippocampus
The precommissural hippocampus (taenia tecta) represents the rostral and ventral continuation of the
supracommissural hippocampus (indusium griseum). Two divisions, the dorsal part and the ventral
part, can be distinguished in the precommissural hippocampus. The ventral part is morphologically
similar to the olfactory areas in the olfactory peduncle and contains extensive and reciprocal
connections to the ipsilateral olfactory bulbs and several olfactory cortical areas (Haberly and Price,
1978a,b; Luskin and Price, 1983a). The dorsal part connections are less clear.
1.10.5 Olfactory periallocortex
Axons from the main olfactory bulb also project to the olfactory periallocortex -- the cortical areas
outside the piriform cortex. In addition to the projections from the main olfactory bulb, afferent axons
are from the posterior part of the piriform cortex, cortical amygdaloid nucleus, and entorhinal area
(Haberly and Price, 1978a; Luskin and Price, 1983a). Other projections come from the ventrobasal
thalamus, parabranchial nucleus (Saper, 1982; Shipley and Geinesman, 1984), as well as those mainly
to the posterior insular cortex such as the mediodorsal nucleus of the thalamus and the basolateral
amygdaloid body (Gerfen and Clavier, 1979; Saper, 1982). Efferent axons from the posterior insular
cortex include the central amygdaloid nucleus, bed nucleus of stria terminalis, ventromedial and
dorsomedial thalamus, and some brain stem structures, including the parabranchial complex and
nucleus of the solitary tract (Saper, 1982; Shipley and Geinesman, 1984; reviewed by Switzer et al.,
1985).
1.10.6 Endopiriform nucleus
The endopiriform nucleus is situated immediately deep to the piriform cortex. It is continuous with the
insular or dorsal claustrum in the dorsal direction, while ventrally it merges with the deepest portion of
the ventromedial primary olfactory cortex and the deep parts of the amygdala. The endopiriform
nucleus is one of the main recipients of subcortical projections from the piriform cortex and from other
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recipients of the main olfactory bulb projection fibers (Luskin and Price, 1983a; Ottersen, 1982). The
endopiriform nucleus is also a subcortical relay centre for fiber systems originating in periallocortical
areas (Beckstead, 1979; Luskin and Price, 1983a). Most of the afferent pathways to the endopiriform
nucleus are reciprocally projected. Efferently, the endopiriform nucleus projects to the mediodorsal
thalamic nucleus, the ventral striatum, the lateral hypothalamus, and the tuberomammillary nucleus
(Krettek and Price, 1977a, 1978a). Projections also lead to the 'vomeronasal amygdala' (Krevetter and
Winans, 1981a) and the ventral subiculum, which are connected with the mediotuberal hypothalamus
(Krettek and Price, 1978b).
1.10.7 Piriform cortex
The piriform cortex represents the major projection target of the main olfactory bulb and thus is the
most extensive and important olfactory area in the brain for the integration and subsequent transmission
of the incoming olfactory stimuli. Afferent axons to the piriform cortex include those from the main
olfactory bulb, accessory olfactory bulb, ventral precommissural hippocampus, nucleus of the lateral
olfactory tract, posterolateral cortical amygdaloid nucleus, anterior cortical amygdaloid nucleus,
endopiriform nucleus, insular cortex, anterior amygdaloid area, sublenticular substantia innominata,
nucleus of the horizontal and vertical limb of the diagonal band (Broca), midline thalamic nuclei, lateral
hypothalamic area, lateral preoptic area, dorsal hypothalamic area, tuberomammillary nucleus, ventral
tegmental area (Tsai), dorsal and medial raphe nucleus, and locus coeruleus (Haberly and Price,
1978a,b; Azmitia and Segal, 1978; Fallon and Moore, 1978; Lindvall and Bjorklund, 1983; Steinbusch,
1981). Efferent axons project to the main olfactory bulb, accessory olfactory bulb, taenia tecta,
periallocortex, olfactory tubercle, endopiriform cortex, anterior amygdaloid area, nucleus of the lateral
olfactory tract, anterior cortical amygdaloid nucleus, posterolateral cortical amygdaloid nucleus,
posteromedial cortical amygdaloid nucleus, basolateral amygdaloid nucleus, basomedial amygdaloid
nucleus, central amgdaloid nucelus, mediodorsal thalamic nucleus, and lateral hypothalamic area
(Luskin and Price, 1983a,b; Heimer and Wilson, 1975; Millhouse and Heimer, 1984; Haberly and
Price, 1978a; Krettek and Price, 1978a; Veening, 1978; Price and Slotnick, 1983; Young et al., 1984) .
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1.10.8 Amygdalopiriform transition area
The amygdalopiriform transition area is located deep to and in the external lip of the amygdaloid
fissure. It receives projections from the piriform cortex, the ventral subiculum, and from some of the
amygdaloid nuclei (Krettek and Price, 1977a, b; Luskin and Price, 1983a, b; Ottersen, 1982). Other
afferent axons are from the insular periallocortex (Beckstead, 1979; Saper, 1982), the endopiriform
nucleus, and the reuniens thalamic nucleus (Herkenham, 1978). Efferent projections lead to the
caudomedial olfactory tubercle and accumbens nucleus, the subgenual periallocortex, basolateral and
central amygdaloid nuclei, and the lateral portion of the bed nucleus of stria terminalis (reviewed by de
Olmos et al., 1985).
1.10.9 Olfactory and vomeronasal amygdala
The olfactory and vomeronasal amygdala were first named by Kevetter and Winas (198la,b) to denote
parts of the amygdaloid complex that receives direct projections from the main and accessory olfactory
bulbs. Areas of the olfactory amygdala include the anterior amygdaloid area, nucleus of the lateral
olfactory tract, anterior cortical amygdaloid nucleus and posterolateral amygdaloid nucleus.
Vomeronasal amygdala includes the bed nucleus of the accessory olfactory tract, medial amygdaloid
nucleus, posteromedial cortical amygdaloid nucleus, and the medial part of the bed nucleus of the stria
terminalis.
Afferent and efferent axons are from the olfactory bulb and the primary olfactory (piriform) cortex, as
well as some subcortical inputs from the telencephalon, the diencephalon, and the locus coerulus from
the brain stem. These have been described in previous sections and will not be repeated here.
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1.11 Development of the eve
1.11.1 Gross morphogenesis of the eye
The eye is derived from four sources of tissues: neuroectoderm of the forebrain, surface ectoderm of the
head , neural crest, and head paraxial mesoderm. In the mouse, the first sign of optic placode formation
can be seen at the 4-somite stage, i.e. at the time when the cephalic neural folds are first clearly
recognizable (Kaufman, 1979; 1992). Shortly afterwards, an indentation in the central part of the optic
placode, the optic pit, forms. This is followed by the fusion of the neural folds to form the forebrain
vesicles at around days 8.5 - 9.0 p.c. in the mouse. During the fusion of the neural folds, the optic pits
appear as an increasingly deepening pair of indentations of the neural ectoderm connected by a pair of
shallow grooves, the optic sulci, in the region of future optic chiasma (Kaufman, 1992). As the neural
folds fuse, the optic sulci evaginate to form hollow diverticula called optic vesicles. The optic vesicles
(see figure 1.8a on the following page) are lateraly outgrowths from the caudal end of the
prosencephalon. The primary optic vesicles form before the two lateral head neural folds fuse
completely with each other, with little evidence of a previous dilation (O'Rahilly and Meyer, 1959; Pei
and Rhodin, 1970). Following appearance of the optic vesicle is the formation of a constriction, the
optic stalk, close to the midline of the prosencephalon. In the distal end of the primary optic vesicle, a
further outgrowth gradually makes contact with the overlying surface ectoderm.
Shortly after the optic vesicle contacts the surface ectoderm, the surface ectoderm thickens and
develops into the lens placode. The lens placode invaginates, pushing the optic vesicle toward the
midline to form a two-layered pocket at each lateral end of the diencephalon (figure 1.8a). The
invaginated lens placodes will detach from the overlying surface ectoderm and differentiate into the
lens. The remaining ectoderm that covers the lens will become the outer layer of the future cornea. The
cornea forms through an epithelium elongation (Bard et al., 1988). A migration of neural crest cells
from the margins of the optic cup contributes to the undersurface of the primary cornea stroma (Noden,
1978; Johnston et al., 1979). The inpocketed optic vesicle later becomes a cup-shaped structure called
the "optic cup". The optic cup is linked with the diencephalon through the optic stalk.
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The optic cup is a double-layered structure: the inner layer (the layer facing toward the lens) is the
neural retina, which is surrounded by the outer layer, the pigmented retinal epithelium. Cells of the
pigmented retinal epithelium at the anterior ridge of the optic cup extend toward the lens and, together
with retinal and neural crest derived cells, form the iris. Surrounding the optic cup are two outer coats -
- the vascularized choroid and the connective-tissue sclera; both are derived from the neural crest
(Johnston, 1979). Only the extrinsic ocular muscles are derived from the head paraxial mesoderm
(Noden, 1983).
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Figure 1.8a Diagrammatic representation of eye morphogenesis. A. At day 9 to 9.5 p.c., the lens
placode forms as a thickened part of the surface ectoderm. The neuroectoderm in close proximity to
the lens placode also becomes thickened. B. At day 9.5 to 10.0 p.c., the area of the lens placode has
enlarged and the early optic cup forms. C. At day 10.5 p.c., Two layers, the prospective neural retina
and pigmented epithelium, of the optic cup become evident as the lens placode indents to form the lens
pit. D. At day 11.5 p.c., the prospective cornea and the lens vesicle appear after the primitive lens is
detached from the surface ectoderm. The lens vesicle will gradually diminish as the primary lens
fibers elongate. E. At day 13.5 p.c., the lens comprises the anterior cuboidal epithelial cells and the
posterior elongating fiber cells. The neural retina layer behind the lens begins to differentiate and the
primitive cornea develops in front of the lens. (From Cvekl and Piatigorsky, 1996).
Figure 1.8b Differentiation of the lens. A. The lens epithelium shortly after detachment from the
surface ectoderm with the hollow cavity of lens vesicle being enclosed. B. The lens vesicle is reduced
as the primary fibers are enlongating. C. Two portions of the lens cells, the anterior and the posterior
portion, are established. D. The posterior portion of the lens cells elongate and produce secondary lens
fibers. E. The crystailin-synthesizing fibers continue to grow and eventually fill the space between the
anterior and the posterior portion of the lens tissue. The anterior cells constitute a germinal epithelium
(anterior lens capsule) which keeps dividing. The dividing cells move toward the equator of the
vesicle (indicated by arrows), and as they pass through the equatorial region, they begin to elongate.
(From Gilbert, 1994).
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Figure 1.8b Diagrammatic representation of lens differentiation (from Gilbert, 1994)
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1.11.2 Differentiation of the lens
As mentioned in section 1.11.1, during the course of neural tube formation, the optic vesicle (a
protrusion of the lateral forebrain that gives rise to the optic stalk, pigmented epithelium, and neural
retina) contacts the surface ectoderm. This ectoderm subsequently forms the lens and cornea. The
optic vesicle then invaginates to form a multilayered optic cup where specific cells can process light
stimuli into spatially organized images. For the correct focusing of light on the retina, correct curvature
of the lens and the cornea is necessary. The differentiation of lens tissue into a transparent membrane
capable of directing light onto the retina involves changes in the cell structure and shape as well as
synthesis of lens-specific proteins, the crystallins. Crystallins are synthesized as cell shape changes
occur, causing the lens vesicle to become the definitive lens (Wistow and Piatigorsky, 1988).
The lens tissue is first invaginated as a continuous but thickened part of the surface ectoderm. Then it
detaches from the surface ectoderm and shapes into a ball-like structure, with the lens vesicle being
enclosed (see figure 1.8b on the preceding page). Thus, two portions of the lens cells, the anterior and
the posterior, are established. Cells in the posterior portion of the lens elongate and, under the influence
of the neural retina (Piatigorsky, 1981; Wistow and Piatigorsky, 1988), produce the lens fibers. As the
fibers continue to grow, crystallins are extensively synthesized such that they fill up the cell and cause
the extrusion of the nucleus. The crystallin-synthesizing fibers continue to grow and eventually fill the
space between the anterior and the posterior portion of the lens tissue.
The anterior cells constitute a germinal epithelium that keeps dividing. The newly-divided cells move
toward the equator of the lens vesicle, and as they pass through the equatorial region, they begin to
elongate. Thus, the lens contains three regions: an anterior zone of dividing epithelial cells, an
equatorial zone of elongating cells, and a posterior and central zone of crystallin-containing fiber cells.
This arrangement of lens cells persists throughout the lifetime of animals, since fibers are continuously
being laid down.
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1.11.3 Differentiation of the retina
Like the cerebral and the cerebellar organization, the neural retina develops into a multiple-layered
structure containing different types of neuronal cells (see figure 1.9 on the following page). The layers
include light-sensitive and colour-sensitive photoreceptor (rod and cone) cells, cell bodies of ganglions,
and bipolar interneurons that transmit the electric stimulus from rod and cone cells to the ganglion cells.
In addition, there are plenty of glial cells to maintain the integrity of the retina, as well as amacrine
neurons and hirizontai neurons that transmit electrical stimuli horizontally.
To form and differentiate such a complicated but well-organized structure like the neural retina, precise
temporal and spatial coordination is needed. As a derivative of the developing neural tube, the
ventricular surface of retina is mitotically active. The ventricular zone initially includes the entire
thickness of the retina, but once the inner plexiform layer has formed, the interkinetic migration
becomes restricted to the region between the inner plexiform layer and the the outer limiting membrane.
This region, where the interkinetic migration is confined, is termed the 'neuroblast' or "cytoblast layer"
by Robinson et al. (1986). Nuclei of the dividing cells enter different phases of the cell cycle as they
traverse the "cytoblast layer" (Robinson et al., 1986). Thus, nuclei enter the M-phase and divide at the
outer limiting membrane. After division, the daughter nuclei enter Gpresting phase and migrate
through the outer part of "cytoblast layer". The nuclei enter S-phase as they reach the inner part of the
"cytoblast layer" and remain in this phase until they reached the inner plexiform layer. During S-phase,
nuclei incorporate molecules they require for the replication of DNA. Nuclei enter G2-resting phase
during their return journey to the outer limiting membrane where they divide again (Sidman, 1961;
Zavarzin and Stroeva, 1964; Denham, 1967; Robinson, 1986).
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Figure 1.9 Laminar structure of the retina after differentiation from a single layer of neuroepithelium. The rod
and cone photoreceptors in close proximity to the pigment layer project through the external limiting membrane
(ext. lim. memb.) to make connection to the bipolar and horizontal cells in the inner nucier layer. The
connection site is located within the external plexiform layer (ext. plexiform). The inter nuclear layer consists
of horizontal, bipolar, and amacrine cells. Bipolar and amacrine cells connect to the dendrites of ganglion cells
within the internal plexiform layer (int. plexiform). Axons of ganglion cells project together to form nerve fiber
layer that eventually contribute to the optic stalk and exit the eye. Miiller glia cells span between the internal
limiting membrane and the outer limiting membrane (Based on an illustration in Kahle, 1986).
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1.12 Development of the teeth
1.12.1 Histogenesis of the teeth
Early development of the teeth can be described in three stages according to morphogenesis: the bud
stage, the cap stage, and the bell stage (Osborn, 1981; reviewed by Thesleff, 1994) (see figure 1.10 on
page 82). In the mouse, the first sign of tooth development is the appearance of the dental lamina, a
ridge of ectoderm overlying the developing bones of the upper and lower jaw, at El 1.0. The dental
lamina gives rise to two buds in the upper jaw and four buds in the lower jaw. These buds form the
primordia of ectodermal components of the teeth (the bud stage). The deep surface of each bud
invaginates to form a cap of ectoderm, the dental papilla, over the mesenchymal thickening (the cap
stage). The cap consists of an outer layer of cells (the outer dental epithelium) and an inner layer (the
inner dental epithelium). The mesenchymal cells of the dental papilla adjacent to the inner dental
lamina then differentiate into odontoblasts that will later produce dentine. As the dentine layer
thickens, the odontoblasts retreat into the dental papilla. The odontoblasts persist in producing
predentine throughout life. The remaining cells of the dental papilla form the pulp of the teeth.
The epithelial cells of the outer dental lamina differentiate into the ameloblasts. The ameloblasts
produce long enamel prisms to deposite over the dentine. The enamel is first laid down at the apex of
the tooth, then spreads towards its neck. As the enamel thickens, the ameloblasts retreat and regress
afterwards.
Root formation begins when the dental epithelial layers penetrate the underlying mesenchyme to form
the epithelial root sheath. The odontoblasts of dental papilla lay down a layer of dentine continuous
with that of the crown, narrowing the pulp chamber to a mere root canal containing blood vessels and
nerves supplying the teeth. The mesenchymal cells in contact with root dentine produce a layer of
cementum (specialized bone) and the peridontal ligaments that hold the tooth in place. During this
process, the mandible and maxilla have grown to surround the tooth, forming medial and lateral
alveolar plates joined by transverse septa between the teeth.
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Figure 1.10 Diagrammatic representation of the formation of the lower first molar tooth at the times
of (A) initiation, (B) dental lamina invagination, (C) bud, (D) cap, (E) early bell, (F) late bell stages of
development. The development of incisors follows the same series of initiation, lamina invagination,
bud, cap, and bell stages. Note that the site of tooth formation is largely located following the
invagination of the dental lamina (dl). Abbreviations: a: ameloblasts; c: cervical loop; df: dental
follicle; dpi: dental placode; dl: dental lamina; dp: dental papilla; e: jaw epithelium; eee: external
enamel epithelium; ek: enamel knot; iee: internal enamel epithelium; m: mesenchyme; o: odontoblast;
si: stratum intermedium; sr: stellate reticulum (Based on an illustration in Mackenzie et al., 1991a).
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1.12.2 Inducing events controling the initiation of odontogenesis
Various theories have been proposed to deduce the mechanism that determines number and shape of
teeth during development. The notable theories include the 'regional field theory' (Butler, 1967), the
'prepattern gradient theory' (Valen, 1970), the 'source-sink theory' (Crick, 1970), the 'clone theory'
(Osborn, 1973, 1978), and the 'innervation theory' (Pearson, 1977; Kollar and Lumsden, 1979;
Lumsden, 1982). Lumsden (1979) grouped those theories into two broad categories: (1) theories share
the requirement of an extrinsic signal generated by an external source to produce patterns in a
homogeneous population and, (2) theories have the common notion that patterns are self-generated
rather than organized from outside. However, none of the above mentioned theories have been strongly
supported by experimental evidence. For example, the innervation theory suggested that initiating
events of odontogenesis might involve a neural component. There are two facts underlying the idea of
innervation theory: (1) the prospective dental nerves enter the jaw long before tooth formation, and (2)
axons occur transiently at sites where odontogenesis will occur. Tooth initiation commences by a local
thickening of the oral epithelium and by an underlying mesenchymal condensation, the dental lamina.
After initiation, the subsequent development of tooth primordia runs more or less autonomously
(Glasstone, 1967, 1973; Thesleff, 1976, 1977a, b; Thesleff and Hurmerinta, 1981). Therefore, if
nervous elements are involved in the initiation of tooth formation, this should occur before or during the
appearance of a dental lamina. However, after specific experiments with E 9.0 - E10.0 mouse
mandibular arch fragments cultivated in vitro , with or without trigeminal ganglion explants, or grafted
in ocuo, Lumsden and Buchanan (1986) concluded that tooth initiation does not involve a nervous
component.
The current view of the initiation of odontogenesis tends to support that the oral epithelium provides
neural crest-derived ectomesenchyme with competence to participate in tooth formation (Mina and
Kollar, 1987; Thomas and Kollar, 1988, 1989; Kollar and Mina, 1991; Slavkin, 1991). These
interactions are mediated by cell surface molecules, extracellular matrix molecules and soluble
molecules (Kollar, 1981; Thesleff and Hurmerinta, 1981; Partanen et al., 1985; Thesleff et al., 1987).
Thus, the local occurrence of growth factors such as epidermal growth factors and its receptors
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(Partanen et al., 1985; Partanen and Thesleff, 1987; Kronmiller et al., 1991a, b), bone morphogenic
proteins (Vainio et al., 1993) and fibroblast growth factors (Vaahtokari et al., 1996), or the local
expression of transcription factors genes such as Msx-I, Msx-2, and Egr-1 (Vainio et al., 1993) have
been implicated as candidate mechanisms in the initiation of odontogenesis.
1.13 Outline of this thesis
When this work was initiated, it was only known that Pax6 is mutated in the Small eye mouse (Hill et
al., 1991) and that Pax6 was important for the development of the eye, nose, and brain (Hogan et al.,
1986, 1988; Hill et al., 1991). Very little was known about the other craniofacial areas affected by
Pax6 mutation, and what the possible roles of Pax6 might be in those affected areas. Pax6 was
regarded as a putative transcription factor, but what gene(s) it might regulate or what gene(s) it might be
regulated were unknown. Pax6 expression in the mouse and in the human was reported (Walther and
Gruss, 1991; Ton et al., 1991), but without detailed description, particularly in the developing central
nervous system. Furthermore, no clue of Pax6 expression in other species was available.
This study began with an attempt to isolate chick Pax6 by screening a cDNA library and by direct
cloning via RT-PCR (Reverse Transcription - Polymerase Chain Reaction), using a mouse Pax6 cDNA
probe for identification. However, chick Pax6 was isolated and sequenced (Li et al, 1994) in another
laboratory before the goal was achieved. I therefore went on to study the expression pattern of Pax6
during chick embryogenesis, in particular, during the later stages that had not been reported previously.
This study also studied Pax6 expression in the mouse, concentrating on the developing visual and
olfactory nervous systems that had not been investigated in detail before (chapter 3). Once the
expression pattern was established, further experiments was conducted to study the role of Pax6 in lens
differentiation (chapter 4), as well as the possible interaction of Pax6 with two homeobox-containing
genes, Msxl and Msx2, in the formation of supernumerary upper incisor teeth in the homozygous Small
eye mutants (chapter 5). In chapter 6, the effect of all-franx-retinoic acid (RA) on Pax6 expression
during early chick embryogenesis is investigated. All details of materials and methods are described in
chapter 2. A summary and some suggested future experiments are in chapter 7.
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Chapter 2: Materials and Methods
All specifications concerning chemicals and solutions, i.e. full names for abbreviations used in this
thesis, recipes, and preparations, are listed in the appendix. Linder's silver staining (chapter 3) was
performed by Miss Corrine Arnott. A substantial amount of the Msxl and Msx2 riboprobes used in this
study (chapter 5) were synthesized by Dr. S. E. Wedden. Mouse embryos (chapters 3 and 5) were
obtained under Professor M. H. Kaufman's license and were dissected, as the license allowed, by
Professor M. H. Kaufman. Chick embryos were prepared for culture (chapter 6) with the assistance of
Dr. Arthur Jurand.
2.1 Small eve mouse mutants
2.1.1 Source of the Small eye mouse mutants
The Small eye mutant mice were originally from stocks in the Department of Animal Genetics,
Edinburgh University (Roberts, 1967) and were provided by Dr. R. Clayton, Department of Animal
Genetics, to Professor M. H. Kaufman, Department of Anatomy (both at Edinburgh University).
2.1.2 Small eye mouse embryos
Homozygous (Sey/Sey) embryos were obtained by mating heterozygous males and females. The
heterozygous (Sey/+) parents were selected on the basis of smaller eye size, in contrast to their wild
type (+/+) littermates. The age of the embryos was judged according the vaginal plugs observed in
their female parents. Twelve midday of the day on which a vaginal plug was observed was assumed to
be day 0.5 p.c. (post coitus). Homozygous embryos were distinguished from their littermates by their
absence of eyes and nasal cavities (Hogan et ai, 1986). Wildtype (+/+) littermates were used as
controls for all experiments.
2.2 Chicken embryos
2.2.1 Source of chick embryos
Fertilized White Feather chick eggs were obtained from the Dryden-Mountmarle farm at Roslin
Institute, Midlothian, Scotland.
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2.2.2 Preparation of chick embryos at defined stages
Fertile eggs were incubated at 38.0° - 38.5° C in an incubator (McKay-and-Lynn, Edinburgh) in a
humidified atmosphere. The eggs were placed and turned in the incubator during incubation so that the
embryo in each egg could float freely to the top of the yolk in the shell. They were "windowed" after
overnight incubation through the following standard procedure (Tickle, 1993):
The blunt end of each egg was swabbed with 70% alcohol and a hole was made into the air sac using a
blunt pair of forceps. The uppermost part of each egg was then swabbed with 70% alcohol. The shell
was punctured carefully with a coarse needle without piercing through the shell membrane. A small
fragment of the shell was carefully picked away, leaving the shell membrane beneath it untouched. A
fine needle was then used to make a hole in the shell membrane and the edge of the membrane was
lifted carefully so that air could enter beneath it. This made the air free to escape from the air sac and
the embryo would drop gradually. Once the embryo dropped, a piece of Sellotape was applied over the
hole. It was then safer to enlarge the hole by cutting into the Sellotape together with the shell and the
shell membrane with a pair of small scissors. Each embryo was then visible through the window and
could be staged according to Hamburger-Hamilton system (Hamburger and Hamilton, 1951).
All embryos were "windowed" after overnight incubation, i.e. at stages 4-6. For embryos to be used at
later stages, the "windowed" eggs were then reincubated until they had reached the required stages.
2.3 Histology for Haematoxvlin-Eosin stain and Linder's silver stain
2.3.1 Preparation of microslides
Microslides for Haematoxylin-Eosin stain and Linder's silver stain were prepared by washing them in
warm soapy water. They were then kept in 96% alcohol for storage. Shortly before use, the
microslides were wiped using clean paper towels to remove alcohol on their surface and air-dried.
2.3.2 Preparation of tissue sections
For Haematoxylin-Eosin staining, chick or mouse tissues were dissected out of embryos. They were
washed sufficiently in PBS (Phosphate-Buffered Saline) to get rid of blood clots or other unwanted
tissues, and fixed in 10% formaldehyde in PBS or Bouin's solution for 4 - 24 hours depending on the
size (Kaufman, 1992). After fixation, embryos were washed twice in PBS and then taken through a
series of increased concentrations of alcohols, i.e. via 30 %, 50%, 75%, 96%, to twice in 100%
alcohol. Large embryos or tissue samples were kept in each alcohol for not less than 2 hours. For
smaller embryos or tissue fragments, the period of time in each alcohol was reduced, but was never less
than 30 minutes. Once sufficiently dehydrated, the tissues were cleared in xylene and embedded in
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paraplast wax (Sherwood Medical Co., St. Louis, USA; Product no. 8889-501007) by soaking in 60° C
liquid paraplast in a vacuum chamber (Charles Hearson & Co. Ltd., London, England) for three times
(at least 20 minutes each), and transferring them to freshly melted paraplast in cubic blocks. They were
then allowed to cool down for sectioning.
Sections at 5 - 7 um in thickness were cut on a Reichert-Jung 2050 microtome and placed on clean pre-
washed slides. The slides were covered with a small volume of distilled water and pre-heated on a 40°
C hot plate before the sections were placed to avoid folding of tissues. Once sections were flattened
well on slides, the distilled water was removed and absorbed with tissue paper. Slides were completely
dried in a 37° C oven and processed for Haematoxylin-Eosin stain or Linder's silver stain (see sections
2.3.3 - 2.3.4).
2.3.3 Haematoxylin-Eosin stain
The Haematoxylin-Eosin stain was performed according to the method described by Culling et al.
(1985). Ehrlich's haematoxylin was used (recipe in appendix B-3). The procedures were:
1. Paraffin wax removed with xylene, two changes, 5 minutes each.
2. Slides treated with absolute alcohol, two changes, 1 minute each.
3. Washed in distilled water.
4. Stained in haematoxylin, 5 minutes.
5. Differentiated in acid alcohol until only nuclei remained blue.
6. Washed in distilled water.
7. Stained in 1% eosin for 3 minutes.
8. Washed in running tap water for I minute.
9. Quickly dehydrated in three changes of absolute alcohol, 10 seconds each.
10. Quickly cleared in two changes of xylene, 30 seconds each.
11. Mounted and covered by coverslips using DPX (BDH Laboratory Supplies, Prod. No. 36029,
England).
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2.3.4 Linder's silver stain
A variety of methods is available for staining non-myelated and myelated nerve fibres. Linder's silver
method (Linder, 1978; recipe in appendix B-27) stains nerve fibers dark brown or black colour with
good definition and was therefore the method of choice used to compare nerve fiber formation with the
expression pattern of Pax6 in the developing mouse brain (Chapter 3). Following silver impregnation,
the tissues were counterstained with 1 % Luxol fast blue which stained the myelinated nerve fibers blue.
The following procedures were performed:
1. Paraffin was removed and sections were brought to distilled water as described in steps 1 - 3 in
section 2.3.3.
2. Sections placed in diluted buffer (recipe in appendix B-27) at 60° C on a hot plate for 20 - 30
minutes.
3. Sections transfered directly to silver impregnating solution at 60° C on a hot plate and incubated for
10-30 minutes.
4. Sections washed by dipping in several changes of distilled water at room temperature for a total of 3
minutes.
5. Sections transferred into the physical developer working solution at room temperature.
6. Sections were stirred constantly in the physical developer working solution and the progress of
development was monitored by washing with distilled water and examing under the microscope.
7. When results were optimal, the sections were counterstained in 1 % Luxol fast blue for 1 minute,
washed in distilled water, dehydrated, cleared and mounted as described in steps 8 - 11 in section 2.3.3.
2,4 In situ hybridization for sections
All the protocols for in situ hybridization used in this thesis were based on DNA Probes, second edition
by G. H. Keller and M.M. Manak, Stockton Press, New York, 1993.
2.4.0 General consideration
Before the in situ hybridization techniques were developed, temporal and spatial distribution of
messenger RNAs of specific genes were studied by blotting and hybridization on membranes
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(nitrocellulose or nylon). The messenger RNAs to be studied were extracted from developing tissues,
further purified through oligo-dT columns, and run on agarose gels to separate them from each other
according to their length. The separated RNA bands were then blotted on membranes and identified by
hybridizing with radio-labelled probes. As the hybridization could be performed on membranes, similar
procedures could be performed on tissue sections. Thus, in situ hybridization techniques were
developed to save the efforts of extracting RNAs from tissues and, at the same time, to give better
definition in localizing tissues where a gene is expressed. Therefore, general considerations that should
be taken for the blotting and hybridization remain the same for in situ hybridization, either for sections
or for wholemounts.
Considerations include: (1) Avoidance of any source of RNase contamination, as RNase can digest the
messenger RNAs to be detected and the riboprobes. The net result of RNase contamination very often
lead to complete loss of signals. Possible contamination was therefore prevented by using depc-treated
distilled water (details in appendix) in riboprobe preparation and storage, as well as in any solution used
before hybridization and in handling tissues. (2) Reduction of non-specific background signals. This
was done by thorough pre-hybridizing and pre-blocking before the real hybridization and antibody
binding were performed. (3) Optimization of hybridization by adjusting the stringency for each probe.
The stringency of hybridization could be affected by the hybridizing temperature and the salt strength
used in the hybridization mix. The stringency for any specific probe used can be optimized for best
results (details in Molecular Cloning, A Laboratory Manual, 2nd edition by J. Sambrook, E. F. Fritsch,
and T. Maniatis, Cold Spring Harbor Laboratory Press, 1989).
Particular consideration was taken in cutting sections, in that the sections are liable to be contaminated
with RNase. Sterile surgical gloves were used whilst cutting all sections for in situ hybridization used
in this thesis. Coughing and talking were avoided as much as possible when preparing sections.
The controls that should be used for in situ hybridization are always controversial. Some people argued
that using only the sense probe for negative controls was not sufficient. Others suggested that positive
controls from readily working probes of other genes should be included for each reaction. For DIG-
labelled riboprobes, because antigen-antibody reaction is applied for colour detection, some people
suggested that non-antibody controls were necessary. In the present work, only hybridization with
sense probe was used for negative controls. The expressing cells, however, were critically checked
against: (1) those non-expressing cells in the same piece of tissue from the same batch of reaction, and
(2) those negative controls hybridized with the sense probe from the same batch of reaction. Results
were regarded as genuine and acceptable only if the expressing cells were specified against their
neighbouring cells and against their negative controls. Furthermore, in situ hybridization at any
developmental stage investigated in this work was performed at least twice to confirm the result as
'genuine' and 'acceptable'. The same principle for controls was also applied for wholemount in situ
hybridization described in section 2.5.
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2.4.1 Preparation of microslides for in situ hybridization
For in situ hybridization on tissue sections, slides were coated with 3-aminopropyltrimethoxy-silane
(TESPA) (Sigma Cat. No. A-1435, St. Louis, U.S.A.) according to the following procedures:
1. Slides were washed with warm soapy water and briefly dipped in 100% alcohol with 2% glacial
acetic acid.
2. Slides were dried at room temperature, overnight.
3. Slides were dipped in acetone with 2% TESPA for 10 - 30 seconds.
4. Slides dipped into 100% acetone for 10 seconds.
5. Slides washed in diethylpyrocarbonate (depc)-treated distilled water (see appendix) for 10 seconds.
6. Slides air-dried at room temperature, overnight. Slides were then kept in their original boxes at 4 °C
until use.
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2.4.2 Preparation of tissue sections for in situ hybridization
2.4.2.1 Direct fixation
For mouse embryos younger than day 19 p.c. and for all chick embryos used in this study, direct
fixation with 4 % para-formaldehyde was performed. Following dissection, embryos or tissues were
promptly washed in cold PBS and fixed in cold (4° C), freshly prepared or defrosted 4 %
paraformaldehyde in lx PBS (Phosphate Buffered Saline). The PBS was prepared in depc-treated
distilled water. Fixation was done at 4°C for at least 6 hours, but for no more than one week. Tissues
were then washed, alcohol-treated, cleared, embedded, and sectioned as described in section 2.3.
Sections were flattened on TESPA-coated slides (see 2.4.1). Particular care was taken to prevent any
possible sources of RNase contamination by wearing gloves and using depc-treated water for placing
sections on TESPA-coated slides. All solutions for in situ hybridization were made up in depc-treated
distilled water. Slides were then dried in a 37° C oven as described in section 2.3.
2.4.2.2 Cardiac perfusion and fixation for the mouse brain
For mouse embryos older than day 19 p.c., cardiac perfusion with cold 4 % paraformaldehyde in PBS
was performed to make sure that the brain could be immediately accessed by the fixative. The embryos
was dissected out of the uteri and the thoracic cavity was opened to expose the heart. A no. 24 - 25
needle was carefully inserted into the left ventricle of the heart. The needle was connected to a syringe
of 4 % paraformaldehyde in PBS so that the solution could be easily pushed into the circulatory system
of the mouse. Approximately, 1 ml of 4 % paraformaldehyde in PBS was used to perfuse per gm of the
mouse body weight. The sufficiency of perfusion was monitored by making a rupture in the liver to
check the outflow of the fixative. Sufficient perfusion usually ended with rigid limbs that indicated the
tissues were thoroughly fixed. Embryos that were not thoroughly fixed were discarded. The mouse
heads were cut off after perfusion and put in cold 4 % paraformaldehyde in PBS at 4° C overnight for
further fixation. They were then briefly washed in 30 % alcohol and put into 70 % alcohol for storage.
The scalp and skull were carefully removed in 70 % alcohol to obtain the intact brain. The mouse brain
was then processed for embedding and sectioning as described in section 2.3.2.
2.4.3 Sources of gene clones
All gene clones used in this thesis were provided by Dr. Robert E. Hill, MRC Human Genetics Unit,
Edinburgh, and have been previously published (Walther and Gruss, 1991; MacKenzie et al., 1991;
Mackenzie et ah, 1992; Monaghan et ah, 1991). The chick Pax6 clone was originally provided by Dr.
Peter Gruss, Max-Planck-Institut for Biophysical Chemistry, Gottingen.
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2.4.4 Synthesis of riboprobes
The gene clones were received as inserts in plasmid vectors. They were grown in compatible host
bacteria according to the following standard plasmid preparation procedures (Sambrook et al., 1989):
2.4.4.1 Transformation and growth of plasmids
1. 40 ml aliquots of LB (Luria-Bertani)medium (recipe in appendix B-l) were added to sterile culture
flasks.
2. One colony of bacteria was scraped from stock plate with a sterile loop.
3. The bacteria colony was transferred to medium and shaken off the loop. The flask was then kept
shaking at 37° C for 5-6 hours or until cells grew to an O.D. (Optical Densitity) of 0.3 to 0.5 measured
at 600 nm.
4. Bacterial cells were spun down at 2500 x g for 5 minutes at room temperature.
5. The supernatant was discarded. The pellet of cells was gently resuspended in 2 - 4 ml of 50 mM
CaCL and topped up to 20 ml with 50 mM solution of CaCL .
6. Bacterial cells were incubated on ice for 30 minutes to make them competent, i.e. ready for
introducing plasmid.
7. Bacterial cells were centrifuged for 5 minutes at 2500 x g at 4° C and resuspended in 4 ml of ice cold
50 mM CaCl2.
8. In a sterile tube, about 0.1 ug of plasmid vector DNA was added to the prepared competent cells and
the cells were reincubated on ice for a further 30 minutes.
9. Cells were heat-shocked by transferring the tube to a water bath maintained at 42° C for 2 minutes.
10. 1 ml of LB medium containing ampicillin (50 pg/ml) was added to the tube and the cells were
allowed to grow for 45 minutes at 37° C with vigorous shaking (300 cycles per minute on Lab Line
Rotary Environ Shaker).
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11. The cells were added to 500ml or 1.0 litre of Terrific Broth medium (prewarmed to 37° C; recipe in
appendix) containing ampicillin (50pg/ml) and incubated for a further 12 - 16 hours at 37° C with
vigorous shaking (300 cycles per minute) in order to achieve large-scale growth of the plasmid.
2.4.4.2 Large-scale preparation of plasmid DNA
1. After the large-scale growth of plasmid described in section 2.4.4.1 was achieved, the bacterial cells
were harvested by centrifugation at 4000 rpm for 15 minutes at 4° C in a Sorvall GS3 rotor.
2. The bacterial pellet was resuspended in 100 ml STE buffer (recipe in appendix B-7) and recollected
by centrifugation as described in step 1.
3. The bacterial pellet was resuspended in 10 ml of Solution I (recipe in appendix B-4).
4. A freshly prepared solution of lysozyme (lOmg/ml in 10 mM Tris-Cl, PH 8.0) was added.
5. 20 ml of freshly prepared Solution II (recipe in appendix B-4) was added and the centrifuge bottle
was gently inverted several times to thoroughly mix the bacterial cells within the solution. The bottle
was kept at room temperature for 5 -10 minutes.
6. 15 ml of ice cold Solution III (recipe in appendix B-4) was added and the bottle was shaken several
times to mix the contents. The bottle was stored on ice for 10 minutes. A flocculent white precipitate
should form after 10 minutes.
7. The contents was centrifuged at 4000 rpm for 15 minutes at 4 ° C in a Sorvall GS3 rotor.
8. The supernatant was filtered through four layers of cheesecloth into a 250-ml centrifuge bottle. The
filtered supernatant was added with isopropanol (60% of the supernatant volume) and the two mixed
well together. The bottle was then stored at room temperature for 10 minutes.
9. The contents (the nucleic acids) were recovered by centrifugation at 5000 rpm for 15 minutes at
room temperature in a Sorvall GS3 rotor.
10. The supernatant was decanted carefully. The pellet on the walls and the bottom of the bottle was
rinsed with 70 % ethanol at room temperature.
11. The 70% ethanol was drained off and the bottle was placed inverted on paper towels to allow the
final traces of ethanol to evaporate.
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12. The pellet was disolved in 3 ml of TE (10 mM Tris-Cl, 10 mM EDTA, PH 8.0).
13. 3 g of solid Cesium Chloride was added to the 3 ml DNA solution (1 g per ml).
14. Ethidium bromide solution (lOmg/ml in water) was added and mixed well in the prepared
DNA/CsCl solution (0.8 ml of ethidium bromide solution per 10 ml DNA/CsCl solution).
15. The solution was centrifuged at 8000 rpm for 5 minutes at room temperature. A furry scum could
be found floating on the top of the solution after centrifugation. A disposable syringe fitted with a
large-gauge needle was used to transfer the clear, red solution under the furry scum to a Beckman Quick
seal tube suitable for centrifugation in a Beckman Optima TL Ultracentrifuge. The tubes were balanced
by filling the remainder of the tubes with light paraffin oil and sealed by Quick-Seal caps.
16. The density gradient (the sealed solution) was centrifuged at 60,000 for 24 hours at 20° C. Two
bands of the DNA, located in the centre of the gradient, should be visible in ordinary light. The lower
band should contain the closed circular plasmid DNA to be purified.
17. The lower band of closed circular plasmid DNA was collected by first inserting a needle into the top
of the tube to allow air to enter, then removing the upper band in the centre of the gradient by another
needle, and finally collecting the lower band in the centre with a third needle (18 gauge).
18. To the solution of the closed circular plasmid DNA, an equal volume of isoamyl alcohol was added.
The two phases of the solution were mixed thoroughly by vortexing.
19. The mixture was centrifuged at 1500 rpm for 3 minutes at room temperature in an Eppendorf
microcentrifuge.
20. The lower, aqueous phase was transferred to another clean tube. Another equal volume of isoamyl
alcohol was added. The extraction (steps 18 - 20) was repeated 4-6 times until all the pink colour of
the ethidium bromide disappeared from both the aqueous phase and the organic phase.
21. CsCl was removed by dialysis for 24 - 48 hours against several changes of TE (PH 8.0).
22. The OD260 of the final solution was measured and the concentration of the plasmid DNA was
calculated. The plasmid DNA was stored in - 20° C in aliquots at a concentration of lpg per p.1.
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2.4.4.3 Confirmation of prepared plasmids
The prepared plasmids were run on a 1.2 % agarose minigel (90 volts for 60 minutes in 1 x TAE
buffer), together with the original plasmid DNA. Those prepared plasmids of the same running distance
were heated in 92° C for 3 minutes and immediately dot-blotted on a Gene Screen Hybridization
transfer membrane (Biotechnology System, Boston, cat. no. NEF-983). The membrane was then placed
in oven for 2 hours at 80° C to bake DNA onto it and probed for confirmation with DIG-labelled RNA
synthesized from the original gene clone according to standard procedures (Sambrook et al., 1989).
The following procedures were taken through for probing:
1. The membrane (with plasmid DNA baked on it) was prehybridized with in situ hybridization mix for
sections (recipe detailed in the appendix B-12). The membrane and the prehybridization mix solution
were placed in a PVC transparent bag which was sealed with as few air bubbles as possible. The
preparation was put in a 65° C water bath for at least 3 hours.
2. DIG-labelled RNA was added at 500 ng per ml in the prehybridization mix to hybridize at 55° C for
at least 6 hours in a water bath.
3. After hybridization, the membrane was washed twice with 4x SSC in 50 % formamide at 65° C in a
water bath for a total of 2 hours. The washes were done in a 50 ml Falcon tube with washing solutions
covering the whole membrane.
4. The membrane and the washing solution was allowed to cool down to room temperature.
5. The washing solution was replaced twice by roughly the same volume of maleic acid buffer (0.1 M
maleic acid, 0.15 M NaCl; pH 7.5). The membrane was in maleic acid buffer for 10 minutes each for a
total of 20 minutes at room temperature.
6. The membrane was blocked by lx blocking reagent (Boehringer-Mannheim, cat. no. 1096 176) for
10 minutes at room temperature.
7. The lx blocking reagent was replaced by colour detection buffer (0.1 M Tris-HCl, 0.1 M NaCl, 50
mM MgCl2 ; pH 9.5) with 9 p.1 NBT (Nitroblue Tetrazolium) solution (Boehringer Mannheim, cat. no.
1383 213) and 7 p.1 X-phosphate (Boehringer Mannheim, cat. no. 1383 221) in per ml of colour
detection buffer.
8. Colour detection was carried out in the dark at room temperature for 15 - 30 minutes.
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9. The presence of correctly prepared plasmids was judged by the appearance of black dots on the
membrane against the background.
2.4.4.4 Linearization of plasmids
Once the purified plasmids were confirmed, plasmids were linearized with restriction enzymes cutting
at specific restriction sites according to supplier's recommendation (see table 2.1) by the following
procedures:
1. 10 pg of prepared plasmid DNA was removed from stock tubes to another Eppendorf tube. The
tubes were put on ice before incubation at 37° C.
2. 2 pi of lOx reaction buffer for specific restriction enzyme (see table 2.1 on the following page) was
added.
3. Specific restriction enzymes (see table 2.1 for details on the following page) were added to the tubes.
The restriction enzymes were made at concentrations of 20 - 40 units in each linearization reaction.
4. The total reaction volume was topped up to 20 p.1 with distilled water and the solution mixed well.
5. After a short spin in an Eppendorf centrifuge, the tubes were incubated at 37° C for 60 - 90 minutes,












psm Eco RI H glaattc 37 1.5 hours
ax<5(mouse),
itisense
psm Bam HI B gXgatcc 37 1.5 hours
ix6(chick),
.nse
PCh6 Eco RI H glaattc 37 1.5 hours
ax6(chick),
itisense
PCh6 Bam HI B gXgatcc 37 1.5 hours
'sxl (mouse),
itisense
ptz 19 Bss HII a gIcgcgc 50 2.0 hours
fsx2(mouse),
■nse
ptz 18 Eco RI H gXaattc 37 1.5 hours
f.yx2(mouse),
itisense
ptz 18 Bam HI B gXgatcc 37 1.5 hours
Table 2.1 Linearilization of plasmids. The buffers used were SuRE/cut Buffers supplied by Boehringer
Mannheim. All linearilizations were checked by running 1.5 - 2.0 % agarose gels stained with ethidium
bromide and viewed under UV transillumination. Complete cuts were confirmed by the presence of
single retarded bands as compared to those intact plasmids. For each restriction enzyme, the recognized
sequence and the cutting site are listed. The arrows indicate the points where the phosphodiester
linkages between two nucleotides were splitted.
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2.4.4.5 Checking the linearization of plasmids
The linearised plasmids were run on 1.2 % agarose minigels (at 90 volts for 60 minutes) in lx TAE
buffer (Tris-acetate buffer; see appendix for recipe) against uncut circular plasmids to check the
efficiency of cutting. Complete cuts were confirmed by single retarded bands. Those incomplete cuts
displayed one retarded band with another band at the same running distance as that of the uncut
controls. If incomplete cuts were found, more units of the same restriction enzymes were added to the
reactions which were then reincubated for another 60 minutes. After that, the reincubated reactions
were run on another 1.2 % agarose gel for a recheck. Only those complete cuts were used for the
synthesis of riboprobes.
2.4.4.6 Synthesis of non-radioactive Digoxigenin-labelled riboprobes
Digoxigenin-labelled in situ probes were transcribed in vitro from those linearized plasmids using RNA
labelling kit from Boehringer-Mannheim according to the manufacturer's protocol:
The following reagents were added to an Eppendorf tube:
depc-treated H20 13.5 pi
lOx transcription buffer 2 pi
lOx DIG RNA labelling mixture (Boehringer-Mannheim, cat. no. 1277 073) 2 pi
RNase inhibitor ( 40 units per pi) (Boehringer-Mannheim, cat. no. 799 017) 1 pi
linearized plasmid (0.5-1.0 pg per pi) 1 pi
20 units of T3 (Boehringer-Mannheim, cat. no. 1031 163) or T7 (Boehringer-Mannheim, cat. no. 881
767) RNA polymerase was added to make a total reaction volume of 20 ul. The T3 RNA polymerase
was used for sense riboprobe synthesis and T7 for anti-sense riboprobe synthesis.
All the reagents were mixed well, spun down briefly (15 seconds at 6000 rpm) in an Eppendorf
microcentrifudge before incubation. The mixtures were incubated in 37°C for 1.5 hours. After
incubation, lpl (20 units per pi) of DNase I (Boehringer-Mannheim, cat. no. 104 132) was added for a
further 10 minutes incubation. The RNA was then precipitated by adding 2.5 pi of 4 M Lithium
Chloride and 75 pi of cold 100% ethanol. This was mixed well and kept in - 70°C for at least 2 hours.
The precipitated synthesized DIG-labelled RNA probes were recovered by spinning again at 4° C, at
12000 rpm for 10 minutes. Normally, a small white pellet could be seen at the bottom of the Eppendorf
tube. The supernatant was pipetted out. The pellet was then washed twice by pipetting in 75 pi of cold
75% ethanol and gentlly rolling the ethanol around the pellet. Pellets were dried in a vacuum chamber
and diluted to a concentration around 100 ng/pl in depc-treated water.
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2.4.4.7 Calibration and storage of synthesized riboprobes
The concentrations of synthesized riboprobes were calibrated by running, at serial dilutions, against
standard RNAs with known concentrations provided by Boehringer-Mannheim on 1.2 % agarose gels
(at 90 volts for 60 minutes in lx TAE buffer) as described in section 2.4.4.1. The expected yield of
synthesized riboprobes was 10 |_Lg of labelled RNA out of 1 p.g of the linearized DNA in each reaction.
The synthesized riboprobes were then stored in a - 70° C freezer and thawed only immediately before
use.
2.4.5 Prehybridization treatment
Fully-dried wax sections on microslides were placed back to back in a slide rack. A maximum of 20
slides were used at each run. The slides were taken through the following procedures:
1. Xylene I 10 minutes
2. Xylene II 10 minutes
3. Alcohols 100 % - 100% -95 % -85%- 70%-50%-30% 1 minute each
4. 2x SSPE (recipe in appendix) 5 minutes
5. Proteinase K (20 pg/ml in buffer) 5 minutes
6. 2x SSPE 30 seconds or a brief rinse
7. 4% cold paraformaldehyde in PBS at room temperature 15 minutes
3. 2x SSPE 5 minutes
9. 0.2 M HC1 15 minutes
10. 2x SSPE 5 minutes
11. Slides placed in 450 mis of 0.1 M TEA (Triethanolamine, Sigma cat. no. T-1377). While stirring,
3 ml of acetic anhydride was added slowly drop by drop for a total of 10 minutes.
12. Soaked in 2x SSPE for at least 5 minutes or until ready for hybridization.
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2.4.6 Hybridization
Synthesized probes were thawed immediately before use. Probes were diluted at a concentration of
approximately 100 ng in every 60 pi hybridization mix (recipe in appendix) in an Eppendorf tube. The
hybridization mix, together with the added probes, were preheated at 80°C for 5 minutes in a multi-
well metal heating block (MacKay-and-Lyn, Edinburgh). They were then quenched on ice for 3
minutes, spun briefly (3000 rpm in an Eppendorf microcentrifudge) and added to slides.
The slides were sitting in 2x SSPE as described in section 2.4.4. They were removed from 2x SSPE
(using a pair of sterile forceps to avoid any source of RNase contamination) and placed onto a piece of
clean paper towel. The slides were air-dried on the clean paper towel before adding probes.
Hybridization mix (with probes added) was carefully spread on each slide, avoiding air bubbles. 60 pi
of hybridization mix, i.e. at least 100 ng of probe was used for each slide. Slides were covered with
coverslips (BDH no. 1, 22mm x 64 mm) straight out of box, ensuring all tissue sections covered with
hybridization mix. Slides were then incubated at 50°C in a humidified chamber (humidified with 50%
formamide in lx salts solution) (see recipe in appendix) for overnight ( or at least 7 hours).
2.4.7 Post-hybridization washes
After overnight incubation, slides were removed from the humidified chamber and placed back to back
in a slide rack. Coverslips were removed from the slides by soaking in 2x SSC (Standard Saline
Citrate; recipe in appendix B-8) at 50°C for at least 10 minutes. The slides were then taken through the
following washes:
1. 2x SSC in 50% fromamide at 65°C 45 minutes
2. 4x SSPE at 50°C 5-8 minutes
3. Quickly rinsed in 4x SSPE at 50°C 30 seconds
4. 20 ug/ml RNase A in 4x SSPE in H20 25 - 30 minutes
5. 50% formamide in 2x SSC at 65°C 45 minutes
6. Slides were then transferred to a 50° C, 2x SSC solution and let cool down in room temperature.
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2.4.8 Binding anti-DIG-alkaline phosphatase conjugates to sections and colour detection
Before use, the anti-DIG-alkaline phosphatase conjugates were preabsorbed against chick serum to
avoid any non-specific binding. Antibody conjugates were preabsorbed by adding at 1 in 5000 dilution
in 1% blocking buffer (Boehringer-Mannheim, Catalogue no. 1096 176) in PBT with 2% chick serum.
The preabsorption was carried out at 4°C overnight or at room temperature for at least 4 hours.
The slides were transferred from the 2x SSC solution and placed back-to-back in a glass container.
This was to reduce the necessary volume of solutions and antibody to be used. The slides were taken
through the following procedures:
1.Washed in PBT at room temperature 10 minutes
2. Soaked in 1 % blocking buffer in PBT 30 minutes
3. Incubated in preabsorbed antibody solution over night, at 4° C
4. Slides were separated and washed in PBT with stirring 3X 20 minutes, at room temperature
5. Incubated in freshly prepared alkaline phosphatase buffer 5 minutes, at room temperature
(alkaline phosphatase buffer also known as NTMT buffer)
6. Incubated in colour detection buffer at room temperature in dark overnight
2.4.9 Mounting coverslips and photography
Slides were examined for positive blue/purple staining on the tissue sections after overnight incubation
in the colour detection buffer. If colours were not satisfactory, slides were incubated again at room
temperature for further 6 - 8 hours in the dark. Slides were then taken through the following
procedures:
1. Incubated in 10 mM Tris-HCl (pH - 7.8), 10 mM EDTA at room temperature 5 minutes
2. Incubated in 1% pyronine B in water 10 minutes
3. 70 % alcohol 10 seconds
4. 90 % alcohol 10 seconds
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5. 96 % alcohol 10 seconds
6. 100 % alcohol 10 seconds
7. 100 % alcohol 10 seconds
8. Xylene I 1 minutes
9. Xylene II 1 minutes
Coverslips were mounted with DPX. Slides were examined and photographed on a Wild Photo
Makroscope M420 (Wild Heerbrugg, Switzerland). Kodak Gold 100 films were used for photography.
Films were developed and printed by a commercial service.
2.4.10 Number of embryos used for in situ hybridization on tissue sections
Mouse embryos at gestation days from 10.0 to 19.0 and 1.0, 7.0, 20.0 postnatally were examined for
Pax6 expression in the head region (chapter 3). The number of embryos used at each gestation age is
listed in table 2.2 on the following page. For Msxl and Msx2 expression in the mouse maxillary
process (chapter 5), the numbers of the homozygous Small eye embryos and their wildtype littermates at
each gestation age are listed in table 2.3 on the following page. Chick embryos at some developmental
stages (chapter 3) were also sectioned for studying Pax6 expression (see table 2.4 on page 108). This
study also investigated chick Pax6 expression by in situ hybridization following tissue culture on
millipore membranes (chapter 4). The number of tissues used is listed in table 2.5 in section 2.7.4.
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age 9.5 10.0 11.0 12.0 13.0 14.0 15.0 16.0 17.0 18.0 19.0 P1.0 P7.0 P20
no. 4 4 3 3 3 2 3 3 4 4 2 4 4 3
Table 2.2 Mouse embryos used for studying Pax6 expression in the head region. The numbers in the
top row indicate days p.c., except for P1.0, P7.0, and P20 which indicate days after birth. Both
transverse and coronal sections were used for the convenience of comparing with published atlases.
Thus, expression at gestation days 9.5, 10, 11, and 12 p.c. were represented by coronal sections.
Transverse sections were used for gestation days 13, 14, 15 p.c.. From day 16.0 p.c. onwards up to 21
days after birth, coronal sections were used. All embryonic sections were in situ hybridized with
antisense DIG-labelled Pax6 probe together with a number of controls hybridized with sense DIG-
labelled probe at the same time. All sections were at 7.0 pm in thickness.
D13 D14 D15 D16 D17
Msxl +/+ 4 5 4 4 4
Msxl Sey/ 4 4 5 4 5
Sey
Msx2 +/+ 4 4 6 4 6
Msx2 Sey/ 4 5 4 5 6
Sey
Table 2.3 Mouse embryos used for comparing Msx-1 and Msx-2 expression in the maxillary process
between wildtypes and Small eye homozygotes. Transverse sections were in situ hybridized with
antisense DIG-labelled Msx-1 and Msx-2 probes together with a number of controls hybridized with
sense DIG-labelled probe at the same time. All sections were at 7.0 pm in thickness
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stage 10 11 12 13 16 17 18 28
no. 3 4 4 6 5 3 3 2
Table 2.4 Number of chick embryos used for studying Pax6 expression via in situ hybridization on
tissue sections in the head region. The stages were judged according to Hamberger and Hamilton
(1951). The number of chick embryos used for studying Pax6 expression through wholemount in situ
hybridization are listed in table 2.5 (in section 2.5.5).
101
2.5 In situ hybridization for wholemount embryos
2.5.0 General consideration
General consideration for avoiding RNase contamination, reducing non-specific background signals,
and the optimization for hybridization conditions were the same as mentioned in section 2.4.0.
Particular considerations for wholemount in situ hybridizations were: (1) Proteinase K treatment was
optimized according to the size of embryos. For chick embryos at stages 6 - 10, 7 minutes in proteinase
K was sufficient. Overdigestion by proteinase K was not necessary and often caused damage to the
embryos. (2) The duration and times of washing were increased. Wholemount embryos could easily
trap non-hybridized riboprobes or non-binding antibodies in tissues, particularly in the closed neural
tube. The duration and times of washing after hybridization and antibody binding were increased, if
non-specific background signals were found to be too strong. (3) Wholemount embryos were very
fragile after bleaching and proteinase K treatment. This was improved, to some extent, by increasing
the refixation period from 20 minutes to 40 minutes. The washes and hybridization procedures were
therefore performed with great care to avoid damage to the embryos.
2.5.1 Preparation of embryos for wholemount in situ hybridization
Embryos were dissected as quickly as possible in cold (preferably in 4°C) lx PBS. They were quickly
rinsed 2-3 times in fresh cold lx PBS to get rid of blood and other unwanted membranes. For chick
embryos at early developmental stages, 3-5 embryos were put in a 2.0 ml microtube (Sarstedt,
Germany, catalogue no 72.694/026). No more than 3 tubes were run for wholemount in situ
hybridization at the same time. Embryos were taken through the following procedures on a spiramix
(Denley, U.K.):
1. Fixed in cold 4% paraformaldehyde at 4°C 4 hours to overnight
2. Washed in PBT at 4°C 5 minutes, twice
3. Washed in 25% -50%-75%-100% methanol 5 minutes each
in PBT at room temperature
4. Rehydrated with 75%-50%-25%-0% methanol in PBT 5 minutes each
at room temperature
5. Bleached with 6% hydrogen peroxide in PBT at room temperature 40-60 minutes
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6. Washed in PBT three times 5 minutes each
7. Treated with 10 ug/ml proteinase K (Sigma) in PBT
at room temperature
7 - 15 minutes
8 Washed with fresh 2 mg/ml glycine (Sigma, catalogue no. G-7126)
in PBT at room temperature
5 minutes
9. Washed twice with PBT at room temperature 5 minutes each
10. Refixed with freshly- prepared 0.2 % glutaraldehyde with 4%
paraformaldehyde in PBS, at room temperature
20 - 40 minutes
11. Washed with PBT twice at room temperature 5 minutes each
12. 1.0 ml of prehybridization mix (recipe in apppendix) was added to each tube.
The solutions in the tube were gentlly, but thoroughly mixed manually.
13 Embryos were transferred to another 2 ml microtube containing 1 ml of prehybridization mix
14. Replaced with fresh 1 ml prehybridization mix,
2.5.2 Hybridization
After the embryos were pre-hybridized for at least 3 hours at 65° C. The pre-hybridization mix was
drained off and replaced by fresh 1.0 ml (or at a volume to make sure embryos were completely
covered) prehybridization mix. Around 0.2 - 1 pg DIG-labelled RNA probe was added in per ml of
the replaced pre-hybridization mix. The tubes were then incubated at 55°C overnight.
and incubated at 65°C in a water bath at least 3 hours
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2.5.3 Post-hybridization washes and antibody binding
Ail the procedures described in this section were performed in a same 2.0 ml microtube as used for
section 2.5.2. All washes were performed on a spiramix (Denley, U.K.) at its pre-designed speed at
room temperature, except for the washes in 37° C and 55° C which were performed in a waterbath
(Grant, England). Wholemount embryos were taken through the following procedures:
1. Washed with 100%-75%-50%-25% prehybridization mix 5 minutes each
in 2x SSC at 55°C
2. Washed twice with 0.1% CHAPS (3-[(3-cholamidopropyl)dimethylammonio]-l-propanesulfonate)
(Sigma, cat. no. C-3023) in 2x SSC at 55° C for 30 minutes.
3. Treated with 20 ug/ml RNase A (Sigma, cat no R-9009) in 2x SSC,
with 0.1 % CHAPS at 37°C 30 minutes
4. Washed twice in 2x SSC with 0.1% CHAPS at room temperature 10 minutes each
5. Washed twice with 0.2 x SSC with 0.1% CHAPS at 55°C 30 minutes each
6. Washed twice with PBS at room temperature 10 minutes each
7. Washed with PBT at room temperature 5 minutes
8. Embryos were pre-blocked by incubating in 10% sheep serum, 1% BSA (Bovine Serum Albumin;
Sigma cat. no. A-9647) in PBT for at least 2-3 hours at room temperature
9. Whilst embryos were pre-blocked, anti-DIG antibody was pre-absorbed at 1 in 2000 dilution in PBT
with 10% sheep serum, 1 % embryo powder, and 1% BSA at room temperature for 2 - 3 hours. After
preabsorption, the antibody solution was briefly spun down to get rid of coarse debris of embryo
powder (see appendix for preparation).
10.The pre-blocking solution was replaced with the pre-absorbed antibody solution and kept in 4° C
overnight on a spiramix.
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2.5.4 Post-antibody washes, colour detection, and photography
All the washes were performed on the same spiramix described in section 2.5.3. Embryos were taken
through the following washes:
1. Washed 5 times in PBT with 0.1 % BSA, at room temperature 1 hour each
2. Washed with PBT at room temperature 30 minutes
3. Washed with NTMT (recipe in appendix) at room temperature 3x10 minutes
4. Incubated in colour detection buffer (recipe in appendix).
(Kept at room temperature in dark.) 20 minutes
5. When colours were developed to the desired extent, the embryos were washed with NTMT at room
temperature for 5 minutes. If colours were not satisfactory, embryos were kept in the colour detection
buffer for 6-12 hours longer or until colours were considered appropriate.
6. Washed in PBT at room temperature 5 minutes
7. Fixed with 4% paraformaldehyde in PBS at 4°C overnight
8. Photographed on a Wild Heerbrugg Photo Makroscope with Kodak Gold 100 films. The films were
developed and printed comercially.
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2.5.5 Embryos used for wholemount in situ hybridization
Only chick embryos were used for wholemount in situ hybridization. The numbers of embryos used for
each stage investigated are listed in table 2.5.
stage 4 6 8 9 10 11 12 28
no. 4 7 10 12 12 10 6 2
Table 2.5 The number of chick embryos used for each stage investigated by wholemount in situ
hybridization for Pax6 expression.
2.6 Immunohistochemistrv
2.6.1 Preparation of microslides for immunohistochemistry
TESPA-coated slides were used for immunohistochemistry. The same procedures as described in
section 2.4.1 was taken for preparing TESPA-coated slides.
2.6.2 Preparation of tissues for immunohistochemistry
Tissues were prepared and sectioned in the same way as described in section 2.3. For tissues to be
stained by immunohistochemistry after millipore culture, they were taken through, together with the
millipore membranes, all the procedures described in section 2.3 and section 2.7.3.
2.6.3 Source of antibody
Chick anti-alpha B crystallin antibody was generously provided by Dr Paul Scotting, Department of
Biochemistry, University of Nottingham.
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2.6.4 Antibody binding and colour detection
Tissue sections were prepared following the same procedures for in situ hybridization. All washes
described in this section were performed by gently pouring solutions over slides and sitting slides in a
humidified chamber for a period of time as required.
Wax-embedded tissue sections were fully-dried in a 37°C oven and taken through the following
procedures:
1. Sections dewaxed and rehydrated as described in section 2.3.
2. Incubated twice in PBS or TBS (Tris-Buffered-Saline, recipe in appendix) for 5 minutes each.
3. Incubated in 10% fetal calf serum (FCS) diluted in PBS or TBS for 10 minutes.
4. The 10 % FCS was drained off and any excess wiped off with a paper towel
5. Incubated in primary antibody (anti-alpha B crystallin) at 1 in 3000 dilution for 60 minutes
at room temperature.
6. Primary antibody was washed off and sections given two PBS or TBS washes, for 5 minutes each.
7. Incubated in 10% FCS in PBS or TBS for 10 minutes.
8. The 10 % FCS was drained off and any excess was wiped off with a paper towel
9. Sections were incubated in biotinylated second antibody (anti-rabbit IgG 1:400 dilution) (Vector, cat
no. Cl-1000) at room temperature for 30 minutes.
10. The biotinylated second antibody was washed off and sections were washed twice in TBS for 5
minutes each.
11. Excess buffer was wiped off and sections were incubated in ABC complex (details in appendix) at
room temperature for 30 minutes.
12. The ABC complex was washed off twice in TBS for 5 minutes each.
13. Colour was developed with freshly-made Vector Red mix (details in appendix) for up to 20 minutes
at room temperature.
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14. Sections were washed in running tap water.
15. Counterstained in 1% methyl green for 30-60 seconds.
16. Washed in tap water and dehydrated in 75%-90%-96%-100% alcohols.
17. Sections were cleared in xylene, mounted in DPX, viewed and photographed as described in section
2.3.
2.6.5 Number of tissues used for immunohistochemistry
The number of tissues used is listed in tables 4.1 and 4.2 in sections 4.2.2.2 - 4.2.2.3.
2.7 Chick tissue grafting and culture on millipore membranes
2.7.0 General consideration
All procedures described in section 2.7 were performed under laminar flow in a tissue culture room to
avoid microbial contamination. Tissues were cultured with underlying mesenchyme and placed directly
on millipore membranes (Whatman, cat. no. B431GN, pore size 0.45pm, 25 mm diameter) without
trypsin treatment.
2.7.1 Grafting of tissues and isolation of ectodermal fragments
1. Whole chick embryos were incubated until suitable stages and were removed from eggs as described
in section 2.2. They were then washed in PBS or medium 199 (Gibco BRL, Scotland, cat. no. 31153-
018) containing 1% penicillin G (Sigma, cat. no. p3032) and 1% streptomycin (Sigma, cat. no. s-9137).
2. Pre-designated areas of tissues (see figure 4.7) were cut and isolated using a sharp Tungsten needle.
The isolated tissues were then washed in medium 199 containing the same antibiotics.
3. The ectodermal layers were incubated for recovery in medium 199 with antibiotics for thirty minutes
to two hours in a 37°C incubator (Vindon Scientific Ltd.) with 5% C02 in air and with saturated
humidity.
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2.7.2 Millipore culture of isolated tissues fragments
1. While the tissues were being recovered, a Falcon organ culture dish (60 x 15 mm style with centre
well, cat. no. 3037) was prepared by adding M199 with antibiotics in the centre well.
2. A pore size 0.45[xm millipore membrane (Whatman, cat no. B431 GN) was placed over the prepared
medium in the centre well. The membrane was completely wet with medium underneath. The
preparation was then placed in an incubator for optimizing the humidity and C02 concentration.
3. The recovered tissues were removed with a sterile pipette from the dishes and placed on the prepared
millipore membranes.
4. The organ culture dishes were immediately put back into a 37° C incubator with saturated humidity
and 5 % C02 in air.
5. Used medium was replaced by freshly balanced medium every day for 4-6 days.
2.7.3 Fixation and sectioning after culture
1. Tissues together with millipore membranes were removed from the culture medium and quickly
washed in cold PBS.
2. Immediately after wash, tissues were fixed in cold 4% paraformaldehyde in PBS in a glass dish for at
least 4-6 hours or overnight at 4 ° C.
3. After fixation, tissues with their underlying millipore membranes were dehydrated through 30%-
50%-70%-90%-96%-100%-100% alcohols and finally cleared with xylene in the same way as described
in section 2.3.
4. Tissues were processed with their attached millipore membranes through embedding, sectioning,
developing on TESPA slides, in situ hybridization, and immunohistochemistry as described in previous
sections.
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2.7.4 Number of tissues grafted for millipore membrane culture, immunohistochemistry, and in
situ hybridization
The number of tissues grafted for millipore membrane culture is listed together with the results of in
situ hybridization and immunohistochemistry in table 4.1 and table 4.2 in sections 4.2.2.2. - 4.2.2.3.
2.8 Retinoic acid (RA) treatment on the developing chick embryos
2.8.0 General consideration
Retinoic acid is light-sensitive. It was therefore prepared and stored in a way to minimize light
exposure by wrapping all containers with foil. Six concentrations of RA were used to treat chick
embryos in six groups. The concentrations of RA and the number of chick embryos used in this study
are listed together with the results in table 6.1.
2.8.1 RA treatment on the developing wholemount chick embryos
2.8.1.1 Preparation of wholemount chick embryo culture
1. A large glass dish was filled with autoclaved Pannet-Compton saline (New, 1955) with 0.1 %
penicillin (Sigma, cat. no. p3032) and 0.1 % streptomycin (Sigma, cat. no. s-9137).
2. An incubated egg was opened at the blunt end at the desired stage of development. The thinner,
water-like albumen (the liquid egg white) was collected in a small beaker for later use.
3. The other eggs at desired stages of development were windowed as described in section 2.2.2. The
eggs were then drained of their albumen by tilting and sucking of the excess fluid with pipettes. Each
egg yolk, together with the embryo, was carefully placed into the prepared Pannet-Compton saline in
the large glass dish. While placing egg yolks, care was taken not to damage the vitelline membrane on
the edge of the windowed egg shells. Each blastoderm, under the vitelline membrane, was kept facing
upwards. If the blastoderm was facing downwards, the yolk was gently turned upside-down with a pair
of blunt forceps.
4. A cut was made with scissors into the vitelline membrane enclosing the yolk just below its equator.
Cutting was performed all the way around the circumference of the yolk.
5. With two pairs of fine forceps, the vitelline membrane, together with the early embryo, was carefully
and completely peeled off from the yolk. The early embryo was kept facing upwards, with its dorsal
side facing the bottom of the dish.
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6. A sterile watch glass (25 mm in diameter) was placed in the saline. The embryo was removed with a
pair of forceps to the centre of the watch glass. The dorsal side of the embryo was kept facing the
bottom of the watch glass. After the embryo was removed and placed in the centre of the watch glass, a
plastic ring (10 mm in diameter) was put over the embryo.
7. With fine forceps, the cut edges of the vitelline membrane was carefully folded over the edge of the
ring, all the way around its circumference.
8. The whole preparation was removed carefully from the dish and out of the saline. The remaining
saline inside and outside the plastic ring was removed as much as possible with a Pasteur pipette. Any
remaining yolk around or over the embryo was washed off with Pannet-Compton saline.
2.8.1.2 Treatment with retinoic acid
1. Stock retinoic acid in DMSO (3mg/ml) was thawed from - 20° C to room temperature. Light
exposure was avoided whenever possible.
2. Pannet-Compton saline with 10 % thinner egg albumen collected in step 2 was prepared by mixing
them thoroughly (egg albumen to saline as 1: 9).
3. The already thawed stock retinoic acid solution was diluted to final desired concentrations (see table
2.6). The DMSO used for desolving retinoic acid was kept under 1% of the total volume. After the
retinoic acid was added, the solution was wrapped in foil and gentlly mixed for 5 minutes.
4. A sterilized Pasteur pippet was used to slowly apply 10 drops of RA-added saline to each embryo.
5. Embryos were reincubated at 38° C in an atmosphere of 100 % humidity and allowed to develop
until suitable stages for further analysis.
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Chapter 3: Pax6 expression during mouse embrvogenesis
3.1 Introduction
3.1.1 Aims of this chapter
In this chapter, I have examined in detail the expression of Pax6 in the mouse with the following aims:
(1) to determine whether mouse Pax6 is expressed along the pathways and in higher centres of the
visual and the olfactory nervous system, (2) to compare areas of mouse Pax6 expression with those of
nerve fiber projection in the brain, (3) to investigate in detail mouse Pax6 expression in areas that have
not been reported before and to establish my own baseline data for further experiments. The rationale
for the aims, except for aim (3) which is obvious, is to be described below (in sections 3.1.2 to 3.1.3).
In the discussion, in addition to the aims, I will cover the implications of other Pax6 functions as
suggested by expression data and mutant phenotypes. Extensive comparisons of Pax6 expression and
mutant phenotypes across species will also be included in the discussion. The rationale for comparing
across species is described in section 3.1.4. Experiments using in situ hybridization on both
wholemount embryos and embryonic tissue sections were performed to obtain mouse Pax6 expression
data. Linder's silver impregnation method was used together with Luxol fast blue stain to detect areas
of nerve fiber projection in the mouse brain.
3.1.2 Rationale for determining Pax6 expression in the visual and olfactory nervous system
Pax6 is obviously involved in the normal development of the visual and the olfactory system in the
mouse, based on the abnormal phenotypes and gene expression data that are described in chapter 1.
This raises some immediate questions: Is the function of Pax6 in the brain specifically involved in the
integration of the visual and the olfactory pathways ? Can anything for Pax6 function in relation to the
eye and the nose be specified in the brain ? If Pax6 is not exclusively engaged in the two systems, what
are the other systems that Pax6 is involved ?
Two initial approaches may be taken to support a role of Pax6 in the integration of the visual and the
olfactory systems. The first is to investigate Pax6 expression in detail in the pathways and the axon
relay centres of the two systems. During the course of this study, Pax6 expression in the mouse has
been extensively reported (Walther and Gruss, 1991; Stoykova and Gruss, 1994; Grindley et al., 1995;
Quinn et al., 1996; Stoykova et al., 1996) but lack in determining the correlation of Pax6 expression with
the integration of the two systems. The second approach is to determine whether abnormalities can be
found specifically within the two nervous systems in the homozygous and the heterozygous Small eye
mutant mice. This approach, again, has not been taken so far. Aim (1) of this chapter is to take the first
approach to investigate Pax6 expression along the pathways and axon relay centres of the visual and
olfactory nervous systems.
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3.1.3 Rationale for comparing areas of Pax6 expression with those of nerve fiber projection
Pax6 expression in the developing mouse brain is extensively investigated in this chapter. The sites of
expression, including some nominated neuronal nuclei, are specified. The fact that Pax6 transcripts are
located in specified sites raises at least one question: Why is Pax6 exclusively expressed in the
specified sites (in other words, what is Pax6 function in those sites) ? This question demands
knowledge of distinctive activities that are only carried out in the Pixc6-expressing areas in contrast to
those non-expressing areas; thus it leads to a search for suitable techniques for a primitive
demonstration of possible distinctive activities.
Neuronal migration sets up the foundation for connection and pathfinding, i.e. the process of nerve fiber
projection (see chapter 1). Defects of neuronal migration was suggested in the Sey"eu mutants (Schmahl
et al., 1993). Furthermore, cerebellar primordium from mice homozygous for Small eye mutation,
when cultured in vitro, fails to develop neuronal projections, while their wildtype controls exhibit
extensive projections with abundant Pax6 proteins detected by immunohistochemistry (van Heningen,
personal communication). Pax6 protein is also demonstrated as a binding protein for three different
sites in the promotor region of the LI gene (Chalepakis et al., 1994). LI encodes a cell surface
glycoprotein that regulates vertebrate neuronal process outgrowth (Fisher et al., 1986; Trisler, 1991;
Kadmon and Altevogt, 1997). One wonders whether Pax6 is involved in neuronal projection that can
not be found in other non-expression areas at the same gestation age ? Linder's silver impregnation
(Linder, 1978) was described as an optimized method for the impregnation of myelinated as well as
non-myelinated fibers, intradentina fibers, and various types of nerve end organs such as a motor end
plate. Thus, the activities of nerve fibre projection can be shown. In conjunction with Luxol fast blue
that gave a sensitive blue stain for myelinated nerves, Linder's method was suitable for the purpose and
was therefore used.
3.1.4 Rationale for comparing expression data and mutant phenotypes across species
Mouse Pax6 expression data obtained in this chapter will be used to compare with the published
information in the same species as well as those in different species. Expression data will also be used
to compare mutant phenotypes across species. These comparisons aim to shed new insights on the
functions of Pax6 for several obvious reasons: (1) The fact that a gene consistently expresses in
specific areas of embryos through evolution implies a major function of that gene within those areas.
(2) The existence of areas that exhibit abnormalities in mutated animals without expression of the
normal gene in the wildtypes reflects an indirect role of that mutated gene in causing the abnormalities.
(3) If a gene is extensively expressed in a specific area through evolution but without causing
abnormalities when mutated, the possibility is that the function of that gene can be compensated by
other genes. (4) The areas of expression for a gene may be expanded or reduced through evolution;
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thus functional change or conservation of the same gene may be indicated by checking changes of
expression areas.
Pax6, being a member of the Pax gene family, carries two conserved motifs — the paired domain and
the paired-specific homeodomain (details in chapter 1). The structural conservation in the DNA
sequence among Pax6 orthologues (Pax6s in different species) through evolution has been extrapolated
to assume that the functions of Pax6 have been conserved through evolution. However, only in some
organs of a certain species experimental evidences are given (for examples, see Quiring et al., 1994;
Chisholm and Horvitz, 1995; Zhang and Emmons, 1995). There is still no general picture across all
species on Pax6 expression and mutant phenotypes being laid out and compared. In light of the above
mentioned reasons, comparisons will be made in the discussion sections in this chapter.
3.2 Results
3.2.1 Pax6 expression during mouse embryogenesis
Section 3.2.1 presents the results of mouse Pax6 expression produced by in situ hybridization on tissue
sections from day 9.5 p.c. up to 21 days after birth. The results are shown in figures 3.1 - 3.10
following the main text at the end of this chapter. Numeric labelling is used in the figures and all the
keys are listed together to avoid repetition. My concentration here is on the mouse head, although Pax6
expression may be found in the other regions.
To describe in a systematic way, the distribution of Pax6 transcripts on transverse sections are
presented from top of the head and serially downward to the cervical spinal cord. For coronal sections,
expression is presented from the anterior to the posterior following the order of telencephalon,
diencephalon, mesencephalon, rhombencephalon and spinal cord. After the spinal cord, Pax6
expression in the eye and other areas are described. All the corresponding figures are presented in the
same order.
To describe the sites of Pax6 expression in the brain, many names of differentiation fields and specified
neural nuclei have to be used. Differentiation fields are more roughly defined than neural nuclei.
Therefore, terms of differentiation fields can be used with much more confidence than those of neural
nuclei. However, when many terms of differentiation fields are used, much precision will be lost in the
description. Thus, readers are reminded that using terms of specific nuclei does not mean that Pax6
transcripts are present exactly in the three-dimensional structures of the specified sites. For example,
Pax6 transcripts may just occupy 1/5 space of a nucleus, or they may cover up a whole nucleus and
their coverage is beyond its borders. In either case, the name of the nucleus is specified to describe
Pax6 expression. Readers are also reminded that neural nuclei are specifically located by extensive
staining (for example Nissl or Golgi preparations) and neurophysiological experiments (for example
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selective stimulation, ablation, or analysis of distribution of neurotransmitters) (Williams and Warwick,
1980). Thus, any neural nucleus described here represents an approximation.
3.2.1.1 Day 9.5 p.c.
At day 9.5 p.c. of mouse embryogenesis, when the proximal end of the optic stalk begins to narrow,
Pax6 expression is seen in the neuroepithelium of the entire telencephalic region and the
neuroepithelium of the optic stalk that surrounds the optic recess (figure 3.1.a). The distal part of the
optic stalk (no. 7 in figure 3.1.a), as it makes contact with the surface ectoderm (no. 6 in figure 3.1.a),
appears to exhibit more intense expression than the proximal part. Pax6 expression can also be
detected in the germinal (ventricular) neuroepithelium of the cervical spinal cord (no. 4 in figure 3.1.a
and no. 10 in figure 3.1.b), as well as in the neuroepithelium of the more posterior spinal cord in the
trunk region (no. 3 in figures 3.1.a - b). The expression in the cervical spinal cord appears to
concentrate in the middle part (for example see no. 4 in figure 3.1.a). Evidence of Pax6 expression is
also seen in the neuroepithelium of the dorsal diencephalon (thalamus, i.e. the neuroepithelium
immediately ventral to the optic vesicle), but not in the ventral diencephalon (hypothalamus, i.e. no. 8 in
figure 3.1.a) by day 9.5 p.c. In the head surface ectoderm, Pax6-expressing cells cover the area
overlying the optic vesicle. There is no sign of Pax6 expression in any region containing the precursors
of cephalic neural crest cells, nor in the mesenchyme of the first and the second branchial arches (see
no. 12 and no. 13 in figure 3.1.b).
3.2.1.2 Day 10.0 p.c.
At day 10.0 p.c., when the proximal end of the optic stalk is seen constricted, Pax6 expression can be
detected in the neuroepithelium of the whole telencephalon as well as in the whole optic stalk (see
figure 3.1.c). At the junction of the proximal end of optic stalk and the ventral diencephalon
(hypothalamus), a sharp boundary between expressing and non-expressing area is seen (see the
boundary between no. 15 and the proximal end of the optic stalk in figure 3.1.c). Pax6 transcripts are
also clearly detected in the ventral half of pontine neuroepithelium (pontine neuroepithelium is labelled
'no. 16' in figure 3.1.c) as well as in the border between ventral pontine neuroepithelium and dorsal
medullary neuroepithelium (no. 18 in figure 3.1.c). The expression clearly extends toward more ventral
areas in the medullary neuroepithelium and appears to extend to the velum medullare (no. 17 in figure
3.1.c). In the head surface ectoderm, area of Pax6 expression overlies the optic vesicle and extends
ventrally to some extent (see no. 6 in figure 3.1.c).
3.2.1.3 Day 11.0 p.c.
At day 11.0 p.c., when the optic cup is formed (no. 27 in figure 3.2.a) and the lateral ganglionic
eminence in the telencephalon becomes evident (see no. 34 in a higher magnified view in figure 3.2.c),
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some interesting changes in Pax6 expression are found. Pax6 expression in the neuroepithelium of
dorsal telencephalon remains; but in the ventral telencephalon most Pax6 transcripts disappear
(compare figure 3.1 .c with 3.2.a), leaving just a slim strip of Paxd-expressing cells along the striatum of
ventral telencephalon, i.e. from point A to point B as indicated in figure 3.2.c. Another change is seen
in the rhombencephalon where Pax6 expression in the ventral pons and the dorsal medulla oblongata is
confined only within two 'comma-shape' areas, i.e. from point C (head of the 'comma') to point D (tail
of the 'comma') as indicated in a higher magnified view in figure 3.2.d. The expression in the vellum
medullare becomes minimal (compare figure 3.1.c with 3.2.a).
In the optic region, the optic stalk remains expressing Pax6 (no. 19 in figure 3.2.a). The sharp
boundary between the expressing and the non-expressing area in the thalamus remains clearly seen.
The surface ectoderm overlying the lens and the optic cup also exhibits evidence of Pax6 expression,
but not as obvious as that at day 10.0 p.c. (compare figure 3.1.c with 3.2.a). In the optic cup, both the
forming neural retina and the future pigmented retinal epithelium exhibit Pax6 expression (nos. 27 - 28
in figure 3.2.a). Pax6 transcripts are also detected in the pituitary primordium (no. 20 in figure 3.2.a),
but not as obvious as that in the optic cup or other areas. The rim of the optic cup appears to exhibit
more intense Pax6 expression than the other portions (see the most distal parts of the optic cup in figure
3.2.a). There is also detectable Pax6 expression in the nasal epithelium, though this is not as intense as
that in the optic cup (see no. 33 in figure 3.2.b).
3.2.1.4 Day 12.0 p.c.
At day 12 p.c., the changes of Pax6 expression formerly noted to have occured by day 11.0 p.c. in the
ventral telencephalon become more apparent (compare 3.2.a with 3.3.a), as the pallidum of the ventral
telencephalon becomes apparent (see nos. 42 and 45 in figures 3.3.a; b). The slim strip of Pax6-
expressing cells located on each side of the ventral telencephalon becomes slimmer as the cells are
traced from the ventral telencephalon through the junction of the striatum and the pallidum (no. 46 in
figure 3.3.b) toward the differentiation field of the pallidum. Beyond the striatum, as they are traced,
the two 'strips' of Pax6-expressing cells become reduced to 'threads' until they end in two aggregates
of Pax6-expressing areas located lateral to the pallidal subventricular zone (see no. 45 in figure 3.3.b).
In the eye region, Pax6 expression in the optic stalks is maintained (see no. 39 in figure 3.3.a), while the
hypothalamic neuroepithelium (ventral diencephalon) remains absent of Pax6 transcripts (see no. 49 in
figure 3.3.a). Pax6 is no longer expressed in the pigmented retinal epithelium by day 12.0 p.c. (see no.
28 in figures 3.3.b; c). In the rhombencephalon, the two 'comma-shape' areas of Pax6 expression in the
neuroepithelium of the pons and the medulla are still present, but these areas of expression become
relatively smaller as compared to the increasing volume of the rest of the rhombencephalon (compare
figure 3.3.a with 3.2.a). It is also noteworthy that no areas of the presumptive dental epithelium shows
evidence of Pax6 expression (not shown).
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3.2.1.5 Day 13.0 p.c.
Pax6 expression at day 13.0 p.c. is shown by serial transverse sections in figures 3.4.a to 3.4.m. To
look serially from top of the head, Pax6 transcripts are first seen in the pretectal and anterior tectal
neuroepitheiium (nos. 56 and 57 in figure 3.4.b) as well as in the thalamic neuroepithelium (nos. 58 and
59 in figure 3.4.b). The tectal neuroepithelium does not appear to have Pax6 expression (no. 55 in
figure 3.4.a). In the anterior thalamic neuroepithelium (no. 59 in figure 3.4.a), Pax6 transcripts are
concentrated in the ependymal (germinal) layer, in contrast to those in the posterior thalamic
neuroepithelium and in the pretectal neuroepithelium which are mostly in the intermediate or marginal
layers (compare no. 59 with nos. 57 - 58 in figures 3.4.b; c). This difference of Pax6 transcripts
distribution becomes more obvious as the transverse planes go further down (see figures 3.4.d; e). In
the dorsoanterior part of thalamus, i.e. the lamina terminalis, Pax6 transcripts are seen within the
neuroepithelial tissues stretching out from the midline (no. 54 in figure 3.4.a).
As the levels of the tranverse planes go further down, Pax6 transcripts are found in the germinal layer
of neocortical neuroepithelium in the telencephalon (no. 30 in figures 3.4.g; h). This Pax6 expression is
continuous within parts of the differentiation field of the amygdala (no. 29 in figure 3.4.h) and medial
hippocampus and is further linked to the lateral part of the thalamus toward the epithalamus (see the
arrow-indicated, continuous Pax6-expressing area that stretches from no. 30 toward no. 29 and links
with the epithalamus in figure 3.4.h). No sign of Pax6 expression is seen in the choroid plexus in the
lateral ventricle (telencephalic ventricle) or in the fourth ventricle (nos. 69 and 72 in figures 3.4.g; h).
In the neuroepithelium of thalamus, Pax6-expressing cells are found in the areas surrounding the sulcus
limitans (the site marked with an asterisk in figures 3.4.f; g; h; also known as hypothalamic sulcus), i.e.
in the areas posterior (figure 3.4.f), lateral (figure 3.4.g), and anterior (figure 3.4.h) to the sulcus
limitans. The expression is continuous with the germinal layer of the anterior thalamic neuroepithelium
(see figure 3.4.h). In the posterior hypothalamus that surrounds the hypothalamic recess, Pax6
transcripts are not detected (for example no. 8 in figure 3.4.g).
Pax6 expression is also detected in the germinal neuroepithelium in the tegmentum (ventral
mesencephalon) and in the rhombic lip where the cerebellar primordium is formed (nos. 64 and 68 in
figure 3.4.h). In the tegmentum, two strips of Paxd-expressing cells are found in the anterior
neuroepithelium where the future reticular formation is located (no. 73 in figure 3.4.h). In the pontine
area, a patch of Pax6-expressing cells is found on each side of the superior central raphe nucleus (no.
75 in figure 3.4.i). There is also evidence of Pax6 expression in the medulla oblongata (no. 71 in figure
3.4.h) where transcripts are confined within the medial ventricular zone. In the spinal cord, Pax6
transcripts are detected in the medial ventricular zone and in the ventral root motor neurons (nos. 89
and 96 in figure 3.4.k).
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In the eye region, Pax6 expression is found in the lens, the optic cup, and the corneal epithelium
(figures 3.4.1; m). Transcripts in the lens appear to be concentrated in the anterior germinal epithelium
(see no. 103 in figure 3.4.m). In the optic cup, both the neural retina (no. 101 in figure 3.4.m) and the
pigmented retinal epithelium (no. 28 in figure 3.4.m) contain Pax6 transcripts. The rim of the optic cup
(no. 98 in figure 3.4.m) remains the area of most intense expression than the posterior parts. In the
corneal epithelium (no. 38 in figure 3.4.m), Pax6 expression is seen limited within the upper and the
lower conjunctivas (no. 37 represents upper conjunctiva in figure 3.4.m; see also figure 3.4.1 for a
clearer demarcation). In the nasal epithelium, a detectable level of Pax6 expression is found (no. 33 in
figure 3.4.1).
3.2.1.6 Day 14.0 p.c.
By day 14.0 p.c., Pax6 expression is generally consistent with that seen at day 13.0 p.c., but some
interesting changes are found (presented in figures 3.5.a to 3.5.p). In the posterior thalamic and
pretectal neuroepithelium (see nos. 57 - 58 in figure 3.5.b), Paxd-expressing areas in the intermediate
and marginal layers appear to expand as both neuroepithelial layers are enlarged (compare figure 3.4.c
with figure 3.5.b). Pax6 transcripts in the anterior thalamic neuroepithelium remain mainly within the
germinal layer in contrast to those in the posterior thalamic neuroepithelium and in the pretectal
neuroepithelium (see figures 3.5.b; c; d). But signs of expansion of Paxd-expressing area in the anterior
thalamic neuroepithelium toward the intermediate and marginal zones are apparent. For example, the
habenular and lateral habenular differentiation fields as well as the epithalamus (pineal gland) is seen
exhibiting intense Pax6 expression (see nos. 61 and 63 in figures 3.5.d; e, and compare with those in
figure 3.4.e). Another change in the thalamus is that, although Pax6 transcripts remain detected in the
area surrounding the sulcus limitans and remain continuous with the anterior thalamic neuroepithelium
(figures 3.5.f; g; h), the area of expression seems to expand in proportion to the enlargement of the
thalamus. Furthermore, this expression area in the thalamus becomes restricted in the more ventral
region where the internal capsule is formed (see no. 106 in figures 3.5.i; j). The posterior hypothalamus
does not show evidence of Pax6 expression, neither does the choroid plexus in the lateral ventricle and
in the fourth ventricle (see figure 3.5.h). The pituitary primordium is clearly seen expressing Pax6 (no.
20 in figures 3.5.1; m; n).
Pax6 transcripts are also detected in the germinal (ventricular) neuroepithelium of the telencephalon as
well as the rhinencephalon where the future main olfactory bulb will be connected (see no. 113 in figure
3.5.o). In the amygdala (for example see no. 29 in figure 3.5.h), Paxd-expressing area is expanded
covering the piriform and endopiriform differentiation fields and the future medial and lateral
amygdaloid nuclei (compare figure 3.4.h with figures 3.5.h -1). In the tegmental neuroepithelium, Pax6
expression remain in the posterior surface and in the area of reticular formation as found at day 13.0
p.c. (compare nos. 64 and 73 in figure 3.5.h with the corresponding areas in figure 3.4.h). In the
pontine neuroepithelium, intense expression is found in the surface granular layer (see no. 104 in figure
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3.5.h). Pax6 expression in the cerebellar germinal layer becomes more obvious (see no. 108 in figure
3.5.j). The rhombic lip (a cerebellar primordium) remains intensively expressing Pax6 (see no. 68 in
figures 3.5.g; h). The rootlet of the vestibulocochlear (VIII) ganglion also exhibits intense Pax6
expression (no. 82 in figure 3.5.j). In the medulla oblongata, Pax6 expression is found in the medial
and surface germinal layers and more intense transcripts are seen in the premedullary neuroepithelium
(nos. 5, 71, 107 in figures 3.5.h; k). Further down to the spinal cord, Pax6 expression is detected in the
same areas as found at day 13.0 p.c., i.e. in the medial ventricular zone and the motor neuron cells in the
ventral root (nos. 89 and 96 in figure 3.5.p).
In the eye region, Pax6 expression remains in the lens, the optic cup, and the corneal epithelium (nos.
38, 98, 103 in figure 3.5.p). The confinement of Pax6 transcripts within the anterior germinal
epithelium in the lens becomes more obvious (compare no. 103 in figure 3.4.m with that in figure
3.5.p). Surprisingly, the optic stalk does not show Pax6 expression, although trace amounts of Pax6
transcripts in the optic chiasma are seen (nos. 39 and 114 in figure 3.5.0). In the nasal epithelium, Pax6
expression is clearly seen (no. 33 in figure 3.5.p).
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3.2.1.7 Day 15.0 p.c.
By day 15.0 p.c., areas of Pax6 transcripts remain in the posterior thalamic neuroepithelium and in the
pretectal neuroepithelium extending toward the tectum (nos. 56, 57 in figure 3.6.b). They are mainly in
the intermediate or marginal layers (see figures 3.6.b; c). In the anterior thalamus, further expansion of
Pax6 expression in the habenular and lateral habenular differentiation fields is seen (see no. 63 in figure
3.6.g and its corresponding area in figures 3.6.f; h; i). Evidence of further expansion of Pax6-
expressing areas in the anterior thalamus (including the epithalamic neuroepithelium) is also seen in the
wall of the thalamic third ventricle (compare figure 3.6.c with figure 3.5.b). This expansion appears to
stretch beyond the germinal layer and reach toward the intermediate or the marginal layers (see nos. 117
- 118 in figure 3.6.c). The pineal neuroepithelium remains exhibiting intense Pax6 expression (no. 120
in figures 3.6.d; e). For the /\xr6-expressing area in the thalamic neuroepithelium surrounding the
sulcus limitans, several differentiating fields and nuclei can be specified by day 15.0 p.c. (see figures
3.6.i to 3.6.r): paraventricular nucleus (no. 129), supraoptic nucleus (no. 139), reticular nucleus (no.
134), zona incerta (no. 131), fields of Forel (no. 130), and dorsal lateral geniculate nucleus (no. 138).
As the transverse plane is further down, this expression area is restricted, leaving a curb-shaped pattern
of expression surrounding the internal capsule as formerly noted by day 14.0 p.c. (compare figure 3.6.p
with figure 3.5.i). A magnified view of this intermediate thalamic differentiation area does show a
substantial population of cells that connect the hippocampus (no. 137) are expressing Pax6 (see figure
3.6.r).
In the amygdaloid neuroepithelium, the endopiriform and piriform differentiation fields remain
expressing Pax6, as well as the area where the medial and the lateral amygdaloid nuclei are presumably
located (for example see nos. 29, 166 in figure 3.6.s). Of particular interest in the telencephalic
neuroepithelium is a hint of secondary germinal layer formation that can be seen, for example, no. 121
in figure 3.6.e. This presumptive secondary germinal neuroepithelium exhibits hints of Pax6
expression. Another interesting finding in the mouse brain by day 15.0 p.c is the presence of
concentrated Pax6 transcripts in the thickening external germinal layer in the cerebellar primordium of
the posterior pontine area (see nos. 122 - 123 in figures 3.6.f; g). This Pax6 expression in the external
germinal neuroepithelium even stretches to cover the anterior part of the medulla oblongata (for
example see no. 127 in figure 3.6.j). In the anterior tegmentum, the midbrain reticular formation can be
specified as a Fax6-expressing area (see no. 73 in figures 3.6.1; m; n). The pontine subventricular
neuroepithelium is also highly concentrated with Pax6 transcripts (no. 133 in figure 3.6.n). The
primordium of cochlear/vestibular complex also expresses Pax6 at a high level (no. 82 in figure 3.6.n).
Pax6 transcripts in the cervical spinal cord remain unchanged, i.e. in the medial germinal zone and in
the ventral root motor neurons (see figure 3.6.s).
In the eye, the same Pax6-expressing pattern as that at day 14.0 p.c. is maintained (figure 3.6.t). In the
lens, Pax6 transcripts are concentrated within the anterior germinal epithelium (no. 103), whereas the
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primary lens does not contain Pax6 transcripts (no. 99). The pigmented retinal epithelium (no. 28) can
be clearly seen without Pax6 expression. The rim of the optic cup (no. 98) appears to have more
intense Pax6 transcripts than the other areas of the optic cup. Pax6 expression also remains in the
corneal epithelium (no. 38) and the expression is demarcated in the conjunctivas (no. 37).
3.2.1.8 Day 16.0 p.c.
By day 16.0 p.c., Pax6 transcripts are detected in the neocortical (telencephalic) neuroepithelium (see
no. 2 in figure 3.7.a) in conjunction with those in the neuroepithelium of subicular area (no. 50),
hippocampal area (Ammon's horn) (no. 137), dentate gyrus (no. 145), and further with the
differentiation fields of strionuclear area (no. 146), pallidum (no. 45), and amygdaloid area (no. 149 in
figure 3.7.c). In the dorsal thalamus, the area of epithalamic neuroepithelium (where the pineal gland,
the habenular and lateral habenular nucleus are differentiated) exhibits obvious Pax6 expression (see
no. 120 in figures 3.7.c and d). This expression is seen, if viewed more caudally, in the lateral posterior
nucleus in the posterior thalamus (no. 157 in figure 3.7.h) and the anterior pretectal nucleus in the
pretectum (no. 159 in figure 3.7.i). Pax6 expression also appears in the areas of stria terminalis and
stria medullaris in the anterior thalamus (nos. 143, 150 in figure 3.7.c). Transcripts of Pax6 are also
seen in the site of the lateral preoptic region in the anterior hypothalamus (no. 148 in figure 3.7.d). As
the coronal sections are viewed further caudally (from the forehead further toward the occipital
direction), Pax6 expression in the intermediate thalamus is seen in a symmetrical branched pattern (see
figures 3.7.d to h). The ventral branch joins with the dorsal branch in the Forelian neuroepithelium at
the wall of hypothalamic third ventricle where the paraventricular nucleus (no. 129) can be specified
(see figure 3.7.h). The dorsal branch stretches dorsolaterally (see figure 3.7.h), starting from the site of
Forelian neuroepithelium and the paraventricular nucleus, to the area of zona incerta (no. 131) and the
reticular nucleus (no. 134); the ventral branch stretches ventrolaterally toward the fields of Forel (no.
130) and the differentiation field of dorsolateral hypothalamus in close proximity to the piriform cortex
(no. 77). In the hypothalamic area, patches of cells appear to exhibit Pax6 expression (not specifically
labelled; see figure 3.7.h).
Further caudally (toward the occipital direction), interesting patterns of Pax6 expression in the
intermediate and posterior thalamus are seen. The dorsal branch (paraventricular-zona incerta-reticular
nucleus) becomes band-shaped and is present in the differentiation field of intermediate thalamus and
ventrolateral geniculate nucleus (no. 160 in figure 3.7.i). Connections of /\2x6-expressing cells
between the dorsal and the ventral branch are apparent (see figure 3.7.j). This dorsal branch, i.e. the
band-shaped expression area, will become segmented (figure 3.7.k) and forked (figure 3.7.1) as it is
viewed more caudally in the tegmental area. The ventral (fields of Forel-dorsolateral thalamus) branch
is also changed; it becomes a patch of cells in the subthalamic nucleus (no. 161 in figure 3.7.i) and, as
viewed more caudally, is gradually diminished in the posterior and lateral hypothalamic differentiating
fields (see figures 3.7.k; 1). The posterior amygdaloid area where the basomedial amygdaloid nucleus
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(no. 166) is located remains exhibiting Pax6 expression as can be seen in figures 3.7.i to 3.7.n. The
deep layers of the superior colliculus are also seen expressing Pax6 (no. 168 in figure 3.7.o). The
pituitary and the mammillary neuroepithelium are also Poxd-expressing areas (nos. 20, 169 in figure
3.7.p). Particularly intense expression can be located in areas of the lateral deep nucleus (no. 171),
ventral tegmental nucleus (no. 172), magnocellular reticular nucleus (no. 175), cochlear nucleus (no.
176), and superior central raphe nucleus in the isthmus (no. 282) (see figures 3.7.p; q; s; t; u; w). The
cerebellar primordium (no. 174 in figure 3.7.n) is also an area of intense Pax6 expression. In the
cervical spinal cord, Pax6 expression remains in the ventral motor neurons (presumably the 7th layer of
the spinal cord) (see no. 96 in figure 3.7.a). This expression is consistent through the whole span of
cervical spinal cord (see figures 3.7.(3; y, 8; e).
Pax6 transcripts remain in the main and the vomeronasal olfactory epithelium as well as in areas of the
eye that are formerly seen by days 14.0 p.c. and 15.0 p.c. (see nos. 33, 91 in figures 3.7.b and c).
3.2.1.9 Day 17.0 p.c.
By day 17.0 p.c., Pax6 transcripts remain in the areas formerly detected at earlier gestation days, with
some minor changes. In the telencephalic region, Pax6 expression remains in the neocortical
neuroepithelium, spanning from the lateral neocortex to the hippocampal neuroepithelium close the
midline (for example see figure 3.8.n) and is linked to the amygdaloid neuroepithelium in the more
posterior region (see figures 3.8.r; s). There is also hints of Pax6 expression in the outer layer of
telencephalic neuroepithelium, although the level of expression is not as high as that in the neocortical
neuroepithelium (for example, see figures 3.8.q; r). Pax6 expression also appears in a patch of cells
outside the brain. These presumably are neural cells (see no. 209 in figures 3.8.0 and 3.8.p). The
anterior thalamic neuroepithelium in the area of medial septum (no. 199 in figure 3.8.k), the pineal
primordium (no. 120 in figure 3.8.s) and the thalamic neuroepithelium (figures 3.8.1 to t) remain
containing Pax6 transcripts. Those previously noted areas in the thalamus, i.e. the paraventricular
nucleus, fields of Forel, zona incerta, reticular nucleus, supraoptic nucleus and the differentiation fields
of intermediate/lateral thalamus remain containing Pax6 transcripts as formerly detected (see figure
3.8.o). The pituitary primordium also appears to express Pax6, although at a very low level (no. 20 in
figures 3.8.q; r).
More caudally, Pax6 expression is seen in the ventrobasal nucleus (no. 215 in figure 3.8.r), medial
geniculate nucleus (no. 214 in figure 3.8.r), and the junction of medial geniculate nucleus and red
nucleus (no. 219 in figure 3.8.t). In the pontine neuroepithelium, the cerebral peduncle (no. 216 in
figure 3.8.t) and superior central raphe nucleus (no. 75) in the anterior pons (no. 217) constitute a
symmetric 'tadpole' pattern of Pax6-expressing area (see figure 3.8.t). The cerebellar primordium,
including the cochlear nucleus, exhibits apparent Pax6 transcripts (no. 174 in figures 3.8.w; x). The
areas of the reticular formation (nos. 73 and 225), the neuroepithelial cells in the wall of the fourth
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ventricle (no. 22), the ventral tegmental nucleus (no. 172) and the lateral vestibular nucleus (no. 224)
are also Pax<5-expressing (figures 3.8.w; x; y). The choroid plexus in the fourth ventricle does not
exhibit Pax6 expression (see no. 69 in figure 3.8.z). In the medulla, Pax6 transcripts are detected in the
medullary reticular formation (no. 228 in figure 3.8.z; a).
In the olfactory epithelium and vomeronasal epithelium (olfactory epithelium in the Jacobson's organ),
a low level of Pax6 expression is detected (nos. 33 and 91 in figures 3.8.a to e). Pax6 expression is
also clearly detected in the tubules of serous gland (no. 194) and in the nasal glandular tissue in lateral
wall of middle meatus (no. 195 in figure 3.8.c). In the main olfactory bulb (no. 196 in figure 3.8.d),
Pax6 transcripts are seen in the neuroepithelium and are connected, posteriorly, to those found in the
lateral migratory stream (no. 200) and the endopiriform nucleus in the rhinencephalon (no. Ill) (see
figures 3.8.f to h). Pax6 transcripts are also detected in the taenia tecta (see no. 283 in figures 3.8.f; h).
These areas of Pax6 expression in the rhinencephalon are linked posterolaterally with the amygdaloid
neuroepithelium, particularly with the piriform cortex (no. 77 in figure 3.8.m).
In the eye (see figure 3.8.j), Pax6-expressing cells remain located in the anterior epithelium of the lens
(no. 103), the neural retina that is differentiated into a multi-layered structure (nos. 201 - 205), as well
as in the corneal epithelium (no. 38). In the pigmented retinal epithelium, however, no detectable Pax6
transcript is found (no. 28 in figure 3.8.j). Pax6 expression is also detected in the optic chiasma (no.
114 in figure 3.8.h) but not in the optic stalk (no. 39 in figure 3.8.j). Particularly interesting finding is
in the differentiating neural retina where Pax6 transcripts appear to distribute in various concentrations
in different layers. The presumptive internal nuclear layer shows the most intense expression than other
layers (no. 203 in figure 3.8.j).
3.2.1.10 Day 18.0 p.c.
By day 18.0 p.c., interesting changes of Pax6 expression are found in the main olfactory bulb and in the
telencephaiic neuroepithelium, as well as in the thalamic neuroepithelium.
In the telencephalon (figures 3.9.i to t), the cingulate cortex and the neocortical neuroepithelium remain
expressing Pax6, but the total area is reduced, i.e. the formerly thick layer of Pax6-expressing
neuroepithelium is reduced to a thin layer (compare no. 2 in figures 3.7.b, 3.8.k, and 3.9.1). In the
thalamic neuroepithelium, the dorsal (paraventricular-zona incerta-reticular) branch and the ventral
(fields of Forel-dorsolateral hypothalamus) branch that are formerly noted at day 16.0 p.c. (in section
3.2.1.8) remain Pax6-expressing; but the total area seems to be slightly reduced as compared to that
seen at day 16.0 p.c. (for example compare figure 3.6.h with figure 3.9.m). The differentiation fields of
fornix (no. 234 in figure 3.9.i), medial septum (no. 199), diagonal band (both horizontal and vertical
limb; see no. 235 in figure 3.9.h and no. 236 in figure 3.9.i) and lateral migratory stream (no. 200) all
contain Pax6 transcripts at identifiable level (see figure 3.9.i). Also, the lateral habenular nucleus (no.
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245 in figure 3.9.q) and the dorsal periaqueductal gray (no. 247 in figure 3.9.t) are ,Pax6-expressing
areas that can be specified. In the hypothalamus, Pax6 transcripts are seen in the intermediate
neuroepithelium (for example, see no. 237 in figure 3.9.k). The pituitary primordium remains
expressing Pax6 (no. 20 in figure 3.9.q; r). Pax6 transcripts are even seen in the pituitary cells in the
ossificating cartilage primordium of hypophyseal fossa of sphenoid bone, i.e. the sella turcica (no. 240
in figure 3.9.1; see also figure 3.9.m).
In the midbrain (see figures 3.9.o; p), Pax6 transcripts are detected in the dorsal lateral geniculate
nucleus, ventral lateral geniculate nucleus, and the junction of reticular nucleus and ventral lateral
nucleus complex (no. 243). In the pontine area, the superior central raphe nucleus (no. 75), pontine
reticular formation (no. 225), cerebral peduncle lateral to the trigerminal motor nucleus (no. 248),
trigeminal motor nucleus (no. 249), as well as the facial motor nucleus (no. 252) can be specified as
foxd-expressing areas (see figures 3.9.s; t; u). The cerebral primordium lateral to the pontine area
remain expressing Pax6 at a high level (see no. 174 in figure 3.9.w).
In the olfactory bulb, the olfactory neuroepithelium and the anterior olfactory nucleus are clearly Pax6-
expressing (nos. 231 and 232 in figure 3.9.d). Pax6 transcripts are also found in the insular area of the
rhinencephalic differentiation field that is in conncetion with the amygdaloid differentiation fields (for
example see no. 200 in figure 3.9.g).
In the eye, Pax6 transcripts are concentrated only in the ganglion cell layer and internal nucleus layer of
the neural retina (nos. 203, 204 in figure 3.9.c) instead of being distributed in several other layers at day
17.0 p.c. (compare 3.9.C with 3.8.j). The pigmented retinal epithelium (no. 28) is seen completely
devoid of its Pax6 expression and the corneal epithelium (no. 38) contains only minimal Pax6
transcripts (see figure 3.9.c).
3.2.1.11 After birth
Pax6 expression after birth is shown in figures 3.10.a to p. By day 1.0 after birth (see figure 3.10.a), in
the olfactory bulb, Pax6 expression is seen in the glomerular layer (no. 253), mitral cell layer (no. 255),
and internal granular cell layer (no. 256). Ventral to the olfactory bulb is the rhinencephalon that
exhibits Pax6 transcripts in the frontal neocortex (no. 257 in figure 3. lO.b). In the telencephalon, hints
of Pax6 expression remain seen in the neocortical neuroepithelium (see no. 2 in figure 3.10-d). The
posterior hypothalamus (no. 259) and the cerebral peduncle (no. 216) also show hints of Pax6
expression, as well as the fields of Forel (no. 130) and cortical plate (no. 258) (see figures 3.lO.d; e). In
the neural retina, convincing evidence for the confinement of Pax6 transcripts within the ganglion cell
layer (no. 204) and the internal nuclear layer (no. 203), as well as the absence of Pax6 expression in the
pigmented retinal epithelium (no. 28) is found (see figure 3.10.p).
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By day 7.0 after birth, Pax6 expression in the telencephalon and diencephalon is generally comparable
to that seen at day 1.0 after birth (compare figures 3.10.d and 3.10.e with figure 3.10.f). However, in
the thalamic area, Pax6 transcripts can be specified in the area of the subthalamic nucleus (no. 161) and
hints of expression are found in the hippocampal neuroepithelium (no. 137) (see figure 3.10.f).
Particularly interesting changes regarding Pax6 expression found by day 7.0 after birth are in the
superior colliculus, the cerebellum, and the inferior olive. In the superior colliculus, Pax6 transcripts
are intensely concentrated in the surface layers of external germinal neuroepithelium (no. 222); this is
not observed before birth (see figure 3. lO.h). The cerebellum at this gestation age has been expanded
to cover the lateral and ventrolateral part of the pons and Pax6 transcripts are concentrated in the
convoluted external granular (germinal) neuroepithelium (no. 229) (see figures 3. lO.g; h). In the
inferior olive, Pax6 is also intensely expressed (nos. 263 and 264 in figure 3.lO.i).
By day 21.0 after birth (see figures 3. lO.j; k), in the olfactory bulb, Pax6 transcripts are seen in the
internal granular cell layer (no. 256) and glomerular layer (no. 253). The mitral cell layer (no. 255) as
well as the external plexiform layer (no. 254) do not exhibit evidence of Pax6 expression. In the
telencephalon and diencephalon (see figures 3.10.m; n; o), Pax6 transcripts are detected in the
neocortical neuroepithelium (no. 2), cortical plate (no. 258), stria medullaris (no. 274), fimbria (no.
272), subicular area (no. 273), and the differentiation field of intermediate thalamus (no. 158).
Particularly interesting is in the corpus callosum (no. 269) and in the deep layers of superior colliculus
(no. 168) where Pax6 transcripts are found along with the left-right neuronal projections (figure 3.10.o).
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3.2.2 Nerve fiber projection as demonstrated by Linder's silver stain in the mouse brain
Linder's silver stain in conjunction with Luxol fast blue on the mouse brain is represented here only at
day 15.0 p.c., although the same procedures have been performed on mouse heads at earlier gestation
days. The reason is that not as much nerve fiber projection can be seen before day 14.0 p.c. and day
15.0 p.c. is more informative than that at day 14.0 p.c.
Seen on serial transverse sections, the mouse brain first shows apparent nerve fiber projections at the
anterior pretectal (no. 56) and tectal region (no. 57) where Pax6 is heavily expressed (compare figures
3.11 .b and 3.1 l.c with figure 3.6.b). As the tranverse planes are lower, nerve fiber projections can be
seen in the paraventricular nucleus (no. 129) and areas surrounding the lateral habenular nucleus (no.
277) (see figure 3.1 l.c). These are also Pax(5-expressing areas (see figures 3.6.g and 3.6.n for a
comparison). Nerve fiber projections are also found in the junction between tegmental formation and
hypothalamus (no. 279 in figure 3.11 .d) where Pax6 transcripts are present (compare figures 3.6.d and
figure 3.1 l.d) as well as in the cerebellar primordium (no. 174 in figure 3.1 l.e) whose Pax6 expression
is obvious (compare figure 3.1 l.e with 3.6.f). Furthermore, the correlations of Pax6 expression with
nerve fiber projection are found in the surface of medulla (no. 107; compare figure 3.6.j with 3.1 l.g), in
the superior central raphe nucleus in the pons (no. 75; compare figure 3.11 .k with 3.5.m), in the neural
retina (no. 205 in figure 3.11.o; compare figure 3.6.t with figure 3.11 .o), in the differentiation field of
olfactory bulb (compare figure 3.1 l.n with figures 3.5.n; o) and in the optic chiasma (no. 114; compare
figure 3.11.0 with figure 3.5.o). In contrast to those with correlation, where there is no Pax6
expression, for example in the choroid plexus (no. 72 in figure 3.4.h) and in the trigeminal ganglion (no.
21), there is no nerve fiber projection (compare figure 3.4.h with 3.1 l.e; also compare figure 3.1 l.n
with figure 3.5.n).
However, there are almost equal number of exceptions to the correlation of Pax6 expression with nerve
fiber projection. In the internal capsule (no. 106; compare figure 3.1 l.f with figure 3.6.p) and the optic
stalk (no. 39; compare figure 3.1 l.o with figure 3.5.o), nerve fiber projections are abundant without the
presence of Pax6 transcripts; while in the olfactory epithelium (no. 33; compare figure 3.5.p with figure
3.11.0), pineal primordium (no. 276; compare figure 3.1 l.b with figures 3.6.d; e) and the telencephalic
neuroepithelium (compare figure 3.6.p with figure 3.1 l.f), Pax6 is intensely expressed without the
appearance of obvious nerve fibers. In the intermediate thalamic differentiation field, i.e. the areas
presumably of the zone incerta, fields of Forel, reticular formation, and paraventricular nucleus, Pax6 is
extensively expressed, but nerve fibers are only seen in the paraventricular nucleus (no. 129; compare
figure 3.6.n with figure 3.1 l.c). In the cerebellar primordium, a sharp boundary of expressing and non-
expressing areas is seen between the tegmentum and the pons (for example, see figure 3.6.g), but nerve
fiber projections appear to extend along the surface of tegmentum where no Pax6 expression is found
(compare figure 3.6.g with figure 3.1 l.e).
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3.3 Discussion
3.3.1 Pax6 in the visual nervous system
Pax6 is obviously involved in the development of visual nervous system as demonstrated by the
distribution of its transcripts. If one colours, according to the presence of Pax6 transcripts, the
components reviewed and schematically represented by Garey et al. (1991) (see figure 1.6 and section
1.9.9), the involvement of Pax6 in the visual nervous system is clearly shown (see figure 3.12 on next
page).
In figure 3.12, almost every major component of the visual nervous system is coloured, except area 17
of the visual cortex and extrastriate cortex where Pax6 expression is not determined; and the
parabigeminal nucleus where Pax6 is not expressed. The brainstem cholinergic nuclei (CH) can be
represented by the area of zona incerta where the ventral tegmental ascending cholinergic pathway is
located (Williams and Warwick, 1980). Thus, Pax6 is not only involved in the development of eye but
also in the higher centres of the visual nervous system. This is not surprising for two reasons: (1) Many
orthologous Pax6 genes in other species are consistently involved in nerves of sense organs, particularly
in the optic nerve (Krauss et al., 1991; Martin et al., 1992; Carriere et al., 1993; Turque et al., 1994; Li
et al., 1994; Rio-Tsonis et al., 1995; Hirsch and Harris, 1996). (2) The optic nerve, as one part of the
visual nervous system is not formed when Pax6 is not functional (Hogan et al., 1986; 1988). This
implies that other components of the visual nervous system may have Pax6 involved in their
development, if the whole system is evolved as an unit of a same origin.
Pax6 may also be involved in the connection of those components of the visual nervous system; but this
is out of the limit of in situ hybridization experiments to demonstrate. However, some areas express
Pax6 in a way that suggests a role of Pax6 in connecting visual pathways. For example, by day 21.0
after birth, Pax6 transcripts are present in the corpus callosum and in the deep layers of superior
colliculus along with left-right neuronal projections (see section 3.2.1.11). The corpus callosum is a
place where the visual cortical areas of the right and left hemispheres are reciprocally interconnected by
axons that run through it (Price, 1991). Similar contralateral connections exist in the superior colliculus
(Fish et al., 1982; Rhoades and Fish, 1982).
Mutant analysis on the Sey/Sey brain also supports a role of Pax6 in the development of visual nervous
system. For example, the area of zona incerta is absent from its normal position and the corpus
callosum is severely underdeveloped in the Sey/Sey prenatal brain (Stoykova et al., 1996). Also, the
regions of zona incerta and ventral lateral geniculate body do not show their characteristic patterning
for applied markers (Pax6 and Dlx 1) and are severely underdeveloped, leaving an enlarged third
ventricle (Stoykova et al., 1996).
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Figure 3.12 A schematic diagram of mouse Pax6 expression in the visual nervous system. This
diagram summarises connections of the main components within the visual nervous system as reviewed
in the laboratory rat, domestic cat, and macaque monkey (from Garey et al„ 1991). The pink-coloured
components are those where Pax6 transcripts are detected. Thus, Pax6 expression is detected in the
neural retina (RET), dorsal lateral geniculate nucleus (LGD), ventral lateral geniculate
nucleus/pregeniculate nucleus (LGV PRE), pulvinar/lateral posterior complex (PUL LP), superior
colliculus (SC), pretectum (PT), raphe nucleus and locus coeruleus (R LC). Area 17 of the striate







The conclusion that Pax6 is involved in the development of higher centres of visual nervous system
implies that the variable effects of aniridia on vision (see section 1.5.2) may partly be due to
abnormalities in the higher visual centres. Thus, to some patients, efforts trying to correct anomalies in
the lens or the cornea may not be sufficient to improve their vision.
3.3.2 Pax6 in the olfactory nervous system
Pax6 is also involved in the development of olfactory nervous system. This is based mainly on the
presence of Pax6 transcripts in most olfactory components. Externally, Pax6 transcripts are present in
the olfactory and vomeronasal epithelium. This expression is connected with that in the main and
accessory olfactory bulb and further posteriorly with the expression of the anterior olfactory nucleus
(AON) and precommissural hippocampus (taenia tecta). Pax6 expression is also found in other
olfactory components: piriform cortex and its promordium (lateral migratory stream), endopiriform
cortex, olfactory periallocortex, and olfactory and vomeronasal amygdaloid areas (see section 1.10.9)
such as the areas presumably of the anterior, lateral, and cortical amygdaloid nucleus. The extensive
distribution of Pax6 transcripts in the olfactory components allows a conclusion that Pax6 is involved
in the development of higher olfactory centres.
Pax6 may also be involved in the connection of olfactory pathways. For example, the connection of
Pax6 expression between hippocampal area and amygadaloid area is seen not only in the anterior
region, i.e. the precommissural hippocampus (tenia tecta) with anterior amygdala. It is also seen at
more caudal area; this is illustrated in figure 3.7.a. Interestingly, the habenular nucleus and lateral
habenular nucleus are parts of this connection (see figure 3.7.a). The habenular nucleus is a station on
some of the olfactory reflex pathways and is probably closely concerned with one of the sources of
innervation of the pineal gland (Williams and Warwick, 1980); both the habenular nucleus and pineal
gland exhibit intense Pax6 expression. Furthermore, connections from amygdaloid nuclei to the
habenular nucleus are supposed to project via the stria terminalis; and from hippocampal formation via
the fornix (Williams and Warwick, 1980). Both the stria terminalis and the fornix exhibit Pax6
expression. These observations suggest a role of Pax6 in connecting olfactory centres.
Mutant analysis by Stoykova et al. (1996) also support a role of Pax6 in the olfactory nervous system.
For example, the amygdala differentiation field is underdeveloped and the restriction of Pax6 and Dlxl
expression in the amygdala is lost in the Sey/Sey brain (represented by figure 1 in Stoykova et al.,
1996).
130
3.3.3 Pax6 in nerve fiber projection
The involvement of Pax6 in nerve fiber projection is suggested by several lines of evidence as
mentioned in section 3.1.3. However, Pax6 expression seems not to correlate with nerve fiber
projection, in that almost equal number of examples of non-correlation are found. But still, one can not
exclude the possible involvement of Pax6 in nerve fiber projection for the following reasons: (1) Pax6
is a transcription factor that is encoded in the nucleus (Glaser et al., 1995; Hanson et al., 1995). Pax6
signals represented by in situ hybridization are therefore located in the neuronal somata. Nerve fibers
mainly represent axon projections that are extended to a distance away from the somata. Thus, lack of
correlation between Pax6 expression and sites of nerve fiber projection does not necessarily mean that
Pax6 is not involved. (2) The mouse brain nerve fiber projection is a process that starts from as early as
E 8.5 (Easter et al., 1993; Mastick and Easter, 1996) and continues even after birth (Edwards et al.,
1989). By day 15.0 p.c. (shown in this study), the sites where Pax6 is expressed but without evident
presence of nerve fibers may start their nerve fiber projection at later stages. (3) Both in situ
hybridization and Linder's silver stain used in this study have their limits. The former may not be able
to demonstrate tiny sites or lower level of expression. The latter reflects only established nerve fibers
that are in detectable bundles under the optic microscope.
Mastick et al. (1997) reported that Sey/Sey embryos exhibited an axon pathfinding defect specific to the
first longitudinal tract, i.e. tract of the posterior commisure (tpoc), in the prosencephalon. Although the
tpoc axons in the mutants have normal initial projections, they make dramatic errors where they contact
the neuron cell bodies, and fail to pioneer the first tract (Mastick et al., 1997). The initial trajectory of
tpoc is correlated well with the pattern of Pax6 expression in the prosencephalon (pi to p3 of
prosomeres and in the optic vesicle region). Mastick et al. (1997) described in the same report that at
least some of the posterior commisure (pc) neurons did not express Pax6 by E 10.5, although the area
of Pax6 expression overlapped extensively with that of pc axon projections. By immunohistochemical
analysis, 93 % (260 out of 279) of pi cell bodies lacked nuclear labeling by E 10.5. However, the pc
neurons project axons substantially at E 9.5 when nearly all pi nuclei were labeled by the Pax-6
antibody (Easter et al., 1993; Mastick et al., 1996). Thus, current data support a role of Pax6 in axon
projection.
There are some presumptive pathways that Pax6 may regulate axon projection. Pax6 may regulate
axonal projection by regulating neuronal process outgrowth through cell surface molecule like LI
(Mastick et al., 1997). Pax6 may also regulate other transcription factor genes like Ets (Plaza et al.,
1994), Lim-1 and Gsh-1 (Mastick et al., 1997) or Pax6 itself through autoregulation (Plaza et al., 1993;
Grindley et al., 1995; Quinn et al., 1996). The downsteram genes of Ets, Lim-1, and Gsh-1 will be of
interest in this aspect; particularly those involved in either extracellular matrix or diffusible molecule
guidance during axon projection. In vitro studies showed that growth factors such as activin A, bFGF,
NGF, BDNF could regulate Pax6 expression (Yamada et al., 1994; Kioussi and Gruss, 1994). In light
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of the above mentioned data, I propose that for the integration of the visual and olfactory nervous
system Pax6 is first expressed in each axon relay centre under the regulation of growth factors. Once
Pax6 expression is established in the relay centres, point-to-point integration of the whole system is
probably achieved by the downstream genes that are activated within the mass of cells where the axons
are to pioneer. The activation of downstrean genes presumably depends on transient Pax6 expression
between each two points of axon relay centres. When the downstream genes are activated, they
presumably exert a negative feedback effect so that Pax6 expression will become downregulated or
even disappeared; a phenomenon in agreement with the common theme of developmental restriction for
Pax6 (to be discussed in section 3.3.4).
Further experiments are necessary to demonstrate the proposed role of Pax6 in nerve fiber projection.
For example, one can have brains of the same gestational stage from Sey/Sey mouse run through
Llnder's silver stain and compare with their wildtype littermates. The double stain technique (Dil
tracing of axons and immunohistochemistry) used by Mastick et al. (1997) can be used for correlation
of axons with Pax6 expression in other areas such as olfactory bulb, cerebellum, and spinal cord. The
correlation together with mutant analyses and in vitro microexplant cultures will give more
understanding on this topic.
3.3.4 Developmental restriction as a common theme for Pax6 expression
Developmental restriction is defined here as a gene expresson that first appear in broader regions of
embryos during earlier stages of development and later the expression is confined within smaller
regions, i.e. become diminished, or the expression disappeared. Developmental restriction, by the
definition, is a common theme for Pax6 in most of its expression regions.
3.3.4.1 Examples of developmental restriction of Pax6 expression
Examples for developmental restriction of Pax6 are plenty in the mouse. As reported by Grindley et al.
(1995), in the head surface ectoderm, Pax6 expression first covers most of the head region but is
gradually restricted to the area overlying the optic vesicle and finally to the presumptive corneal
epithelium. Furthermore, in the pigmented neural epithelium at day 15.0 p.c., Pax6 expression is only
seen in the anterior region, i.e. near the rim of the optic cup (Grindley et al., 1995), whereas Pax6
transcripts are detected everywhere in the optic cup in earlier gestation days. In the neuroepithelium of
spinal cord, Pax6 first expresses in the whole ventricular layer but is gradually excluded from the dorsal
and basal plate and is finally restricted to the medial ventricular zone (Walther and Gruss, 1991).
There are also plenty of examples that are not previously reported: (1) In the lens ectoderm, Pax6
transcripts first appear in the entire lens placode but by day 13.0 p.c. it is already confined within the
anterior germinal epithelium. (2) In the neural retina, Pax6 expression is first seen evenly in all layers
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but is gradually concentrated in several layers by day 16.0 p.c. and is further restricted to the inner
nuclear layer and the ganglion cell layer by day 18.0 p.c. (3) In the telencephalic neuroepithelium,
Pax6 expression is developmentally restricted by two steps. The first step occurs between day 10.0 p.c.
and day 11.0 p.c. during which the striatal and pallidal neuroepithelium become almost non-expressing.
This restriction results in the 'strip' of Paxd-expressing cells along the lateral walls of the
neuroepithelium. The second step is a gradual process that occurs from day 13.0 p.c. and afterwards
when Pax6 expression in the cerebral cortex is reduced from a thick zone to a thin layer. Some parts of
the telencephalic neuroepithelium, for example the hippocampal and the dentate gyrus neuroepithelium,
even become non-expressing. (4) In the pontine and medullary neuroepithelium, Pax6 expression is
also restricted to the 'comma-shape' area as the embryo develops. (5) By day 13.0 p.c., the optic stalk
is seen no longer expressing Pax6, whereas intense expression is found at the same site at day 12.0 p.c..
(6) In the thalamic neuroepithelium, Pax6-expressing cells first cover a large proportion of the thalamus
but the coverage area is gradually reduced to become a branched band.
There are also many examples of developmental restriction for Pax6 in other species whose Pax6
expression profiles are described in sections 1.4.2 to 1.4.7. These are not to be readdressed in
avoidance of repetition.
3.3.4.2 Implication of stage-dependent functions by developmental restriction
Why is developmental restriction found ? The following two possible explanations may be made: (1)
The expression is relatively diminished due to the increase of non-expressing areas as the embryo
develops and becomes large, i.e. the net area and the original pattern of expression is not changed. This
is not the case for two obvious reasons. Firstly, the pattern of Pax6 expression is changed, for example,
from a broad patch to branched lines in the thalamus. Secondly, some expressions even disappear, for
example, the disappearance of Pax6 expression can be found in the optic stalk, the posterior lens
ectoderm and pigmented retinal epithelium. (2) The expression is deveiopmentally restricted in
correlation with stage-dependent gene functions. Pax6 may function initially in broader domains as it is
expressed and then, as the embryo grows, the function(s) being carried on by Pax6 is either replaced by
other gene(s) or become unnecessary. Pax6 expression is therefore restricted accordingly. This is very
likely the case for Pax6 expression and function during embryogenesis and is to be discussed in the
following sections.
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3.3.4.3 Pax6 functions in different areas as supported by developmental restriction
Pax genes are generally expressed in highly mitotic or immature cells (see section 1.6.2 for details).
Pax6 follows the general theme for all Pax genes by expressing in the ventricular layer of
neuroepithelium in the developing brain and spinal cord, in the anterior germinal epithelium of the lens,
and in the proliferative neural retina. All these Pax6 expressions, as mentioned in the previous section,
are developmentally restricted. In light of the stage-dependent nature of developmental restriction for
Pax6, one wonders what sort of function(s) can be inferred when the stage-dependent developmental
events are compared. This section is to specify these functions based on such comparisons.
3.3.4.3.1 Pax6 is involved in proliferation during forebrain development
As introduced in section 1.8.2, the ventricular layer first covers the entire thickness of the
neuroepithelium and is a layer of neuroblast proliferation. Following proliferation the main tasks
during brain development are to form three-zone pattern and its modifications through migration,
pathfinding, connection and in the meantime myelination. Pax6 is expressed in the developing brain
and should be involved in one or several such tasks. So what is Pax6 doing during brain development ?
As mentioned in section 1.8.4, Altman and Bayer (1995) divided prenatal brain development into three
stages according to the structural features that indicate the distribution of germinal epithelium. The first
stage (day 11.0 p.c. to day 14.0 p.c.) is characterized by rapid expansion of the primary germinal
neuroepithelium. This first stage can be correlated well with the rapid expansion of Pax6 expression in
the ventricular layer during the same period. The second (intermediate) stage (from day 15.0 p.c. to day
18.0 p.c.) is characterized by the addition of secondary germinal epithelium and the maintenance of
prominent primary germinal neuroepithelium. Looking at the present Pax6 expression data in the
developing brain, the addition of external granular germinal epithelium in the cerebellar primordium
and pontine neuroepithelium and the secondary germinal epithelium in the telencephalic region during
this period best fits the definition by Altman and Bayer. The third stage (from day 20.0 p.c. to day 22.0
p.c) which is characterized by the gradual dissolution of the germinal epithelium is also correlated with
the rapid reduction of Pax6-expressing area in the developing brain, except the cerebellum. The
correlation of areas of expression and its developmental restriction with developmental events supports
a role of Pax6 in the proliferation of neuroblast cells.
The involvement of Pax6 in neuroblast proliferation is also supported by a study reported by Schmahl
et al. (1993). It was reported that 100 % (11 out of 11 embryos examined) of homozygous (Seyneu
/Seyneu ) embryos exhibited reduced cell content in the cortical plate and hypocellularity in the
intermediate zone. In contrast, the heterozygous littermates exhibited the same condition for only 12.5
% (11 out of 16 embryos examined) and none (0 out of 11 embryos examined) of the wildtype
littermates exhibited the same abnormality (Schmahl et al., 1993). The hypocellularity in the cortical
plate and in the intermediate zone may be due to impairment of neuroblast proliferation or migration or
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both. Warren and Price (1997) reported that diencephalic proliferative rates were abnormally low in
mutants and the low proliferative rate lead to a depletion of the proliferative precursor pool. This
resulted in a reduction in total diencephalic cell numbers in homozygous (Sey/Sey) mutants. Thus,
normal expression of Pax6 is required for the correct regulation of diencephalic precursor proliferation
is concluded (Warren and Price, 1997). However, possible impairment of neuroblast migration in
mutants can not be excluded for several reasons: (1) Regional differences in the diencephalic cell
density that are normally found in the wildtypes as markers of prosomeric borders are lost in
homozygous (Sey/Sey) mutants (Warren and Price, 1997). The markers of prosomeric borders are
several transverse strips of low cell density that run dorsoventrally. The different cell density reflects
regulation of the neuroblast distribution that is likely achieved through controlled migration. (2)
Heterotopic groups of cells were found in the cerebral cortex of the homozygous mutant mice (Schmahl
et al., 1993; Grindley, 1996). Comparable heterotopic cell groups are also found in the cerebellum
where neuroblast proliferation is also affected by Pax6 mutation (van Hevningen, personal
communication). These findings suggest that at least some neuroblasts have lost their normal
distribution and are confined in groups. (3) Sey/Sey and +/+ cells are segregated into separate domains
in the eyes of chimeras (Quinn et al., 1996), suggesting that cell interactions and normal distribution of
neuroblasts are altered.
3.3.4.3.2 Pax6 is involved in proliferation, migration, and neuronal connection in the neural
retina
Pax6 transcripts are initially distributed in the whole area of optic cup and is gradually restricted there.
This restriction is observed in many species. In the mouse, only the ganglion cells layer and the internal
nuclear layer exhibits Pax6 transcripts by day 18.0 p.c. as the result of developmental restriction. The
underlying developmental events can be correlated with the distribution of Pax6 transcripts in several
steps: (1) At earlier stages, the main tasks for the development of the optic cup are proliferation and
migration. The primitive optic cup acts as a single layer of germinal epithelium like the ventricular
layer in the brain or spinal cord. Active mitosis is undertaken in the entire optic cup for neuroblast
proliferation (Sidman, 1961; Robinson et al., 1986). Migration is carried out by interkinetic movement.
During these earlier stages, Pax6 expression is detected within the entire optic cup. (2) Following the
activities of proliferation and migration, differentiation and stratification of the optic cup is initiated.
This included the formation of the pigmented retinal epithelium and layers of cells, including the
internal plexiform layer. Once the inner plexiform layer has formed, the interkinetic migration becomes
restricted to the 'cytoblast' layer, i.e. the region between the inner plexiform layer and the the outer
limiting membrane (Robinson et al., 1986). Nuclei of the dividing cells enter different phases of the
cell cycle as they traverse different parts of the cytoblast layer. Thus, nuclei enter the M-phase and
divide at the outer limiting membrane. After division, the daughter nuclei enter G[ -resting phase and
migrate through the outer part of the cytoblast layer. The nuclei enter S-phase as they reach the inner
part of the cytoblast layer and remain in this phase until they reached the internal plexiform layer.
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During S-phase, nuclei incorporate molecules they require for the replication of DNA. Nuclei enter G2-
resting phase during their return journey to the outer limiting membrane where they divide again
(Sidman, 1961; Zavarzin and Stroeva, 1964; Denham, 1967; Robinson, 1986). During this period,
Pax6 expression disappears in the pigmented retina epithelium and is characterised by stratified patterns
between the external limiting membrane and the internal plexiform layer. (3) At later stages, the main
event of proliferation is replaced by neuronal connection. A functional neural retina demands two
neuronal connecting sites, the internal and the external plexifrom layers, in order to send the impulses
stimulated by light from the rod and cone photoreceptors through the nerve fiber layer (see figure 1.9;
Kahle, 1986) and via the optic stalk to the higer visual centres (see figure 1.5). Cell bodies that are
involved in the two connecting sites are the amacrine, horizontal, and bipolar cells in the internal
nuclear layer and the ganglion cells in the ganglion cell layer. Both the internal nuclear layer and the
ganglion cell layer exhibit intense Pax6 expression at later stages from day 18.0 p.c. afterwards.
The correlation between the distribution of Pax6 transcripts and the developmental events in the optic
cup, as described above, suggests that Pax6 is involved in the proliferation, migration, and neuronal
connection in the neural retina. The pigmented retinal epithelium, after being differentiated from the
neuroectoderm, does not contain Pax6 transcripts by day 15.5 p.c. (Grindley et al., 1995). The
distribution of Pax6 transcripts is developmentally restricted in close correlation to developmental
events. This close correlation is not unique in the neural retina. Similar close correlations are also
found in other Pax(5-expressing regions and the functions of Pax6 are further supported by evidence
from mutant analysis (for example, the reduced cell content and hypocellularity mentioned in 3.3.2.1)
and other experiments (to be further discussed in other sections).
3.3.4.3.3 Pax6 is involved in initiation and proliferation during lens development
During lens development, Pax6 is first expressed in the lens placode before invagination (Walther and
Gruss, 1991; Grindley et al., 1995). Following invagination, Pax6 transcripts are distributed in the
whole primitive lens (see figures 3.6.a; 3.7.a; b) and by day 13.0 p.c. are restricted within the anterior
germinal epithelium which is the only source of secondary lens fiber (see figure 1.8a; b). Based on the
distribution of Pax6 transcripts during lens development, two developmental events have the chance of
direct Pax6 involvement, initiation of lens development and proliferation of lens cells. The role in
proliferation is supported by the confinement of Pax6 transcripts in the anterior germinal epithelium.
Pax6 in the initiation of lens development is supported by the absence of lens formation in the
homozygous (Sey/Sey) mouse mutants (Hogan et al., 1986; 1988). Furthermore, the loss of lens
regenerating capacity in older axolotl eyes is accompanied by the decline of Pax6 expression (Del Rio-
Tsonis et al., 1995). This also suggests a role of Pax6 in the initiation of lens development. This
aspect of Pax6 function will be investigated in chapter 4.
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3.3.5 Developmental expansion of Pax6 expression and its implications
Developmental expansion is defined here as (1) a gene expresson that first appear in smaller areas of
embryos during earlier stages of development and later the expression is expanded into larger areas, or
(2) a de novo gene expression that is detected within newly formed tissues, for example the olfactory
bulb, as the embryo develops. Section 3.3.5 will list examples of developmental expansion for Pax6
and discuss their implications.
3.3.5.1 Examples and common aspects of developmental expansion for Pax6 expression
Developmental expansion, like developmental restriction, is common for Pax6 expression during mouse
embryogenesis. Examples are in the secondary germinal neuroepithelium in the cerebral cortex,
cerebellar neuroepithelium, surface layer of superior colliculus, and in the olfactory bulb. There are
two common aspects in these areas: (1) All of these areas are not initially formed during early brain
development; but as the brain develops, they are formed in the due time. (2) All of these areas are
highly proliferative.
3.3.5.2 Pax6 function as implicated by developmental expansion
The common aspects of developmental expansion explicitly imply Pax6 functions in those areas. Pax6
is either involved in the initiation or in the proliferation of those areas of developmental expansion.
The region that represents the future olfactory bulb in the anterior rhinencephalon is identifiable only
after day 13.0 p.c. (Kaufman, 1992) and at the same time Pax6 transcripts are found in the olfactory
epithelium (see figure 3.4.1). By day 14.0 p.c., Pax6 expression is seen in the rhinencephalic
neuroepithelium where the future olfactory bulb is projected (see figure 3.5.o). Mutant analyses show
that the olfactory bulb and nasal cavities are not formed in the Sey/Sey mouse (Hogan et al., 1986;
1988). During vertebrate nasal development, the formation and invagination of nasal placode (to form
the nasal epithelium) from the head surface ectoderm is coordinated with the formation of olfactory
bulbs from the head neuroectoderm (Farman, 1992; Halasz, 1990). Therefore it is possible that Pax6
transcripts in the olfactory epithelium and in the site of future olfactory bulb projection may coordinate
in the formation of olfactory bulb and nasal cavity.
In the Seyneu mutation, although the homozygous embryos fail to develop nasal cavities, a substantial
proportion (10/16; 62.5%) of heterozygous embryos exhibit enlarged nasal cavities (Schmahi et al.,
1993). In the nasal epithelium, an even higher proportion (13/16; 81.2%) of the heterozygous embryos
exhibit increased diameter of germinative epithelium as compared to their wildtype controls (Schmahi
et al., 1993). These findings suggest that Pax6 may be more involved in the formation of nasal
epithelium than of the nasal cavity. Furthermore, a trend of increasing the diameter of germinative
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epithelium was also found in the frontonasal forebrain, the dorsal forebrain, the diencephalon and the
cerebellum both in the heterozygous and the homozygous embryos (Schmahl et al., 1993); all these ares
are Pax6-expressing. It may therefore be possible that the failure of sufficient presumptive olfactory
neuronal migration at early stages of embryogenesis leads to the failure of nasal placode invagination
in the homozygous embryos. This possibility is, of course, to be further supported by experimental
evidence.
In the cerebellar primordium, Pax6 transcripts are seen as early as day 13.0 p.c. in the thin structure of
primary germinal layer. As the cerebellum is expanded, areas of Pax6 expression is expanded
accordingly. Furthermore, Pax6 transcripts are located in the gray matter (for example, see figure
3.10.g) where the nuclei are undertaking active mitotic activities. Pax6 is therefore implied in the
proliferation of the cerebellum neuroepithelium. Developmental expansion is also seen in the
presumptive secondary germinal epithelium in the cerebral cortex and in the superior colliculus; both
undertake highly mitotic activities. This also suggests a role of Pax6 in cellular proliferation.
3.3.6 Conservation and deviation of Pax6 functions as supported by comparing data across
species
As mentioned in sections 3.1.1 and 3.1.4, the expression profiles and mutant phenotypes of Pax6 and its
orthologous genes will be compared in order to shed new insights on Pax6 functions. Here, I list all
Pax6 gene expression profiles published so far and my data obtained in this study in table 3.1 (see next
page). Readers are reminded that the published information may not describe every organ listed here.
Thus, those organs that are listed as information 'not available' in table 3.1 do not necessarily mean
non-expression, simply that no information regarding these regions is available. In the following
sections (3.3.7.1 - 3.3.7.5), I will discuss comparison across species in different organs.
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3.3.6.1 In the eye
In the eye, all the species listed in table 3.1 (see preceding page) exhibit Pax6 expression. This
conserved expression of Pax6 in the eye across species does indicate that Pax6 has a major role in eye
formation and this role is already specified in early period of phylogenesis. The importance of Pax6 in
eye development is further supported by the absence of eye in loss-of-function mutations in the human
(Ton et al., 1991), the mouse (Hill et al., 1991), and the Drosophila (Quiring et al., 1994).
Furthermore, in the Drosophila ey2 mutation (another lack of eye mutation similar to the ey mutation),
the ey gene expression was found absent, futher suggesting that ey gene is directly involved in the
development of eye (Quiring et al., 1994). Despite the different morphology and the mode of eye
development in the Drosophila as compared to that in the vertebrates, the most important and the
strongest evidence comes from the artificial production of ectopic eyes by targeted expression of the ey
gene (the orthologous Pax6 gene in Drosophila) on the wings, the legs, and the antennae (Haider et al.,
1995).
By comparing Pax6 expression in the eye region across species, however, some minor differences are
found. For example, one difference exists in the pigmented retinal epithelium. Chick Pax6 is expressed
persistently in the pigmented retinal epithelium even at later stages (stages 17-18) (data in chapter 4),
whereas mouse Pax6 expression appears at early stages but becomes absent by around day 15.5 p.c.
(Grindley et al., 1995) and similar developmental restriction is observed for Xenopus Pax6 expression
(Hirsch and Harris, 1996). In the quail (Martin et al., 1992; Carriere et al., 1993) and in the human
(Ton et al., 1991), however, Pax6 expression in the pigmented retinal epithelium have not been
reported. This variation of Pax6 expression implies a transient or dispensable role of Pax6 there,
particularly when the pigmented retinal epithelium is differentiated. The possible transient role of Pax6
in the pigmented retinal epithelium is supported by data from Martin et al. (1992). They reported that
quail neuroretina can differentiate into pigment and lens cells in vitro. Pax-QNR transcripts are found
in the neuroretina and in the lens, but not in the transformed pigmented retinal epithelium (Martin et al.,
1992). Another example of difference exists in the rim of the optic cup where in the chick, the mouse,
and the human, Pax6/PAX6 was found to be most intensely expressed, whereas in the zebrafish (Krauss
et al., 1991; Puschel et al., 1992), the urodele (Rio-Tsonis et al., 1995), and the quail (Martin et al.,
1992; Carriere et al., 1993; Turque et al., 1994), no similar observation was reported. It is possible that
the difference in the rim of optic cup between species may be due to a trend of gain-of-function for
Pax6 through the evolution of higher vertebrates. This is supported by mutant phenotypes, for that in
the human AN mutation, the iris in the rim of optic cup is absent (Ton et al., 1991), whereas in the
mouse there is no report regarding the absence of iris in the Small eye mutants. This difference in the
mutant phenotypes between the mouse and the human implies that Pax6 is more crucial in the iris of the
human than in that of the mouse. This deviation of Pax6 function is probably gained through evolution.
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3.3.6.2 In the nose
In the nasal region, Pax6 is expressed in the nasal epitheliumin the chick (data in chapter 4) and the
mouse (Walther and Gruss, 1991; Grindley et al., 1995). In the mouse, Pax6 is also expressed in the
higher olfactory centres (this study). In the zebrafish (Krauss et al., 1991; Puschel et al., 1992) and the
human (Ton et al., 1991), the olfactory bulb is found expressing Pax6. In the nematode, although no
olfactory organ can be specified, many head neurons are expressing Pax6 (Chisholm and Horvitz, 1995;
Zhang and Emmons, 1995). This consistent involvement of Pax6 in the olfactory system in different
species suggests a conserved role of Pax6 there through evolution.
3.3.6.3 In the brain
In the brain, Pa.td-expressing domains exhibit interesting deviations across species. In the nematode,
Pax6 expression is observed in a broad domain across the developing head (see table 3.1). The broad
expression domains in the brain appear to have narrowed through evolution. In the brain of
Drosophila, ey gene expression was found in a bilaterally symmetrical pattern without segmentation; in
the spinal cord of Drosophila, ey gene is expressed in every segment of the ventral nervous system
(Drosophila has dorsal nervous system and ventral nervous system; both are a part of its central nervous
system) (Quiring et al., 1994; Haider et al., 1995). Whereas, in the zebrafish, pax[zf-a]expression in
the brain is confined within the forebrain and hindbrain and the transcripts in the midbrain are excluded
(Krauss et al., 1991; Puschel et al., 1992). Comparable exclusion of Pax6 expression in the midbrain
persists in the Xenopus, the quail, the chick, and the mouse; but Pax6 remain expressing in the forebrain
(see table 3.1 and references therein). In the human, PAX6 transcripts were not detected in the
forebrain (Ton et al., 1991), suggesting that a further restriction of regional functions in the forebrain
could have happened through the evolution of higher mammals.
What does the restriction of Pax6 expression in the brain through evolution imply ? Could the
restriction through evolution in the brain imply a role of Pax6 in the embryonic segmentation as
suggested for many homeobox-containing genes (Holland, 1988; Gaunt et al., 1988) ? Since no
homeotic transformation was found in Pax6 mutations across species, it seems not to be the case.
Instead, the restriction of Pax6 expression in the midbrain (as found in the fish, chick, and mouse) and
the forebrain (as found in the human) through evolution may reflect the changing roles for this gene
from in primitive species 'for specification of sense-organ identity' as described by Zhang and Emmons
(1995) or for 'head-region specification' as described by Chisholm and Horvitz (1995) to later become
involved in more specilized and localized functions such as the eye and nasal formation or even the
migration of neuroblasts as suggested by Schmahl et al. (1993) or proliferation of neuroblasts as
suggested in this study.
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Another deviation of Pax6 expression in the brain across species is found in the rhombomeres. In the
zebrafish (Krauss et al., 1991; Puschel et al., 1992) and the mouse (Walther and Gruss, 1991; Stoykova
et al., 1996), Pax6 expression extends from the first rhombomere (rl), whereas in the chick the most
anterior presence of Pax6 transcripts is in rhombomere 3 (r3) (Li et al., 1994). This deviation may
reflect the dynamic nature of Pax6 expression in the spinal cord. It may also reflect that the identity of
r3 in the chick probably corresponds, through evolution, to rl in the mouse and the zebrafish.
3.3.6.4 In the spinal cord
Based on all available information in the vertebrates so far, Pax6 is consistently expressed in the spinal
cord (see table 3.1). In the Drosophila, ey is expressed in every segment of the ventral nervous system
(Quiring et al., 1994) that is presumably comparable to the spinal cord in the vertebrates. Particularly
interesting is that in the chick Pax6 expression in the spinal cord appears to be coordinated with
somitogenesis and appears to be more intense in the areas flanked by somites (data in chapter 4); this is
not observed in other species. The conservation of Pax6 expression in the vertebrate spinal cord
indicates that Pax6 functions there.
3.3.6.5 In the pituitary and pancreas
As listed in table 3.1, Pax6 expression is conserved in the pancreas in four species and in the pituitary
in two species according to the information so far available. However, no abnormality in the pituitary
or the pancreas have been reported as one part of Pax6 mutant phenotypes. This does not necessarily
indicate that Pax6 has no function in the pituitary or pancreas, for that it is unlikely that a gene is
persistently expressed in a specific site through evolution without any function there. In fact, in gene
knock-out experiments in the mouse, many regions where a gene is intensely expressed do not appear to
exhibit abnormalities. Several arguments have been advanced to explain the lack of a striking
phenotype when so-called important genes have been disrupted (Ferguson, 1994). For example, the
gene may function in the specific region in a redundant way and is easily compensated by other genes.
Alternatively, maternal factors that pass across the placenta may compensate for the knock-out
functions. Both can constitute parts of the reason why the pituitary and the pancreas is not apparently
affected by Pax6 mutation. The pituitary is one part of the hypothalamus-pituitary-gonadal axis that
regulates neuroendocrine activities of reproduction. In the hypothalamus, the paraventricular nucleus
and supraoptic nucleus constitute the major source of neurons that synthesize the neurohormones
vasopressin and oxytocin and send axons to the posterior lobe of the pituitary, i.e. the neurohypophysis
(Knobil et al., 1988); both nuclei are Favb-exprcssing. The paraventricular nucleus has a greater
variety of connectivity and cell types than does the supraoptic nucleus and accordingly is also involved
in control of anterior pituitary (Armstrong, 1985) where the gonadotropic hormones are released. The
heterozygous (Sey/+) mice for Pax6 mutation are generally poor in breeding performance than
wildtypes (Douglas Scott, personal communication). Furthermore, Pax6 mutation in the nematode
143
exhibits defects in gonadogenesis in the male tail and the identity of one pair of male-specific genital
sensilla (a simple male reproductive sense organ) is transformed (Chisholm and Horvitz, 1995; Zhang
and Emmons, 1995). It is therefore possible that Pax6 mutation may affect directly the function of
pituitary and indirectly affect reproductive performance.
3.3.6.6 In the salivary gland
In the Drosophila, ey expression is seen in the salivary gland, whereas in the same area no expression is
found in other species, except in the mouse whose tubules of serous gland are clearly Aax6-expressing
(see figure 3.8.c). However, information about Pax6 expression in other species is not reported so far.
This aspect of Pax6 is worthy of further investigation.
3.3.6.7 Deviations of Pax6 expression and mutant phenotypes found in the head neural crest cells
and in the upper incisor teeth
In the rat homozygous for the Small eye mutation, failure of Pax6 function leads to impairment of
neural crest migration in the midbrain region, whereas Pax6 transcripts are not detected in the neural
crest cells in the wildtype rats (Matsuo et al., 1994). Neither in the mouse nor in the chick, is Pax6 ever
reported being expressed in the neural crest cells. In the mouse homozygous for the Small eye
mutation, a shorter snout is observed (Hill et al., 1991) and a cartilaginous rod-like structure that
projects from the rostral part of cranial base is found (Kaufman et al., 1995). Most of the cells in the
snout and rostral cranial base are contributed by neural crest cells (Le Douarin, 1981; Noden, 1986; see
section 1.7). Thus, they are not Pox6-expressing. In the mouse homozygous for the Small eye
mutation, supernumerary upper incisor teeth (usually one or two) is found in the premaxillae area
(Kaufman et al., 1995). The area of upper incisor teeth is not Pax6-expressing either. Then, why are
abnormalities found there ?
Pax6 mutation must affect those areas in an indirect way or during very early stages of embryogenesis.
In the mouse, the earliest presence of Pax6 transcripts are found at day 8.0 p.c. in the presumptive
forebrain and hindbrain (Walther and Gruss, 1991). By day 8.0 p.c., the head neural crest cells are still
at premigratory stage (Serbedzija et al., 1992). This gives the opportunity for Pax6 transcripts to affect
the premigratory neural crest cells. Osumi-Yamashita et al. (1994) reported that the lateral edge of the
prosencephalon produced crest cells which migrated to the frontonasal mass. On the other hand, cells at
the anterior neural ridge in the prosencephalon contributed mainly to the head epithelium including the
nasal placode (Osumi-Yamashita et al, 1994). Both the lateral edge and the anterior neural ridge are
Pax6-zxpressing areas at 8.0 days p.c. (Walther and Gruss, 1991). The frontonasal mass constitutes a
high proportion of the total mass of the snout. It is therefore possible that the failure of Pax6 function
can deter the migration of neural crest cells from the lateral edge of the prosencephalon toward the
frontonasal mass, in a way comparable to the impaired migration of crest cells in the midbrain found in
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the rSey/rSey mouse. Thus, a shorter snout is found. Alternatively, the loss of Pax6 function may
detour neural crest cells toward the premaxillae area instead of the frontonasal mass. Thus,
supernumerary upper incisor teeth are induced by the astrayed crest cells. One may also speculate that
the failure of nasal placode formation in the Sey/Sey mouse is presumably caused to some extent by the
failure of neural crest contribution from the anterior neural ridge of the prosencephalon.
Pax6 may not be directly involved in the contribution of neural crest cells in the affected areas where
Pax6 transcripts are not present in the wildtypes. In the premaxillae area, for example, no obvious
tissue mass reduction comparable to that of the snout is reported. Therefore, it is possible that the
formation of the supernumerary upper incisor teeth as well as the rod-like structure in the Sey/Sey
mouse is not due to abnormal neural crest migration. Instead, Pax6 may indirectly affect its
downstream genes when it is mutated and leads to local abnormalities that are not necessarily located
within its expression areas. This possibility will be further investigated in chapter 5.
3.3.7 Pax6 expression in relation to neuromeric regionalization
Pax6 expression generally respects neuromeric regionalization in both the prosomeres and
rhombomeres (Stoykova and Gruss, 1994). In the dorsal border of pi (prosomere 1) and
mesencephalon, transcripts of Pax6 do not trespass the mesencephalic side (Stoykova and Gruss, 1994;
Stoykova et al., 1996; Mastick et al, 1997). In the ventral border of rl and mesencephalon, Pax6
transcripts do not trespass the mesencephalic side, either (Stoykova et al., 1996). While Pax6
expression in relation to neuromeric regionalization is considered, it should be noted that the earliest
mouse Pax6 transcripts in the brain are detected by day 8.0 p.c. (Walther and Gruss, 1991). The first
immunoreactive neurons (using neuron-specific class III (3-tubulin as a marker) appear at day 8.5 p.c.
and the first axons appear at day 9.0 p.c. (Easter et al., 1993). The prosomere formation is defined at
around day 10.5 p.c. (Puelles and Rubenstein, 1993). Pax6 has a potential involvement in ail the events
that occurs after its expression.
Neuromeres are centers for the proliferation, migration, compartmentation, and differentiation of
neuroblasts (Kallen, 1965; Layer and Alber, 1990; Fraser et al., 1990; Fidger and Stern, 1993;
Brigbauer and Fraser, 1994). What are the possible roles that Pax6 is likely to play in respect of
neuromeric regionalization ? Pax6 is involved in the correct regulation of diencephalic precursor
proliferation (Warren and Price, 1997). Pax6 is also likely involved in the proliferation of neocortical
neuroepithelium, cerebellar neuroepithelium and the spinal cord ventricular layer, as suggested by
expression patterns. However, in the diencephalon and spinal cord, the role of Pax6 in proliferation
seems more transient as compared to that in the telencephalon and cerebellum. This is implied by the
fact that at later stages Pax6 transcripts remain in the whole neocortical neuroepithelium and cerebellar
primordium, whereas, in the ventricular layer along the longitudinal axis of the spinal cord, Pax6
transcripts almost disappear by around day 16.0 p.c. as illustrated by figure 3.7.a. Instead, by day 16.0
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p.c., Pax6 expression in the spinal cord is concentrated in the intermediate and marginal zones where
neuroblast proliferation has not occurred (see figure 3.7.e). In the diencephalon, only discreet regions
(the dorsal and ventral branches of expression areas illustrated in figure 3.7) are Pax6-expressing by
day 16.0 p.c.. Furthermore, Pax6's role in regulating proliferation is in agreement with the fact that
after day 16.0 p.c. the volume of the diencephalon and of the spinal cord is not increased as much as
that of the telencephalon and of the cerebellum.
Instead of being persistently involved in the proliferation of neuroblasts in the diencephalon, Pax6 plays
multiple roles in boundary formation, regional patterning, neuron specification and axon guidance; all
the roles presumably are playing parts or as parts of the processes in the establishment of neuromeric
identity and they are supported by mutant analyses (Stoykova and Gruss, 1996; Warren and Price,
1997; Mastick et al., 1997). Pax6 may distinguish the identity of pi from mesencephalon by
controlling expression of some markers such as Lim-1, Gsh-1, and Pax6 itself in the caudal
prosencephalon (Mastick et al., 1997). When Pax6 is not functional, expression of the three markers
disappear and the pi/mesencephalon boundary is lost. The result is an anteriorization of the expression
of Dbx (a mesencephalic marker) in the supposed pi region (Mastick et al., 1997). As no evidence of
pi deletion is found, the identity of pi is apparently transformed to that of mesencephalon when Pax6 is
mutated. The involvement of Pax6 in establishing pi identity is probably not via building the border of
expressing and non-expressing areas, as suggested by the sharp border between pi and mesencephalon
in wildtype brains. The strips of low cell density that correspond to pl/p2 and p2/p3 borders exist in
wildtype brains (Warren and Price, 1997) and they are within the Pax6-expressing area without obvious
downregulation (Mastick et al., 1997). In the mutant mouse brain homozygous for Sey mutation, the
strips of low cell density are lost together with the expression of Lim-1,Gsh-1, and Pax6 itself in the pi
region, while the pl/p2 and p2/p3 boundaries remain expressing truncated Pax6 transcripts (Warren and
Price, 1997; Mastick et al., 1997). Thus, unless the regulation of boundary formation for
pi/mesencephalon differs from that of pl/p2 and p2/p3, border-building of Pax<5-expressing and non-
Pax6-expressing areas is unlikely to help establish pi identity.
Interneuromeric cells are known to divide at a lower rate than those in neuromeres (Martinez et al.,
1992). Pax6 could directly or indirectly inhibit proliferarion of interneuromeric cells to form the strips
of low cell density observed by Warren and Price (1997). Alternatively, Pax6 could direct formation of
transversely oriented axons or glial cells like those observed in the rhombomeric boundaries (Lumsden
and Keynes, 1989; Keynes and Lumsden, 1990). The axons or glial cells can exert a cell migration
limitation that has been found in the pl/mesencephalon boundary in the chick (Figdor and Stern, 1993).
This possibility is supported by the co-increase of vimentin (a marker for radial glial or glial precursors)
and Pax6 expression in the chick rhombomeric boundaries (Heyman et al., 1995).
Pax6 could also be important for axonal projection by means of neuromeric regionalization. Small eye
mutants exhibit errors in tpoc (tract of the postoptic commissure) axon pathfinding (Mastick et al.,
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1997). The errors include axon projections that are too far into cerebral vesicle and far more axons that
form loops, as well as the failure of tpoc caudal projection to project from p3 into p2 in contrast to that
pass as far as pl/mesencephalon boundary in the wildtypes (Mastick et al., 1997). All the errors may
well have resulted from the failure of neuromeric regionalization that characterizes local identity at both
the cellular and molecular levels in which Pax6 is involved.
3.3.8 Conclusion: Pax6 functions in a multiple, tissue-dependent and stage-dependent way during
development
The expression and mutant phenotypes discussed in previous sections allows a conclusion that Pax6
functions in a multiple, tissue-dependent and stage-dependent way during embryonic development. The
first line and the most ancient Pax6 function could be for the proliferation and specification of head
regions, including the establishment of sense-organ identity in the developing CNS and in the head
surface ectoderm. More specific and localized lines of functions for Pax6 was developed through
evolution. In the brain, neuroblast migration, axon projection and pathfinding has likely added to Pax6
functions in higher animals. Likewise, the roles of Pax6 in eye development have likely evolved from
establishing an optic nerve forming bias to more specilizd functions such as lens and optic cup
differentiation. These more localized and specilized functions of Pax6 are reflected by the
developmental restrictions observed in Paxd-expressing areas in different species. However,
developmental restriction does not deviate Pax6 function as a master visual or olfactory gene. The
extensive presence of mouse Pax6 transcripts in the higher visual and olfactory nervous systems as well
as external and accessory apparatuses demonstrated clearly the conserved function of Pax6 for the two
systems.
Pax6 functions may also deviate in different tissues through evolution, as suggested by the not-so-
conserved expression data in the pituitary, salivary gland and pancreas, although in the same species,
Pax6 could have slightly deviated functions in different tissues. For example, mouse Pax6 is suspected
to be more involved in the proliferation of neocortical neuroepithelium after day 16.0 p.c. as compared
to that in the diencephalon. More obvious examples can be found in comparing Pax6 function in the
lens or cornea with that in the brain. Pax6 functions may also differ according to developmental stages,
as suggested by expression data in the retina and in the lens.
To carry out such multiple functions with a variety of tissue- and stage-dependence, Pax6 must be
posed in a complicated hierachy of gene activities with upstream and downstream genes that
presumably are different according to tissues and gestational stages. Some genes in the hierachy are
beginning to emerge. This is to be discussed further in chapter 5.
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Keys for mouse Pax6 expression
1. third ventricle
2. neocortical neuroepithelium
3. neuroepithelium in the trunk spinal cord
4. neuroepithelium in the cervical spinal cord
5. medullary neuroepithelium
6. surface ectoderm covering optic vesicle region
7. neuroepithelim enclosing optic vesicle
8. hypothalamic neuroepithelium
9. telencephalic neuroepithelium
10. neuroepithelium of middle cervical spinal
cord
11. neuroepithelium of ventral cervical spinal
cord
12. second branchial arch
13. mandibular component of first branchial arch
14. neuroepithelium forming optic cup




18. border between ventral pontine
neuroepithelium and dorsal medullary
neuroepithelium
19. optic stalk formation
20. pituitary primordium
21. trigeminal (V) ganglion
22. fourth ventricle
23. neuroepithelium in the ventral medulla
24. neuroepithelium in the border of ventral pons
and dorsal medulla




28. pigmented retinal epithelium
29. amygdala (differentiation field)
30. neocortical neuroepithelium
31. ventricular layer of medullary
neuroepithelium
32. otic vesicle
33. olfactory (nasal) epithelium
34. lateral ganglionic eminence
35. future piriform cortex
36. neuroepithelium in the ventral pons
37. conjunctiva
38. corneal epithelium
39. optic stalk [optic nerve (II)]
40. hypothalamic neuroepithelium in connection
with optic stalk
41. pontine neuroepithelium
42. neuroepithelium of pallidum
43. cingulate cortex neuroepithelium
44. inferior sagittal dural venous sinus
45. pallidal neuroepithelium











56. anterior tectal neuroepithelium
57. pretectum
58. posterior thalamus (intermediate/marginal
zone)
59. anterior thalamus (ventricular zone)
60. aqueduct
61. pineal recess
62. floor of aqueduct
63. primitive habenulopeduncular tract formation
64. tegmentum
65. roof of ventral part of mesencephalon
66. lateral ventricle
67. roof of neopallial cortex
68. rhombic lip
69. choroid plexus in the fourth ventricle
70. posterior thalamus (ventricular zone)
71. medulla oblongata
72. choroid plexus in the lateral ventricle
73. midbrain reticular formation
74. motor neuron column in the medulla
75. superior central raphe nucleus (pontine)
76. infundibular recess
77. piriform cortex
78. frontal part of telencephalic vensicle
79. caudopallidal angle
80. ganglionic eminence
81. infundibulum (future pars nervosa)
82. vestibulocochlear ganglion (VIII)
83. medullary raphe
84. junction between fourth ventricle and central
canal of spinal cord
85. extrinsic ocular muscle
86. first evidence of primitive eyelid
87. ventral telencephalic neuroepithelium
88. cervical spinal cord
89. medial ventricular zone of cervical spinal
cord
90. primitive nasopharynx
91. vomeronasal organ (Jacobson's organ)
92. nasal cavity
93. primordium of first upper molar tooth
94. Meckle's cartilage
95. pinna of ear
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96. motor neurons
97. upper cervical dorsal root ganglion
98. rim of optic cup
99. primary lens
100. proliferative zone of anterior germinal lens
epithelium
101. future inner part of neural retina
102. tongue
103. anterior lens epithelium
104. external granular epithelium of pons
105. posterior neocortical neuroepithelium
106. internal capsule
107. surface of medulla oblongata
108. cerebellar primordium
109. anterolateral wall of thalamus
110. lateral piriform cortex
111. rhinencephalic neuroepithelium
112. ventricular neuroepithelium of
rhinencephalon
113. rhinencephalic neuroepitheiium (site of
future olfactory bulb projection)
114. optic chiasma
115. saccule
116. glossopharyngeal (IX) ganglion
117. wall of third ventricle (ventricular zone)
118. wall of third ventricle (intermediate zone)
119. subcommisural organ
120. pineal primordium
121. presumptive external germinal layer of
cerebrum
122. cerebellar primordium injunction with
external granular layer of pons
123. external granular layer of cerebellar
primordium
124. squamous part of occipital bone
125. cerebellar germinal trigone
126. hypothalamic differentiating field
127. anterior premedullar neuroepithelium
128. lateral recess of fourth ventricle
129. paraventricular nucleus
130. fields of Forel
131. zona incerta
132. intermediate thalamic neuroepithelium
133. pontine subventricular zone
134. reticular nucleus
135. central canal of anterior spinal cord
136. choroidal fissure
137. hippocampal neuroepithelium (Ammon's
horn)
138. dorsal lateral geniculate nucleus
139. supraoptic nucleus
140. lateral hypothalamic differentiation field
141. bed nucleus of strial terminalis
142. medial forebrain bundle
143. stria medullaris
144. medial amygdala
145. dentate gyrus neuroepithelium
146. strionuclear neuroepithelium
147. nasal septum
148. lateral preoptic nucleus
149. lateral amygdaloid nucleus
150. stria terminalis
151. sign of external germinal layer formation
152. lateral preoptic region (anterior
hypothalamus)
153. lateral thalamus (anterior)
154. oropharynx
155. third ventricle (thalamic and hypothalamic)
156. cartilage primordium of sphenoid bone
enclosing optic chiasma
157. lateral posterior nucleus
158. intermediate thalamus (differentiation field)
159. anterior pretectal nucleus
160. ventral lateral geniculate nucleus
161. subthalamic nucleus
162. conjunctival sac
163. primordium of right upper molar tooth
164. midbrain differentiation field
165. junction between medial geniculate nucleus
and ventral lateral geniculate nucleus
166. basomedial amygdaloid nucleus
167. red nucleus in tegmentum
168. superior colliculus (deep layer)
169. mammillary neuroepithelium
170. hypothalamus (posterior)
171. lateral deep nucleus (migration)
172. ventral tegmental nucleus (pontine)
173. aqueduct (tegmental and superior tectal)
174. cerebellar neuroepithelium
175. magnocellular reticular nucleus
176. cochlear nucleus (differentiation field)
177. pons
178. basiocciput
179. thymus (right lobe)
180. entrance into trachea
181. thyroid
182. entrance into esophagus
183. premedullary neuroepithelium
184. body of cervical vertebra
185. scapula
186. tranverse processes of cervical vertebra
187. lung
188. cervical vertebra




193. primordium of incisor teeth
194. tubules of serous gland
195. nasal epithelial tissue
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196. olfactory bulb
197. rhinencephalon (differentiation field)
198. primordium of lower molar tooth
199. medial septum
200. lateral migratory stream
201. external nuclear layer of retina
202. external plexiform layer of retina
203. internal nuclear layer of retina
204. ganglion cell layer of retina
205. nerve fiber layer of retina
206. anterior chamber
207. eyelid
208. internal surface of eyelid
209. nerve pathways outside of brain
210. junction between ventrolateral and
dorsolateral nuclear complex
211. intermediate zone of lateral telencephalic
neuroepithelium
212. epithalamic recess
213. amygdaloid fork of lateral ventricle
214. medial geniculate complex
215. ventrobasal nuclear complex
216. cerebral peduncle
217. anterior pons (differentiation field)
218. trigeminal boundary cap
219. junction between medial geniculate nucleus
and red nucleus
220. superior olivary nucleus
221. superior tectal neuroepithelium
222. superior colliculus
223. aqueduct (superior tectal/tegmental)
224. lateral vestibular nucleus/ventral tegmental
nucleus
225. pontine reticular formation
226. anterior pontine neuroepithelium
227. isthmus
228. medullary reticular formation
229. cerebellum
230. aqueduct (inferior tectal)
231. neuroepithelium of olfactory bulb
232. anterior olfactory nucleus
233. cartilage primordium of sphenoid bone
234. fornix
235. diagonal band (vertical limb)
236. diagonal band (horizontal limb)
237. intermediate hypothalamic neuroepithelium
238. endopiriform nucleus
239. lateral hypothalamus (differentiation field)
240. pituitary cells within sella turcica
241. trigeminal ganglion (V) in Meckel's cave
242. ossification within cartilage primordium of
hypophyseal fossa (sella turcica) of sphenoid
bone
243. junction of reticular nucleus and ventral
lateral nuclear complex
244. hippocampal neuroepithelium near dentate
gyrus
245. lateral habenular nucleus
246. aqueduct (pretectal)
247. dorsal periaqueductal gray
248. cerebral peduncle lateral to trigeminal motor
nucleus
249. trigeminal motor nucleus
250. cerebral peduncle lateral to superior olivary
nucleus
251. principle trigeminal nucleus
252. facial motor nucleus
253. glomerular layer of olfactory bulb
254. external plexiform layer of olfactory bulb
255. mitral cell layer





261. third ventricle (hypothalamic)
262. Purkinje cell layer of cerebellum
263. germinal epithelium of inferior olive
264. inferior olive
265. internal plexiform layer of olfactory bulb
266. basal ganglia
267. insular cortex






274. stria medullaris leading to fimbria
275. optic tract
276. epithalamus (pineal primordium)
277. parahabenular nucleus
278. external surface of pons
279. junction between tegmental reticular
formation and hypothalamus
280. aqueduct (tegmental/pontine)
281. internal plexiform layer of retina
282. superior central raphe nucleus (isthmus)
283. taenia tecta
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Figure3.1Mo sPax6expre sionrepresent dbyinsituhybridizationnt su sections.Theplaneofcuttingarowints emat cdiagr m( ir gh panelofthisge),(a).Acoronalsectioninep st riorhe dreg td y9.5 p.c.Pax6expressionise nnthn uroepithel umenclosingto ticv si le (no.7)andithesurfaceect d rmcov ringoptivesicler g on( .6).P x6 transcriptsrelsodetect dihn uroepith liumtc rv calspinrd(n . 4)andintheru kspinalcor( .3)b)Aoro lsectionnte iorhea regionatd y9.5p.c.P x6expressionisetectednthel ncephalic neuroepithelium(n .9)andthneuroepitheliumi midd ec v calspinar (no.10)NPax6expressionisfoundthecondbranchialrch2) themandibularcomponentffirstbranchialarch(no.13)Atr sverse sectionintheheadr giatd y10.0p c.P x6expressiont neocorticaleuroepitheliumithelence ha icr gion(n .2),prim tiveopt cup(no.14),thesurfaceect dermov ringoptivesiclr g on6),and thebord retwe nventralpo tineneuro pitheliuma dd salmedul ary neuroepithelium(n .18)Thexpr ssionapp arstxt ndv lum medullare(no.17)Notethatash rpdem rc tionb tweeexpr ssingndno - expressingareacanbseentthhypothalamicneuroepitheliumitventral diencephalon( o.15)Alscalebarsrep esent0.1mm
(a) <-\>) Cc)
 
Figure3.2Mo sPax6expre sioninthheadregiontd y11.0p c.present d
byinsituhybridizationonti suesections.Theplanefcut i garhownit schematicdiagramonthrighpa elft ispa e,( )ndbr nsverse sectionsondiff re tlevelsfthheadregion,(c)ima n fiedvi wt telencephalicregioni(a),d)smagnifiedvi wothpont ned medullaryregionin(a).P x6expressiosnithneocortica neuroepithelium(n .30),thop icstalkformation.19tdifferentia ion fieldoftheamyg ala(no.29),pigmentedretinalpi h lium8topt c cup(no.27),thelensprimordium6 ,tpituitaryrim rdium( .0 ventralmedulla(no.23),a ditheneuroepitheliumbord rfv n r lp s anddorsalmedulla(no.24)P x6transcriptsrel oseeniholfac ory epithelium(no.33)andithventricularlayeroftmed laryn uroepitheli (no.31)Itheventralelenceph lon,aslimtripofPaxfi-exp essi gc llsanb tracedowarhlateralg nglioniceminence(no.34),i.frp i tAB asindicated(c).Inthr ombenc phalon,symmetric'comma-shape'areasof expressiona ese ,i. .frompointC(h adf'com a')tpointD( l 'comma')asindicated( ).Alls aleb rrepres nt0.1milength
 
Figure3.3Mo sPax6expre sioninthheadregiontd y12.0p c.epresented
byinsituhybridizationonti suesections.Thepla fcu i ghown schematicdiagramonthrightpa elfisg ,( )itr nsversesection headregion,(b)ancrema nifiedviewstoshowhelencephalicr theeyeregion.Inel ncephalon,Pax6expr ssioniseocorlical (no.2)neuroepithelium,cingulatortex43 ,andithsubicular neuroepithelium(n .50)Pax6transcriptscanbtra edhroughju ctionf striatumandpallid(no.46)tow rdtefhlidalneu epi heliumwhe e somePax<5-expr ssingc llsareggregat d(n .4 )Itheyregion,x6 expressioncanbl arlyseinthuralretin( o.47),pigm tedi epithelium(no.28),cornealepit li3thopt csta k9)A demarcationb tweeexpr ssingndnon-expressinasithh asurfac ectodermiseennthconjunctiva( .37)Ihypothalamicneuroepithelium inconjunctionwiththeop icstalk( o.40),parti ularlyar undrec ss (no.48),Pax6tr nscriptsrelsodetected.Thpituitaryrimo diumi Pmt6-expressing(no.20)Them dullaryneuroepithelium5alsocontain Pax6transcripts.Scaleb rs:i( ),0.1mm;b)nd.05.
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Figure3.4(atoh;becontinu dthfoll wingpag )MousPax6 expressioninthh adregionatd y13.0p c.r pres ntedbysituhybridiz t n onserialtransverseti uesection .Thv ntr lidfeachtionp int downwards.Theplaneofcuttingars owni chematicdiagr m(tright panelofthisg ).Sectionsfr mhareserialectionot pfad. Pax6expressionisdet ctednthlaminat rm alis( o.54i ),anteriorct l neuroepithelium( .56ib),pretec um(n7),ost riorthalamus8nd anteriorthalamus(no.59)seebndc)Tpi ealrec ss( .61),tprimitive habenulopedunculartractform tion( .63),andhet gm ntumn4)rls Paxb-expressing(s edande).Asthlev lsoftr nsverplan sgofu th r down,Pax6tr nscriptsreseeihrooffneopallialc rt x(n .670 andinthereaspost rior(sh wnf),later lig),ndanteriorht sulcuslimitant(indicatedbyasteriskif-h).P x6expr ssionthneoco ical neuroepithelium(n .30ih)scontinuouswi hinpartsfthamygdala differentiationf ld(no.29)aextendstowarhpithalamu(indic teby arrowsinh).Ithemidbrainndhindb ainregio ,Pax6exp essionsde cte
inthetegmentum( o.64f),r ombiclipwh recerebellarprimordiumis formed(no.68i),thmidbraineticularformation( o.73ihandt medullaoblongat(n .71ih).N tethatPax6expr ssionse n choroidplexus(n .69igand.72h).Allscaleb rsre r sent0.4mm length.
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Figure3.5(atoh;bec ntinu dhfoll wingpag )MousePax6 expressioninthheadregionatd y14.0p c.repres n edbysituhybridizati onserialtransversei uesection .Thv ntr lsidpointdownwa d . planesofcuttingarshowninsc emat cdiagr m(othrightpanelfis page).Intopfhhe d,Pax6expressionise ntlaminaermi alis(n . 54),anteriortectalneuroepithelium(n .6),pr tec um7dos rior thalamus(no.58)indb).Ast eransverseplaneis ightlylow r,P x6 transcriptsreseenihpin alprimordium(n .120d),tp itive habenulopedunculartractform tion( o.63id,),andhet gm ntum4 d).Inthetelencephalon,Pax6expr ssionisfoundwholeneo rtic neuroepithelium(n .2i ),incl d ngthposteriora ts105h).Pax6 expressionisalsdet ctednthhalam cn uroepitheliumu roundings lc s limitans( nd c tedbyasterisksif,g,h)ndthamygdaladifferen iationl (no.29ih).Ithemidbrainandindbra ,P x6transc iptsrseen midbrainreticularformatio(no.73),thehombiclip.68 ,teg entum, (no.64),theexternalgranul rpi heliumofpo s( .104andtmed ll oblongata(n .71)Allscalebarsrep esent0.5mmile gth
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Figure3.5(itop)MousPax6expre sioninhheadregiontd y14.0c.I thediencephalon,Pax6expressionisnthfloorfh lamus,includ g anterolateralwall(n .109ij),buntheinternc psulo.6)i,. Intheamygdaladifferentiationf l ,P x6transcriptsrouni piriform (no.77im)andthelateralpiriformco t x( .110)Pax6slso expressedinthr inenc phalon(nos.Ill,112),trhine lic neuroepitheliumwh rethfut rolfactorybulbproj s(n .113i ),andt pituitaryrimordium(n .20i1,,)Ithemidbrain,Pax6transcrip sr detectedinthv stibulocochlearganglion(VIII).82),t gmentumo64 thepontineneuroepithelium(n .41),a di midbra nr ticularfor ation 73)(seejandk).Ithhindbrain,P x6i expressedcerebellarprimo dium (no.108ij),aswellthmedullaoblongat5ndn7k;74 1).Inthespinalcord,Pax6r nscriptsrconfi ei medi lvent cul rzo (no.89)andithem torneurons96ip)Ieyer gi n,P x6 expressionisdet ctedntho icchiasma( o.114),orn alepith l um (no.38ip),theopticcup(particularlyrim;see.9nd anteriorle sepithelium(no.103ip)Itho ticstalk,howeveoPax6 expressionisfound(no.39o)Allcalebar pr ent0.5mmle gth.
 
Figure3.6(atoh;bec ntinu dhefoll wingpage)Mo sP x6 expressioninthheadregionatd y15.0p c.presentedbysituybridizatio onserialtransverseections.Thv nt lidepoi tdownwardla sf cuttingareshowninsc ematicdiagram(onthrightpa lfisg ).T viewfromt pfhhead,Pax6expr ssionisirste nnneuroepithelium surroundingthelaminaerm nalis(no.54),anteriort c um6d pretectum(no.57)sb),asw llithneuroepithelius rroundingi d ventricle(no.117a dn8ic)Oslightlylowertransversplanes,P x6 transctiptsredetect dihsubcommissuralorgan(n .119),pin a primordium(n .120),anitheelencephalicneuroe ithelium9s ,d e).Intheel ncephalon,Pax6xpr ssionislse npr sumptiveext rn l germinallayer(no.121i )andthprimitivehabenulopeduncularract formation(no.63ig)Itheidbrain,hin sofPax6expres ionpp ars junctionbetweetegm ntalreticularformatiandhypoth lamus( o.279id), theegmentum(no.64ih),cer b llarprimordiju tionw thex rn l granularlayerofpons(n .122if,),a dthext rn l cerebellarprimordium(n .123if).Ithhi db ain,Pax6expressios detectedinthmedullaryepithelium( o.5h)Alsca ebrasr pres nt0.5m inle gth.
 
Figure3.6(itop;bec ntinuedohfoll wingpag )M usPax6 expressioninthheadregionatd y15.0p c.presentedbysituhybridizati onserialtransverseections.Thv ntr lidepoi tdownwa d .lanef cuttingareshowninsc ematicdiagram(onthrightpa lfisage).I telencephalon,Pax6xpr ssionise nhtelencephalic(n o ortical) neuroepithelium(labelledi3.6.th).Ihdienc phalin,P x6tra scripts areseeninthhypothalamicdifferenti tionf lds( o.126,j)dm y sitesthatc nbpecifiedinthalamicneuroepithelium,incl d ng paraventricularnucle s(no.129),fieldsofF30z aincer1 intermediatethalamicneuroepithel um(n .132),ticularcleus4and choroidfissure(n .136)ee-p)Tinternalcapsule0o,)th thalamusdoesnotexpreP x6,le vingp rfsymmetricalcurb-shapeda ofPax6expressioninthh lamus.Imidbrain,tectum( o.55j), tegmentum(no.64ik).hpontineventricularz133),a dt midbrainreticularfor atio(no.73i1,)areArab-expressing.Int n eP x6 expressionisalsdet ctednthcereb llarprimordium( .108), cerebellarg rmin ltrigone(n .125),hvestibulococh rganglionVIII)i midbrain-hindbrainjunctio .Ithehi d rai ,Pax6isexp essedn or premedullaryneuroepithelium(n .127ij)anthsu faceofmedulla oblongata(n .107ip)Allscalebarsrepresent d0.5mmle gth
 
Figure3.6(qto)Mo sPax6expre sioninhheadregiontd y15 0p c. representedbyinsituhybridization.Thv n rals dpo ntsdownwards. planesofcuttingarshownins ema icdiagr m(othrightpanelfis page),qandsre ialtransversesectionconti uefr mthosipr ing pages,rism gnifiedviewothsquar dar aintermediath lam c differentiationf ldinq.tsamagnifiedviewoheyregion.It intermediatethalamicdiff entiationf l ,Pax6xpr ssi nisnpairof symmetriccurb-shapeda e s,incl dingthparaventricularnucleus( o.129), fieldsofF rel(no.130),dorsallateg niculateucleu( 8r ti ul r nucleus(no.134),lateralhypothalamicn uroepith li m( .40andsupr ptic nucleus(no.139)ThPaA'6-expressingc llsit ereticu aru l uapp arob inconjunctionwiththoseehippocampalneur epithelium(Ammo 'sor ;. 137inr).Asthetransverseplanefu th rlow r(se ,P x6expressionis inthewallofirdvent icleintermediathalamicneuroepith lium(n . 132),bednucleusofstrialtermin li(no.141),medi lfor brainbund( .2), striamedullaris(no.143),andithem i la ygdalbasonr i amygdaloidnucleus(no.166)Pax6islsoexpressedthu faceofpontin area(no.41)ndithsuperiorcent alr hecl us( .75),aswellit medulaandcervicalspinacor(n .71an88)Itheyereg on(s), Pax6tr nscriptsrede ectedithcorn alepithelium(n .38),o ticu (particularlytherime,no.98),n eriorle sepitheli m(no.103).T igment d retinalepithelium(no.28),n rvefib rlayeofr tina.05andthc nnecting
siteofp ictalk(no.39)arclearlyseenwithoutP x6transc ipts.Scalb rs:i qands,0.5mm;inr50pt,12m.
Figure3.6(day15.0p c.;transv rsesections;continued)
Figure3.7(atoh;bec ntinuedothfollowingpag )MousePax6 expressioninthheadregionatd y16.0p c.repres n edbysituhybridiz n onserialcoronalsectio s.Thev ntr lsidp intsdownwa d .pla f cuttingareshowninsc ematicdiagram(onthrighfispage).Acontinuous patternofPax6expressioise n(in-c)fr mthn ocortiealeuro pilhelium (no.2)throughhesubicularare( .50 ,hippocampalarAmm n's)n . 137),dentategyrus(no.45strionucleara ea( .6),dthpallidum 45)towardheamygdaloidr a(no.149ic)Idors lth lamus,aref epithalamicneuroepithelium(wh rtpin lgland,hab u ra dlat habenularnucleusardiffere tiated)exhibi sobviouPax6xpression(no.120i candd).Thisexpressioniseen,fviewedmoraudally,ntlat alpost ior nucleusithposteriorhalam(n .157h)andt nteriorpret ctalnucleus inthepretectum( o.159).Pax6expressionlspp arst r asofst i terminalisa dstriamedull rinheanter orth lamus(nos.143,50c),w asinthesitoflateralpreopticr giontanteriorhypothalamus(no.148i d).Asthecoronalsectionsaviewedfurth rcaudally,P x6expre sioninth intermediatethalamussennsymm tricalbra chedp tt(sedoh).T ventralbranchjoi swithedorsalr chintF reli nneuroep thelium wallofhypothal micthirdvent ic ew ertparaventr cularnucl us(no.129) canbesp cified(inh).Thedorsalbran hst etchesdor ol t rally(se ,tart ng fromthesitefForelianneuroep theliumandtparaven ricularnucl s,h areaofzonincert(n .131)ndthreticularnucl us.34);v ntral branchstret hesve trolaterallytowardhfieldsfF l(no.130)d
differentiationf ldofdorsolateralhypothalamusinclosepr ximityt piriformcortex(n .77)Ithhypothalamica ea,patch sfcellsp ar exhibitPax6expression(notspec ficallylab lled;h).ialsoex r ssed
intheolfactoryepithelium( o.33b)andtv meronasalepitheliu(n91 inb),aswelltheyeregion( otlab lled).Ascalrr pr s t0.5mm length.
 
Figure3.7(itop;becontinuedothefoll wi gpag )M usePax6 expressioninthheadregionatd y16.0p.c.represent dbyinsituhybridization onserialcoro alsections.Theventralsidpointsdownwards.Theplan sf cuttingareshowninschematicdiagra(otherightpanelofth spage). Interestingpatt rnsofPax6expressioninthintermedi tea dposteriorthalamus areseen.Thdor albranch(paraventricular-zonaincerta-reticularnucle s;s thedescriptiononpage171)becomesband-shapednispresentinth differentiationfieldofintermediatethalamusanventrolat ralgeniculatenucl s (no.160i).ConnectionsfPax6-expressi gcellsbetweethdorsalandthe ventralbranchareappa t(inj).Thedors lbranch,i.e.theband-sh ped expressionar a,willbecomesegmented(sk)andfork(se1)asitviewed morecaudallyinthetegmentalarea.Thventral(fieldsofForel-dorsolater l thalamus)branchisalsocha ged;itbecomesapa hofcellinthsubthalamic nucleus(no.161i)a d,sviewedmorcaudally,isgradudimini hedithe posteriorandlateralhypothalamicdifferenti ti gfields(se1).Thpost rio amygdaloidarewherethbasomedialamygdaloinucleus(no.166)islocated remainsexhib tingPa 6expr ssionac nbseinf gur s3.7.ito3.7.n.The deeplay rsofthesup riocolliculusarealsseenexpr singPa 6(no.168io). ThepituitaryandthemammillaryneuroepitheliuarlsPax6-expr ss ngreas (nos.20,169ip).Allscalebarsrepresent0.5mminlength.
 









Figure3.7(ytoe)Mo sPax6expre sioninhh adregiontd y16.0p c. representedbyinsituhybridizationonerialcoro ls ctio s.Thv n rad pointsdownwards.Thelaneofcuttingars wni chematiciagr m( therightpanelofisg ).Sectionsiny,z(fand8rserialect ont t continuousfr mprecedingages,ism g ifievi wothpi alorda e showninz.eamagnifiedvieot pi alcordyP x6ex r ssio isdetectednthprem dullaryn uroepithelium( .183y)anm or neuronsofthec rvicalspino d(s o.96iz,a;lso74y)Hints Pax6expressioncanlsbse ninthventricularzonec rvic li ard (no.89ia)Ithem repost iorspinalc d,P x6r n criptsrdetect theependymallay r(no.190)asw llinterm diatez ne1d marginalzone(n .192)Sc lebars:i nde,20pm;lothers,0.5.
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Figure3.8(atoh;tobecontinuedothefollowingpage)MousePax6 expressioninthheadr gionatd y17.0p.c.representedbyinsituhybridization onserialcor nalsection .Thventralsidepointsdownwards.Theplanesof cuttingareshowninaschematicdiagramontherightpanelofthispage.Inthe olfactoryepithelium(no.33ia,b,ce)andvomeronasalepithelium(no.91ia), alowlevelfPax6expr ssi nisdetected.Pax6expressionisalsoclearly detectedinthtubulesofserousgland(no.194ic)andinthenasalglandular tissueinlateralwallofm ddlmeatus(no.195ic).Inthemaiolfactorybulb (no.196id),Pax6transcriptsareseenanthdistributionofPax6transcripts appearstoconnect,posteriorly,tohatfoundintherhinencephalon(no.197ig) andinthepiriformcortex(no.77ih),aswellasint elater lmigratorystream (no.200i;seethfollowingpage)andtheendopiriformnucleusinthe rhinencephalon(no.Ill)(seeftoh).Pax6transcriptsa ealsodetectedinth taeniatecta(sno.283inf;h).Allsca ebarsrepre ent0.5mminlength.
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Figure3.8(itop;becontinuedhefoll wingpag )MousPax6 expressioninthheadregionatd y17.0p c.repres ntedbysituhybridizati onserialcoronalectio s.Theven alidep intdownwards.lanesf cuttingareshowninc ematicdiagramonthrighpanelfisg .I telencephalicregion,Pax6expr ssi nisnhn o ort calneur epithelium (no.2)andithemedialseptum( .199 ,sw lltla eramigratory streaminthamygdala(no.200)in).Ite esej ,Pax6- xpr ssingc lls remainlocatedinthanteriorepith liumoftle s(no.103),u lre ina thatisdifferentiatedntoamulti-l yer dstructu( os.2015),well thecornealepithelium(n .38)Itpigmentedr ti alepi h ,howev ro detectablePax6tr nscriptisfound(no.28j).expressionld ted intheopticc iasma( o.114h)bu ttopticst lk(n39j). Particularlyinterestingfindingsthd ffe entia gneurar tinwh reP x6 transcriptsppearodistributeivariousconcentrationsdiffer ntlayers.Th presumptiveinternalnucle rlayershowstm stin ensxpre sionhanoth layers(no.203ij).Pax6expressionlsp arpatchofcell ,r sumably neuralc lls,outsidethebrain(s o.209i ,p).Ta t riorthalamic neuroepitheliumitha aofmedi lseptum(n .199ik),tpin a primordium(n .120is)anthehalamicneuroepithelium(i)r main containingPax6transcripts.Th seprev ouslyn tedasofexpressio ,i. .t paraventricularnucleus(no.129),fieldsofF l( 30zonaince t.1), reticularnucleus(no.134),andthdifferentiationf ldsoflat rhypot alamus
(no.140)remaincont ingPax6tr nscriptssformerlydetect dio).Allscale barsrepresent0.5mminle gth. / ?
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Figure 3.10 (a to h; to be continued on the following page) Mouse Pax6 expression in the brain
after birth represented by in situ hybridization on coronal sections.. The ventral side points downwards.
The planes of cutting are shown below in a schematic diagram. Tissues in a to e are at day 1.0 after
birth. Those tissues in f to h are at day 7.0 after birth. At day 1.0 after birth (see a), in the olfactory
bulb, Pax6 expression is seen in the glomerular layer (no. 253), mitral cell layer (no. 255), and internal
granular cell layer (no. 256). Ventral to the olfactory bulb is the rhinencephalon that exhibits Pax6
transcripts in the frontal neocortex (no. 257 in b). In the telencephalon, hints of Pax6 expression
remain seen in the neocortical neuroepithelium (no. 2 in d). The posterior hypothalamus (no. 259) and
the cerebral peduncle (no. 216) also show hints of Pax6 expression, as well as the fields of Forel (no.
130) and cortical plate (no. 258) (see d; e). At day 7.0 after birth, Pax6 expression in the telencephalon
and diencephalon is generally comparable to that seen at day 1.0 after birth (compare 3.10.d, e with
3.10.f). However, in the thalamic area, Pax6 transcripts can be specified in the area of the subthalamic
nucleus (no. 161) and hints of expression are found in the hippocampal neuroepithelium (no. 137) (see
3. lO.f). Particularly interesting changes regarding Pax6 expression found by day 7.0 after birth are in
the superior colliculus, the cerebellum, and the inferior olive. In the superior colliculus, Pax6
transcripts are intensely concentrated in the surface layers of external germinal neuroepithelium (no.
222); this is not observed before birth (see 3.10.h). The cerebellum at this gestation age has been
expanded to cover the lateral and ventrolateral part of the pons and Pax6 transcripts are concentrated in
the convoluted external granular (germinal) neuroepithelium (no. 229 in g; h). Scale bars: in a to e, 5





Figure 3.10 (i to p) Mouse Pax6 expression in the brain after birth represented by in situ hybridization
on coronal sections.. The ventral side points downwards. The planes of cutting are shown in a
schematic diagram below. The tissue in i is at day 1.0 after birth. Those tissues in j to o are at day 21.0
after birth, k is a magnified view of the olfactory bulb shown in j. p is a magnified view on the
proximal end of the optic cup. In the neural retina at day 1.0 after birth, convincing evidence for the
confinement of Pax6 transcripts within the ganglion cell layer (no. 204) and the internal nuclear layer
(no. 203), as well as the absence of Pax6 expression in the pigmented retinal epithelium (no. 28) is
found (see 3.10.p). In the inferior olive at day 7.0 after birth, Pax6 is also intensely expressed (nos. 263
and 264 in 3. lO.i). At day 21.0 after birth (see 3. lO.j, k), in the olfactory bulb, Pax6 transcripts are seen
in the internal granular cell layer (no. 256) and glomerular layer (no. 253). The mitral cell layer (no.
255) as well as the external plexiform layer (no. 254) do not exhibit evidence of Pax6 expression. In
the telencephalon and diencephalon (see 3.10.m, n, o), Pax6 transcripts are detected in the neocortical
neuroepithelium (no. 2), cortical plate (no. 258), stria medullaris (no. 274), fimbria (no. 272), subicular
area (no. 273), and the differentiation field of intermediate thalamus (no. 158). Particularly interesting
is in the corpus callosum (no. 269) and in the deep layers of superior colliculus (no. 168) where Pax6
transcripts are found along with the left-right neuronal projections (see 3.10.o). Scale bars: in i, 6 mm;




gure 3.10 (postnatal; coronal sections; continued)
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Chapter 4: Pax6 expression during chick embrvogenesis and its correlation with lens
differentiation
4.1 Introduction
4.1.1 Aims of this chapter
Aims of this chapter are (1) to investigate Pax6 expression during chick embryogenesis, particularly at
stages relevant to eye formation and (2) to investigate whether Pax6 expression correlates with lens
differentiation in the chick head surface ectoderm. In situ hybridization on wholemount embryos and
tissue sections was used to obtain the expression data. For the correlation of Pax6 expression with lens
differentiation, specified areas of chick head surface ectoderm were cultured in vitro and aB crystallin
as a marker for lens differentiation was detected by immunohistochemistry (Scotting et al., 1991). All
technical details are described in chapter 2 (sections 2.6 - 2.7).
4.1.2 Rationale for determining chick Pax6 expression at later stages of development
During the course of this study, Pax6 expression in the chick was reported by Li et al. (1994), Heyman
et al. (1995), Simon et al. (1995) and Buxton et al. (1997). The latter three reports only looked at Pax6
expression in the rhombomeres. The expression data reported by Li et al., however, did not go beyond
stage 14. Li et al., therefore, did not describe whether Pax6 is expressed in the optic cup, lens, optic
stalk, and corneal epithelium. Furthermore, whether Pax6 is expressed in the olfactory epithelium was
not determined and the precise pattern of Pax6 expression in the definite fore-, mid-, or hindbrain was
not described. The lack of chick Pax6 expression data in these areas makes it difficult to use chick as a
model animal. Thus, the first aim of this chapter is to investigate chick Pax6 expression in the tissues
and at the stages that have not been previously reported, with particular emphasis on the expression of
Pax6 during eye formation.
4.1.3 Rationale for correlating chick Pax6 expression with lens differentiation
When this study was initiated, several lines of evidence suggested that Pax6 is involved in lens
differentiation. For example, Pax6 mutation causes absence of lens as a part of the failure of eye
formation in the mouse (Hogan et al., 1986; 1988). The absence of lens in the Sey/Sey mice does not
result from degeneration or developmental retardation of lens or lentoid cells, but rather from the lack
of lens placodes (Grindley, 1996). It was also found that Pax6 expression in the normal mouse head
surface ectoderm is first in a broad domain and is downregulated and specifically maintained in the
developing lens placode at later stages (Grindley et al, 1995). Furthermore, Pax6-expressing tissues
such as the pineal gland, embryonic retina, iris, and the anterior pigmented retinal epithelium (Walther
and Gruss, 1991; Grindley et al., 1995) are capable of being transdifferentiated into lens (reviewed by
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Okada, 1991). Pax6 expression could therefore be a prerequisite for establishing a lens-forming bias in
those tissues.
The distribution of lens differentiation capacity in the chick head surface ectoderm during early stages
of development had been investigated by Barabanov and Fedtsova (1982). It was demonstrated that, in
addition to presumptive lens ectoderm, the lateral head ectoderm and stomodeal ectoderm of stages 10 -
11 (S10 - S11) chick embryos could differentiate into lens when cultured without adjacent mesenchyme
(Barabanov and Fedtsova, 1982). Chick head surface ectoderm at earlier stages (S4 - 5, S6 and S8)
also exhibited lens forming capacity in broad domains that were not necessarily located within the
presumptive lens ectoderm. Comparison of the distribution of lens differentiation capacity in the chick
head surface ectoderm reported by Barabanov and Fedtsova (1982) with the distribution of Pax6
transcripts reported by Li et al. (1994) shows striking similarity, supporting the idea that Pax6 may
establish a lens forming bias. For example at stage 6, the area marked A in Barabanov and Fedtsova's
report (see figure 4.6), which exhibits high lens-forming capacity, corresponds to a high level of Pax6
expression. This is in contrast to adjacent areas (marked B) with a low level of Pax6 expression and
low lens-forming capacity. Furthermore, Barabanov and Fedtsova (1982) reported restriction of lens-
forming capacity in the surface ectoderm adjacent to the mesencephalon in which Li et al. (1994)
demonstrated downregulation of Pax6 expression.
However, there is one point that devalues Barabanov and Fedtsova's data (1982) in supporting the
involvement of Pax6 in lens differentiation — no controls were used in their study. Surface ectoderm
outside the presumably broad lens-forming domain, for example from more caudal region such as the
rhombencephalon or trunk region, could have been used as negative controls to exclude the possible
lens-inductive effect from unknown factors in the culture medium. Particularly, the medium used by
Barabanov and Fedtsova (1982) contained 10 % fetal calf serum and 10 % embryonic extract from 9-
day chick embryos (although without eyes). Transcriptional stimulation of 5l-crystallin is found in
growth factors such as insulin and insulin-like growth factor I (IGF-I) (Beebe et al., 1987; Alemant et
al., 1990; Hyatt and Beebe, 1992); both are commonly present in fetal calf serum and in embryonic
tissues (McAvoy and Chamberlain, 1990). Thus, the lens-forming capacity observed by Barabanov and
Fedtsova in some areas of head surface ectoderm could possibly be conferred by the stimulatory effects
of growth factors rather than by innate factors.
The above mentioned data prompt me to investigate the correlation of Pax6 expression and lens
differentiation. If Pax6 expression is switched off during culture and lens tissues are still obtained after
culture, it is less likely that Pax6 functions in the process of lens differentiation. Pax6 may be switched
on in those tissues where Pax6 transcripts are not present in the beginning of culture. Determination of
whether lens is differentiated in those tissues will better define the role of Pax6 during the process of
lens differentiation.
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In light of the above mentioned reasons, a precise correlation of Pax6 expression and lens
differentiation is performed in this study.
4.2 Results
4.2.1 Pax6 expression during chick embryogenesis
4.2.1.1 Stage 6+
No Pax6 expression is found at stages earlier than stage 6 (i.e. stage 4). The earliest appearance of
Pax6 expression in the chick is seen at stage 6+ in the anterior margin of the neural plate and in the
neural ridge in the anterior part of the embryo (see figure 4.l.a, no. 6). The neural plate itself (no. 1),
however, does not appear to exhibit Pax6 expression. There is also evidence of expression in the
posterior 1/3 of the developing embryo at stage 6+. The surrounding cells of Hensen's node (no. 3)
appear to show higher level of expression than the others within the posterior region. This expression
in the posterior 1/3 of the developing embryo and in the cells surrounding Hensen's node is never
detected in the controls (not shown).
4.2.1.2 Stage 8
At stage 8, intense Pax6 expression is detected in the neural folds, particularly in the neural ridge (no. 5
in figure 4.l.b), in the prospective cephalic region (see figure 4.Lb). The expression is less intense in
the cephalic neural plate (no. 1) which is located lateral to the cephalic neural folds. In the trunk
region, Pax6 transcripts are detected in the developing neural folds adjacent to the sites of somite
formation (see the first pair of somites, i.e. no. 8 in b). This expression diminishes in the portion
immediately caudal to the last pair of somites seen at this stage of development. Evidence of Pax6
expression is also found in the area surrounding Hensen's node (no. 3 in b).
4.2.1.3 Stage 9
At stage 9 (7 - 8 pairs of somites), Pax6 is expressed in two lateral cephalic regions in the rostral half of
the cephalic region (see no. 10 in figure 4.1.c). There are sharp boundaries between the expressing and
non-expressing regions. In the wall of the anterior neuropore (no. 9), no obvious presence of Pax6
transcripts is found.
In the trunk region, Pax6 transcripts are detected in the neural fold as noted at stage 8. This expression
extends rostrally to the cephalic region and caudally to a region just beyond the last defined pair of
somites that are present at this stage of development. The somites and the intersomitic grooves do not
show any Pax6 expression. In the trunk neural folds where Pax6 transcripts are detected, the
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expression appears to be more intense in the segments that are not flanked by somites. In the site of
Hensen's node (no. 3), Pax6 transcripts are only minimally detectable.
4.2.1.4 Stage 10
At stage 10 (9-10 pairs of somites), Pax6 expression in the cephalic region is found in the two lateral
bulges of presumptive optic vesicles (see figure 4.1.e, no. 10). This expression in the cephalic region is
similar to that formerly noted at stage 9 (compare figure 4.1.e with figure 4.1.d), and the sharp lines of
demarcation between the caudal and the rostral as well as between the lateral and the midline cephalic
regions are maintained. In particular, as viewed externally in wholemount preparations, Pax6 is absent
from the wall of anterior neuropore (no. 9) and from the cephalic midline region (nos. 11 and 12). To
confirm the lack of expression in the two regions, in situ hybridization on coronal sections was
performed. The results (see figure 4.2.a) show apparent absence of Pax6 transcripts in both the surface
ectoderm and the neuroectoderm that surround the anterior neuropore. In the midline cephalic
neuroepithelium (see the intense stain surrounding the future third ventricle, i.e. no. 16 in figure 4.2.a),
however, Pax6 transcripts are detected.
In the trunk region, Pax6 expression within the developing neural folds extends more caudally in
association with the formation of additional somites. The more intense expression in the neural fold
segments that are not flanked by somites, i.e. the intersomitic trunk neuroepitheiium (no. 14 in figure
4.1.e) becomes more obvious (see figure 4.1.e; compare no. 14 with no. 15 ). In Hensen's node (no. 3
in figure 4.1.e), however, no evidence of Pax6 expression is seen by stage 10.
4.2.1.5 Stages 11 - 12
At stage 11, when the optic vesicles are clearly present and bulge laterally into the optic recesses (no.
30 in figure 4.2.b) in the presumptive forebrain, Pax6 expression is detected in loop-shaped structures
that constitute the surface ectoderm (no. 24) and the neuroectoderm (no. 25) of the primitive optic
primordium (see figure 4.2.b). In the neuroepithelium of the presumptive mesencephalon (no. 29) and
anterior rhombencephalon (no. 28), no evidence of Pax6 expression is found, nor are Pax6 transcripts
present in the neuroepithelium that surrounds the closing anterior neuropore (no. 22 in figure 4.2.b). In
the more caudal rhombencephalic region, however, hints of Pax6 expression are found in the
neuroepithelium and in the cells flanking rhombomere 3 (r3) and rhombomere 5 (r5) at stage 11 (see
arrows in figure 4.5.a). By stage 12, Pax6 expression in those cells becomes more evident (see figure
4.5.b). In the head surface ectoderm, the part surrounding the closing anterior neuropore shows no
expression, while the two lateral regions overlying the optic vesicles as well as regions overlying the
presumptive mesencephalon and rhombencephalon show intense expression (see figure 4.2.b). In the
trunk region, Pax6 expression within the neural folds extends more caudally as more somites are
formed (data not shown).
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4.2.1.6 Stage 13
At stage 13, Pax6 continues to be expressed in the loop-shaped structures that constitute the primitive
optic stalks (see figures 4.2.c, d). Pax6 transcripts are clearly present in the telencephalic
neuroepithelium (no. 40 in figure 4.2.d) and at the most anterior end of the presumptive prosencephalic
neuroepithelium, i.e. at the site of the now closed anterior neuropore (see figure 4.2.d). This is
confirmed in transverse sections in figure 4.3.a, although only few /\2x6-expressing cells are seen and
the level of expression is not as intense as that in the lateral surface ectoderm. Pax6 is also expressed in
the neuroepithelium of the presumptive prosencephalon (see figures 4.2.c; d), but not in the
presumptive mesencephalon (see figure 4.3.b).
Pax6-expressing cells are present around the entire area of head surface ectoderm at the same level of
transverse plane as the optic vesicle (see figure 4.2.c). In contrast, in the region close to the anterior
neuropore, only the lateral parts of the head surface ectoderm display evidence of Pax6 expression (see
no. 43 in figure 4.3.a). The same Pax6 expression in the lateral head surface ectoderm is also detected
in the presumptive mesencephalic region (see no. 46 in figure 4.3.b).
Pax6 transcripts are clearly seen in the neuroepithelium of the anterior (no. 38) and the posterior (no.
39) spinal cord in the trunk region, as demonstrated in figure 4.2.d.
4.2.1.7 Stage 16
By stage 16, when the epithelium of the lens placode has invaginated and the optic cup has
differentiated into an inner neural retina (no. 48) and an outer pigmented neural epithelium (no. 49),
Pax6 expression is detected in the differentiating lens (no. 52) and the surface ectoderm overlying it
(no. 50) (see figure 4.3.c). Pax6 transcripts are also present in the neural (no. 48) and pigmented layer
(no. 49) of the optic cup, the neuroepithelium of the rostral part of the prosencephalon (no. 58), as well
as in the anterior medulla (no. 53) in the rhombencephalon which is in close proximity to the otic
vesicles (no. 55) (see figure 4.3.c). In the optic cup, higher levels of expression are seen in the rim (no.
57). This is particularly obvious for the neural retina. The hypothalamic neuroepithelium and the otic
vesicles do not exhibit Pax6 expression. In the head surface ectoderm, Pax6 expression covers a broad
area overlying the eye and extends both dorsally and ventrally.
4.2.1.8 Stages 17 - 18
By stages 17 - 18, Pax6 expression in the anterior part of the head neuroepithelium (no. 64) (now the
neocortical neuroepithelium in the anterior forebrain) is still apparent (see figure 4.4.a). Pax6
expression remains in the optic cup and the optic stalk (no. 59), although the expression is not as
obvious as that at stage 16. Transcripts of Pax6 are also detected in the head surface ectoderm
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overlying the presumptive eye region, particularly the corneal epithelium (no. 60) (figure 4.4.a), as well
as in the ventral pontine neuroepithelium and the dorsal part of medullary neuroepithelium (no. 62 and
no. 71 in figure 4.4.a). Efforts have been made to detect Pax6 transcripts in the olfactory epithelium,
but only by stage 17 is definite Pax6 expression seen (see figure 4.4.b, no. 66).
4.2.1.9 Stage 28
By stage 28, Pax6 expression appears to be detectable within the surface ectoderm covering the eye
region as shown in the whole mount preparation illustrated in figure 4.4.C.
4.2.2 Correlation of Pax6 expression with lens differentiation in vitro
To investigate correlation of Pax6 expression with lens differentiation, small tissue fragments from
designated areas of chick head surface ectoderm (with their underlying mesenchymes) at stages 8 and
11 were cultured in vitro. The areas of head surface ectoderm were designated according to Pax6
expression pattern reported by Li et al. (1994), as shown in figure 4.7.
Following culture, the presence of Pax6 transcripts and aB crystallin were analysed (technical details in
sections 2.6 - 2.7 in chapter 2).
4.2.2.1 Morphological varieties of cultured surface ectoderm and definition of lens differentiation
At the onset of this study, it was observed that lens or lens-like cellular differentiation exhibited a
variety of morphological forms after culture. For example, with a simple eosin staining, some cultured
tissues from different areas of the surface ectoderm exhibited a typical lens shape that appeared to
contain primary lens fibers (figure 4.8.a). Others just showed bubble-like lentoid bodies combined with
fibre-like structures (figure 4.8.b). More commonly, they were simply fibre-like (figure 4.8.c) or
bubble-like structures (figure 4.8.d). The formation of these morphological variations was irrespective
of the origin of cultured tissues, i.e. all designated areas were capable of forming each type of
morphology mentioned above. To examine whether a specific morphology could be readily regarded as
'positive in lens differentiation', an antibody against aB crystallin was used. The results showed that
no specific morphology could be readily correlated with the presence of aB crystallin. Thus, the
cultured surface ectoderm was defined 'positive in lens differentiation' only on the basis of aB
crystallin expression, i.e. irrespective of their morphology. Two examples are shown in figure 4.9 (a
and c; with their respective Pax6 expression pattern in b and d).
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4.2.2.2 Head surface ectoderm cultured from stage 8
Table 4.1 shows the expression of aB crystallin and Pax6 in different areas of stage 8 chick head
surface ectoderm following 4 - 6 days of culture on millipore membranes.




















AA 8 8 3 3 3
AP 7 7 2 2 2
B 12 12 8 8 8
C 10 0 0 0 0
Table 4.1 Correlation of Pax6 expression and lens differentiation in stage 8 chick head surface
ectoderm. All tissues were grafted with underlying mesenchyme and cultured on millipore membranes
for at least 4 days. The area codes were according to those illustrated in figure 4.7. All the Pax6-
expressing tissues were also expressing aB crystallin. Whenever aB crystallin was absent after culture,
Pax6 expression was also absent.
4.2.2.3 Head surface ectoderm cultured from stage 11
Table 4.2 shows the expression of aB crystallin and Pax6 in different areas of stage 11 chick head
surface ectoderm following 4-6 days of culture on millipore membranes.
area total no. of no. of surface aB Pax6 aB crystallin
cultures ectoderm with crystallin expression expression combined
performed presumptive expression after with Pax6 expression
and analysed Pax6 expression after culture after culture
before culture culture
a 6 6 6 6 6
b 6 6 3 3 3
c (dorsal) 5 0 0 0 0
c (ventral) 6 0 3 3 3
d 4 0 0 0 0
e 4 0 0 0 0
Table 4.2 Correlation of Pax6 expression and lens differentiation in stage 11 chick head surface
ectoderm. All tissues were grafted with underlying mesenchyme and cultured on millipore membranes
for at least 4 days. The area codes were according to those illustrated in figure 4.7. All the Pax6-
expressing tissues were also expressing aB crystallin. Whenever aB crystallin was absent after culture,
Pax6 expression was also absent.
207
4.3 Discussion
4.3.1 Establishment of Pax6 expression in the olfactory epithelium, the eye region, the brain and
the head surface ectoderm after stage 14
Results of this study confirm the data previously reported by Li et al. (1994) on chick Pax6 expression
before stage 14. Furthermore, transient Pax6 expression in the Hensen's node is found at stages 6+- 9,
which is not previously reported. After stage 14, Pax6 expression in the eye region, the brain and the
head surface ectoderm is established by this study. Particularly, this study demonstrates the presence of
Pax6 transcripts in the olfactory epithelium, which was not determined by Li et al. (1994).
Chick Pax6 expression data after stage 14 is consistent with what has been found in many other species
as discussed in chapter 3. The data also supports involvement of Pax6 during the development of
olfactory and visual nervous system. For example, in the developing eye, extensive Pax6 expression in
the optic cup, optic vesicle, cornea and lens after stage 14 is found. The rim of the optic cup exhibits
the most intense expression, which is similar to the situation in the mouse. In the developing brain,
Pax6 transcripts are detected in the presumptive telencephalic and thalamic neuroepithelium, but not in
the hypothalamic area. Again, this is comparable to the expression patterns in the mouse.
Pax6 expression during chick embryogenesis also exhibits developmental restriction that has been
defined and discussed for mouse expression in chapter 3 (see section 3.3.4). In the brain, for example,
the most obvious developmental restriction occurs between stage 8 to 9. By stage 8, the neural plate
and the neural ridge in the presumptive head exhibit Pax6 expression throughout the whole region,
whereas by stage 9 only the anterior half of the presumptive head expresses Pax6, and the expression in
not found in the midline (compare figure 4.l.b with 4.1.c). Another example of developmental
restriction is found in the head surface ectoderm. At stages 17 - 18, Pax6 transcripts are still detected in
a broad domain. By stage 28, however, Pax6 transcripts are distributed only in the head surface
ectoderm covering the eye (compare figure 4.4.a with 4.4.c). Although the precise timing of this
developmental restriction is not clear, it must occur between the two stages. The implications of the
developmental restrictions observed in the chick are likely to be similar to those in cellular
proliferation, migration, and differentiation as have been discussed in chapter 3 for the mouse. My
particular interest is in the relevance of this restriction to lens differentiation and this is further
discussed in section 4.3.7.
4.3.2 The different first appearance of Pax6 expression between the chick and the mouse
Li et al. (1994) reported that the first appearance of chick Pax6 transcripts appeared earlier than stage 6
and they described 'a scattered population of weakly Pax6-positive cells at the anterior end of the
embryo, near the prechordal plate', although they also mentioned that stage 6 embryos are 'the earliest
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to exhibit definite expression of Pax6'. In this study, the earliest Pax6 expression was observed at
stage 6 in the same region as described by Li et al. (1994). My result has confirmed that stage 6 is the
first stage when definite Pax6 expression can be observed in the chick.
The first expression of Pax6 in the chick in the non-neural ectodermal cells is surprisingly different
from the data in the mouse whose earliest detectable Pax6 expression is seen in the neuroepithelium of
the presumptive forebrain and hindbrain by day 8.0 p.c. (Walther and Gruss, 1991). This difference of
earliest site of Pax6 expression may be due to the different mode of embryogenesis between the chick
and the mouse. Alternatively, mouse Pax6 may be first expressed in the non-neural ectodermal cells
that have not been described in previous reports.
Both the mouse and the chick embryo start to develop by cell divisions (mitosis) from a single fertilized
cell. Following cell divisions, the total number of cells is multiplied and differentiation of lineages of
cells become possible. In the chick, early cell divisions after fertilization lead to the formation of the
epiblast, the hypoblast, with the blastocoelic cavity located between the epiblastic and the hypoblastic
layers of cells (Stern, 1990). By this arrangement, the early embryonic cells migrate from the margins
of the blastocoel to become extra-embryonic derivatives which are approximately equivalent to the
trophectodermal cells in the mouse. However, in the mouse, the first cell divisions lead to the
formation of the inner cells mass (ICM), the trophectoderm, and the blastocyst (blastocoelic) cavity
(Kaufman, 1992). The blastocoelic cavity is surrounded by the trophectodermal cells which are
approximately equivalent to those in the margins of the blastocoel in the chick. As the embryo
develops, cells migrate rostrally from the primitive knot. In the chick, those cells that are located in the
anterior margin of blastocoel migrate forward during embryogenesis in the anterior direction (Spratt,
1946; Stern, 1990). This migration results in a crescent-shaped band of cells in the anterior margin of
the head neural plate, though the cells do not form the neural plate itself (Spratt, 1946). This crescent-
shaped band of cells described by Spratt (1946) corresponds well to the site where Pax6 expression was
first observed at stage 6 (Li et al., 1994). In the Xenopus, the first detectable embryonic Pax6
expression is reported to be located in a similar crescent-shaped area in the anterior part of the embryo
(Hirsch and Harris, 1997), suggesting that the specific site of earliest expression may be common in
vertebrates.
In the mouse, similar to that in the chick, cell migration of trophectodermal cells in the anterior margin
of the blastocoelic cavity is observed (Tam and Beddington, 1992). The first appearance of Pax6
expression may therefore be in the trophectodermal cells, i.e. in the extra-embryonic derivatives of the
ICM adjoining the anterior amniotic fold by days 7.5 - 8.0 p.c. This area of extra-embryonic
derivatives was not described in the previous reports and remains to be investigated.
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4.3.3 Implications of Pax6 expression in the Hensen's node
Evidence of Pax6 expression in the chick Hensen's node between stage 6 +to stage 9 was observed in
this study, which was not previously reported. After stage 9, Pax6 expression in the Hensen's node was
minimal as the signals were not significantly different from the background, reflecting the transient
nature of Pax6 expression in this site.
The transient expression of Pax6 in the Hensen's node has interesting implications. Hensen's node is
the site where most hypoblastic cells start to migrate anteriorly (Stern, 1990). The migrating cells leave
Hensen's node in an elongated array that gives rise to midline structures including the notochord, the
floor plate, the midline endoderm and the medial part of somites (Hogan et al., 1992). The period of
hypoblastic cell migration in the chick overlaps with the period when Pax6 transcripts are present in the
Hensen's node. Hensen's node is also an organising centre governing the formation of the anterior-
posterior axis in the chick embryo (Chen et al., 1992). Furthermore, retinoic acid (RA), a presumptive
morphogen, is enriched in Hensen's node and is developmentally regulated in the early chick embryo
(Hogan et al., 1992). Thus, it was suggested that endogenous retinoids may establish a concentration
gradient from Hensen's node and play a role in establishing the primary anterior-posterior axis in the
vertebrate (Chen et al., 1992). One may therefore speculate that chick Pax6 could possibly be
implicated in the migration of the hypoblastic cells, as well as in the establishment of anterior-posterior
axis under the regulation of RA during early chick embryogenesis. This possible involvement of Pax6
in embryonic cell migration is supported by the abnormal cell sorting (Quinn et al., 1996), as well as by
the presence of heterotopic groups of cells found in the cerebral cortex in the Sey/Sey mice (Schmahl et
al., 1993; Grindley, 1996). The abnormal cell sorting is suggested to result from changes of adhesion
molecules or cell surface molecules (Quinn et al., 1996); both kinds of molecules are involved in cell
migration. Possible involvement of Pax6 in the establishment of primary anterior-posterior axis is
supported by the loss of anterior-posterior identity of prosomeres in the Sey/Sey mouse (Warren and
Price, 1997). The loss indicates that at least some parts of the anterior-posterior axis is disturbed.
4.3.4 Chick Pax6 expression in the hindbrain suggests roles in establishing rhombomeric identity,
axonogenesis and neuronal cell migration
In the rhombencephalon, as reported by Li et al. (1994), Pax6 transcripts could be detected in the
rhombomere 3 (r3) at stage 9. By stage 11, Pax6 transcripts can be seen in r3 and r5 (illustrated in
figure 2.F of Li et al., 1994). In this study, however, no similar expression was found at stage 9 (see
Figure 4.1.c) and by stage 11 Pax6 expression is seen in the entire rhombencephalic neuroepitheiium
(figure 4.5.a). In addition, the Pax6-expressing cell populations flanking the neuroepitheiium of r3 and
r5 were not described by Li et al. (1994). The differences between the present data and that of Li et al.
(1994) likely result from the dynamic nature of Pax6 expression in the chick hindbrain, which is
suggested by other reports. For example, Heyman et al. (1995) reported that, although chick Pax6 is
210
expressed in specific rhombomeres at stage 11, the transverse rhombomere specific stripes disappear
and dorsal-ventral differences become more apparent at about stage 16. From stages 16-24, chick
Pax6 is preferentially expressed in rhombomere boundaries and in longitudinal stripes in the basal plate
(Heyman et al., 1995). Simon et al. (1995) reported that, at stage 15, Pax6 expression in the alar plate
of r3 and r5 weakens, while in the r2, r4 and r6 Pax6 expression disappears altogether. Buxton et al.
(1997) reported that, at stage 14, r2, r4, and r6 (and more caudally) show Pax6 expression in the lateral
and ventral neural tube, whereas expression in r3 and r5 extends more dorsally. Thus, significant
changes of Pax6 expression occur between stages 11-15, reflecting the dynamic nature of Pax6
expression in the hindbrain.
There are several functions that can be suggested by Pax6 expression in the rhombomeres. Firstly, the
fact that Pax6 is expressed specifically in non-neuroectodermal cells in r3 and r5, as observed at stage
11, suggests a role of Pax6 in establishing r3 and r5 identities, in that cells from neighbouring
neuromeres do not mix, while cells from two odd-numbered or two even-numbered neuromeres
generally mix (Fraser et al., 1990; Guthrie and Lumsden, 1991; Figdor and Stern, 1993; Guthrie et al.,
1993). Secondly, the preference of Pax6 expression in the rhombomere boundaries (Heyman et al.,
1995) suggests that Pax6 may be involved in axonogenesis. Rhombomere boundaries become
delineated by transversely oriented axons from the time the first neurons differentiated (Lumsden and
Keynes, 1989; Keynes and Lumsden, 1990). Thirdly, Pax6 is reported to be co-expressed and co-
increased with vimentin, a marker for radial glial and glial precursors (Heyman et al., 1995). This
suggests a role of Pax6 in neuronal cell migration and is supported by the observation in this study that
Pax6 transcripts are not confined only within the neural tube but are also found in the cell populations
flanking both r3 and r5.
4.3.5 Chick Pax6 expression in the trunk neuroectoderm suggests a role in trunk neurogenesis
Results from this study on chick Pax6 expression in the trunk neuroectoderm generally confirm the data
formerly reported by Li et al. (1994). In addition, there are two new findings that are not previously
described by Li et al. (1994). Firstly, more intense Pax6 expression is found in segments of the trunk
neuroectoderm that is flanked by intersomitic grooves in contrast to those flanked by somites.
Secondly, Pax6 expression appears to correlate with somitogenesis, in that both are gradually extended
in the caudal direction.
The preference of Pax6 expression in areas that are flanked by intersomitic grooves, i.e. the boundaries
of somites, is comparable to Pax6 expression in the hindbrain where transcripts are preferentially
expressed in the rhombomeric boundaries (Hevman et al., 1995). Thus, similar to the suggested roles
in the hindbrain, Pax6 is also possibly involved in neuronal cell migration and axonogenesis in the
trunk region.
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The correlation of Pax6 expression with somitogenesis is of particular interest in the relevance to trunk
neurogenesis. The segmented disposition of spinal nerves is consequent on the formation of somites
(Lehman, 1927; Detwiler, 1934) as well as the subdivision of the paraxially repeated mesodermal units
into anterior (A) and posterior (P) halves. The anterior and posterior halves are distinguished by the
migration of crest cells that set up the basis of sensory neuron development in the trunk region
(Rickmann et al., 1985; Teillet et al., 1987). The crest cell migration and differentiation are speculated
to be regulated by Pax6 for two reasons: (1) Midbrain crest migration has been found to be impaired in
the rat Sey mutants (Matsuo et al., 1993). Although no morphological malformation have been
reported in the Sey/Sey mice so far, subtle abnormalities in the trunk crest cell migration may exist.
Possible involvement of Pax6 in the trunk neural crest cell migration can not be excluded. (2) The crest
cell populations contain full range of developmental potentials. For example, forebrain crest (which
normally does not produce neural derivatives) gives rise to dorsal root ganglion when transposed to the
trunk level (Le Duarin et al., 1986). Thus, the specific environment into which (or through which) the
crest cells migrate is important in the determination of their fates. NGF and BDNF are factors that
provide the environmental cues for trunk neurogenesis (Davies, 1987; Hofer and Barde, 1988) and both
can regulate Pax6 expression in vitro (Kioussi and Gruss, 1994).
4.3.6 Involvement of Pax6 in lens determination and differentiation
4.3.6.1 Chick Pax6 expression correlates with lens determination and differentiation in vivo
Li et al. (1994) reported that chick Pax6 is regionally expressed in the head surface ectoderm during the
same period and in the corresponding location where early lens determination takes place in Xenopus
(Henry and Grainger, 1990). Furthermore, the domain of Pax6 expression remains present during
further development of the head ectoderm and is gradually divided into bilateraly patchces of Pax6-
positive ectoderm that define the population of cells from which the lens is derived (Li et al., 1994).
Results of this study confirm the data previously reported by Li et al. (1994). This study further
demonstrates that at later stages (SI6 - SI8) Pax6 expression in the head surface ectoderm remains
present and the expression is gradually restricted to the eye region before stage 28. Thus, Pax6 is
expressed in the head surface ectoderm in a gradually restricted way similar to that in the mouse
(Grindley et al., 1995). Furthermore, this study demonstrates that Pax6 is expressed in the primitive
lens at stage 16 in the chick. This suggests that Pax6 is involved in lens determination and
differentiation (Li et al., 1994; Grindley et al., 1995; Cvekl and Piatigorsky, 1996).
4.3.6.2 Pax6 expression persists with the determination of lens formation in vitro
Results of this study show that lens determination is correlated with Pax6 expression under in vitro
conditions. At stage 8, 8 out of 12 fragments of surface ectoderm from the presumptive lens-forming
area (coded 'B' in figure 4.7) go into lens differentiation, whilst at stage 11 all fragments (6 out of 6)
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from the presumptive lens-forming area (coded 'a' in figure 4.7) give lens (see data in tables 4.1 - 2).
Thus, the data reflect a gradual determination of lens formation in the presumptive lens-forming surface
ectoderm when cultured in vitro. Pax6 is expressed persistently with this gradual determination before
(shown by Li et al., 1994) and after culture (shown in table 4.1), suggesting its involvement in lens
determination.
4.3.6.3 Pax6 expression is necessary for lens differentiation in vitro
Results in this study show that whenever lens differentiate in culture, Pax6 is always expressed,
irrespective of whether it is expressed in the fragments before culture or not (see tables 4.1; 4.2). This
suggests that Pax6 expression is necessary during the process of lens differentiation. This necessity,
during the course of this study, is demonstrated through investigations on the expression of ocA, ccB,
and 81 crystallins by a combination of DNA binding studies, immunological identification of proteins
forming protein-DNA gel-shift complexes, loss of function after site-specific mutagenesis of the Pax6
protein binding sites in transfected lens cells, and gain of function in co-transfection experiments using
fibroblasts (reviewed by Cvekl and Piatigorsky, 1996). Multiple Pax6 binding sites are implicated. For
example, mouse aB crystallin is presumably controlled by multiple regulatory elements with four Pax6
binding sites (Gopal-Srivastava et al., 1995; Cvekl and Piatigorsky, 1996).
Results in this study also indicate that lens can differentiate from non-Pax6-expressing head surface
ectoderm, whilst Pax6-expressing surface ectoderm does not always give rise to a lens (see tables 4.1
and 4.2). For example, some fragments from non-Pax6-expressing area c (ventral) of stage 11 embryos
differentiate into lens, while some from the Pax(5-expressing area b do not. This is not contradictory to
the necessity for Pax6 during the process of lens differentiation. Pax6 may be switched on or off
during the course of in vitro culture, which is demonstrated in this study.
The switch-on or switch-off of Pax6 expression in the cultured tissues is consistent with the picture of
multiple regulatory elements that control crystallin expression (Gopal-Srivastava et al., 1995; Cvekl and
Piatigorsky, 1996). Some members of the multiple regulatory elements, for example activin A, are
diffusible factors that do not co-exist with Pax6 transcripts (Cvekl and Piatorsky, 1996). In stead, they
can be synthesized by surrounding non-Pax6-expressing cells. Grafting out and culturing specific areas
of surface ectoderm from an intact head implies that the effect of diffusible factors can be lost, which
leads to the failure of crystallin expression. Lens differentiation, therefore, does not occur in those
/Jax6-expressing tissue fragments under in vitro condition. Thus, the Pax6 autoregulatory loops of self-
stimulation (Plaza et al., 1993; Grindley et al., 1995; Cvekl and Piatigorsky, 1996) fail, leading to the
switch-off of Pax6 expression.
Alternatively, Pax6 can be switched on due to grafting and culturing under in vitro condition.
Macdonald et al. (1995) and Ekker et al. (1995) suggested that Shh (Sonic hedgehog) or closely related
213
signalling molecules emanating from ventral midline of the neural tube in the forebrain may inhibit
Pax6 expression in the zebrafish. Their suggestion may explain why Pax6 is switched on in some of
the cultured surface ectoderm (for example, area c in stage 11 embryos), in that the inhibitory effect
from the ventral midline of the neural tube is removed when the surface ectoderm is grafted.
4.3.7 Pax6 is crucial in both the lens ectoderm and the optic vesicle
Despite extensive efforts, the whole picture of detailed molecular events in the processes of lens
differentiation is still unknown (Saha et al., 1992; Grainger, 1992; Cvekl and Piatigorsky, 1996; Li et
al., 1997). Although Pax6 can be involved in lens determination and differentiation as supported by the
results in this study and by many other published data, it is only one of many transcription factors that
are implicated in lens development. Pax6 mutation in the homozygous state, however, does not only
lead to the failure of lens differentiation; it also leads to the absence of all the other structures of the
eye. It is therefore interesting to take my discussion further on the reason why other structures of the
eye are absent due to a single Pax6 gene mutation.
To form a functional vertebrate eye, coordinated development of the neuroectoderm, surface ectoderm,
neural crest and paraxial mesoderm has be be achieved (introduced in section 1.11.1). Single or
combined defects in these components will lead to different degrees of abnormalities in the eye. Sey
mutation leads to the most severe phenotype, since no eye derivative is formed. Analyses of Sey/Sey
phenotypes reveal that the optic vesicles are abnormally broad and fail to constrict proximally
(Grindley et al., 1995). The abnormal optic vesicles eventually become distorted and degenerate
(Hogan et al., 1986; 1988). The lens placode, however, is not even formed (Hogan et al., 1988), which
is confirmed by morphological criteria and by using a lens-specific marker (Grindley et al., 1995). The
phenotypes raise some possibilities for elucidating the absence of lens placode in the Sey/Sey mice: (1)
The lens-enhancing property of the optic vesicle (reviewed by Grainger, 1992) may be maintained,
while primary lens induction in the presumptive lens ectoderm fails. (2) Both the lens-enhancing
property in the optic vesicle and primary lens induction in the presumptive lens ectoderm are faulty. (3)
The optic vesicle does not maintain its lens-enhancing property, while primary lens induction occurs in
the presumptive lens ectoderm without apparent placode formation.
The possibilities described above prompt tissue recombination studies. Fujiwara et al. (1994) cultured
optic vesicles combined with presumptive lens ectoderm from rSey/rSey mice and their littermates.
They found that the failure of lens forming capacity in the presumptive lens ectoderm of day 10.0 p.c.
rSey/rSey rat could not be reversed by culturing with normal (+/+ or rSey/+) optic vesicles, whilst the
presumptive lens ectoderm of normal rat could differentiate into lens even cultured with optic vesicles
from the rSey/rSey mice. Their data indicates that, at least at day 10.0 p.c., lens differentiation in the
presumptive lens ectoderm is autonomous, i.e. independent of effects from optic vesicles.
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If Pax6 is involved in the autonomy of lens differentiation in the presumptive lens ectoderm, it has to be
expressed there irrespective of the presence of optic vesicles. This is demonstrated by the data
published by Li et al. (1994). Li et al. (1994) performed neural plate ablation that resulted in the
absence of the optic vesicle in chick embryos. Pax6, however, remained expressed in the presumptive
lens ectoderm in lack of optic vesicles. The autonomy of lens differentiation in the presumptive lens
ectoderm is also supported by the in vitro lens differentiation studies by Barabonov and Fedtsova
(1982) and in this study. Head surface ectoderm can differentiate into Paxb-expressing lens under in
vitro culture conditions which obviously does not involve optic vesicles. Furthermore, Quinn et al.
(1996) produced chimeric mouse embryos composed of wildtype and Sey mutant cells. They found that
mutant cells were excluded from the lens epithelium in the chimeric embryos with lens sizes
comparable to the wildtypes. When high proportions of mutant cells were found in the chimeric
embryos, the lenses were either reduced in their sizes or completely absent (Quinn et al., 1996). These
lines of evidence indicate that Pax6 is autonomously crucial in the lens ectoderm during the process of
lens differentiation.
The lens has been proposed as an 'organizer' during eye development (Beebe and Dhawan, 1997). For
example, targetted ablation of lens cells by transgenic hybrids of crystallin and diphtheria (a cytotoxic
protein) leads to abnormal phenotypes including size reduction in the sclera, cornea and ciliary
epithelium and the formation of a highly convoluted retina that extensively fills the vitreous chamber
(Breitman et al., 1989; Kaur et al., 1989; Harrington et al., 1991; Klein et al., 1992; Key et al., 1992).
The absence of lens formation in the Sey/Sey mice, therefore, leads to the loss of 'organizer' activity
and probably contributes to the absence of many other eye structures.
Although the Sey mutation does not eradicate optic vesicle formation (Hogan et al., 1986, 1988;
Grindley et al., 1995), Pax6 is also crucial in the optic vesicle. This is not only supported by
expression data and mutant phenotypes, but also by evidence from chimaeric mouse embryos that
exhibit severely affected morphology in the optic cup (Quinn et al., 1996).
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Keys for chick Pax6 expression
1. neural plate
2. border between neural plate and neural ridge
3. Hensen's node
4. first somite formation
5. neural ridge
6. anterior margin of the neural plate (head
fold)
7. migrating pre-cardiac cells
8. first somite
9. anterior neuropore (unfused)
10. lateral cephalic region
11. midline of the dorsal encephalic region
12. midline of the ventral encephalic region
13. heart tube
14. intersomitic neuroepithelium
15. neuroepithelium medial to somite





21. neuroepithelium near the anterior
neuropore
22. closing anterior neuropore
23. third ventricle
24. surface ectoderm covering optic vesicle








33. anterior dorsal aorta
34. surface ectoderm covering optic vesicle
35. neuroepithelium enclosing optic vesicle
36. optic cup
37. somites
38. spinal neuroepithelium (anterior)
39. spinal neuroepithelium (posterior)
40. telencephalic neuroepithelium
41. anterior neuropore
42. neuroepithelium surrounding anterior
neuropore




46. lateral surface ectoderm in the
mesencephalic region
47. third ventricle









57. rim of optic cup
58. neocortical (telencephalic) neuroepithelium








66. nasal (olfactory) epithelium
67. olfactory cavity
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Figure 4.6 A comparison of areas of chick head surface ectoderm cultured by Barabanov and Fedtsova
(1982) for lens differentiation in vitro with the patterns of Pax6 expression in the corresponding areas
reported by Li et al. (1994). Embryos in (a), (c), and (e) (on the left) indicate the areas grafted for
culture by Barabanov and Fedtsova (1982). Those in (b), (d), and (f) show the areas of Pax6
expression. Note that the stages investigated by Li et al (1994) do not exactly correspond to those by
Barabanov and Fedtsova (1982). For each coded area in (a), (c), and (e) (on the left), following in vitro
culture, the number of explants containing lens cells out of the total number is listed as X/Y (from
Barabanov and Fedtsova, 1982). X represents the number of explants containing lens cells. Y
represents total number of explants that have been cultured. Abbreviations: hn, Hensems node; si, first
somite. Scale bars: a, 0.5 mm; b, 0.4 mm; c, 2 mm; d, 4mm; e, 2 mm; f, 4 mm. (figures are from
Barabanov and Fedtsova (1982) and Li et al. (1994) with permission)
Barabanov and Fedtsova (1982)
A: 9/12 L
(a)
Stage 6 (longitudinal section)
Li et_ai (1994)
Stage 6 (dorsal view)
Stage 10 (ventral view) Stage 11 (dorsal view)
Figure 4.7 Fragments of chick head surface ectoderm that were grafted and cultured in this study. All
fragments are grafted under the dorsal view. For the coded area 'c' at stage 11, both dorsal and ventral
surface ectoderm are used. It was noted that, in grafting different areas of the surface ectoderm, no
apparent line of demarcation could be seen in the intact chick embryos. A consistency in grafting areas
of surface ectoderm was therefore demanded, to ensure that the lines of demarcation could be used for
distinguishing Paxb-expressing and non-Paxb-expressing areas. This was tested initially by measuring
the length and width of each grafted area in relation to the whole head. The grafted areas were analysed
to determine whether they were consistent with the pattern of Pax6 expression. Chick embryos at the
same developmental stage, however, could vary in their size, which lead to inconsistent demarcation.
Furthermore, grafting by measurement could take such a long time that the tissues would not survive
during the subsequent culture. Later, a consistency in grafting was achieved by dividing the head
region in three parts of the same length — rostral, intermediate, and caudal, according to morphological
features that were distinguishable under a dissection microscope. The stage 8 heads were cut into
thirds, spanning from the rostral end to the first pair of somites. Thus, the rostral part had areas AA,
AP, and B, whilst C was in the intermediate part and the caudal part was not grafted. The stage 11
heads were also cut into three parts. They spanned from the rostral end to rhombomere 3 (r3). Thus,
the area 'a' belonged to the rostral part. Areas 'b' and 'c' were in the intermediate part, whilst areas'd'
and 'e' were grafted from the caudal part. All tissue fragments were grafted in avoidance of borderlines
to ensure that they were within the designated areas. Five batches of grafts obtained by dividing the
head region into three parts were analysed by wholemount in situ hybridization. All of them were
consistent with the pattern of Pax6 expression. The tissues used for culture in this study were therefore
obtained by first dividing the developing chick head region into three parts as described above.
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Chapter 5: Comparison of Msx-1 and Msx-2 expression in the nremavilla between Sev/Sev mice
and wildtypes
5.1 Introduction
The phenotype of the Sey/Sey mice is not limited to a lack of eyes and nasal derivatives. They also
have shorter snouts (Hill et al., 1991) and, perhaps more surprisingly, possess supernumerary upper
incisor teeth and a cartilaginous rod-like structure (Kaufman et al., 1995). These extra structures are
unexpected in the sense that Pax6 is not reported to be expressed in the developing premaxilla and I
found no evidence of expression during my investigations in chapter 3. The aim of this chapter is to
investigate the formation of the supernumerary upper incisor teeth in more details, and in particular
examine the expression of Msx-1 and Msx-2 in order to give some explanations for the abnormalities in
the Sey/Sey premaxillary region.
Msx-1 and Msx-2 are genes implicated in tooth formation (Mackenzie et al., 1991a, 1991b, 1992;
Jowett et al., 1993; Satokata and Maas, 1994) and have been shown to be expressed in the premaxilla,
in the primitive teeth, and in some parts of nasal derivatives (Robert et al., 1989; Hill et al., 1989;
Mackenzie et al., 1991a, 1991b, 1992). It is therefore of interest to find out whether patterns of Msx-1
and Msx-2 expression are altered in the mice homozygous for the Sey mutation. There is also some
evidence that Msx-1 may be a target for Pax6 (Grindley et al., 1995). This is suggested by the altered
expression pattern of an Msx-1 transgene in the Sey/Sey mice. The lack of a functional Pax6 protein
may therefore have an affect on Msx genes, which may be reflected in tooth development. In this
preliminary study, I investigated Msx-1 and Msx-2 expression using non-radioactive in situ
hybridization, in the premaxilla of the Sey/Sey mice and their wildtype littermates.
5.2 Results
The expression of Msx-1 and Msx-2 during normal tooth development in wildtype mice has been
previously reported (Robert et al., 1989; Hill et al., 1989; Mackenzie et al., 1991a, 1991b, 1992; Jowett
et al., 1994). I have documented it here for comparison with the expression in the Sey/Sey mice.
Efforts have been made to process wildtype and Sey/Sey tissue sections through in situ hybridization at
the same time and under the same conditions, to ensure that the comparisons are not biased on
methodological variations.
5.2.1 Observation of phenotypes and expression of Msx-1 and Msx-2 in the Sey/Sey and wildtype
embryos on sagittal sections at day 13.0 p.c.
Figure 5.1 shows the expression of Msx-1 and Msx-2 on sagittal sections at day 13.0 p.c. The wildtype
embryos at the same stage of development are generally larger than the Sey/Sey embryos and the latter
have a shorter and smaller snout (compare figure 5.1.a with 5.Lb). The formation of the nasal cavity
has invariably failed in the Sey/Sey embryos (for example, see figure 5.l.b).
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Msx-l is expressed in the mesenchyme of the lateral nasal, maxillary and mandibular processes in the
wildtype embryos, but the expression does not extend to the surface, oral, or nasal epithelium (see
figures 5.l.a; c). In the Sey/Sey embryos, Msx-l is expressed in the areas, which despite differences in
morphology, roughly correspond to those of their wildtype littermates (compare figure 5.l.a with 5.1.b;
figure 5.1.C with 5.1 .d). For example, the lateral nasal process is located rostral to the maxillary
process, forming the roof of the external naris (arrow in figure 5. l.a) in the wildtype embryos as seen on
sagittal sections. The corresponding area of the lateral nasal process, despite the fact that there are no
nostrils, should therefore be located rostral to the maxillary process in the Sey/Sey mice (see figure
5.l.b).
The level of Msx-l expression appears to be higher in the Sey/Sey embryos than that in their wildtype
littermates and this higher level of expression appears throughout the embryo, including the limb bud
(compare figures 5.La; c with 5. Lb; d). One exception to this is in the mesenchymal capsule that
surrounds the anterior prosencephalon, where more intense Msx-l expression is seen in the wildtypes
than in their Sey/Sey littermates (compare the arrow-indicated areas in figures 5.1.c; d). This may be
explained by the fact that the section shown in figure 5.1.d is more lateral than that in 5.I.e.
Msx-2, like Msx-l, is expressed in both the Sey/Sey embryos and their littermates, but at a lower level
(see figures 5.1.e; f)- Hints of Msx-2 expression can be found in the lateral nasal, maxillary and
mandibular processes, as well as in the mesenchymal capsule and its covering surface ectoderm (see
arrows in figures 5.1.e, f) that surrounds the rhombencephalon. Msx-2 expression is also found in the
limb bud at a similar level to that in the maxillary process.
It is impossible to make comparisons on the level of Msx-2 expression between the Sey/Sey embryos
and their wildtype littermates.
5.2.2 Observation of phenotypes and expression of Msx-l in the Sey/Sey and wiidtype premaxilla
on transverse sections at days 14 - 17 p.c.
Msx-l expression in the developing maxillary process at days 14 - 17 p.c. is shown by transverse
sections in figure 5.2. It is noted that the Sey/Sey embryos are behind in development by at least 24
hours as compared to their wildtype littermates. It may therefore be of interest to compare the Sey/Sey
embryos with their wildtype littermates that are 24 hours younger.
5.2.2.1 Day 14 p.c.
In the wildtype embryos, Msx-l is expressed in the nasal derivatives including the nasal capsule and the
nasal septum, as well as in the mesenchymal cells and surface ectoderm that surround them; but it is
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excluded from the nasal epithelium that flanks the nasal septum (see figure 5.2.a). Msx-1 is also
expressed in the mesenchymal cells that disperse in the region between the nasal derivatives and the
dental lamina and their surrounding areas. There are, however, symmetrical zones which do not express
Msx-1 but are located within the mesenchymal condensations of the presumptive dental papilla (arrows
in figure 5.2.a). The thickening dental lamina, which forms the future enamel organ, does not contain
any Msx-1 transcripts (figure 5.2.a).
In the Sey/Sey maxillary process, no nasal derivatives are seen (see figure 5.2.b). The Sey/Sey maxillary
process shows more torsions in its external contour in contrast to that in the wildtype embryos. A
clump of non-Msx-1 -expressing cells that presumably constitutes the rod-like cartilaginous structure
(see figure 5.2.b) is seen amid the mesenchyme where Msx-1 is expressed. The mesenchymal
expression of Msx-1 appears to be at a higher level than that in the wildtype embryos (compare figure
5.2.a with 5.2.b). The presumptive more intense Msx-1 expression in the Sey/Sey embryos does not
seem to be due to a higher cell density in this region, in that no apparent compaction of cells is seen
under higher magnification (not shown). The development of upper incisors is retarded in the Sey/Sey
maxilla in that the dental lamina is still not formed in contrast to the thickening of the dental papilla in
the wildtypes (compare figure 5.2.a with 5.2.b).
5.2.2.2 Day 15 p.c.
At day 15 p.c., the distribution of Msx-1 transcripts in the wildtype maxillary process is comparable to
that found at day 14 p.c. (figure 5.2.c). Msx-1 expression is seen in the nasal septum, the anterior and
lateral nasal capsule, as well as in the mesenchymal cells that surround the nasal derivatives and
disperse within the maxillary process. Msx-1 is also expressed in the mesenchymal cells between the
primitive enamel organs and the mesenchymal condensations. Transcripts of Msx-1 remain absent in
the nasal epithelium flanking the nasal septum, in the condensed mesenchyme of the presumptive dental
papilla, as well as in the future enamel organs. All the non-Msx-1 -expressing areas are located in left-
right symmetrical pairs that are separated by Msx-1 -expressing cells in the middle. This is particularly
interesting in the presumptive incisor region where the separation by Msx-1-expressing cells is not
obvious at day 14 p.c., but it becomes evident at day 15 p.c. as the primitive enamel organs are formed.
In the maxillary process of the Sey/Sey embryos, Msx-1 is expressed in the mesenchymal cells that
surround the rod-like structure and the presumptive dental derivatives. Transcripts of Msx-1 are also
found in the mesenchymal cells between the primitive enamel organs and their surrounding
mesenchymal condensations (see figure 5.2.d), which is comparable to that in the wildtype embryos
(compare figure 5.2.C with 5.2.d). The primitive enamel organs of upper incisors, as illustrated in figure
5.2.d, are surrounded by a single large condensation of mesenchyme which forms the future dental
papilla. The single dental papilla, in contrast to that in the wildtypes, is not evidently separated by Msx-
7-expressing cells (compare figure 5.2.c with 5.2.d).
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The Sey/Sey maxilla also appears to form more torsions in its internal contour (the oral epithelium) as
compared to the wildtype maxilla (compare figure 5.2.c with 5.2.d; see also arrows in 5.2.f). One of the
internal torsion appears to form an epithelial thickening similar to presumptive dental lamina (arrow in
figure 5.2.d) that is significantly retarded as compared to the other incisors.
The cells that constitute the presumptive rod-like cartilaginous structure appear to be Msx-l-expressing
in figure 5.2.d. This expression, however, is not found in any other Sey/Sey preparations at the same
stage of development.
5.2.2.3 Day 16 p.c.
At day 16 p.c., Msx-1 expression in the wildtype maxilla is detected in the dental papilla that is
previously non-expressing (see figure 5.2.e). In the mesenchymal cells, particularly those surrounding
the lateral side of the dental derivatives, the previously observed high level of expression is decreased.
Minimal expression of Msx-1 also appears to be present in the nasal capsule and the nasal septum.
There are also signs of Msx-1 expression in the whisker follicles (see figure 5.2.e).
In the Sey/Sey maxilla. Msx-1 is also expressed in the dental papilla (see figure 5.2.f). Of the specific
example illustrated in figure 5.2.f, the presumptive upper incisors are arranged in two groups that are
separated by Msx-l-expressing cells. The one with two presumptive dental papillas (on the right) is
surrounded by a single enamel organ. Transcripts of Msx-1 are also seen in the whisker follicles and the
mesenchymal cells between the enamel organs. The cells within the rod-like structure remain non-Msx-
7-expressing.
5.2.2.4 Day 17 p.c.
At day 17 p.c., Msx-1 expression in the wildtype maxilla follows the same theme as observed at day 16
p.c. Transcripts of Msx-1 are found in the nasal septum and the lateral nasal capsule (see figure 5.2.g).
The nasal epithelium remains non-Msx-1 -expressing. The cartilage primordium of the sphenoid bone is
clearly seen without Msx-1 transcripts by day 17 p.c. In the incisors, Msx-1 is expressed in the dental
papilla, while the enamel organ is non-expressing. The expression appears to be more intense in the
demarcation between the dental papilla and its enclosing enamel organ. Transcripts of Msx-1 are also
found in the presumptive dental follicles that flank the medial side of the upper incisors. In the
mesenchymal cells surrounding the lateral side of the upper incisors, Msx-1 expression is reduced,
which is comparable to that observed at day 16 p.c. The mesenchymal cells between the incisors,
however, remain expressing Msx-1 at a level comparable to that in the dental papilla. Between the
dental follicle and the medial mesenchyme, a non-expressing zone is found in each side of the maxilla
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(see arrows in figure 5.2.g). In the wildtype whisker follicles, Msx-1 expression is maintained at day 17
p.c.
In the Sey/Sey maxillary process at day 17 p.c., Msx-1 is expresed in the dental papilla, as well as in the
whisker follicles and in the medial mesenchymal cells (see figure 5.2.h). The rod-like structure does
not express Msx-1. The pattern of Msx-1 expression in the dental papilla seems similar in the wildtype
and the Sey/Sey embryos. The Sey/Sey dental papilla, however, is reduced in size. The non-expressing
zones between the dental follicle and the medial mesenchyme are significantly reduced in the Sey/Sey
embryos as compared to those in the wildtypes (compare arrow-indicated areas in figure 5.2.g and
5.2.h).
5.2.3 Expression of Msx-2 in the Sey/Sey and wildtype premaxilla on transverse sections at days
13 - 15 p.c.
Msx-2 expression in the wildtype and Sey/Sey maxillary processes at days 13 - 15 is shown by
transverse sections in figure 5.3.
At day 13 p.c., hints of Msx-2 expression in the wildtype maxilla are detected along the oral epithelium,
particularly in the site where the dental epithelium is presumably located (see figure 5.3.a). Signs of
Msx-2 expression are also found in the nasal epithelium in the wildtype embryos. In the Sey/Sey
embryos at day 13 p.c., no apparent Msx-2 expression is found in the maxilla, while localized Msx-2
expression is seen in the mandible (figure 5.3.b).
At day 14 p.c., Msx-2 expression is clearly seen along the oral epithelium in the wildtype maxilla (see
figure 5.3.c). In particular, the sites of dental lamina exhibit more intense expression. Msx-2
expression is also seen around the entrance of the nasal cavity, in the surface ectoderm covering the
nasal derivatives, and in the nasal septum. Transcripts of Msx-2 are also detected in the whisker
follicles in the wildtype maxillary process. In the Sey/Sey maxillary process, hints of Msx-2 expression
is seen in the dental laminas and in other specified areas where presumably the dental epithelia are
localized (see figure 5.3.d; in this specific example, two torsions of presumptive dental epithelium are
found).
At day 15 p.c., Msx-2 expression is detected notably in the dental papilla in the wildtype maxilla (figure
5.3.e). Signs of Msx-2 expression also appear in the anterior nasal capsule and in the oral epithelium.
In the Sey/Sey maxilla, Msx-2 transcripts are detected in the thickening dental lamina and in the site
where the dental epithelium is presumably located (see figure 5.3.f). The expression in the dental
primordia appears to be continuous with that in the oral epithelium. More than three upper incisor
primordia are commonly found in the Sey/Sey maxilla. In the specific example shown in figure 5.3.f,
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four dental laminas with a torsion in the oral epithelium are found. Msx-2 is also expressed in the
whisker follicles in the Sey/Sey maxillary process, as shown in figure 5.3.f.
5.3 Discussion
5.3.1 Mutant phenotypes in the Sey/Sey mice and Msx-1, Msx-2 expression in the wildtype
embryos
This study confirms all the abnormalities that have been previously reported in the Sey/Sey premaxilla.
Results in this study on Msx-1 and Msx-2 expression in the wildtype maxilla also confirm previously
reported data by MacKenzie et al. (1991a, 1991b, 1992) and Jowett et al. (1993) in that: (1) Msx-1 is
expressed in the papillary and follicular mesenchyme (for example see 'df and 'dp' in figure 5.2.g) and
is excluded from the dental epithelium (for example see the 'eg' that is differentiated from dental
epithelium in figure 5.2.g). (2) Msx-2 is expressed initially in the dental epithelium (or called dental
lamina when it becomes thickened; see 'de' and 'dl' in figures 5.3.a; c) and later is expressed in the
mesenchyme of the dental papilla (see 'dp' in figure 5.3.e).
In addition to the confirmation of previously reported data, this study shows that Msx-1 is not expressed
in the condensing mesenchyme that constitutes the future dental papilla of the upper incisor. This
exclusion of Msx-1 expression can obviously be seen between day 14 and 15 p.c. By day 17 p.c., a
symmetrical non-Msx-1 -expressing zone can be seen between the dental follicle and the medial
mesenchyme, which has never been reported before.
5.3.2 Msx-1 expression in the Sey/Sey maxiila
Although in situ hybridization does not give differential expression on a quantitative basis, results of
this study suggest that Msx-1 expression is increased and that the increase seems to occur in most areas
of expression in the Sey/Sey embryos. For Msx-2 expression, results of this study do not allow a direct
comparison between wildtype and Sey/Sey embryos based on in situ hybridization. It would therefore
be interesting to investigate, for example, by quantitative Northern transfers or quantitative in situ RT-
PCR (Reverse Transcriptase - Polymerase Chain Reaction) to determine this issue.
Increase of Msx-1 expression may imply that it is involved in the formation of supernumerary upper
incisors in the Sey/Sey mice, as Msx-1 is suggested to involve in the initiation of tooth development
(MacKenzie et al., 1991a, 1991b, 1992). Mina and Kollar (1987) reported that the mesenchyme
beneath pre-patterned regions of the oral epithelium, during the process of condensation, becomes
capable of inducing tooth formation when cultured in combination with oral epithelium and non-oral
epithelium. This property of mesenchyme to induce odontogenesis has been suggested to be due to the
presence of Msx-1 transcripts. Msx-1, as a putative transcription factor, may play a role in regulating
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the expression of other genes in the mesenchyme or in the epithelium during tooth formation (Jowett et
al., 1993). One can, however, argue against that the formation of supernumerary upper incisors
involves an increase of Msx-l. Msx-1 expression also appears to increase in the mandibular process (as
seen in figure 5.l.b), but no formation of supernumerary lower incisors has ever been reported.
Increase of Msx-1 expression can also imply that Pax6 may directly or indirectly have an inhibitory
effect on Msx-l expression. This is particularly supported by Msx-1 expression in the maxillary
process, in that areas of Msx-1 expression do not overlap with those of Pax6 expression. In the
wildtype maxillary process, the nasal cavity and Pax6-expressing nasal epithelium obviously take up
some space that can be filled with Msx-1 -expressing mesenchyme, indicating that at least an indirect
effect exists.
5.3.3 Origin of the rod-like cartilaginous structure
Kaufman et al. (1995) reported that, in addition to the supernumerary upper incisors, the Sey/Sey mice
also exhibit a median cartilaginous rod-like structure in the premaxilla and that the exact derivation of
the rod-like structure is unclear. This study shows that Msx-1 is not expressed in the rod-like structure
(see figures 5.2.b;f;h), indicating that the rod-like structure is derived from cells without the presence of
Msx-1 transcripts. In the wildtype premaxilla, Msx-1 is not expressed in three areas: the future dental
papilla (the condensed mesenchyme), the primitive enamel organ (the thickening dental epithelium) and
the nasal epithelium flanking the nasal septum (see figures 5.2.a; c). Thus, the rod-like structure in the
Sey/Sey mice is likely derived from one or more than one of the three non-Mrx-Z-expressing areas
(compare figure 5.2.a with 5.2.b). Another possibility is that it is derived from tissues where Msx-1 is
initially expressed, but the expression is later turned off as the cells change their characteristics. The
third possibility is that the rod-like structure is derived from an aberrant, ectopic outgrowth of non-Msx-
7-expressing structure from outside of the maxillary process.
The rod-like structure, however, is most likely to have originated from outside of the maxillary process
for the following reasons: (1) It is differentiated into cartilaginous cells in contrast to the other
candidates. (2) It co-exists with the other non-ATsx-1 -expressing areas and, in some cases, shows
obvious detachment from them (for example, see figures 5.2.d). (3) The non-Msx-1 -expressing cells
within the mesenchymal condensation of future dental papilla will eventually be transfromed into Msx-
7-expressing cells. This is not seen in the rod-like structure. (4) The enamel organ, be it from wildtype
or Sey/Sey embryos, will have Msx-1 -expressing cells of dental papilla wrapped inside it (see figures
5.2.g; f). This, again, is not seen in the rod-like structure. (5) Most importantly, the rod-like
cartilaginous structure is continuous with the base of the skull (Kaufman et al., 1995) where Msx-1
expression has never been documented.
5.3.4 Non-synchronized formation of upper incisor primordia in the Sey/Sey maxilla
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Results in this study show that torsions of the oral epithelium (presumably secondary dental epithelia),
which are never found in the wildtypes, appear in the Sey/Sey maxilla after the primary dental epithelia
are invaginated to form the presumptive enamel organs (for example, see figure 5.2 f). The identity of
some of the torsions of the oral epithelium are confirmed by the presence of Msx-2 transcripts as
exemplified in figures 5.3.d and 5.3.f. Thus, the supernumerary upper incisors are developed in a non-
synchronous way, in that some of the dental epithelia have already been differentiated into the primitive
enamel organs, while others are still torsions of the oral epithelium.
The presence of secondary dental epithelia in the Sey/Sey maxilla indicates that the epithelial-
mesenchymal interaction is maintained after the primary dental epithelia are invaginated. Pax6
mutation therefore either lifts the presumptive inhibition of primary epithelial-mesenchyme interaction
or cause a de novo secondary induction. In either case, it is interesting to see that the maintained
primary induction or the secondary induction are potentially capable of producing more than two upper
incisors, as suggested by figure 5.2.f. It is also interesting to see that a condensed or condensing
mesenchyme always accompanies a dental lamina (as seen in figure5.2.f) in close proximity, suggesting
that the condensation is necessary for induction.
The non-synchronous nature reflects that Pax6 mutation does not only affect the number of upper
incisors but also the temporal determination of those upper incisors.
5.3.5 Symmetrical vs asymmetrical distribution of supernumerary upper incisors
Results of this study indicate that the supernumerary upper incisors are formed either symmetrically or
asymmetrically in the Sey/Sey maxilla. This could result from the disturbance of left-right symmetry or
the formation of odd numbers of incisors that will eventually be distributed unequally to each side of
the maxilla. The disturbance of left-right symmetry is less likely for the following reasons: (1) In the
Sey/Sey maxilla, no other obvious asymmetry in the other tissues, for example the hair follicles, is
observed in this study. The possibility of a local effect on symmetry may be excluded. (2) No
disturbance of left-right symmetry is reported in the other areas of the Sey/Sey mice. (3) In the Sey/Sey
maxilla, the cartilaginous rod-like structure is always located in the median plane, suggesting that a
sense of left-right identity is maintained. (4) In rare cases of Sey/Sey maxilla that form 5 primitive
upper incisors, a left-right balance is commonly maintained (see figure 5.3.f for example).
5.3.6 Non-corresponding number of dental papilla formation in relation to the enamel organ
Results of this study show that encapsulement of two dental papillas by a single large enamel organ is
common in the Sey/Sey maxilla (for example, see figures 5.2.d; f; h). The enamel organ itself, however,
is invariably surrounded by a single dental follicle. The fact that the formation of the enamel organ and
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the dental papilla does not correspond may be due to fusion of neighbouring enamel organs during
odontogenesis. Alternatively, it may result from dividing a single mesenchyme condensation into two
separate dental papillas. Analyses of Sey/Sey embryos at day 14 p.c. readily reveal that the dental
placodes (which will form enamel organs) can outnumber mesenchyme condensations and the former
are usually linked in their epithelial surface before invagination, suggesting that fusion of neighbouring
enamel organ is more likely the case. For example, in figure 5.2.d, three invaginated dental placodes
are surrounded by two mesenchyme condensations. Thus, results in this study indicate that the
previously reported supernumerary upper incisors in the Sey/Sey maxilla (Kaufman et al., 1995) were
counted by the number of dental papillas, not by the number of enamel organs.
In the wildtype embryos, the formation of a dental placode is always on a one-to-one basis with the
condensation of dental papilla mesenchyme. This reflects a precise mechanism that controls the number
of teeth in either the maxilla or the mandible. Obviously, the Sey/Sey maxilla does not follow the one-
to-one basis so that the number of upper incisors is increased. The increase is probably mediated by the
capability of inducing two or more dental placodes by a single condensation of dental papilla. The
Sey/Sey mandible, however, has so far not been reported to exhibit supernumerary lower incisors or
other apparent abnormalities, suggesting that the formation of supernumerary upper incisors is caused
by a local interference rather than general effects on odontogenesis.
5.3.7 Formation of a shorter snout in the Sey/Sey maxilla
Hill et al. (1991) reported that the Sey/Sey mice exhibit shorter than normal snouts as compared to their
wildtype littermates. This was also observed in this study. The mouse snout is composed mostly of the
neural crest cells that form the mesenchymal and skeletal elements in the maxillary process (Le
Douarin, 1982; Noden, 1986), with relatively few epithelial cells contributing to the nasal and surface
epithelium. The shorter snout in the Sey/Sey mice, therefore, may be caused by the following two
mechanisms that can determine the final numer of neural crest cells in that region:
The first possible mechanism is that it may be caused by abnormally excessive apoptosis following the
accumulation of neural crest cells that are initially comparable in cell numbers to those in the wildtypes.
Apoptosis is involved in the development of many embryonic regions, including the maxillary process.
During odontogenesis, apoptosis is implicated in the removal of the enamel knots, disruption of dental
lamina and reduction of dental epithelium during enamel formation (Vaahtokari et al., 1996). Marazzi
et al. (1997) reported that Msx-2, whose expression is seen in the maxilla (MacKenzie et al., 1992;
Jowett et al., 1993), is involved in the BMP4-mediated programmed cell death pathway. Furthermore,
Msx-2 has been implicated in programmed cell death of neural crest cells during development (Graham
et al., 1993; 1994). The possible involvement of apotosis in causing the shorter snout in the Sey/Sey
mice therefore remains an open question.
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The second possibility is that the shorter snout may result from deficit of the neural crest, either via
insufficient migration or mitosis. Matsuo et al. (1993) reported that anterior midbrain neural crest cells
in rats homozygous for the rSey mutation migrated only to the presumptive eye region and did not reach
the nasal rudiments. Their data suggest that Pax6 mutation can impair midbrain neural crest migration
toward the maxillary process. The maxillary neural crest cells are reported to be mainly from the
midbrain (Tarn and Morris-Kay, 1986; Serbedzija et al., 1992; Osumi-Yamashita et al., 1994), strongly
supporting that the shorter snout is caused by shortage of crest cells. Interestingly, however, the
midbrain is not a region of Pax6 expression during the period of neural crest migration and Pax6 has
never been reported to be expressed in the migrating neural crest cells (Walther and Gruss, 1991;
Stoykova and Gruss, 1994; Grindley et al., 1995; Stoykova et al., 1996; Warren and Price, 1997;
Mastick et al., 1997). How can Pax6 mutation affects neural crest migration or mitosis ? In the mouse,
the earliest presence of Pax6 transcripts is found at day 8.0 p.c. in the presumptive forebrain and
hindbrain (Walther and Gruss, 1991). By day 8.0 p.c., the head neural crest cells are still at
premigratory stage (Serbedzija et al., 1992). This gives an opportunity for Pax6 transcripts to affect the
premigratory neural crest cells. Osumi-Yamashita et al. (1994) reported that the lateral edge of the
prosencephalon produced crest cells which migrated to the frontonasal mass. On the other hand, cells at
the anterior neural ridge in the prosencephalon contributed mainly to the head epithelium including the
nasal placode (Tarn and Morris-Kay, 1986; Serbedzija et al., 1992; Osumi-Yamashita et al., 1994).
Both the lateral edge and the anterior neural ridge are Pax6-expressing areas at 8.0 days p.c. (Walther
and Gruss, 1991). The frontonasal mass constitutes a high proportion of the total mass of the snout. It
is therefore possible that the failure of Pax6 function can deter the migration of neural crest cells from
the lateral edge of the prosencephalon toward the frontonasal mass, in a way comparable to the
impaired migration of crest cells in the midbrain found in the rSey/rSey mouse. Thus, a shorter snout is
found.
5.3.8 Abnormalities in the Sey/Sey maxilla may be caused by the failure of nasal derivative
formation
In section 5.3.7, two explanations for the formation of a shorter snout in the Sey/Sey maxillary process
are discussed, with particular interest in the determination of the number of neural crest cells. The two
explanations may not be exclusive and may overlap to some extent. Whatever is the case, one can
develop the question further by asking why does excessive apoptosis and/or impaired migration (or
mitosis) of the neural crest cells occur ?
Extensive reports have been published on the absence of nasal derivatives in the Sey/Sey embryos
(Hogan et al., 1986, 1988; Hill et al., 1991; Kaufman et al., 1995; Grindley et al., 1995). The failure of
nasal derivative formation is characterized by the absence of nasal placode formation. Furthermore,
Pax6 expression is turned off in the nasal region of Sey/Sey embryos (Grindley et al., 1995). Nasal
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derivatives are therefore never present in any primitive form in the Sey/Sey embryos. This means that
any possible local effect from nasal derivatives on the maxilla can not occur in the Sey/Sey embryos.
The nasal placode is a source of hormone-producing cell populations which migrate to the medial basal
forebrain (Schwanzei-Fukuda and Pfaff, 1990) and probably induce the formation of the olfactory bulb
(Gong and Shipley, 1995). The hormone-producing cell populations, during migration, have an
opportunity to interact with the maxillary mesenchyme, which may play a role in the normal
development of the maxillary process. The nasal region may be a source of developmentally important
diffusible molecules such as growth factors. A possible example is FGF8 that is expressed in the nasal
placode (Crossley and Martin, 1995). Lack of such a source in the nasal region means that factors to
attract or direct neural crest cell migration is lost. Alternatively, the nature of the maxillary
mesenchyme may be altered in the absence of diffusible molecules from the nasal region, which results
in supernumerary mesenchymal condensations in the Sey/Sey maxilla.. The nasal derivatives may also
contribute to the boundary formation in the base of the skull by diffusible inhibitory factors. When the
inhibitory effects fail in the Sey/Sey maxilla, overgrowth of the skull leads to the formation of the rod¬
like structure.
5.3.9 Summary — the whole picture of abnormalities in the Sey/Sey maxilla and possible
involvement of Msx-1 and Msx-2
In this study, as well as in previous reports, abnormal phenotypes in the maxillary process are found in
the Sey/Sey mice. The abnormal phenotypes can be caused by localized effects in the maxilla, as well
as be associated with malformations in the eye and the brain.
Pax6 is unlikely to be involved directly in the process of odontogenesis, in that it is not expressed in
any tooth primordium, nor in the mesenchymal or epithelial tissues. The fact that the lower incisors or
molars are not affected in the Sey/Sey mice also supports that Pax6 does not possess a direct role during
odontogenesis. Instead, the formation of supernumerary upper incisors in the Sey/Sey mice appears to
be associated with localized effects — the failure of nasal formation and the formation of the rod-like
cartilaginous structure (discussed in section 5.3.3), as well as the impaired contribution of midbrain
neural crest cells that normally constitute the major source of the maxillary mesenchyme. Failure of
nasal formation and the presence of the rod-like cartilaginous structure in the Sey/Sey mice indicate that
the normal compartmentation in the maxillary process is disturbed, which may lead to the disturbance
of local identity in the mesenchyme. As the local identity in the mesenchyme is disturbed, the number
of dental papilla no longer corresponds to that of the enamel organ (see section 5.3.6).
The abnormalities in the Sey/Sey maxilla may also be associated with the defects in the eye or the brain.
Lack of eye formation means that the neural crest cells from the prosencephalon can migrate more
freely before they reach the frontal nasal mass. The disturbance of pl/mesencephalon boundary and the
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absence of regional cell density in the diencephalon (Warren and Price, 1997; Mastick et al., 1997)
implies that the normal contribution of the neural crest cells from these regions can be affected.
Little is known about the molecular activities underlying the normal morphogenesis of the maxilla and
less is understood during odontogenesis. Efforts made in this study to interpret the malformation in the
Sey/Sey maxilla on a molecular basis, therefore, has to be preliminary. The presumably upregulation of
Msx-1 suggests that it is involved. The involvement, however, has to be indirectly implicated for the
following reasons: (1) Areas of expression between Msx-1 and Pax6 are not overlapped extensively,
and (2) No gel shift assay showing that Pax6 protein can affect the electrophoretic motility of Msx-1
transcripts has been reported so far. (3) The effect of Pax6 mutation on upper incisor formation differs
from that of the eye and the nose. Formation of the eye and nose is completely blocked, indicating that
the sequential events and gene activities involved therein have never happened. The formation of upper
incisors (including the activities of both Msx-1 and Msx-2), is allowed to proceed although in an
abnormal way.
If Msx-1 and Msx-2 are unlikely to be the direct targets of Pax6, one has to wonder why Pax6 mutation
may lead to upregulation of both genes ? Vainio et al. (1993) reported that bone morphogenetic protein
4 (BMP-4), a member of the transforming growth factor (3 superfamily, is expressed in the presumptive
dental epithelium at the initiation of tooth development. Subsequently, the epithelial BMP-4 signalling
can induce its own mesenchymal expression, as well as the expression of Msx-1, Msx-2, and Egr-1
(Vainio et al., 1993). BMP-2 can also stimulate Msx-1 and Msx-2 expression in vitro (reviewed by
Thesleff et al., 1995). Msx-2, in particular, has been further demonstrated as a downstream gene of
BMP-4 and is implicated in the BMP-4-mediated programmed cell death pathway (Marazzi et al.,
1997). It is therefore likely that BMP-2 and BMP-4 are upregulated in the Sey/Sey mice and their
overexpression is responsible for the formation of the rod-like cartilaginous structure. Abnormalities in
the Sey/Sey mice are also found in the skull (Kaufman, personal communication), supporting the
possible involvement of the two BMP proteins.
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Figure 5.1 Msx-1 and Msx-2 expression in the +/+ and Sey/Sey embryos sagitally sectioned at day 13
p.c. (see the schematic diagram below). The left panels (a, c, e) represent Msx-1 expression in the
wildtypes. The panels on the right (b, d, f) represent Msx-1 expression in the Sey/Sey mice. All the
embryonic tissues are processed under the same condition through in situ hybridization (detailed in
chapter 2). a and b show the maxillary process under higher magnification. Note that the Sey/Sey
embryos are reduced in size, without nasal cavity, and with shorter snouts, as compared to their
wildtype littermates. Msx-1 is expressed in the mesenchyme of lateral nasal, maxillary, and mandibular
process (in a), as well as in the mesenchymal capsule that surrounds the anterior prosencephalon and in
the limb bud (in c). In the Sey/Sey embryos, although no nasal derivatives are formed, Msx-1 appears to
be expressed in the corresponding regions as compared to those in the wildtypes (in b). Msx-2
expression is less obvious, but still can be seen in the lateral nasal, maxillary, mandibular process, as
well as in the limb bud and in the mesenchymal capsule surrounding the rhombencephalon (in e). Msx-
2 expression in the Sey/Sey embryo also corresponds to that in the wildtypes (in f). Note that Msx-1
expression appears to increase in the Sey/Sey embryos. Abbreviations: lb, limb bud; In, lateral nasal
process; mes, mesencephalon; mn, mandibular process; mx, maxillary process; nc, nasal cavity; nep,
nasal epithelium; pro, prosencephalon; r, residual lumen of Rathke's pouch; rho, rhombencephalon.
Scale bars: a - b, 750 pm; c - f, 500 pm.
+/+ Sey/Sey
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Figure 5.2 Msx-l expression in the +/+ and Sey/Sey maxillary processes transversly sectioned at days
14, 15, 16 and 17 p.c. (see the schematic diagram below). The left panels (a, c, e, and g) represent Msx-
1 expression in the wildtype maxilla. The right panels (b, d, f, and h) represent Msx-l expression in the
Sey/Sey maxilla. All the embryonic tissues are processed under the same condition through in situ
hybridization (detailed in chapter 2). In the wildtype embryo, Msx-l expression is seen in the nasal
septum, in the anterior and lateral nasal capsule, and in the mesenchymes that disperse within the
maxilla (in a, c). Msx-l expression is excluded from the nasal epithelium, the mesenchymal
condensation that forms the future dental papilla, and the dental lamina (in a, c). Later at day 16 and 17
p.c., Msx-l expression is seen in the dental papilla and the dental follicle (in e, g). In the Sey/Sey
maxilla, Msx-l is expressed in the mesenchyme, but is excluded from the rod-like structure (in b). Later
at day 16 and 17 p.c., Msx-l is expressed in the dental papilla in a pattern comparable to that in the
wildtypes (compare g with h). Note that Msx-l is expressed in the whisker follicles in the wildtype and
Sey/Sey maxillary processes. Note also that the Sey/Sey maxillas have more torsions along the oral
epithelium as compared to the wildtypes. Abbreviations: anc, anterior nasal capsule; cm, condensed
mesenchyme; cps, cartilaginous primordium of the sphenoid bone; df, dental follicle; dl, dental lamina;
dp, dental papilla; eg, enamel organ; i, incisor; lnc, lateral nasal capsule; m, mesenchyme; nep, nasal
epithelium; ns, nasal septum: r, rod-like structure; t, tongue; wf, whisker follicle. Scale bars: 500 p.m.
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Figure 5.3 Msx-2 expression in the +/+ and Sey/Sey maxillary processes on transverse sections at days
13, 14 and 15 p.c. (see the schematic diagram below). The left panels (a, c, e) represent Msx-2
expression in the wildtypes. The panels on the right (b, d, f) represent Msx-2 expression in the Sey/Sey
mice. All the embryonic tissues are processed under the same condition through in situ hybridization
(detailed in chapter 2). In the wildtype maxilla, Msx-2 expression is already located in the dental
epithelium along the line of oral epithelium by day 13 p.c. (in a). This is in contrast to that in the
Sey/Sey embryo whose Msx-2 expression can only be seen in the mandibular process (in b). Msx-2
expression in the wildtypes is more clearly seen when the dental epithelium is further developed into the
dental lamina (in c), and by day 15 p.c., the expression is seen in the dental papilla (in e). In the
Sey/Sey maxilla, however, Msx-2 expression remains in the dental laminas, indicating that the embryo is
retarded in development. Note that Msx-2 is expressed in the nasal derivatives in the wildtypes. Msx-2
is also expressed in the whisker follicles, in both the wildtype and Sey/Sey embryos. Abbreviations:
anc, anterior nasal capsule; cm, condensed mesenchyme; cps, cartilaginous primordium of the sphenoid
bone; df, dental follicle; dl, dental lamina; dp, dental papilla; eg, enamel organ; i, incisor; lnc, lateral
nasal capsule; m, mesenchyme; nep, nasal epithelium; ns, nasal septum; r, rod-like structure; t, tongue;







Figure 5.3 Msx-2 expression in the +/+ and Sey/Sey embryos at days 13, 14 and 15 p.c. (see preceding page
for legend).
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Chapter 6: The effect of retinoic acid (RA) on Pax6 expression following in vitro treatment on
gastrulating chick embryos
6.1 Introduction
6.1.1 Aim of this chapter
The aim of this chapter is to investigate the effect of all-rrans-retinoic acid (RA) on Pax6 expression
following its treatment on the gastrulating chick embryos. Chick embryos at Hamburger-Hamilton
stage 4 were treated in vitro with RA at concentrations ranging from 1 x 10"8 M to 5 x 10"5 M.
Following RA treatment, the embryos were examined and Pax6 expression was investigated by in situ
hybridization on wholemounts. All the technical details are described in chapter 2 (section 2.8, pages
110- 111).
6.1.2 Rationale for investigating the effect of RA on Pax6 expression
Several lines of experimental data suggest that RA might regulate Pax6 expression: (1) Deficiency of
maternal vitamin A (the metabolic precursor of RA) causes a variety of abnormalities, including
micropthalmia, that are also seen in the Sey/+ mice (Hale, 1937; Wilson et al., 1953; Sporn et al., 1994;
Blomhoff, 1994; Chambon, 1994). Micropthalmia can be prevented by supplementing the maternal
vitamin-A deficient diet with RA (Howell et al., 1964; Blomhoff, 1994). (2) Many Pax-6-expressing
areas overlap with sites where endogenous RA is present. For example, both Pax6 transcripts (see
chapter 4) and endogenous RA (Hogan et al., 1992; Chen et al., 1992) are present in Hensen's node and
both are implicated in the development of eye and brain. (3) Pax6 expression falls into the areas where
high or low doses of RA (or its precursor) can cause abnormalities. In vitamin A-deficient quail
embryos, for example, the segmentation of rhombomeres 4-8 (where Pax6 is expressed) is disrupted
(Maden et al., 1996). (4) Expression of some other Pax genes, for example AmphiPaxl (Holland and
Holland, 1996) and Pax2 (Zhang et al., 1996), is affected by RA. In light of the above mentioned
experimental data, the effect of RA treatment on Pax6 expression in the early chick embryo is
investigated.
6.2 Results
The results are shown in table 6.1 and in figures 6.1 - 6.8 at the end of this chapter. The effects of RA
treatment on early chick embryos are mainly in the developing head, heart, and neural plate, with some
malformations in the developing somites (see table 6.1). Malformations are examined both
macroscopically and microscopically.
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6.2.1 Macroscopic effect of RA treatment
6.2.1.1 Effect on the head development
RA treatment on the gastrulating chick embryos causes a variety of abnormalities in the rostral region of
the embryos, including (1) condensed "heads" that are shorter than untreated controls (see figure
6.1.A; B), (2) formation of multiple bubble-like structures that are presumably derived from head
neuroectoderm (for examples, see figures 6.1.C, D, E; 6.6.a, c and 6.7.a), (3) complete absence of head
formation (see figure 6.3.c), and (4) formation of strip structures (see figures 6.8.a, b, c) that are
presumably resulted from hyperplasia of the neuroectoderm. These abnormalities are due to the effect
of RA treatment, as no comparable malformations are commonly found in the controls (see table 6.1).
Specific effects on the fore-, mid-, or hindbrain were not distinguishable in most cases, since most of
the head abnormalities occurred before the gross morphological subdivisions on the brain were
distinguishable (for example, see figures 6.1.B, C, D, E). The abnormalities were therefore counted
together without distinguishing which specific part (or parts) of the brain was affected. In a few cases,
however, specific effects on the fore-, mid- and hindbrain were seen. In figure 6.2.B, for example, the
RA-treated embryo exhibited a smaller, underdeveloped forebrain as compared to the control (figure
6.2.A), whilst its midbrain and hindbrain were not formed.
6.2.1.2 Effect on heart development
RA treatment lead to the enlargement and bifurcation of hearts, as well as the absence of heart
formation in a substantial amount of embryos (see table 6.1). Typically, the heart enlargement or
bifurcation were accompanied by the condensed malformation as illustrated in figure 6.1 .A. In most of
the cases when multiple, bubble-like structures were found, no heart was formed. Interestingly, in 3
cases (1 in group III and 2 in group IV) when no head was formed, the embryos maintained a beating
heart without enlargement or bifurcation.
6.2.1.3 Effect on neural plate development
The neural plates following RA treatment exhibited zigzag malformation (see figure 6.3.A), as well as
abnormally short or retarded formations (figure 6.3.B). In 3 specific cases (1 in group I and 2 in group
II), complete loss of one side of the neural plate (or neural tube) together with the absence of
somatogenesis on the same side were found (see figure 6.3.C).
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6.2.1.4 Effect on somite development
RA-treated embryos exhibited somites of smaller size (see figure 6.2.B), as well as bilateral (for
example, see figures 6.3.B, C; 6.1.D, E) or unilateral (see figure 6.3.C) absence of somitogenesis.
6.2.2 Dosage-dependent, differential effect of RA treatment in different regions
RA treatment caused dosage-dependent, differential effect in different regions. As the concentrations of
RA were increased, the percentage of abnormalities in the head region became higher (see Table 6.1).
Head abnormalities constituted 3 out of 22 cases of abnormal embryos following RA treatment in
Group I, but increased to 11 out of 13 cases in Group VI. The increase of head abnormalities was
mainly due to more formation of 'multiple bubble-like structures' which amounted to 62 % (8/13) of the
abnormal embryos in the experimental Group VI, whereas none was found in Group I and II. The
percentage of condensed 'heads' increased from 14 % (3/22) in Group I to 58 % (14/24) in Group III.
The percentage of heart abnormalities did not change as much as compared to those in the head. Heart
abnormalities ranged from 16/22 (Group I) to 20/24 (Group III), and to 13/13 in Group VI.
The percentage of neural tube abnormalities decreased as the concentrations of RA were increased. A
total of 18 % (Group I) - 58 % (Group II and Group III) decreased to 8 % (Group VI) - 9 % (Group V).
6.2.3 Microscopic effect of RA treatment
A total of 24 embryos out of all treated abnormal embryos (7, 3, 3, 5, 4, and 2 embryos from Groups I
to VI respectively) were sectioned and stained for histological analyses. Results are described below.
6.2.3.1 Hyperplastic effect on the neuroectoderm and suppresive effect on the mesoderm
Hyperplasia was found in the neuroectoderm of most (18/24) of the embryos sectioned for histological
analyses. The hyperplastic effect was seen in the head as well as the trunk region (see figures 6.4.B, D).
Gross morphological malformations were commonly accompanied by hyperplasia in the
neuroectoderm, but this is not always the case. In figure 6.2.B, for example, the head neuroectoderm
exhibited underdevelopment instead of hyperplasia.
The effect of RA treatment on the mesodermal cells was suppressive in all (24/24) embryos that were
sectioned for histological analyses. The numbers of mesodermal cells were reduced in the RA-treated
embryos as compared to those in the controls. The reduction occurred in the head region (see figure
6.4), as well as in the trunk region (see figure 6.5).
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6.2.3.2 Enlargement of the dorsal aorta and dispersion of the somitic cells
Among the 24 embryos that were sectioned and analysed, a primitive vascular system was seen in 16 of
them. Enlargement of the dorsal aorta was seen in all (16/16) the analysed embryos that developed a
primitive vascular system (see figures 6.2 B; 6.5.B). In some embryos, the dorsal aortas were so
enlarged that they took up the space where the surrounding mesodermal derivatives should be (see
figure 6.5.B).
Somitogenesis was also affected by RA treatment. Somitic cells were dispersed, leaving a non-
aggregated somitic formation with a cavity in the centre (see figure 6.5.D). Somitic abnormalities were
often concurrent with disturbance of neural tube closure (not shown).
6.2.4 Pax6 expression following RA treatment
At least 4 embryos from each RA-treated experimental group were used to study Pax6 expression
following RA treatment. The results are summarised in the following sections.
6.2.4.1 Pax6 expression is maintained after RA treatment
In all RA-treated embryos that were investigated by wholemount in situ hybridization, Pax6 expression
was maintained and the level of expression appeared roughly equivalent to that in the controls. This
maintenance of Pax6 expression was unaffected by different concentrations of RA treatment. In the
head region, Pax6 expression is seen in the neuroectoderm, although it is less obvious in the surface
ectoderm (see figures 6.6.b, d). Pax6 transcripts are also detected in the trunk region in the
presumptive neuroectoderm, although the morphology can be very abnormal (see figures 6.8.a, c).
6.2.4.2 Pax6 is expressed in the multiple bubble-like structures in the RA-treated embryos
Pax6 expression is found in the multiple bubble-like structures, presumably within the cephalic region
in the RA-treated embryos (see figures 6.6; 6.7). The bubble-like structures exhibit double (for
example, see figures 6.6.a, b), triple (see figures 6.6.C, d; 6.7.a, b), as well as more complicated (figure
6.7.d) or simplified (figure 6.7.c) circular formations. Pax6 appears to be expressed in ail the varieties
of the bubble-like structures.
6.2.4.3 Pax6 is expressed in the strip structures in the RA-treated embryos
Pax6 is also expressed in the strip structures that are found in the RA-treated embryos (see figures 6.8.a,
b). The strips of Pax6 expression are continuous with the more caudal areas of Pax6 expression in the
trunk region.
255
6.2.4.4 Pax6 expression in the trunk neural plate
Pax6 expression is detected in the trunk region of the RA-treated embryos. Expression is located in the
the neural plate, when it exists (see figure 6.8.a). Malformations in the trunk neural plates, for example
the zigzag structures, do not affect Pax6 expression (see figures 6.8.c, d).
6.3 Discussion
This study investigates the effect of RA treatment on wholemount chick embryos during their
gastrulation in vitro, in order to determine whether Pax6 expression can be regulated by RA. Results
show that a variety of abnormalities can be induced by RA treatment during gastrulation, which has not
been previously reported and has many implications in the roles of RA during chick embryogenesis.
Since the effect of RA on Pax6 is the main goal for this study, this discussion concentrates on the data
that are related to Pax6 regulation or function. Other data will be referred only when necessary.
6.3.1 Concentrations of RA used in this study as compared to endogenous RA sources
The concentration of endogenous RA in the limb bud of stage 21 chick embryos has been reported to be
between 1.9 - 4.9 x 10"8 M (Thaller and Eichele, 1987). In another report, with a different assay
method, RA concentration was reported to be 2.1 x 10"9 M in limb buds at stage 23-24, and 1.3 - 1.5 x
10"9M in Hensen's nodes at stage 4 -6 (Chen and Solursh, 1992). As all the embryos used in our study
were treated with RA at stage 4, the concentrations for all six experimental groups were higher than
those of endogenous sources when compared to that of stage 4 -6 Hensen's node. The concentrations of
RA used in this study were, however, lower than or similar to those previously used under in vitro
systems by other authors (Dhouailly and Hardy, 1978; Osmond et al., 1991; Chuong et al., 1992;
Dersch and Zile, 1993). They were therefore regarded as suitable for the purpose of this study.
6.3.2 Pax6 expression supports the neuroectodermal origin of the multiple, bubble-like structures
Multiple, bubble-like structures in the presumptive cephalic region were found in the RA-treated
embryos. The multiple, bubble-like structures are likely derived from surface ectoderm or
neuroectoderm, since the two tissues constitute most of the early cephalic region and are the only tissues
visible on wholemount preparations. There are, however, two points that favour the neuroectodermal
origin: (1) The structures are continuous with the neural plate in the trunk region (see figures 6.1.C - E),
suggesting that they are derived from neuroectoderm. (2) In many cases, Pax6 is expressed in the
bubble-like structures in a way similar to that observed in the neuroectoderm of the controls. In figure
6.6.d, for example, the circular structures '1' and '3' are Pax6-expressing and located bilaterally in
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relation to the midline, resembling by their morphology and position the optic vesicles in the normal
embryos.
6.3.3 Strip structures in the RA-treated head are rhombomeric units as suggested by Pax6
expression
Strip structures that are presumably derived from head neuroectoderm are found in the RA-treated
embryos in this study. Pax6 is expressed in all of the strip structures, which are continuous with Pax6-
expressing areas in the more caudal part of the brain, as well as in the trunk neural plate (figures 6.8.a;
b). Thus, the pattern of Pax6 expression indicates that the strip structures are derivatives of the head
neuroectoderm. Pax6 expression also suggests that they are rhombomeric units, in that only r3 and r5
in the developing chick brain exhibit strip pattern of expression (see figure 4.5.b).
The strip structures could be derived from anteriorization of the whole rhombencephalon with repetitive
formation of r3 or r5 or both, whilst the area of forebrain is reduced. RA induced anteriorization of the
expression of genes or gene families has been reported in a wide range of tissues and the developing
nervous system seems to be a primary target for RA-induced teratology (Leonard et al., 1995). In
particular, the hindbrain is most susceptible to the effects of exogenous RA (Holder and Hill, 1991;
Morris-Kay et al., 1991; Marshall et al., 1992; Kessel, 1993). The anteriorization involves
respecification of a Hox code, which then leads to respecification of regional identity (Krumlauf, 1993).
Once the regional identity is respecified, cell fate may be changed with a concurrent loss of the
forebrain, which has been demonstrated in the Xenopus (Agarwal and Sato, 1993). Higher doses of RA
lead to progressively more severe truncations in the Xenopus brain (Agarwal and Sato, 1993).
Results in this study demonstrate that RA can also induce anteriorization of Pax6 expression as a
concurrent event with the anteriorization of rhombomeric units.
6.3.5 Effect of RA on Pax6 expression ~ direct or indirect ?
Although various malformations were observed in a certain proportion in the RA-treated experimental
groups (see table 6.1), Pax6 expression is maintained in all embryos analysed by wholemount in situ
hybridization. Even in the highly twisted zigzag structures of the trunk neural plate or in the bubble¬
like malformations of the cephalic region, Pax6 expression can still be detected. The maintenance of
Pax6 expression suggests that Pax6 is unlikely to be a direct target of RA, neither is it likely to be
involved in the RA regulatory pathways.
One needs to be cautious, however, because Pax6 may be upregulated or downregulated in a way that is
beyond the limits of in situ hybridization, i.e. Pax6 expression may have been modified in a subtle way
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that can not be detected by in situ hybridization. Minor upregulation, downrgulation, expansion,
reduction, or displacement of Pax6 expression are still possible.
The regulation of RA activities is complicated. For a long time an operational explanation for the
action of RA remained elusive. RA regulation involves retinoid receptors (RARS and RXRS ) and
retinoid binding proteins (CRABPS and CRBPS) (reviewed by Underhill et al., 1995). Factors that
influence retinoid receptor activity include ligand availability, receptor dimerization, inhibitors of
receptor function, factors that promote retinoid receptor-mediated transcativation, post-translational
modification of the receptors, as well as configuration and sequence of the DNA binding site (Underhill
et al., 1995). These factors may at a certain level (or levels) affect Pax6 expression, either directly or
indirectly.
RA has been reported to be involved in the regulation of Sonic hedgehog (Shh) (Riddle et al., 1993;
Chang et al., 1994), members of the transfoming growth factor (3 (TGF-(3) family such as TGF-J31,
TGF-J32 (Mahmood et al., 1992), BMP-2, BMP-4 (Rogers et al., 1992; Francis et al., 1994), and
members of Hox genes (Krumlauf, 1993; Mavillo, 1993; Langston and Gudas, 1994), as well as cellular
and neural adhesion molecules (Husmann et al., 1989; Jonk et al., 1994). These RA-regulated genes,
growth factors, or extracellular matrix will certainly interact with Pax6 function, at least in the context
of local histogenesis or organogenesis. Shh, for example, has been suggested to either directly or
indirectly inhibit the expression of Pax6, while the optic stalks are partitioned with the retinal tissues
(Macdonald et al., 1995). Thus, a possible indirect regulation of RA on Pax6 expression can not be
excluded.
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Figure 6.1 Wholemount preparations of the RA treated embryos showing the main effects of RA on
the head and on the heart. (A) At 2 x 10"8 M, some treated chick embryos are able to develop to
stages 12-13 (left), showing typical abnormalities of head condensation and heart enlargement as
compared to the control (right). The neural tube of the treated embryo is noticeably shorter than the
control. (B) A condensed head abnormality. The embryo is retarded at stage 8+ as compared to the
controls which are at stages 11 - 12. Note that the neuroectoderm is hyperplastic and the 'zigzag' is
formed (arrows). (C - E) Various multiple, bubble-like structures at rostral end of the RA-treated
embryos. The bubble-like structures are continuous with the neural plate, indicating that they are
derivatives of the neuroectoderm. In (A), the slit in the trunk region of the RA-treated embryo (left)
is an artefact. Magnifications: A, X 25; B - E, X 60. Abbreviation: h, heart.
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Figure 6.2 Macroscopic
effects of RA treatment at
concentration 2 x 10"8 M on
the head, the heart, and the
somites. The treated
embryo (B) develop to a
comparable stage as the
control (A), but without the





the dorsal aorta, and
formation of smaller
somites. Abbreviations: h,
heart; s, somite; da, dorsal
aorta; uht, unfused heart
tube; pro, mes, and rho,
same as in figure 5.1.
Magnifications: A - B, X
40.
Figure 6.3 Various neural
tube abnormalities found in
wholemount embryos
following RA treatment
(concentrations: A, 5 X 10"
6
M; B and C, 5 X 10"5 M).
(A) the 'zigzag' shape of
neural tube. (B) clumps of
neuroectodermal tissues
without indication of the
somitic tissue aggregations.
(C) complete loss of one
row of somites in one side
of the the neural tube.
Note also lack of head
formation in (B) and (C).
Magnifications: A - C X
60.
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Figure 6.4 Transverse sections showing the hyperplastic effect on the neuroectoderm and
suppresive effect on the mesodermal cells following RA treatment at 1 X 10~8 M (B and D). A and C
are control embryos. The arrows indicate the more thickened neuroectoderm in the head and in the
trunk regions of the RA-treated embryos, as compared to the controls. Note in B and D that few
mesodermal cells could be found in the treated embryos. Abbreviations: m, mesodermal cells; ov,
optic vesicle; h, heart. Magnifications: A - D, X 120.
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Figure 6.5 Transverse sections showing enlargement of the diameters of the dorsal aortas in the
head region following RA treatment at 1 X 10"8M (A, C, controls; B, D, RA-treated embryos). In B,
note that the dorsal aortas are enlarged as compared to the controls. In D, note that the somitic cells
were dispersed, surrounding cavities (arrow and "c"-marked areas) in the trunk region of the
embryo following the same treatment as for B, in contrast to the aggregated somitic cells in the




Figure 6.6 Examples of RA-treated embryos showing abnormalities and Pax6 expression, (a) and (c)
are wholemount preparations without staining; (b) and (d) are preparations of wholemount in situ
hybridization with chick Pax6 riboprobe. (a) An embryo treated by RA at 2 x 10"6 M. Note that the
presumptive head neuroectoderm is hyperplastic and forms two circular, bubble-like structures.
Different degrees of zigzag malformations can be seen in the trunk neural plate, (b) Another embryo
exhibiting similar abnormalities to those in (a). Pax6 expression can be seen in the circular, bubble-like
structures, (c) An embryo treated by RA at 5 x 10"6 M shows hyperplasia in the presumptive cephalic
and trunk neuroectoderm. Three circular, bubble-like structures are formed in the cephalic region, (d)
Another embryo showing similar abnormalities to those in (c). Pax6 expression is detected in the three
circular, bubble-like structures. Note that the two lateral bubbles (1 and 3) are morphologically









Figure 6.7 Examples of RA-treated embryos showing abnormalities and Pax6 expression, (a) is a
wholemount preparation without staining; (b), (c), and (d) are preparations of wholemount in situ
hybridization with chick Pax6 riboprobe. (a) Three circular, bubble-like structures are formed in an
embryo treated with RA at 5 x 10"6 M. Note that hyperplasia in the presumptive neuroectoderm can be
been in the cephalic and trunk region, (b) Another embryo exhibiting similar abnormalities to those in
(a). Pax6 expression can be seen in the circular, bubble-like structures, particularly in 1 and 3. (c) An
embryo treated by RA at 5 x 10~5 M. Pax6 transcripts are detected along the presumptive head
neuroectoderm. Note that little or no trunk neural plate is developed, (d) Another embryo treated by
RA at 5 x 10"5 M. The embryo exhibits a condensed malformation enclosed by a single circular
structure, with a bubble-like formation attached rostrally. Pax6 expression is seen in the lateral margins
of the circular structure and the expression is continuous caudally. (Magnifications: a and b, X 60\ c, X






Figure 6.8 Examples of RA-treated embryos showing abnormalities and Pax6 expression, (a) - (d) are
preparations of wholemount in situ hybridization with chick Pax6 riboprobe. (a) An embryo treated
with RA at 5 x 10"6 M showing strips (see arrows) of P«jc6-expressing structures in the cephalic region.
Note that Pax6 expression in the cephalic region is continuous with that in the zigzag neural plate in the
trunk region, (b) The same embryo as in (a) viewed under higher magnification. The strips are clearly
seen (arrows), (c) Another embryo treated by RA at 5 x 10"6 M. The embryo is developmental^
retarded. Pax6 expression is maintained throughout the presumptive head and trunk neuroectoderm
(see arrows), (d) Another example of RA-treated (2 x 10~6 M) embryo. The embryo does not exhibit
apparent fore-, mid-, or hindbrain divisions. Instead, it shows continuous zigzag malformation along
the anterior-posterior axis of the neural plate. Pax6 expression is seen within the dorsal neural plate
(arrows), (magnifications: a and c, X 60; b, X 180\ d, X120 approximately).
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Chapter 7: General discussion
This chapter aims (1) to give an overall review of this study, which will be more comprehensive than
the abstract, and (2) to describe some future experiments.
7.1 Summary of this study
In the beginning of this study, the overall plan was to start with establishing Pax6 expression in the
mouse, as well as in the chick. The data of Pax6 expression would then be used as a baseline
information for further investigation. However, reports about Pax6 expression in the mouse had been
published extensively before and during the course of this study (Walther and Gruss, 1991; Goulding et
al., 1993; Turque et al., 1994; Stoykova and Gruss, 1994; Grindley et al., 1995; Stoykova et al., 1996;
Quinn et al., 1996; Warren and Price, 1997; Mastick et al., 1997). Pax6 expression in the chick had
also been published extensively (Li et al., 1994; Turque et al., 1994; Heyman et al., 1995; Simon et al.,
1995; Buxton et al., 1997). Despite intensive interest and attention from so many developmental
biologists in recent years, Pax6 has been such a versatile and important gene during vertebrate
development that it allowed me to exploit further on gene expression patterns.
Results of this study demonstrated that Pax6 was expressed in higher centres of the visual and the
olfactory nervous systems in the mouse. This was shown by the identification of many Paxb-expressing
neural nuclei in the developing brain that has not been previously analysed in detail. Pax6 expression
was detected, along the visual pathway, in the neural retina, optic nerve, pretectum, superior colliculus,
pulvinar, dorsal and ventral lateral geniculate nucleus and other nuclei that had been implicated in
visual connections. Within the olfactory nervous system, transcripts of Pax6 were found in the
olfactory and vomeronasal epithelium, main and accessory olfactory bulb, anterior olfactory nucleus,
precommisural hippocampus, piriform and endopiriform cortex, as well as olfactory and vomeronasal
amygdaloid areas.
This study also showed that developmental restriction has been a common theme for Pax6 expression in
the mouse, giving many examples that were not formerly described. The examples of developmental
restriction included Pax6 expression in the lens ectoderm, neural retina, telencephalic neuroepithelium,
pontine and medullary neuroepithelium, optic stalk, and thalamic neuroepithelium. Furthermore,
developmental expansion of mouse Pax6 expression was shown in the cerebral cortex, cerebellar
neuroepithelium, surface layer of superior colliculus, and in the olfactory bulb. Both developmental
restriction and expansion were correlated with normal developmental events, as well as previously
published mutant phenotypes found in the Sey/Sey or Sey/+ mice. Thus, Pax6 was implicated in the
proliferation and migration of forebrain neuroblasts, as well as in the neuromeric regionalization. In the
neural retina, in addition to proliferation and migration, Pax6 was further implicated in the process of
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axonal initiation and connection. Pax6 was also implicated in the process of lens initiation and lens cell
proliferation.
Expression data and mutant phenotypes in different species were compared in an effort to shed new
insights on the functions of Pax6. The species for comparision included Drosophila, nematode,
zebrafish, Xenopus, urodele, quail, chick, mouse/rat, and human. Pax6 has been well documented
across species as a crucial gene in eye development. In the pigmented neural retina and rim of the optic
cup, however, changes were found in Pax6 expression and mutant phenotypes across species,
suggesting that the function of Pax6 might have been altered evolution within both tissues. In the
developing brain, Pax6 expression domains appeared to be narrowed through evolution. Thus, it was
suggested that the roles of Pax6 had been changed from 'for specification of sense-organ identity'
(Zhang and Emmons, 1995) or 'for head-region specification' (Chisholm and Horvitz, 1995) in
primitive species to become involved in more specialized and localized functions in higher mammals.
In the spinal cord, Pax6 has been consistently expressed across species. In the pituitary, pancreas, and
salivary gland, Pax6 expression maintained a certain degree of conservation through evolution. Areas
of Pax6 expression, therefore, had been generally maintained across species in concordance with the
conservation of paired domain DNA sequence through evolution. There were, however, two deviations
of Pax6 expression in comparison with the Sey/Sey mutant phenotypes. Abnormalities were found in
the Sey/Sey maxillary process, which involved the head neural crest cells and the upper incisor teeth;
both were confirmed without Pax6 transcripts in this study. The deviations reflected a complicated
hierarchy of gene activities between Pax6 and the other genes, as well as the interactions between Pax6-
expressing and non-Pax6-expressing cells.
Pax6 expression in the chick was also investigated, with particular interest in the eye and the olfactory
epithelium after Hamburger-Hamilton stage 14, which had not previously been reported. Results of this
study confirmed previuosly reported data and, in addition, established that chick Pax6 was expressed in
the olfactory epithelium, the eye region, the brain, and the head surface ectoderm after Hamburger-
Hamilton stage 14. Furthermore, a transient chick Pax6 expression in Hensen's node before stage 9 and
the presence of Pax6 transcripts in cell populations flanking rhombomeres 3 and 5 were found. Pax6
was speculated to be involved in the migration of hypoblasts that played a part in establishing anterior-
posterior axis during early embryogenesis. Pax6 was also implicated in rhombomeric and trunk
neurogenesis.
Chick Pax6 expression has been described to correlate with lens determination and differentiation in
vivo, in reference to data found in the Xenopus (Li et al., 1994). This study investigated directly
whether chick Pax6 expression was correlated with lens differentiation, by culturing Paxd-expressing
and non-Paxd-expressing head surface ectoderm in vitro. It was shown that the lens can differentiate
from non-Paxd-expressing head surface ectoderm, while Pnxd-expressing head surface ectoderm did
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not always give rise to a lens. When lens differentiated in culture, Pax6 was always expressed. The
results indicated that Pax6 expression was necessary for lens differentiation in vitro.
In light of the deviation between Pax6 expression and mutant phenotypes found in the Sey/Sey
maxillary process, a preliminary investigation on the formation of supernumerary upper incisor teeth
was conducted. In particular, the expression of Msx-1 and Msx-2 were examined in order to give some
explanations for the abnormalities. The results showed that both Msx-1 and Msx-2 were expressed in
the Sey/Sey maxillary process. Patterns of Msx-1 and Msx-2 expression did not differ between the
Sey/Sey and the wildtype mice, although areas of expression were increased in the Sey/Sey embryo as
the number of upper incisors was increased. Furthermore, the level of Msx-1 expression appeared to
increase ubiquitously in the Sey/Sey mice. Results of this study also showed some details of the Sey/Sey
mutant phenotypes that had not previously been reported. This included the non-synchronized
formation of upper incisor primordia and the non-corresponding number of dental papilla in relation to
the enamel organ. Msx-1 expression pattern supported the view that the rod-like cartilaginous structure
in the Sey/Sey mice has been derived as a protrusion from the base of the skull.
Finally, the effects of all-frarcx-retinoic acid (RA) on Pax6 expression in gastrulating chick embryos
were investigated, using an in vitro system. Macroscopic effects of RA treatment were shown by
abnormalities in the head, heart, neural tube, and somites. Microscopically, RA treatment had a
hyperplastic effect on the neuroectoderm and a suppresive effect on the mesoderm. RA treatment also
caused enlargement of the dorsal aorta and dispersion of the somitic cells. Results of in situ
hybridization on wholemount embryos showed that Pax6 expression was not switched off following RA
treatment, although the morphology of RA-treated embryos could be very abnormal. While the results
indicates that Pax6 expression was less likely under the direct regulation by RA, the possibility of an
indirect regulation could not be excluded.
7.2 Future experiments
As introduced on page 1 of this thesis, any topic involved with "gene" and "development" can be
approached starting with either phenotypes (genetics) or genotypes (reverse genetics). For
convenience, I will address future experiments in terms of these two categories. The nature of any
scientific research is always the same — more questions are produced while in the process of solving a
single question. Pax6, being such a versatile and crucial gene during development, is liable to produce
more questions out of the scope of this study. I will therefore propose only a limited number of future
experiments that are either revelant to this study or interesting to me. Some of them have been
described in previous chapters, but they can be properly put in this chapter for a general discussion.
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7.2.1 Starting with "phenotypes"
Many mutant phenotypes of the Sey/Sey or Sey/+ mice have been described before and during the
course of this study, such as those in the eye and nose (Hogan et al., 1986; 1988), in the maxillary
process (Hill et al., 1991; Kaufman et al., 1995), and in the brain (Schmahl et al., 1993; Warren and
Price, 1997; Mastick et al., 1997). These previously reported phenotypes emphasize mostly on gross
morphogenesis. Phenotypes in morphology, however, should not be limited by the level of
magnification or by the technique of staining. For example, efforts have been made to locate axon
projections by Linder's silver staining in the wildtype mice in order to compare with normal Pax6
expression patterns. The same analyses should be performed in the Sey/Sey and Sey/+ embryos to add
to more mutant "phenotypes". Since this study shows that Pax6 is expressed along the visual and the
olfactory pathways in the wildtype mice, Golgi or Nissl preparations may reveal differential distribution
of revelant neural nuclei in the Sey/Sey mice. Another example is to use double stain technique (tracing
axons with Dil stain and using an anti-Pax6 antibody for immunochemical stain), which has been
performed by Mastick et al. (1997) for correlating Pax6 expression with local axonogenesis.
Furthermore, differential morphogenesis between the Sey/Sey mice and their littermates may be
extended to cellular or subcellular levels.
In addition to changes in morphology, there are plenty of other "phenotypes" that can be explored. For
example, neurophysiological functions such as alteration in transduction of electric pulse or in
thresholds for action potential may change in the Sey/Sey visual or olfactory pathways. Chimeric mouse
studies, as demonstrated by Quinn et al. (1996), offer a good approach to see the effect of different
proportions of Sey/Sey cells on the development of local tissues. Since current data concentrate mainly
on the prosencephalon, researchers interested in cellular proliferation may find chimeric mouse studies
useful in demonstrating Pax6 functions in the formation of olfactory bulbs, which contain intensvie
Pax6 expression and do not exist in the Sey/Sey mice.
7.2.2 Starting with "genotypes"
Reports revelant to Pax6 "genotypes" have also been published extensively before and during the
course of this study. Most commonly, orthologous genes of Pax6 in other species are cloned and
characterized by their DNA sequence and patterns of expression (see table 3.1 for examples). Ectopic
Pax6 expression causes ectopic formation of optic structures, which demonstrates that Pax6 is a crucial
gene for eye formation (Haider et al., 1995). Overexpression of Pax6 leads to oncogenesis, suggesting
that Pax6 is involved in cellular proliferation (Maulbecker and Gruss, 1993). These are examples of
starting with "genotypes", as described on page 1 of this thesis.
My interests are in the regulation of Pax6 expression. Although this study shows that Pax6 expression
is not switched off following RA treatment, an indirect effect of RA on Pax6 expression can not be
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excluded. This is due to the limitation of in situ hybridization used in this study, and probably is also
due to the complicated regulation of Pax6 expression. Pax6 has been implicated in a hierarchy of
genes, including Shh (Macdonald et al., 1995), Ets (Plaza et al., 1994), Lim-1, and Gsh-1 (Mastick et
al„ 1997). In vitro studies shows that growth factors such as activin A, bFGF, NGF, and BDNF can
regulate Pax6 expression (Yamada et al., 1994; Kioussi and Gruss, 1994). Some of these genes or
growth factors may be regulated by RA. For example, Pax6 expression may be altered through
regulation of Shh by RA, according to data published by Riddle et al. (1993) and Macdonald et al.
(1995).
The effect of RA on Pax6 expression may be investigated using a microexplant culture system. The
system has been successfully applied in culturing brain tissues with specific antibodies to detect axons
or glial cells, in an effort to differentiate the role of Pax6 in axonogenesis or gliagenesis (Veronica van
Heyningen, personal communication). The system may be modified by adding RA, growth factors, cell
adhesion molecules, extracellular matrix, and transcripts of genes in different combinations to study the
complicated hierarchy that regulates Pax6 expression. For example, the Sey/Sey maxillary process
provides interesting prospects in elucidating the interactions among Pax6, Msx-1, Msx-2, BMP-2, BMP-
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Appendix
A. List of Abbreviations
ABC avidin-biotinylated enzyme-complex
bp base pair











PBT phosphate buffered saline with 0.1% Tween 20
PCR polymerase chain reaction
rpm revolutions per minute
SDS sodium dodecyl sulphate







Tween 20 polyoxyethylenesorbitan monolaurate
BCIP 5-bromo-4-chloro-3-indolyl phosphate
B. Recipes and preparations:
1. LB (Luria-Bertani) medium (from Sambrook et al., 1989):
To 950 ml H20 add:
10 g bacto-tryptone
5 g bacto-yeast extract
10 g NaCl
Adjust to pEl 7.4 with 1 N NaOH
Add HjO to 1 liter; autoclave to sterilized
2. Terrific Broth (from Tartof and Hobbs, 1987):
To 900 ml of deionized H,0, add:
bacto-tryptone, 12 g
bacto-yeast extract, 24 g
glycerol, 4 ml
Shake until the solutes have dissolved and sterilize by autoclaving for 20 minutes at 15 lb/sq. in. on
liquid cycle. Allow the solution to cool to 60° C or less, and then add 100 ml of 0.17 M KH2P04, 0.72
M K,HP04
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3. Ehrlich's haematoxylin (from Culling et al., 1985):
Haematoxylin 6 g
Absolute alcohol 300 ml
Distilled water 300 ml
Glycerol 300 ml
Glacial acetic acid 30 ml
Potassium alum- to saturation 10 - 14 g
The haematoxylin should be fully dissolved in the alcohol before the other ingredients are added.
4. Solutions for large-scale plasmid preparation (from Sambrook et al., 1989):
Solution I:
50 mM glucose
25 mM Tris.Cl (pH 8.0)
lOmM EDTA (pH 8.0)
Prepared in batches of 100 ml, autoclaved for 15 minutes at 10 Ib/sq. in. on liquid cycle, and stored at
4° C.
Solution II:
0.2 N NaOH (freshly diluted from a 10 N stock)
1% SDS
Solution III:
5 M potassium acetate 60 ml
glacial acetic acid 11.5 ml
H,0 28.5 ml
The resulting solution is 3 M with respect to potassium and 5 M with respect to acetate.
5. TAE (tris-aceft&te buffer), 40 X:
To make 1 liter:
Tris base (1.6 M) 193.6 g
Na acetate.3 H,0 (0.8M) 108.9 g
EDTA-Na, .2 H20 (40 mM) 15.2 g
pH to 7.2 with acetic acid; add water to make 1 liter
6. TE (Tris-EDTA) buffer:
To make 100 ml:
Tris, lOmM, pH 7.4 0.5 ml of 2 M stock
0.1 mM EDTA, pH 8.0 20 ul of 0.5 M stock
Add H,0, 99.3 ml; store at room temperature
7. STE buffer:
To make 100 ml:




8. SSC buffer, 20 X:
To make 1 liter:
20 ul of 0.5 M stock
0.2 ml of 5 M stock
NaCl, 3 M 175.3 g
Na^Citrate. 2 H20, 0.3 M 88.2 g
water 800 ml
Adjust pH to 7.0 with 1 M HC1; add H20 to 1 liter
9. SSPE buffer, 20 X:
To make 1 liter:
NaCl (3 M) 175.3 g
NaH2P04. H20 ( 0.2 M) 27.6 g
EDTA-Na, (0.02 M) 40 ml of 0.5 M EDTA stock solution
Add 800 ml water; add 10 N NaOH to pH to 7.4 and add water to make 1 liter
Sterize by autoclaving; all components will dissolve into solution in autoclave.
10. Proteinase K buffer, 20 X:
To make 100 ml:
1 M Tris, pH 7.5 50 ml 2.0 M stock
0.1 M EDTA 20 ml 500 mM stock
Add distilled water to 100 ml.
11. 2.0 M TEA (Triethanolamine) :
To make 100 ml:
Add 26.6 ml TEA to 50 ml distilled water. pH to 8.0 by 10.0 M HC1 and then top up to 100 ml.
12. In situ hybridization mix for sections:
To make 10 ml:
Deionized formamide (Sigma) 5 ml
20x SSPE 1 ml
Denhardt's solution, 100 x 0.5 ml
50% dextran sulphate (in depc-treated water) 2.0 ml
tRNA (yeast) 0.2 ml of 10 mg/ml stock
SDS 0.5 ml of 10% stock
depc-treated H,0 0.8 ml
13. In situ hybridization mix for wholemounts:
To make 10 ml:
Deionized formamide (Sigma)





50 ul of 10 mg/ml stock
1.0 ml of 10 % stock
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Heparin 5 ul of 100 mg/ml stock
Mixed well and stored in -20° C; thawed and mixed well before use.
14. PBT (Phosphate Buffered Saline with 0.1% Tween 20):
To make 1 litre:
PBS, 10 X 100 ml
Distilled water 900 ml
Tween 20 1 ml
15. PBS (Phosphate Buffered Saline), 10 X:




Add water to make 1 litre; sterilize by autoclaving.
16. Denhardt's solution, 100 X:
To make 50 ml:
Polyvinylpyrolidone (PVP) 1.0 g
Bovine serum albumin (BSA) 1.0 g
Ficoll 400 1.0 g
Top up with distilled water to make 50 ml. Sterilize by filters; store at 4° C and mix well before use.
17. Ca++, Mg++ free Chick Ringer's solution:
To make 100 ml:
NaCl 0.9 g
KC1 0.42 g
Add distilled water to make 100 ml. Autoclave before use.
18. 4 % paraformaldehyde:
To make 1 litre:
Add 40 g of paraformaldehyde powder in 900 ml distilled water in a large flask. Heat the solution to 60
° C with stirring on a hot plate. Add a few drops of 10 N NaOH to help dissolve the powder. Allow the
solution to cool down and store in - 20° C. Thaw immediately before use.
19. depc-treated water:
To make 1 liter:
Add 0.75 ml depc to a litre distilled water under hood. Shake well and sit (preferably with stirring) the
solution at room temperature under hood for at least 30 minutes. Sterilize by autoclaving.
20. NTMT:
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Freshly made before use to avoid decrease of pH.





Levamisol (Vector Laboratories, U.K.)
1.5 ml of 4 M stock
3 ml of 2 M stock
3 ml of 1 M stock
60 ul
12 drops (optional)
Add distilled water to make up 60 ml.
21. Alkaline phosphatase buffer:
Same as NTMT.
22. Colour detection buffer:
For sections:
Add 34 p.1 of NBT (4-nitro blue tetrazolium chloride) and 27 p.1 of BCIP (5-bromo-4-chloro-3-indolyl-
phosphate; also known as X-phosphate) in 75 ml of NTMT. Both NBT and BCIP are ready-to-use
solutions that are commercially available from Boehringer-Mannhein.
For wholemounts:
Add 4.5 p.1 NBT and 3.5 p.1 BCIP per ml of NTMT.
23. TESPA coated slides:
As described in section 2.4.1.
24. Pannet-Compton saline (from Stern, 1993):
Solution A:
Add distilled water to 1 liter.
Before use, mix (in order): 40 ml Solution A, 900 ml H20, and 60 ml Solution B.
25. Embryo powder:
Step 1: Homogenize embryos (12.5 - 14.5 days post coitus in the mouse; Hamburger-Hamilton stages
15 - 20 in the chick) in minimum volume of lx PBS and then add 4 volumes of ice-cold acetone, mix
and incubate on ice for 30 minutes.
NaCl 121g
K CI 15.5 g
CaCl2. 2H20 10.42 g
MgCl,. 6H,0 12.7 g
Add water to 1 liter.
Solution B:
Na.HPO,. 2H20 2.365 g
NaH2P04 2H,0 0.188 g
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Step 2: Spin the solution at 3 - 4 K rpm for 10 minutes.
Step 3: Discard the supernatant. Wash the pellet with ice-cold acetone and spin again.
Step 4: Transfer the pellet out to a filter paper. Spread and grind the pellet into fine powder and allow it
to be air-dried. The embryo powder can then be stored in an air-tight tube at 4° C.
26. TBS (Tris-Buffered Saline), 20 X:
To make 100 ml:
Tris.HCl, pH 7.4 5 ml of 1 M stock
NaCl 5 ml of 4 M stock
Add distilled water to make 50 ml.
27. Linder's silver stain solutions:
a. Buffer stock solution
2.4.6-Collidine 6.6 ml
Distilled water 450 ml
Adjust pH to 7.2 - 7.4 with 10 per cent nitric acid, and make up to 500 ml with distilled water.
b. Diluted buffer
Buffer stock 8 ml
Distilled water 92 ml
c. Silver cyanate impregnating solution
Distilled water 84 ml heated to 60° C
1% Silver nitrate 4 ml
0.38 % sodium cyanate 4 ml
0.38 % sodium cyanate 4 ml
Buffer stock solution 8 ml
d. Physical developer stock solution:
Sodium sulphite 20 g
Sodium tetraborate 4.75 g
Distilled water 450 ml
Heat the solution to about 50° C and add Gelatine 5.0 g (Belgium Gold label).
e. Physical developing working solution
Physical developer stock solution 95 ml
2 % hydroquinine 5 ml
1% silver nitrate 2 ml
Add the silver nitrate stirring constantly.
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